<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/the-healthy-enterprise" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>The Healthy Enterprise</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/the-healthy-enterprise</itunes:new-feed-url>
    <description>Hosted by Heath Fletcher, The Healthy Enterprise explores how innovation, technology, and leadership are reshaping the life sciences industry—from discovery and development to commercialization and care delivery. Each episode features candid, heart-centered conversations with founders, scientists, executives, and investors, sharing real-world experiences and insights for building resilient, future-ready organizations.

Created and Produced by Bullzeye Global Growth Partners — Let’s build it together!
</description>
    <copyright>© 2025 Bullzeye Global</copyright>
    <podcast:guid>aca3f5f4-593e-59c2-b6ef-36eaf519960a</podcast:guid>
    <podcast:locked owner="heath@bullzeyeglobal.com">no</podcast:locked>
    <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
    <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
    <podcast:trailer pubdate="Mon, 14 Apr 2025 12:57:00 -0700" url="https://media.transistor.fm/2c703c20/e41900d4.mp3" length="794208" type="audio/mpeg">The Healthy Enterprise Trailer</podcast:trailer>
    <language>en</language>
    <pubDate>Tue, 28 Apr 2026 22:18:42 -0700</pubDate>
    <lastBuildDate>Tue, 28 Apr 2026 22:19:17 -0700</lastBuildDate>
    <link>https://healthyenterprise.transistor.fm/</link>
    <image>
      <url>https://img.transistorcdn.com/TNPRCVDfe4nDQnaXnkjmAf_f0skVmmp-enU8ZJbp1lY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.jpg</url>
      <title>The Healthy Enterprise</title>
      <link>https://healthyenterprise.transistor.fm/</link>
    </image>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <itunes:category text="Business"/>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Heath Fletcher</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/TNPRCVDfe4nDQnaXnkjmAf_f0skVmmp-enU8ZJbp1lY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.jpg"/>
    <itunes:summary>Hosted by Heath Fletcher, The Healthy Enterprise explores how innovation, technology, and leadership are reshaping the life sciences industry—from discovery and development to commercialization and care delivery. Each episode features candid, heart-centered conversations with founders, scientists, executives, and investors, sharing real-world experiences and insights for building resilient, future-ready organizations.

Created and Produced by Bullzeye Global Growth Partners — Let’s build it together!
</itunes:summary>
    <itunes:subtitle>Hosted by Heath Fletcher, The Healthy Enterprise explores how innovation, technology, and leadership are reshaping the life sciences industry—from discovery and development to commercialization and care delivery.</itunes:subtitle>
    <itunes:keywords>Life Sciences, Leadership, HealthTech podcast, Digital Health podcast, Healthcare Business podcast, Medical Technology podcast, Healthcare Leadership podcast, Healthcare Marketing podcast, Healthcare Entrepreneurship podcast, Healthcare Industry Executives, AI in Healthcare podcast, Healthcare Startups podcast, Patient-Centered Care, Healthcare Strategy, Future of Medicine, HealthTech Trends, Scaling Healthcare Businesses, Telemedicine and Virtual Care, Investing in HealthTech, Healthcare Growth, HealthTech, Digital Health, Healthcare Business, Medical Technology, Healthcare Leadership, Healthcare Marketing, Healthcare Entrepreneurship, Industry Executives, AI in Healthcare, Healthcare Startups, Telemedicine &amp; Virtual Care,Investors</itunes:keywords>
    <itunes:owner>
      <itunes:name>Bullzeye Growth Partners</itunes:name>
      <itunes:email>heath@bullzeyeglobal.com</itunes:email>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>The Hidden Crisis of Medication Mismanagement with Dr. Anthony Sterns</title>
      <itunes:episode>71</itunes:episode>
      <podcast:episode>71</podcast:episode>
      <itunes:title>The Hidden Crisis of Medication Mismanagement with Dr. Anthony Sterns</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4597459a-5129-4280-bfcf-c96adf3652d8</guid>
      <link>https://share.transistor.fm/s/df6ed0f4</link>
      <description>
        <![CDATA[<p>This episode dives into the high-stakes problem of medication non-adherence and its impact on patient outcomes and healthcare costs. Dr. Anthony Sterns, CEO of iRx Reminder, shares how his team is using cognitive prosthetics and connected devices to improve medication management, patient independence, and mental health monitoring. The conversation also explores the behavioral side of adherence, the realities of scaling healthtech solutions, and practical advice for building in the healthcare space.</p><p><strong>Chapters</strong>:<br>00:00 The Medication Adherence Crisis<br>02:48 Introducing iRx Reminder<br>05:52 Understanding Medication Mismanagement<br>08:45 Innovative Solutions for Medication Adherence<br>12:06 Behavioral Insights in Medication Taking<br>15:08 The Evolution of iRx Reminder<br>21:53 Engineering Solutions for Health Challenges<br>25:02 Cognitive Prosthetics and Memory Magic Program<br>26:26 Medication Adherence and IoT Innovations<br>28:54 Monitoring Mental Health Through Technology<br>31:53 The Role of Apps in Patient Engagement<br>33:03 Navigating the Valley of Death in Healthcare Startups<br>35:00 Behavioral Health Challenges and Solutions<br>38:41 Investment Needs and Scaling Challenges<br>42:10 Advice for Aspiring Entrepreneurs</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Anthony Sterns</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/anthonysterns/"><strong>https://www.linkedin.com/in/anthonysterns/</strong></a></li><li>Company / Affiliation<strong>:  iRx Reminder </strong><a href="https://www.irxreminder.com/"><strong>https://www.irxreminder.com/</strong></a></li><li>Guest's Bio: <strong>Anthony Sterns</strong> is a CEO, engineer, and organizational psychologist focused on advancing innovation in gerontechnology. He holds a BS in Engineering from University of Michigan and a PhD in Organizational Psychology from University of Akron. A recognized pioneer in technology for aging populations, Anthony holds 12 U.S. patents, has published 33 papers, and delivered over 100 presentations globally. He has led the development of 13 products, bringing six to market. His most widely adopted solution, the Memory Magic Program, is used in more than 2,400 care facilities across seven countries, impacting over 500,000 people living with dementia and their families.</li></ul><p><strong> Takeaways:</strong></p><ul><li>700,000 ER visits and 125,000 deaths are avoidable with proper medication adherence.</li><li>Medication adherence is a major unsolved problem in healthcare.</li><li>iRx Reminder aims to help patients take medications safely and independently.</li><li>Many patients struggle with medication management due to cognitive impairments.</li><li>Situational smart alerting can enhance medication adherence.</li><li>Patients often forget to refill their prescriptions or feel they no longer need their medications.</li><li>The average transplant patient takes between 9 to 25 medications.</li><li>Behavioral psychology plays a crucial role in medication adherence.</li><li>iRx Reminder's technology focuses on behavioral health diagnoses.</li><li>The evolution of iRx Reminder reflects a deep understanding of patient needs.  </li><li>Cognitive prosthetics can significantly aid older adults' socialization.</li><li>Small process changes can lead to substantial improvements in care.</li><li>Monitoring mental health through technology is becoming increasingly feasible.</li><li>Apps can enhance patient engagement and medication adherence.</li><li>Behavioral health organizations face high disengagement rates.</li><li>Investment is crucial for scaling healthcare innovations.</li><li>Building a supportive team is essential for entrepreneurial success.</li><li>Navigating regulatory challenges is a key hurdle for startups.</li><li>Understanding patient needs can drive product development.</li><li>Entrepreneurs must balance personal values with business goals.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This episode dives into the high-stakes problem of medication non-adherence and its impact on patient outcomes and healthcare costs. Dr. Anthony Sterns, CEO of iRx Reminder, shares how his team is using cognitive prosthetics and connected devices to improve medication management, patient independence, and mental health monitoring. The conversation also explores the behavioral side of adherence, the realities of scaling healthtech solutions, and practical advice for building in the healthcare space.</p><p><strong>Chapters</strong>:<br>00:00 The Medication Adherence Crisis<br>02:48 Introducing iRx Reminder<br>05:52 Understanding Medication Mismanagement<br>08:45 Innovative Solutions for Medication Adherence<br>12:06 Behavioral Insights in Medication Taking<br>15:08 The Evolution of iRx Reminder<br>21:53 Engineering Solutions for Health Challenges<br>25:02 Cognitive Prosthetics and Memory Magic Program<br>26:26 Medication Adherence and IoT Innovations<br>28:54 Monitoring Mental Health Through Technology<br>31:53 The Role of Apps in Patient Engagement<br>33:03 Navigating the Valley of Death in Healthcare Startups<br>35:00 Behavioral Health Challenges and Solutions<br>38:41 Investment Needs and Scaling Challenges<br>42:10 Advice for Aspiring Entrepreneurs</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Anthony Sterns</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/anthonysterns/"><strong>https://www.linkedin.com/in/anthonysterns/</strong></a></li><li>Company / Affiliation<strong>:  iRx Reminder </strong><a href="https://www.irxreminder.com/"><strong>https://www.irxreminder.com/</strong></a></li><li>Guest's Bio: <strong>Anthony Sterns</strong> is a CEO, engineer, and organizational psychologist focused on advancing innovation in gerontechnology. He holds a BS in Engineering from University of Michigan and a PhD in Organizational Psychology from University of Akron. A recognized pioneer in technology for aging populations, Anthony holds 12 U.S. patents, has published 33 papers, and delivered over 100 presentations globally. He has led the development of 13 products, bringing six to market. His most widely adopted solution, the Memory Magic Program, is used in more than 2,400 care facilities across seven countries, impacting over 500,000 people living with dementia and their families.</li></ul><p><strong> Takeaways:</strong></p><ul><li>700,000 ER visits and 125,000 deaths are avoidable with proper medication adherence.</li><li>Medication adherence is a major unsolved problem in healthcare.</li><li>iRx Reminder aims to help patients take medications safely and independently.</li><li>Many patients struggle with medication management due to cognitive impairments.</li><li>Situational smart alerting can enhance medication adherence.</li><li>Patients often forget to refill their prescriptions or feel they no longer need their medications.</li><li>The average transplant patient takes between 9 to 25 medications.</li><li>Behavioral psychology plays a crucial role in medication adherence.</li><li>iRx Reminder's technology focuses on behavioral health diagnoses.</li><li>The evolution of iRx Reminder reflects a deep understanding of patient needs.  </li><li>Cognitive prosthetics can significantly aid older adults' socialization.</li><li>Small process changes can lead to substantial improvements in care.</li><li>Monitoring mental health through technology is becoming increasingly feasible.</li><li>Apps can enhance patient engagement and medication adherence.</li><li>Behavioral health organizations face high disengagement rates.</li><li>Investment is crucial for scaling healthcare innovations.</li><li>Building a supportive team is essential for entrepreneurial success.</li><li>Navigating regulatory challenges is a key hurdle for startups.</li><li>Understanding patient needs can drive product development.</li><li>Entrepreneurs must balance personal values with business goals.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 21 Apr 2026 10:21:35 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/df6ed0f4/fcfc0cad.mp3" length="72001334" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/HSgq5Tz-C2lEijUKLrk9EfUPSeYE-tJ4djLlbICGbdc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85ZGIz/NzUzNzI1NWZkNTcx/ODRhZDUxYjA1YjU5/ZTA4ZS5qcGc.jpg"/>
      <itunes:duration>2991</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This episode dives into the high-stakes problem of medication non-adherence and its impact on patient outcomes and healthcare costs. Dr. Anthony Sterns, CEO of iRx Reminder, shares how his team is using cognitive prosthetics and connected devices to improve medication management, patient independence, and mental health monitoring. The conversation also explores the behavioral side of adherence, the realities of scaling healthtech solutions, and practical advice for building in the healthcare space.</p><p><strong>Chapters</strong>:<br>00:00 The Medication Adherence Crisis<br>02:48 Introducing iRx Reminder<br>05:52 Understanding Medication Mismanagement<br>08:45 Innovative Solutions for Medication Adherence<br>12:06 Behavioral Insights in Medication Taking<br>15:08 The Evolution of iRx Reminder<br>21:53 Engineering Solutions for Health Challenges<br>25:02 Cognitive Prosthetics and Memory Magic Program<br>26:26 Medication Adherence and IoT Innovations<br>28:54 Monitoring Mental Health Through Technology<br>31:53 The Role of Apps in Patient Engagement<br>33:03 Navigating the Valley of Death in Healthcare Startups<br>35:00 Behavioral Health Challenges and Solutions<br>38:41 Investment Needs and Scaling Challenges<br>42:10 Advice for Aspiring Entrepreneurs</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Anthony Sterns</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/anthonysterns/"><strong>https://www.linkedin.com/in/anthonysterns/</strong></a></li><li>Company / Affiliation<strong>:  iRx Reminder </strong><a href="https://www.irxreminder.com/"><strong>https://www.irxreminder.com/</strong></a></li><li>Guest's Bio: <strong>Anthony Sterns</strong> is a CEO, engineer, and organizational psychologist focused on advancing innovation in gerontechnology. He holds a BS in Engineering from University of Michigan and a PhD in Organizational Psychology from University of Akron. A recognized pioneer in technology for aging populations, Anthony holds 12 U.S. patents, has published 33 papers, and delivered over 100 presentations globally. He has led the development of 13 products, bringing six to market. His most widely adopted solution, the Memory Magic Program, is used in more than 2,400 care facilities across seven countries, impacting over 500,000 people living with dementia and their families.</li></ul><p><strong> Takeaways:</strong></p><ul><li>700,000 ER visits and 125,000 deaths are avoidable with proper medication adherence.</li><li>Medication adherence is a major unsolved problem in healthcare.</li><li>iRx Reminder aims to help patients take medications safely and independently.</li><li>Many patients struggle with medication management due to cognitive impairments.</li><li>Situational smart alerting can enhance medication adherence.</li><li>Patients often forget to refill their prescriptions or feel they no longer need their medications.</li><li>The average transplant patient takes between 9 to 25 medications.</li><li>Behavioral psychology plays a crucial role in medication adherence.</li><li>iRx Reminder's technology focuses on behavioral health diagnoses.</li><li>The evolution of iRx Reminder reflects a deep understanding of patient needs.  </li><li>Cognitive prosthetics can significantly aid older adults' socialization.</li><li>Small process changes can lead to substantial improvements in care.</li><li>Monitoring mental health through technology is becoming increasingly feasible.</li><li>Apps can enhance patient engagement and medication adherence.</li><li>Behavioral health organizations face high disengagement rates.</li><li>Investment is crucial for scaling healthcare innovations.</li><li>Building a supportive team is essential for entrepreneurial success.</li><li>Navigating regulatory challenges is a key hurdle for startups.</li><li>Understanding patient needs can drive product development.</li><li>Entrepreneurs must balance personal values with business goals.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>medication adherence, healthcare technology, patient independence, medication management, behavioral health, AI in healthcare, health technology, medication reminders, chronic illness, patient care Cognitive Prosthetics, Memory Magic, Medication Adherence, IoT, Mental Health Monitoring, Patient Engagement, Behavioral Health, Healthcare Startups, Investment, Entrepreneurship</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.irxreminder.com/" img="https://img.transistorcdn.com/4bbjKJ685QEDwMdYzSULQLJcpsmBGcGUE8ofuXmee-U/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDZl/MmFjMzQyMTY0Y2M2/YjBmMWRiODc3Y2Iw/M2MyYi5qcGVn.jpg">Dr. Anthony Sterns</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/df6ed0f4/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Empowering Women Through Community with Aalyiah Heath and Naomi Cosman</title>
      <itunes:episode>70</itunes:episode>
      <podcast:episode>70</podcast:episode>
      <itunes:title>Empowering Women Through Community with Aalyiah Heath and Naomi Cosman</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ebd20de7-4582-4da7-a67f-2ead76e04427</guid>
      <link>https://share.transistor.fm/s/1df3926d</link>
      <description>
        <![CDATA[<p>Women’s leadership, community, and collaboration take center stage in this conversation with Aalyiah Heath and Naomi Cosman, founding members of Club Mamabee. They discuss the power of supportive networks, the challenges women face in securing funding, and how traditionally “nurturing” traits can translate into strong, effective leadership. The conversation also explores the role of storytelling, meaningful connections, and gender diversity in shaping the next generation of female leaders, while highlighting Club Mamabee’s mission to create spaces where women can connect, grow, and support one another. </p><p><strong>Chapters:</strong><br>00:00 Empowering Women: Strengths in Leadership<br>03:12 Building the Hive: Community and Collaboration<br>05:58 The Importance of Connection: Overcoming Loneliness<br>08:50 Nurturing Leadership: The Role of Women in Business<br>11:55 Breaking Barriers: Gender Diversity in the Workplace<br>15:03 Funding Challenges: The Struggle for Female Entrepreneurs<br>17:53 Creating Opportunities: The Club Mamabee Approach<br>21:05 Engaging the Community: Attracting New Members<br>24:53 Building Community Through Storytelling<br>27:14 The Power of Women Supporting Women<br>30:15 Tangible Outcomes and Growth<br>32:12 Collaboration Over Competition<br>34:23 The Health Benefits of Community<br>36:49 The Role of Women in Leadership<br>38:30 Timing and the Right Connections<br>40:39 Shaping the Next Generation of Female Leaders<br>43:52 Invitation to Join Club Mamabee</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Aalyiah Heath</strong></li><li>Guest's Title/Position:<strong>  Director of Editorial &amp; Community Curation </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aalyiah-heath/"><strong>https://www.linkedin.com/in/aalyiah-heath/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Aalyiah Heath</strong> is a writer, creative strategist, and community curator currently serving as <strong>Director of Editorial &amp; Community Curation</strong> at Club Mamabee, a platform dedicated to connecting and empowering women leaders. In her role, Aalyiah leads editorial strategy and curates community experiences that foster meaningful dialogue, amplify women’s voices, and create space for thoughtful storytelling and connection. Her work sits at the intersection of editorial content, culture, and community building.  Originally from Detroit, Aalyiah brings a global perspective shaped by her international experiences and creative background in fashion, writing, and communications. She is passionate about the power of storytelling to build community, elevate diverse perspectives, and create spaces where women can share ideas, insights, and lived experiences.<p></p></li><li>Guest's Name:<strong> Naomi Cosman</strong></li><li>Guest's Title/Position:<strong>  Marketing Lead </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/"><strong>https://www.linkedin.com/in/naomicosman/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the <strong>Global Head of Marketing at Koning</strong>, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin–Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School.She brings over a decade of marketing experience—five years at a Fortune 500 company in branding and campaign management, followed by five years working with startups across multiple sectors. At Koning, Naomi partners closely with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare. In addition to her role at Koning, Naomi is also the <strong>Marketing Lead for Club Mamabee</strong>, a global community dedicated to connecting and empowering women leaders. Through this work, she helps amplify stories, initiatives, and experiences that support women in leadership, entrepreneurship, and personal growth.</li></ul><p><strong> Takeaways</strong></p><ul><li>Being emotional is a strength, not a weakness.</li><li>Women should build spaces of their own.</li><li>Community is a health intervention, not just a strategy.</li><li>The hive mentality promotes collaboration and support.</li><li>Women are excited to join initiatives that empower them.</li><li>Nurturing qualities in women enhance leadership.</li><li>Gender diversity leads to increased innovation.</li><li>Women face unique challenges in securing funding.</li><li>Club Mamabee offers actionable steps for women in business.</li><li>Personal stories can attract women to join supportive communities. </li><li>The importance of storytelling in building community.</li><li>Personal stories resonate and inspire others to share.</li><li>Being a mother is a strength in leadership.</li><li>Women supporting women leads to greater success.</li><li>Collaboration is more beneficial than competition.</li><li>Community can reduce burnout and enhance well-being.</li><li>Women in leadership can break outdated beliefs.</li><li>Timing and the right connections are crucial for success.</li><li>Shaping the next generation of female leaders is essential.</li><li>Everyone has valuable perspectives to contribute.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Women’s leadership, community, and collaboration take center stage in this conversation with Aalyiah Heath and Naomi Cosman, founding members of Club Mamabee. They discuss the power of supportive networks, the challenges women face in securing funding, and how traditionally “nurturing” traits can translate into strong, effective leadership. The conversation also explores the role of storytelling, meaningful connections, and gender diversity in shaping the next generation of female leaders, while highlighting Club Mamabee’s mission to create spaces where women can connect, grow, and support one another. </p><p><strong>Chapters:</strong><br>00:00 Empowering Women: Strengths in Leadership<br>03:12 Building the Hive: Community and Collaboration<br>05:58 The Importance of Connection: Overcoming Loneliness<br>08:50 Nurturing Leadership: The Role of Women in Business<br>11:55 Breaking Barriers: Gender Diversity in the Workplace<br>15:03 Funding Challenges: The Struggle for Female Entrepreneurs<br>17:53 Creating Opportunities: The Club Mamabee Approach<br>21:05 Engaging the Community: Attracting New Members<br>24:53 Building Community Through Storytelling<br>27:14 The Power of Women Supporting Women<br>30:15 Tangible Outcomes and Growth<br>32:12 Collaboration Over Competition<br>34:23 The Health Benefits of Community<br>36:49 The Role of Women in Leadership<br>38:30 Timing and the Right Connections<br>40:39 Shaping the Next Generation of Female Leaders<br>43:52 Invitation to Join Club Mamabee</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Aalyiah Heath</strong></li><li>Guest's Title/Position:<strong>  Director of Editorial &amp; Community Curation </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aalyiah-heath/"><strong>https://www.linkedin.com/in/aalyiah-heath/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Aalyiah Heath</strong> is a writer, creative strategist, and community curator currently serving as <strong>Director of Editorial &amp; Community Curation</strong> at Club Mamabee, a platform dedicated to connecting and empowering women leaders. In her role, Aalyiah leads editorial strategy and curates community experiences that foster meaningful dialogue, amplify women’s voices, and create space for thoughtful storytelling and connection. Her work sits at the intersection of editorial content, culture, and community building.  Originally from Detroit, Aalyiah brings a global perspective shaped by her international experiences and creative background in fashion, writing, and communications. She is passionate about the power of storytelling to build community, elevate diverse perspectives, and create spaces where women can share ideas, insights, and lived experiences.<p></p></li><li>Guest's Name:<strong> Naomi Cosman</strong></li><li>Guest's Title/Position:<strong>  Marketing Lead </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/"><strong>https://www.linkedin.com/in/naomicosman/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the <strong>Global Head of Marketing at Koning</strong>, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin–Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School.She brings over a decade of marketing experience—five years at a Fortune 500 company in branding and campaign management, followed by five years working with startups across multiple sectors. At Koning, Naomi partners closely with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare. In addition to her role at Koning, Naomi is also the <strong>Marketing Lead for Club Mamabee</strong>, a global community dedicated to connecting and empowering women leaders. Through this work, she helps amplify stories, initiatives, and experiences that support women in leadership, entrepreneurship, and personal growth.</li></ul><p><strong> Takeaways</strong></p><ul><li>Being emotional is a strength, not a weakness.</li><li>Women should build spaces of their own.</li><li>Community is a health intervention, not just a strategy.</li><li>The hive mentality promotes collaboration and support.</li><li>Women are excited to join initiatives that empower them.</li><li>Nurturing qualities in women enhance leadership.</li><li>Gender diversity leads to increased innovation.</li><li>Women face unique challenges in securing funding.</li><li>Club Mamabee offers actionable steps for women in business.</li><li>Personal stories can attract women to join supportive communities. </li><li>The importance of storytelling in building community.</li><li>Personal stories resonate and inspire others to share.</li><li>Being a mother is a strength in leadership.</li><li>Women supporting women leads to greater success.</li><li>Collaboration is more beneficial than competition.</li><li>Community can reduce burnout and enhance well-being.</li><li>Women in leadership can break outdated beliefs.</li><li>Timing and the right connections are crucial for success.</li><li>Shaping the next generation of female leaders is essential.</li><li>Everyone has valuable perspectives to contribute.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 07 Apr 2026 18:34:33 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/1df3926d/20e47d6e.mp3" length="65888524" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/85E4xkzM9fEki7ajLv126S4kU2mDoUbzkCOgdooVTgM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zYTNm/ZDA0ZWQ3N2Q2ZDgz/YWY1N2ZjODEyNzk2/ODJlZS5qcGc.jpg"/>
      <itunes:duration>2730</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Women’s leadership, community, and collaboration take center stage in this conversation with Aalyiah Heath and Naomi Cosman, founding members of Club Mamabee. They discuss the power of supportive networks, the challenges women face in securing funding, and how traditionally “nurturing” traits can translate into strong, effective leadership. The conversation also explores the role of storytelling, meaningful connections, and gender diversity in shaping the next generation of female leaders, while highlighting Club Mamabee’s mission to create spaces where women can connect, grow, and support one another. </p><p><strong>Chapters:</strong><br>00:00 Empowering Women: Strengths in Leadership<br>03:12 Building the Hive: Community and Collaboration<br>05:58 The Importance of Connection: Overcoming Loneliness<br>08:50 Nurturing Leadership: The Role of Women in Business<br>11:55 Breaking Barriers: Gender Diversity in the Workplace<br>15:03 Funding Challenges: The Struggle for Female Entrepreneurs<br>17:53 Creating Opportunities: The Club Mamabee Approach<br>21:05 Engaging the Community: Attracting New Members<br>24:53 Building Community Through Storytelling<br>27:14 The Power of Women Supporting Women<br>30:15 Tangible Outcomes and Growth<br>32:12 Collaboration Over Competition<br>34:23 The Health Benefits of Community<br>36:49 The Role of Women in Leadership<br>38:30 Timing and the Right Connections<br>40:39 Shaping the Next Generation of Female Leaders<br>43:52 Invitation to Join Club Mamabee</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Aalyiah Heath</strong></li><li>Guest's Title/Position:<strong>  Director of Editorial &amp; Community Curation </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aalyiah-heath/"><strong>https://www.linkedin.com/in/aalyiah-heath/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Aalyiah Heath</strong> is a writer, creative strategist, and community curator currently serving as <strong>Director of Editorial &amp; Community Curation</strong> at Club Mamabee, a platform dedicated to connecting and empowering women leaders. In her role, Aalyiah leads editorial strategy and curates community experiences that foster meaningful dialogue, amplify women’s voices, and create space for thoughtful storytelling and connection. Her work sits at the intersection of editorial content, culture, and community building.  Originally from Detroit, Aalyiah brings a global perspective shaped by her international experiences and creative background in fashion, writing, and communications. She is passionate about the power of storytelling to build community, elevate diverse perspectives, and create spaces where women can share ideas, insights, and lived experiences.<p></p></li><li>Guest's Name:<strong> Naomi Cosman</strong></li><li>Guest's Title/Position:<strong>  Marketing Lead </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/"><strong>https://www.linkedin.com/in/naomicosman/</strong></a></li><li>Company / Affiliation<strong>: Club Mamabee </strong><a href="https://mamabee.com/"><strong>https://mamabee.com/</strong></a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the <strong>Global Head of Marketing at Koning</strong>, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin–Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School.She brings over a decade of marketing experience—five years at a Fortune 500 company in branding and campaign management, followed by five years working with startups across multiple sectors. At Koning, Naomi partners closely with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare. In addition to her role at Koning, Naomi is also the <strong>Marketing Lead for Club Mamabee</strong>, a global community dedicated to connecting and empowering women leaders. Through this work, she helps amplify stories, initiatives, and experiences that support women in leadership, entrepreneurship, and personal growth.</li></ul><p><strong> Takeaways</strong></p><ul><li>Being emotional is a strength, not a weakness.</li><li>Women should build spaces of their own.</li><li>Community is a health intervention, not just a strategy.</li><li>The hive mentality promotes collaboration and support.</li><li>Women are excited to join initiatives that empower them.</li><li>Nurturing qualities in women enhance leadership.</li><li>Gender diversity leads to increased innovation.</li><li>Women face unique challenges in securing funding.</li><li>Club Mamabee offers actionable steps for women in business.</li><li>Personal stories can attract women to join supportive communities. </li><li>The importance of storytelling in building community.</li><li>Personal stories resonate and inspire others to share.</li><li>Being a mother is a strength in leadership.</li><li>Women supporting women leads to greater success.</li><li>Collaboration is more beneficial than competition.</li><li>Community can reduce burnout and enhance well-being.</li><li>Women in leadership can break outdated beliefs.</li><li>Timing and the right connections are crucial for success.</li><li>Shaping the next generation of female leaders is essential.</li><li>Everyone has valuable perspectives to contribute.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>women empowerment, leadership, community building, gender diversity, entrepreneurship, networking, female founders, Club Mamabee, collaboration, support system community, women empowerment, storytelling, leadership, collaboration, support, networking, personal growth, female leaders, Club Mamabee</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://mamabee.com/" img="https://img.transistorcdn.com/ctbQg1eZcVfzmdhojaZuVCejsgySCeUX4MS-uewlPk4/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNDg2/MTJkNDUyMTZjZWUz/MzU2ZTc0NmVlYjlh/OWIxMi5wbmc.jpg">Aalyiah Heath</podcast:person>
      <podcast:person role="Guest" href="https://www.koninghealth.com/" img="https://img.transistorcdn.com/gwuTxnUmfuC91S946EYcaWBj1OTNBzGSW8hQwnbPtac/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zM2I2/NGZiMzUzZDUzMzRh/NDQxMTQ5NTcwZDI1/ZmJiMS5qcGVn.jpg">Naomi Cosman</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/1df3926d/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Dietary Intelligence: The Future of Food Allergy Tech &amp; Transparency with Dylan McDonnell</title>
      <itunes:episode>69</itunes:episode>
      <podcast:episode>69</podcast:episode>
      <itunes:title>Dietary Intelligence: The Future of Food Allergy Tech &amp; Transparency with Dylan McDonnell</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f1cd2d5f-32a9-4543-ae2e-28c293a46170</guid>
      <link>https://share.transistor.fm/s/0ef16b66</link>
      <description>
        <![CDATA[<p>In this conversation, Dylan McDonnell, founder and CEO of Foodini, discusses the challenges faced by individuals with food allergies and dietary restrictions, and how his company aims to provide transparency in food options through technology. He shares his personal journey from being a corporate lawyer to creating a dietary intelligence platform that partners with restaurants to offer personalized menu solutions. The discussion highlights the importance of dietary transparency, the impact of food choices on health, and the potential for restaurants to tap into a growing market by catering to diverse dietary needs. In this conversation, Dylan shares his journey from being a lawyer to founding Foodini, a food tech company focused on addressing food allergies. He discusses the challenges of transitioning from a founder to a CEO, the importance of resilience in the startup world, and the brutal process of fundraising. Dylan emphasizes the significance of building a lean team and staying updated with rapidly evolving technology, particularly AI. He also highlights recent regulatory changes in the food industry that present opportunities for growth and innovation.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Food Transparency and Legislation<br>02:49 Dylan's Journey: From Law to Food Tech<br>05:52 The Importance of Dietary Transparency<br>09:09 Understanding Foodini's Technology and Solutions<br>12:08 Market Expansion and Consumer Discovery<br>14:50 The Broader Impact of Dietary Needs<br>17:53 Onboarding Restaurants and Subscription Model<br>23:27 Transitioning from Lawyer to Entrepreneur<br>26:00 The Shift from Founder to CEO<br>28:39 Navigating the Investor Landscape<br>32:39 Building a Lean and Effective Team<br>35:00 Staying Ahead in a Rapidly Evolving Tech Landscape<br>40:39 Regulatory Changes and Opportunities in Food Tech</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Dylan McDonnell</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/dylan-mcdonnell-a5787574/"><strong>https://www.linkedin.com/in/dylan-mcdonnell-a5787574/</strong></a></li><li>Company / Affiliation<strong>: </strong><a href="https://foodini.co/"><strong>Foodini https://foodini.co/</strong></a></li><li>Guest's Bio: <strong>Dylan McDonnell</strong> is the <strong>Founder and CEO of Foodini,</strong> a foodtech platform connecting the 1 in 3 people with dietary needs to restaurants and menu items suitable for them through a dietitian-led verification model. Motivated by his own experience with Celiac disease, Dylan is focused on building technology that bridges the gap between consumers with dietary requirements and the hospitality industry. Under his leadership, Foodini has gained international recognition, including <strong>Startup of the Year (2022)</strong> from the International Association of Corporate Counsel and <strong>FoodTech CEO of the Year – Australia (2023)</strong> from APAC Insider.</li></ul><p> <br><strong>Takeaways:</strong></p><ul><li>California's SB68 bill mandates menu labeling for allergens.</li><li>Dylan's personal experience with celiac disease inspired Fudini.</li><li>The market for dietary needs is vast and underserved.</li><li>Transparency in food options is crucial for consumer trust.</li><li>Foodini uses AI and dietitian expertise to provide accurate information.</li><li>Restaurants can reduce allergy incidents with better data.</li><li>Consumer awareness about food health is increasing.</li><li>Foodini aims to expand into various food service environments.</li><li>The onboarding process for restaurants is designed to be simple.</li><li>Dietary needs impact social interactions and dining experiences. </li><li>The transition from law to entrepreneurship requires adaptability.</li><li>Resilience is key in the startup world; expect many rejections.</li><li>The shift from founder to CEO involves balancing vision and business strategy.</li><li>Fundraising is a challenging but necessary process for growth.</li><li>Building a lean team can lead to greater efficiency and innovation.</li><li>Staying updated with technology is crucial for competitive advantage.</li><li>Regulatory changes can create significant opportunities in food tech.</li><li>Understanding your market and consumer needs is essential for success.</li><li>Strategic investors can provide valuable insights and support.</li><li>Networking and building relationships are vital in the business landscape.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Dylan McDonnell, founder and CEO of Foodini, discusses the challenges faced by individuals with food allergies and dietary restrictions, and how his company aims to provide transparency in food options through technology. He shares his personal journey from being a corporate lawyer to creating a dietary intelligence platform that partners with restaurants to offer personalized menu solutions. The discussion highlights the importance of dietary transparency, the impact of food choices on health, and the potential for restaurants to tap into a growing market by catering to diverse dietary needs. In this conversation, Dylan shares his journey from being a lawyer to founding Foodini, a food tech company focused on addressing food allergies. He discusses the challenges of transitioning from a founder to a CEO, the importance of resilience in the startup world, and the brutal process of fundraising. Dylan emphasizes the significance of building a lean team and staying updated with rapidly evolving technology, particularly AI. He also highlights recent regulatory changes in the food industry that present opportunities for growth and innovation.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Food Transparency and Legislation<br>02:49 Dylan's Journey: From Law to Food Tech<br>05:52 The Importance of Dietary Transparency<br>09:09 Understanding Foodini's Technology and Solutions<br>12:08 Market Expansion and Consumer Discovery<br>14:50 The Broader Impact of Dietary Needs<br>17:53 Onboarding Restaurants and Subscription Model<br>23:27 Transitioning from Lawyer to Entrepreneur<br>26:00 The Shift from Founder to CEO<br>28:39 Navigating the Investor Landscape<br>32:39 Building a Lean and Effective Team<br>35:00 Staying Ahead in a Rapidly Evolving Tech Landscape<br>40:39 Regulatory Changes and Opportunities in Food Tech</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Dylan McDonnell</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/dylan-mcdonnell-a5787574/"><strong>https://www.linkedin.com/in/dylan-mcdonnell-a5787574/</strong></a></li><li>Company / Affiliation<strong>: </strong><a href="https://foodini.co/"><strong>Foodini https://foodini.co/</strong></a></li><li>Guest's Bio: <strong>Dylan McDonnell</strong> is the <strong>Founder and CEO of Foodini,</strong> a foodtech platform connecting the 1 in 3 people with dietary needs to restaurants and menu items suitable for them through a dietitian-led verification model. Motivated by his own experience with Celiac disease, Dylan is focused on building technology that bridges the gap between consumers with dietary requirements and the hospitality industry. Under his leadership, Foodini has gained international recognition, including <strong>Startup of the Year (2022)</strong> from the International Association of Corporate Counsel and <strong>FoodTech CEO of the Year – Australia (2023)</strong> from APAC Insider.</li></ul><p> <br><strong>Takeaways:</strong></p><ul><li>California's SB68 bill mandates menu labeling for allergens.</li><li>Dylan's personal experience with celiac disease inspired Fudini.</li><li>The market for dietary needs is vast and underserved.</li><li>Transparency in food options is crucial for consumer trust.</li><li>Foodini uses AI and dietitian expertise to provide accurate information.</li><li>Restaurants can reduce allergy incidents with better data.</li><li>Consumer awareness about food health is increasing.</li><li>Foodini aims to expand into various food service environments.</li><li>The onboarding process for restaurants is designed to be simple.</li><li>Dietary needs impact social interactions and dining experiences. </li><li>The transition from law to entrepreneurship requires adaptability.</li><li>Resilience is key in the startup world; expect many rejections.</li><li>The shift from founder to CEO involves balancing vision and business strategy.</li><li>Fundraising is a challenging but necessary process for growth.</li><li>Building a lean team can lead to greater efficiency and innovation.</li><li>Staying updated with technology is crucial for competitive advantage.</li><li>Regulatory changes can create significant opportunities in food tech.</li><li>Understanding your market and consumer needs is essential for success.</li><li>Strategic investors can provide valuable insights and support.</li><li>Networking and building relationships are vital in the business landscape.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Wed, 25 Mar 2026 15:13:42 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/0ef16b66/1095ad17.mp3" length="65238541" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/5rHcNvXevq0OQB2O4kjAU510xYxK3MOzEp9kMETsJb0/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kN2Ez/MzhkM2Y0NTUzNTQ1/ZGY0OWI3ZmZmMzc1/NmFkYy5qcGc.jpg"/>
      <itunes:duration>2713</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Dylan McDonnell, founder and CEO of Foodini, discusses the challenges faced by individuals with food allergies and dietary restrictions, and how his company aims to provide transparency in food options through technology. He shares his personal journey from being a corporate lawyer to creating a dietary intelligence platform that partners with restaurants to offer personalized menu solutions. The discussion highlights the importance of dietary transparency, the impact of food choices on health, and the potential for restaurants to tap into a growing market by catering to diverse dietary needs. In this conversation, Dylan shares his journey from being a lawyer to founding Foodini, a food tech company focused on addressing food allergies. He discusses the challenges of transitioning from a founder to a CEO, the importance of resilience in the startup world, and the brutal process of fundraising. Dylan emphasizes the significance of building a lean team and staying updated with rapidly evolving technology, particularly AI. He also highlights recent regulatory changes in the food industry that present opportunities for growth and innovation.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Food Transparency and Legislation<br>02:49 Dylan's Journey: From Law to Food Tech<br>05:52 The Importance of Dietary Transparency<br>09:09 Understanding Foodini's Technology and Solutions<br>12:08 Market Expansion and Consumer Discovery<br>14:50 The Broader Impact of Dietary Needs<br>17:53 Onboarding Restaurants and Subscription Model<br>23:27 Transitioning from Lawyer to Entrepreneur<br>26:00 The Shift from Founder to CEO<br>28:39 Navigating the Investor Landscape<br>32:39 Building a Lean and Effective Team<br>35:00 Staying Ahead in a Rapidly Evolving Tech Landscape<br>40:39 Regulatory Changes and Opportunities in Food Tech</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Dylan McDonnell</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/dylan-mcdonnell-a5787574/"><strong>https://www.linkedin.com/in/dylan-mcdonnell-a5787574/</strong></a></li><li>Company / Affiliation<strong>: </strong><a href="https://foodini.co/"><strong>Foodini https://foodini.co/</strong></a></li><li>Guest's Bio: <strong>Dylan McDonnell</strong> is the <strong>Founder and CEO of Foodini,</strong> a foodtech platform connecting the 1 in 3 people with dietary needs to restaurants and menu items suitable for them through a dietitian-led verification model. Motivated by his own experience with Celiac disease, Dylan is focused on building technology that bridges the gap between consumers with dietary requirements and the hospitality industry. Under his leadership, Foodini has gained international recognition, including <strong>Startup of the Year (2022)</strong> from the International Association of Corporate Counsel and <strong>FoodTech CEO of the Year – Australia (2023)</strong> from APAC Insider.</li></ul><p> <br><strong>Takeaways:</strong></p><ul><li>California's SB68 bill mandates menu labeling for allergens.</li><li>Dylan's personal experience with celiac disease inspired Fudini.</li><li>The market for dietary needs is vast and underserved.</li><li>Transparency in food options is crucial for consumer trust.</li><li>Foodini uses AI and dietitian expertise to provide accurate information.</li><li>Restaurants can reduce allergy incidents with better data.</li><li>Consumer awareness about food health is increasing.</li><li>Foodini aims to expand into various food service environments.</li><li>The onboarding process for restaurants is designed to be simple.</li><li>Dietary needs impact social interactions and dining experiences. </li><li>The transition from law to entrepreneurship requires adaptability.</li><li>Resilience is key in the startup world; expect many rejections.</li><li>The shift from founder to CEO involves balancing vision and business strategy.</li><li>Fundraising is a challenging but necessary process for growth.</li><li>Building a lean team can lead to greater efficiency and innovation.</li><li>Staying updated with technology is crucial for competitive advantage.</li><li>Regulatory changes can create significant opportunities in food tech.</li><li>Understanding your market and consumer needs is essential for success.</li><li>Strategic investors can provide valuable insights and support.</li><li>Networking and building relationships are vital in the business landscape.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>food allergies, dietary transparency, food tech, Fudini, restaurant solutions, health impact, consumer needs, dietary intelligence, food safety, menu labeling entrepreneurship, food tech, investment, leadership, AI, startups, food allergies, business transition, team management, regulatory changes</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://foodini.co/" img="https://img.transistorcdn.com/ZXm6z4mIyjUnTfgAn7U4GFgexfvqC-kmVjFuBRBpBUc/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84ZDdh/MmM0YzkwNGZmZDUz/NmE0YjkzZmM0N2Ix/ZjA5Yi5qcGVn.jpg">Dylan McDonnell</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/0ef16b66/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Emergency Response Biotech: Real-Time Health Monitoring in Extreme Environments with Jonathan López</title>
      <itunes:episode>68</itunes:episode>
      <podcast:episode>68</podcast:episode>
      <itunes:title>Emergency Response Biotech: Real-Time Health Monitoring in Extreme Environments with Jonathan López</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ef8f35ae-62b7-41a5-b4af-6eedd341f06c</guid>
      <link>https://share.transistor.fm/s/ed03f137</link>
      <description>
        <![CDATA[<p>In this conversation, Jonathan López, a medical doctor and founder of karē Corp, discusses his innovative approach to biotech, focusing on a modular platform for drug delivery in extreme environments. He shares his journey from med school to entrepreneurship, the challenges he faced, and his vision for making a global impact, particularly for Puerto Rico. The discussion highlights the importance of real-time health monitoring and the potential applications of his technology in defense and emergency response.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Next-Gen Biotech<br>05:05 The Vision Behind karē Corp<br>10:00 The Modular Platform Explained<br>15:11 Real-Time Monitoring and Team Awareness<br>19:58 Challenges and Growth as a Founder<br>24:56 The Shift from Cannabis to Defense<br>29:59 Current Status and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Jonathan López</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jonathanlopez92/"><strong>https://www.linkedin.com/in/jonathanlopez92/</strong></a></li><li>Company / Affiliation<strong>: karē Corp  </strong><a href="https://karembio.com/"><strong>https://karembio.com/</strong></a></li><li>Guest's Bio: Jonathan López is the Founder and CEO of karē Corp, a physician-trained entrepreneur focused on building regulated, science-first human performance systems. His work centers on the development of advanced subcutaneous infusion platforms that integrate pharmacology, hardware, and software to support human health and performance in demanding environments.<br>Jonathan leads the company’s strategy across FDA-regulated development pathways, intellectual property creation, and dual-use deployment for civilian healthcare, first responders, defense, and space applications. He is currently advancing multiple patented platforms designed to align with federal innovation and research programs, with the goal of delivering next-generation biomedical solutions for extreme and mission-critical environments.</li></ul><p><strong> Takeaways:</strong></p><ul><li>Jonathan López is building next-gen biotech platforms for drug delivery.</li><li>karē Corp aims to provide real-time health monitoring in extreme environments.</li><li>The platform is modular and can be tailored for different users like soldiers and astronauts.</li><li>Real-time data can help prevent medical emergencies in the field.</li><li>Jonathan's journey reflects the challenges of pursuing innovation in healthcare.</li><li>He emphasizes the importance of inspiring Puerto Ricans to believe in their potential.</li><li>The shift from cannabis to defense technology was a strategic decision for broader impact.</li><li>Jonathan faced external doubt from family and friends about his entrepreneurial path.</li><li>The technology aims to enhance human performance in critical situations.</li><li>Jonathan is currently in the process of securing grants and patents for his innovations.</li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Jonathan López, a medical doctor and founder of karē Corp, discusses his innovative approach to biotech, focusing on a modular platform for drug delivery in extreme environments. He shares his journey from med school to entrepreneurship, the challenges he faced, and his vision for making a global impact, particularly for Puerto Rico. The discussion highlights the importance of real-time health monitoring and the potential applications of his technology in defense and emergency response.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Next-Gen Biotech<br>05:05 The Vision Behind karē Corp<br>10:00 The Modular Platform Explained<br>15:11 Real-Time Monitoring and Team Awareness<br>19:58 Challenges and Growth as a Founder<br>24:56 The Shift from Cannabis to Defense<br>29:59 Current Status and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Jonathan López</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jonathanlopez92/"><strong>https://www.linkedin.com/in/jonathanlopez92/</strong></a></li><li>Company / Affiliation<strong>: karē Corp  </strong><a href="https://karembio.com/"><strong>https://karembio.com/</strong></a></li><li>Guest's Bio: Jonathan López is the Founder and CEO of karē Corp, a physician-trained entrepreneur focused on building regulated, science-first human performance systems. His work centers on the development of advanced subcutaneous infusion platforms that integrate pharmacology, hardware, and software to support human health and performance in demanding environments.<br>Jonathan leads the company’s strategy across FDA-regulated development pathways, intellectual property creation, and dual-use deployment for civilian healthcare, first responders, defense, and space applications. He is currently advancing multiple patented platforms designed to align with federal innovation and research programs, with the goal of delivering next-generation biomedical solutions for extreme and mission-critical environments.</li></ul><p><strong> Takeaways:</strong></p><ul><li>Jonathan López is building next-gen biotech platforms for drug delivery.</li><li>karē Corp aims to provide real-time health monitoring in extreme environments.</li><li>The platform is modular and can be tailored for different users like soldiers and astronauts.</li><li>Real-time data can help prevent medical emergencies in the field.</li><li>Jonathan's journey reflects the challenges of pursuing innovation in healthcare.</li><li>He emphasizes the importance of inspiring Puerto Ricans to believe in their potential.</li><li>The shift from cannabis to defense technology was a strategic decision for broader impact.</li><li>Jonathan faced external doubt from family and friends about his entrepreneurial path.</li><li>The technology aims to enhance human performance in critical situations.</li><li>Jonathan is currently in the process of securing grants and patents for his innovations.</li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 13 Mar 2026 15:21:09 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ed03f137/ae77a323.mp3" length="56680476" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/tgFcxEiWFil6eJGi-_NFhGdKPXhexLXFnbeKYIlwfZM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81YzFh/NDNlMjEyYjM3YTU5/ZjA1N2FhYWE1ZTY2/MzgyMy5qcGc.jpg"/>
      <itunes:duration>2357</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Jonathan López, a medical doctor and founder of karē Corp, discusses his innovative approach to biotech, focusing on a modular platform for drug delivery in extreme environments. He shares his journey from med school to entrepreneurship, the challenges he faced, and his vision for making a global impact, particularly for Puerto Rico. The discussion highlights the importance of real-time health monitoring and the potential applications of his technology in defense and emergency response.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Next-Gen Biotech<br>05:05 The Vision Behind karē Corp<br>10:00 The Modular Platform Explained<br>15:11 Real-Time Monitoring and Team Awareness<br>19:58 Challenges and Growth as a Founder<br>24:56 The Shift from Cannabis to Defense<br>29:59 Current Status and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Jonathan López</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jonathanlopez92/"><strong>https://www.linkedin.com/in/jonathanlopez92/</strong></a></li><li>Company / Affiliation<strong>: karē Corp  </strong><a href="https://karembio.com/"><strong>https://karembio.com/</strong></a></li><li>Guest's Bio: Jonathan López is the Founder and CEO of karē Corp, a physician-trained entrepreneur focused on building regulated, science-first human performance systems. His work centers on the development of advanced subcutaneous infusion platforms that integrate pharmacology, hardware, and software to support human health and performance in demanding environments.<br>Jonathan leads the company’s strategy across FDA-regulated development pathways, intellectual property creation, and dual-use deployment for civilian healthcare, first responders, defense, and space applications. He is currently advancing multiple patented platforms designed to align with federal innovation and research programs, with the goal of delivering next-generation biomedical solutions for extreme and mission-critical environments.</li></ul><p><strong> Takeaways:</strong></p><ul><li>Jonathan López is building next-gen biotech platforms for drug delivery.</li><li>karē Corp aims to provide real-time health monitoring in extreme environments.</li><li>The platform is modular and can be tailored for different users like soldiers and astronauts.</li><li>Real-time data can help prevent medical emergencies in the field.</li><li>Jonathan's journey reflects the challenges of pursuing innovation in healthcare.</li><li>He emphasizes the importance of inspiring Puerto Ricans to believe in their potential.</li><li>The shift from cannabis to defense technology was a strategic decision for broader impact.</li><li>Jonathan faced external doubt from family and friends about his entrepreneurial path.</li><li>The technology aims to enhance human performance in critical situations.</li><li>Jonathan is currently in the process of securing grants and patents for his innovations.</li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>biotech, healthcare, drug delivery, emergency response, defense technology, Puerto Rico, innovation, super soldier, wearable technology, health monitoring</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://karembio.com/" img="https://img.transistorcdn.com/ZrXXReCSAD_5vXy9FPbnTbCIT0ESCYKfTTI-biOv-xg/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNjQy/MTI5YzhlMjU0OTU2/YjM1MWZlZWFjYzI5/ZTBjYS5wbmc.jpg">Jonathan López</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ed03f137/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>MONEY BALL Episode 4 - Chandi Bandara, Precision Quantomics</title>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>MONEY BALL Episode 4 - Chandi Bandara, Precision Quantomics</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0d066232-ac12-457b-b855-15a21fe38134</guid>
      <link>https://share.transistor.fm/s/4024f1c9</link>
      <description>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher speaks with Chandi Bandara, CEO of Precision Quantomics, about the challenges and innovations in drug development. They discuss the inefficiencies in the pharmaceutical industry, the importance of effective pitching to investors, and the insights gained from the Money Ball program. Chandi shares his journey from a molecular biologist to a CEO, the lessons learned in storytelling for pitches, and the significance of feedback in refining business strategies. The conversation emphasizes the need for entrepreneurs to seek guidance and input from experienced peers in their journey.</p><p><strong>Chapters:</strong><br>00:00 Introduction to The Healthy Enterprise and Money Ball Series<br>00:39 Chandi Bandara: CEO of Precision Quantomics<br>02:04 Innovative Solutions in Drug Development<br>03:49 Company Progress and Market Presence<br>05:07 Chandi's Journey to Precision Quantomics<br>06:26 The Art of Pitching to Investors<br>09:00 Crafting the Perfect Pitch Story<br>11:28 Refining the Pitch with Money Ball Program<br>13:30 Learning from Investor Feedback<br>15:22 Common Mistakes in Pitching<br>18:17 Unique Perspective as a Non-Founder CEO<br>20:03 Impact of Money Ball Program on Pitching<br>22:28 Advice for Aspiring Entrepreneurs<br>25:54 Conclusion and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chandi Bandara</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/cabandara/"><strong>https://www.linkedin.com/in/cabandara/</strong></a></li><li>Company / Affiliation: <strong>Precision Quantomics</strong> <a href="https://precisionquantomics.com/"><strong>https://precisionquantomics.com/</strong></a></li><li>Guest's Bio:<strong>  Chandima Bandara</strong> is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry.<br>He began his career in R&amp;D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&amp;D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences &amp; Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Precision Quantomics addresses inefficiencies in drug development.</li><li>90% of drugs fail to reach the market due to outdated models.</li><li>Chandi Bandara transitioned from science to business development.</li><li>Effective pitching requires understanding the audience's perspective.</li><li>The Money Ball program helped refine Chandi's pitch.</li><li>Investors need to hear the problem and solution quickly.</li><li>Iterating on the pitch deck is crucial for success.</li><li>Feedback from investors is invaluable for improvement.</li><li>Every entrepreneur's journey is unique and requires tailored advice.</li><li>Building a supportive ecosystem is essential for startup growth.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher speaks with Chandi Bandara, CEO of Precision Quantomics, about the challenges and innovations in drug development. They discuss the inefficiencies in the pharmaceutical industry, the importance of effective pitching to investors, and the insights gained from the Money Ball program. Chandi shares his journey from a molecular biologist to a CEO, the lessons learned in storytelling for pitches, and the significance of feedback in refining business strategies. The conversation emphasizes the need for entrepreneurs to seek guidance and input from experienced peers in their journey.</p><p><strong>Chapters:</strong><br>00:00 Introduction to The Healthy Enterprise and Money Ball Series<br>00:39 Chandi Bandara: CEO of Precision Quantomics<br>02:04 Innovative Solutions in Drug Development<br>03:49 Company Progress and Market Presence<br>05:07 Chandi's Journey to Precision Quantomics<br>06:26 The Art of Pitching to Investors<br>09:00 Crafting the Perfect Pitch Story<br>11:28 Refining the Pitch with Money Ball Program<br>13:30 Learning from Investor Feedback<br>15:22 Common Mistakes in Pitching<br>18:17 Unique Perspective as a Non-Founder CEO<br>20:03 Impact of Money Ball Program on Pitching<br>22:28 Advice for Aspiring Entrepreneurs<br>25:54 Conclusion and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chandi Bandara</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/cabandara/"><strong>https://www.linkedin.com/in/cabandara/</strong></a></li><li>Company / Affiliation: <strong>Precision Quantomics</strong> <a href="https://precisionquantomics.com/"><strong>https://precisionquantomics.com/</strong></a></li><li>Guest's Bio:<strong>  Chandima Bandara</strong> is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry.<br>He began his career in R&amp;D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&amp;D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences &amp; Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Precision Quantomics addresses inefficiencies in drug development.</li><li>90% of drugs fail to reach the market due to outdated models.</li><li>Chandi Bandara transitioned from science to business development.</li><li>Effective pitching requires understanding the audience's perspective.</li><li>The Money Ball program helped refine Chandi's pitch.</li><li>Investors need to hear the problem and solution quickly.</li><li>Iterating on the pitch deck is crucial for success.</li><li>Feedback from investors is invaluable for improvement.</li><li>Every entrepreneur's journey is unique and requires tailored advice.</li><li>Building a supportive ecosystem is essential for startup growth.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 11 Feb 2026 18:06:55 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/4024f1c9/40206d53.mp3" length="39806724" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/8QkyiPvegS8S7SRNMifMlD0dctyvOW5yTC_EjgT9maE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hNDQ4/N2Y2ZThmOWNlNzcy/YjE4M2FiNjA1MWE0/YzFlZS5wbmc.jpg"/>
      <itunes:duration>1650</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher speaks with Chandi Bandara, CEO of Precision Quantomics, about the challenges and innovations in drug development. They discuss the inefficiencies in the pharmaceutical industry, the importance of effective pitching to investors, and the insights gained from the Money Ball program. Chandi shares his journey from a molecular biologist to a CEO, the lessons learned in storytelling for pitches, and the significance of feedback in refining business strategies. The conversation emphasizes the need for entrepreneurs to seek guidance and input from experienced peers in their journey.</p><p><strong>Chapters:</strong><br>00:00 Introduction to The Healthy Enterprise and Money Ball Series<br>00:39 Chandi Bandara: CEO of Precision Quantomics<br>02:04 Innovative Solutions in Drug Development<br>03:49 Company Progress and Market Presence<br>05:07 Chandi's Journey to Precision Quantomics<br>06:26 The Art of Pitching to Investors<br>09:00 Crafting the Perfect Pitch Story<br>11:28 Refining the Pitch with Money Ball Program<br>13:30 Learning from Investor Feedback<br>15:22 Common Mistakes in Pitching<br>18:17 Unique Perspective as a Non-Founder CEO<br>20:03 Impact of Money Ball Program on Pitching<br>22:28 Advice for Aspiring Entrepreneurs<br>25:54 Conclusion and Future Aspirations</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chandi Bandara</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/cabandara/"><strong>https://www.linkedin.com/in/cabandara/</strong></a></li><li>Company / Affiliation: <strong>Precision Quantomics</strong> <a href="https://precisionquantomics.com/"><strong>https://precisionquantomics.com/</strong></a></li><li>Guest's Bio:<strong>  Chandima Bandara</strong> is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry.<br>He began his career in R&amp;D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&amp;D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences &amp; Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Precision Quantomics addresses inefficiencies in drug development.</li><li>90% of drugs fail to reach the market due to outdated models.</li><li>Chandi Bandara transitioned from science to business development.</li><li>Effective pitching requires understanding the audience's perspective.</li><li>The Money Ball program helped refine Chandi's pitch.</li><li>Investors need to hear the problem and solution quickly.</li><li>Iterating on the pitch deck is crucial for success.</li><li>Feedback from investors is invaluable for improvement.</li><li>Every entrepreneur's journey is unique and requires tailored advice.</li><li>Building a supportive ecosystem is essential for startup growth.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Precision Quantomics, drug development, fundraising, investor pitching, biotechnology, startup journey, Money Ball program, entrepreneurial advice, proteomics, pharmaceutical innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://precisionquantomics.com/" img="https://img.transistorcdn.com/z25FVHJpM6LBMEW4AeuYroqn-nVkJhBzHIazYAu2kZk/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzNm/ZWYyYjg4ZjMyNjFk/ZTM0MWQ4YzVjMDRl/OWFlOS5qcGVn.jpg">Chandima  Bandara</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/4024f1c9/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>MONEY BALL Episode 3 - Doug Cohen, IR Medtek </title>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>MONEY BALL Episode 3 - Doug Cohen, IR Medtek </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6eedf755-fe25-407b-afd0-8ab9a2975513</guid>
      <link>https://share.transistor.fm/s/8aa42f66</link>
      <description>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher interviews Doug Cohen, the Co-Founder and CEO of IR Medtek, about his journey in developing a groundbreaking technology for cancer detection. Doug shares his unique background in mechanical engineering and how it led him to identify a significant gap in the healthcare market, particularly in skin cancer detection. The conversation delves into the development process of their innovative device, the challenges faced, and the importance of refining their pitch to investors through the Money Ball program. Doug emphasizes the value of collaboration, confidence in their technology, and the potential impact on patient care.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Money Ball and IR Medtek<br>01:14 Doug's Unique Background and Journey<br>02:27 Identifying the Gap in Cancer Detection<br>05:51 The Development Journey of the Technology<br>07:41 Current Progress and Future Steps<br>08:39 Understanding the Device and Its Functionality<br>10:58 Enhancing Primary Care with Technology<br>13:25 Investor Response and Presentation Experience<br>14:34 Refining the Pitch through Money Ball<br>18:32 Public Speaking and CEO Responsibilities<br>21:12 The Advantage of an Engineering Background<br>24:11 Reflections on the Money Ball Experience</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Doug Cohen</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/doug-cohen-64761410/"><strong>https://www.linkedin.com/in/doug-cohen-64761410/</strong></a></li><li>Company / Affiliation: <strong>IR Medtek </strong><a href="https://www.irmedtek.com/"><strong>https://www.irmedtek.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Doug's background in mechanical engineering shaped his approach to IR Medtek.</li><li>The technology developed can differentiate tumor from non-tumor tissue.</li><li>Skin cancer detection is a significant market opportunity.</li><li>The device provides real-time feedback to primary care doctors.</li><li>Investor confidence is crucial for the success of startups.</li><li>Refining the pitch can significantly improve investor engagement.</li><li>Public speaking skills are essential for CEOs in fundraising.</li><li>Collaboration with experts enhances the team's capabilities.</li><li>The Money Ball program provided valuable networking opportunities.</li><li>The technology has the potential to improve patient outcomes significantly.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher interviews Doug Cohen, the Co-Founder and CEO of IR Medtek, about his journey in developing a groundbreaking technology for cancer detection. Doug shares his unique background in mechanical engineering and how it led him to identify a significant gap in the healthcare market, particularly in skin cancer detection. The conversation delves into the development process of their innovative device, the challenges faced, and the importance of refining their pitch to investors through the Money Ball program. Doug emphasizes the value of collaboration, confidence in their technology, and the potential impact on patient care.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Money Ball and IR Medtek<br>01:14 Doug's Unique Background and Journey<br>02:27 Identifying the Gap in Cancer Detection<br>05:51 The Development Journey of the Technology<br>07:41 Current Progress and Future Steps<br>08:39 Understanding the Device and Its Functionality<br>10:58 Enhancing Primary Care with Technology<br>13:25 Investor Response and Presentation Experience<br>14:34 Refining the Pitch through Money Ball<br>18:32 Public Speaking and CEO Responsibilities<br>21:12 The Advantage of an Engineering Background<br>24:11 Reflections on the Money Ball Experience</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Doug Cohen</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/doug-cohen-64761410/"><strong>https://www.linkedin.com/in/doug-cohen-64761410/</strong></a></li><li>Company / Affiliation: <strong>IR Medtek </strong><a href="https://www.irmedtek.com/"><strong>https://www.irmedtek.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Doug's background in mechanical engineering shaped his approach to IR Medtek.</li><li>The technology developed can differentiate tumor from non-tumor tissue.</li><li>Skin cancer detection is a significant market opportunity.</li><li>The device provides real-time feedback to primary care doctors.</li><li>Investor confidence is crucial for the success of startups.</li><li>Refining the pitch can significantly improve investor engagement.</li><li>Public speaking skills are essential for CEOs in fundraising.</li><li>Collaboration with experts enhances the team's capabilities.</li><li>The Money Ball program provided valuable networking opportunities.</li><li>The technology has the potential to improve patient outcomes significantly.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 30 Jan 2026 11:29:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/8aa42f66/fe1dcb4c.mp3" length="38571098" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/V_iSmT1bRQAWRFWzoGos7o5FWx42wbTSFs3JARGj-YE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yMDJm/MGYzMWNkNTcxZTll/OTBiOTBhNzY1ZTI5/ZjE0ZS5wbmc.jpg"/>
      <itunes:duration>1599</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode of The Healthy Enterprise, host Heath Fletcher interviews Doug Cohen, the Co-Founder and CEO of IR Medtek, about his journey in developing a groundbreaking technology for cancer detection. Doug shares his unique background in mechanical engineering and how it led him to identify a significant gap in the healthcare market, particularly in skin cancer detection. The conversation delves into the development process of their innovative device, the challenges faced, and the importance of refining their pitch to investors through the Money Ball program. Doug emphasizes the value of collaboration, confidence in their technology, and the potential impact on patient care.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Money Ball and IR Medtek<br>01:14 Doug's Unique Background and Journey<br>02:27 Identifying the Gap in Cancer Detection<br>05:51 The Development Journey of the Technology<br>07:41 Current Progress and Future Steps<br>08:39 Understanding the Device and Its Functionality<br>10:58 Enhancing Primary Care with Technology<br>13:25 Investor Response and Presentation Experience<br>14:34 Refining the Pitch through Money Ball<br>18:32 Public Speaking and CEO Responsibilities<br>21:12 The Advantage of an Engineering Background<br>24:11 Reflections on the Money Ball Experience</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Doug Cohen</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/doug-cohen-64761410/"><strong>https://www.linkedin.com/in/doug-cohen-64761410/</strong></a></li><li>Company / Affiliation: <strong>IR Medtek </strong><a href="https://www.irmedtek.com/"><strong>https://www.irmedtek.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Doug's background in mechanical engineering shaped his approach to IR Medtek.</li><li>The technology developed can differentiate tumor from non-tumor tissue.</li><li>Skin cancer detection is a significant market opportunity.</li><li>The device provides real-time feedback to primary care doctors.</li><li>Investor confidence is crucial for the success of startups.</li><li>Refining the pitch can significantly improve investor engagement.</li><li>Public speaking skills are essential for CEOs in fundraising.</li><li>Collaboration with experts enhances the team's capabilities.</li><li>The Money Ball program provided valuable networking opportunities.</li><li>The technology has the potential to improve patient outcomes significantly.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>fundraising, cancer detection, MedTech, investor pitch, primary care, skin cancer, technology development, healthcare innovation, entrepreneur journey, Moneyball program</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.irmedtek.com/" img="https://img.transistorcdn.com/8osCeg0rHzgbIeJvRV6fRabLrs98_L5vzrVCMa377Bo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yMjU4/MTc2NDgxYmRiYTMy/NzgyOWNiMGY2ZGFh/OGQ0YS5qcGVn.jpg">Doug Cohen</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/8aa42f66/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>MONEY BALL Episode 2 - Robert Boyce, Plakous Therapeutics</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>MONEY BALL Episode 2 - Robert Boyce, Plakous Therapeutics</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e0e9f8a4-7ae2-4b3c-adbf-79f54f2f2df2</guid>
      <link>https://share.transistor.fm/s/bc6ebfdb</link>
      <description>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Plakous Therapeutics<br>01:08 Understanding Necrotizing Enterocolitis (NEC)<br>04:23 The Genesis of Plakous Therapeutics<br>06:24 Innovative Approach to Treatment<br>09:27 Real-Life Impact: Case Study of Laurel<br>13:32 Navigating the Funding Landscape<br>16:06 Refining the Pitch Process<br>22:05 Challenges in the Current Investment Climate<br>25:11 Current Stage and Future Plans</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Robert Boyce</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/robertwboyce/"><strong>https://www.linkedin.com/in/robertwboyce/</strong></a></li><li>Company / Affiliation: <strong>Plakous Therapeutics </strong><a href="https://www.plakoustherapeutics.com/"><strong>https://www.plakoustherapeutics.com/</strong></a></li><li>Guest's Bio:<strong>  Rob Boyce</strong> is the <strong>CEO of Plakous Therapeutics</strong>, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson &amp; Johnson, marketing the Tylenol Brand. While at J&amp;J he led worldwide Sales and Marketing for Independence Technology, a Johnson &amp; Johnson company specializing in state-of-the-art rehabilitation technology. Rob launched his career as a naval flight officer in the Navy’s E-2C Hawkeye.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Rob Boyce is the CEO of Plakous Therapeutics, focusing on regenerative medicine.</li><li>Necrotizing enterocolitis (NEC) is a severe condition affecting premature infants.</li><li>The last FDA-approved medicine for NICU babies was in 1991.</li><li>Plakous's product mimics amniotic fluid to support GI tract development.</li><li>Laurel's case illustrates the challenges faced by NEC patients.</li><li>Funding for pediatric biotech is particularly challenging.</li><li>Networking and preparation are crucial for successful investor pitches.</li><li>Understanding the audience is key to effective presentations.</li><li>Regulatory pathways for pediatric treatments are complex and uncertain.</li><li>Plakous aims to raise $8 million for further development.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners<a href="https://bullzeyeglobal.com/"> https://bullzeyeglobal.com/</a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Plakous Therapeutics<br>01:08 Understanding Necrotizing Enterocolitis (NEC)<br>04:23 The Genesis of Plakous Therapeutics<br>06:24 Innovative Approach to Treatment<br>09:27 Real-Life Impact: Case Study of Laurel<br>13:32 Navigating the Funding Landscape<br>16:06 Refining the Pitch Process<br>22:05 Challenges in the Current Investment Climate<br>25:11 Current Stage and Future Plans</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Robert Boyce</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/robertwboyce/"><strong>https://www.linkedin.com/in/robertwboyce/</strong></a></li><li>Company / Affiliation: <strong>Plakous Therapeutics </strong><a href="https://www.plakoustherapeutics.com/"><strong>https://www.plakoustherapeutics.com/</strong></a></li><li>Guest's Bio:<strong>  Rob Boyce</strong> is the <strong>CEO of Plakous Therapeutics</strong>, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson &amp; Johnson, marketing the Tylenol Brand. While at J&amp;J he led worldwide Sales and Marketing for Independence Technology, a Johnson &amp; Johnson company specializing in state-of-the-art rehabilitation technology. Rob launched his career as a naval flight officer in the Navy’s E-2C Hawkeye.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Rob Boyce is the CEO of Plakous Therapeutics, focusing on regenerative medicine.</li><li>Necrotizing enterocolitis (NEC) is a severe condition affecting premature infants.</li><li>The last FDA-approved medicine for NICU babies was in 1991.</li><li>Plakous's product mimics amniotic fluid to support GI tract development.</li><li>Laurel's case illustrates the challenges faced by NEC patients.</li><li>Funding for pediatric biotech is particularly challenging.</li><li>Networking and preparation are crucial for successful investor pitches.</li><li>Understanding the audience is key to effective presentations.</li><li>Regulatory pathways for pediatric treatments are complex and uncertain.</li><li>Plakous aims to raise $8 million for further development.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners<a href="https://bullzeyeglobal.com/"> https://bullzeyeglobal.com/</a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 02 Jan 2026 10:54:22 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/bc6ebfdb/5e3d3331.mp3" length="40501354" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/4YMJtC9jHgwqwy2Dmv5WmZ8mM4ThVEXpuQOT_22IQo8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82Nzdl/MzEwOGY3NzQwNmZk/YzIyNjQyM2VjOGIz/MjE1MC5wbmc.jpg"/>
      <itunes:duration>1679</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Plakous Therapeutics<br>01:08 Understanding Necrotizing Enterocolitis (NEC)<br>04:23 The Genesis of Plakous Therapeutics<br>06:24 Innovative Approach to Treatment<br>09:27 Real-Life Impact: Case Study of Laurel<br>13:32 Navigating the Funding Landscape<br>16:06 Refining the Pitch Process<br>22:05 Challenges in the Current Investment Climate<br>25:11 Current Stage and Future Plans</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Robert Boyce</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/robertwboyce/"><strong>https://www.linkedin.com/in/robertwboyce/</strong></a></li><li>Company / Affiliation: <strong>Plakous Therapeutics </strong><a href="https://www.plakoustherapeutics.com/"><strong>https://www.plakoustherapeutics.com/</strong></a></li><li>Guest's Bio:<strong>  Rob Boyce</strong> is the <strong>CEO of Plakous Therapeutics</strong>, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson &amp; Johnson, marketing the Tylenol Brand. While at J&amp;J he led worldwide Sales and Marketing for Independence Technology, a Johnson &amp; Johnson company specializing in state-of-the-art rehabilitation technology. Rob launched his career as a naval flight officer in the Navy’s E-2C Hawkeye.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Rob Boyce is the CEO of Plakous Therapeutics, focusing on regenerative medicine.</li><li>Necrotizing enterocolitis (NEC) is a severe condition affecting premature infants.</li><li>The last FDA-approved medicine for NICU babies was in 1991.</li><li>Plakous's product mimics amniotic fluid to support GI tract development.</li><li>Laurel's case illustrates the challenges faced by NEC patients.</li><li>Funding for pediatric biotech is particularly challenging.</li><li>Networking and preparation are crucial for successful investor pitches.</li><li>Understanding the audience is key to effective presentations.</li><li>Regulatory pathways for pediatric treatments are complex and uncertain.</li><li>Plakous aims to raise $8 million for further development.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners<a href="https://bullzeyeglobal.com/"> https://bullzeyeglobal.com/</a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>plakous therapeutics, blpn club, money ball, funding, necrotizing enterocolitis, regenerative medicine, placental tissue, pediatric healthcare, funding strategies, investor relations, biotech industry, JP Morgan conference, healthcare innovationics, necrotizing enterocolitis, regenerative medicine, placental tissue, pediatric healthcare, funding strategies, investor relations, biotech industry, JP Morgan conference, healthcare innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.plakoustherapeutics.com/" img="https://img.transistorcdn.com/WC_9HObrj22Fv9DfU0E_rwdqL9Rr3BQY_-H46kYsVio/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iMDM1/YzA1ZGY2ZjRmNzQy/OThlMDZmM2JmY2E4/YWNjMy5qcGVn.jpg">Rob Boyce</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/bc6ebfdb/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>MONEY BALL Episode 1 - James Lovgren, Aspiro Therapeutics</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>MONEY BALL Episode 1 - James Lovgren, Aspiro Therapeutics</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c8858258-6c9e-4fd7-8569-c775e1d65ea9</guid>
      <link>https://share.transistor.fm/s/5b54ce32</link>
      <description>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this conversation, James Lovgren shares his insights on the funding process for biotech startups, emphasizing the importance of team expertise, the art of pitching, and the need to balance scientific detail with storytelling. He discusses the iterative nature of pitching, the significance of understanding investor expectations, and the value of targeting the right investors to enhance the chances of success. James reflects on his experiences in the Money Ball program, highlighting the lessons learned and the importance of adaptability in investor conversations.</p><p>Chapters:<br>00:00 Introduction to Money Ball and Aspiro Therapeutics<br>01:13 Understanding Obstructive Lung Diseases<br>02:59 Innovative Solutions in Lung Disease Treatment<br>05:04 The Journey of Aspiro Therapeutics<br>07:05 The Importance of Team Dynamics<br>09:09 Mastering the Pitch Process<br>10:50 Evolving the Pitch: Lessons Learned<br>12:58 Investor Engagement and Feedback<br>14:56 Navigating Investor Relationships<br>17:09 Refining the Pitch Through Iteration<br>19:01 The Role of Investor Fit<br>21:07 Future Directions for Aspiro Therapeutics</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> James Lovgren</strong></li><li>Guest's Title/Position:<strong>  CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/jameslovgren/"><strong> https://www.linkedin.com/in/jameslovgren/</strong></a></li><li>Company / Affiliation: <strong>Aspiro Therapeutics </strong><a href="https://aspirotx.com/"><strong>https://aspirotx.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>As the CEO of Aspiro Therapeutics, <strong>James Lovgren </strong>leads the company’s mission to revolutionize the treatment of obstructive lung diseases with innovative CC16-inspired therapies.<br>James is an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing global product portfolios exceeding $250 million. His extensive background spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has successfully brought a wide range of products, services, and reagents to market in the pharmaceutical, diagnostics, and life science sectors.<br>James’ strategic insight and operational expertise are instrumental in guiding Aspiro Therapeutics through its preclinical development stage and beyond.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Investors prioritize team expertise in funding decisions.</li><li>The pitching process requires practice and iteration.</li><li>Balancing scientific detail with storytelling is crucial.</li><li>Understanding investor backgrounds can shape the pitch.</li><li>Feedback from peers can refine the pitch effectively.</li><li>High-level narratives often resonate more than technical data.</li><li>Each investor may have different areas of interest.</li><li>Flexibility in presentation can lead to better engagement.</li><li>Building a targeted investor list saves time and effort.</li><li>Long-term relationships with investors are essential for success.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this conversation, James Lovgren shares his insights on the funding process for biotech startups, emphasizing the importance of team expertise, the art of pitching, and the need to balance scientific detail with storytelling. He discusses the iterative nature of pitching, the significance of understanding investor expectations, and the value of targeting the right investors to enhance the chances of success. James reflects on his experiences in the Money Ball program, highlighting the lessons learned and the importance of adaptability in investor conversations.</p><p>Chapters:<br>00:00 Introduction to Money Ball and Aspiro Therapeutics<br>01:13 Understanding Obstructive Lung Diseases<br>02:59 Innovative Solutions in Lung Disease Treatment<br>05:04 The Journey of Aspiro Therapeutics<br>07:05 The Importance of Team Dynamics<br>09:09 Mastering the Pitch Process<br>10:50 Evolving the Pitch: Lessons Learned<br>12:58 Investor Engagement and Feedback<br>14:56 Navigating Investor Relationships<br>17:09 Refining the Pitch Through Iteration<br>19:01 The Role of Investor Fit<br>21:07 Future Directions for Aspiro Therapeutics</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> James Lovgren</strong></li><li>Guest's Title/Position:<strong>  CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/jameslovgren/"><strong> https://www.linkedin.com/in/jameslovgren/</strong></a></li><li>Company / Affiliation: <strong>Aspiro Therapeutics </strong><a href="https://aspirotx.com/"><strong>https://aspirotx.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>As the CEO of Aspiro Therapeutics, <strong>James Lovgren </strong>leads the company’s mission to revolutionize the treatment of obstructive lung diseases with innovative CC16-inspired therapies.<br>James is an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing global product portfolios exceeding $250 million. His extensive background spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has successfully brought a wide range of products, services, and reagents to market in the pharmaceutical, diagnostics, and life science sectors.<br>James’ strategic insight and operational expertise are instrumental in guiding Aspiro Therapeutics through its preclinical development stage and beyond.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Investors prioritize team expertise in funding decisions.</li><li>The pitching process requires practice and iteration.</li><li>Balancing scientific detail with storytelling is crucial.</li><li>Understanding investor backgrounds can shape the pitch.</li><li>Feedback from peers can refine the pitch effectively.</li><li>High-level narratives often resonate more than technical data.</li><li>Each investor may have different areas of interest.</li><li>Flexibility in presentation can lead to better engagement.</li><li>Building a targeted investor list saves time and effort.</li><li>Long-term relationships with investors are essential for success.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 02 Jan 2026 10:53:15 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/5b54ce32/436e4834.mp3" length="38846253" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Qo7VfPJ3qM8R_MpwLDYdsefJhbzAyz9HEHYYyVVKaB4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NmI3/ODQyNDc3ZjMzYTYz/Y2JkMzUyNGY2Njcy/YzhlMi5wbmc.jpg"/>
      <itunes:duration>1610</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This episode is part of a limited series called Money Ball in conjunction with the <a href="https://blpn.club/"><strong>BLPN Club</strong></a><strong> </strong>. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.</p><p>In this conversation, James Lovgren shares his insights on the funding process for biotech startups, emphasizing the importance of team expertise, the art of pitching, and the need to balance scientific detail with storytelling. He discusses the iterative nature of pitching, the significance of understanding investor expectations, and the value of targeting the right investors to enhance the chances of success. James reflects on his experiences in the Money Ball program, highlighting the lessons learned and the importance of adaptability in investor conversations.</p><p>Chapters:<br>00:00 Introduction to Money Ball and Aspiro Therapeutics<br>01:13 Understanding Obstructive Lung Diseases<br>02:59 Innovative Solutions in Lung Disease Treatment<br>05:04 The Journey of Aspiro Therapeutics<br>07:05 The Importance of Team Dynamics<br>09:09 Mastering the Pitch Process<br>10:50 Evolving the Pitch: Lessons Learned<br>12:58 Investor Engagement and Feedback<br>14:56 Navigating Investor Relationships<br>17:09 Refining the Pitch Through Iteration<br>19:01 The Role of Investor Fit<br>21:07 Future Directions for Aspiro Therapeutics</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> James Lovgren</strong></li><li>Guest's Title/Position:<strong>  CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/jameslovgren/"><strong> https://www.linkedin.com/in/jameslovgren/</strong></a></li><li>Company / Affiliation: <strong>Aspiro Therapeutics </strong><a href="https://aspirotx.com/"><strong>https://aspirotx.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>As the CEO of Aspiro Therapeutics, <strong>James Lovgren </strong>leads the company’s mission to revolutionize the treatment of obstructive lung diseases with innovative CC16-inspired therapies.<br>James is an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing global product portfolios exceeding $250 million. His extensive background spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has successfully brought a wide range of products, services, and reagents to market in the pharmaceutical, diagnostics, and life science sectors.<br>James’ strategic insight and operational expertise are instrumental in guiding Aspiro Therapeutics through its preclinical development stage and beyond.<p></p></li></ul><p><strong>Takeaways:</strong></p><ul><li>Investors prioritize team expertise in funding decisions.</li><li>The pitching process requires practice and iteration.</li><li>Balancing scientific detail with storytelling is crucial.</li><li>Understanding investor backgrounds can shape the pitch.</li><li>Feedback from peers can refine the pitch effectively.</li><li>High-level narratives often resonate more than technical data.</li><li>Each investor may have different areas of interest.</li><li>Flexibility in presentation can lead to better engagement.</li><li>Building a targeted investor list saves time and effort.</li><li>Long-term relationships with investors are essential for success.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>aspiro therapeutics, blpn club, money ball, jp morgan week, funding, pitch process, investor relations, biotech, storytelling, team dynamics, investor targeting, startup journey, feedback, investor expectations</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://aspirotx.com/" img="https://img.transistorcdn.com/b9hC96ep5NnxAlQB4_ySRQn2AS2uQSTqFhfeSPgjzfM/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82NGQ5/MjVkYzEzMDE5ZjVm/Yjk4ZWExNDQ2OWVm/MDcxYi5qcGVn.jpg">James Lovgren</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/5b54ce32/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Power of Positive Psychology: Coaching, Identity &amp; Workplace Success with Elissa Zylbershlag</title>
      <itunes:episode>67</itunes:episode>
      <podcast:episode>67</podcast:episode>
      <itunes:title>Power of Positive Psychology: Coaching, Identity &amp; Workplace Success with Elissa Zylbershlag</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d2f1e3b4-4ea4-42a3-98e8-c5987a452f07</guid>
      <link>https://share.transistor.fm/s/a114cc64</link>
      <description>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, host Heath Fletcher engages with Elissa Zylbershlag, Founder of Work Wise Labs, who specializes in proactive HR strategies and positive workplace environments. Elissa shares her journey from being an anti-bias educator to establishing her own business, emphasizing the importance of fostering a positive work culture. She explains the concept of anti-bias education, which aims to create a more just and equitable world, and how it connects to workplace dynamics. Alissa also introduces the principles of positive psychology, highlighting how focusing on strengths rather than weaknesses can lead to a more fulfilling and productive work life.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Elissa Zylbershlag and Work Wise Labs<br>01:23 Understanding Anti-Bias Education<br>07:06 The Shift to Positive Psychology<br>13:52 Work Wise Labs: Services and Offerings<br>20:41 The Journey to Entrepreneurship<br>22:10 Challenges Faced by Leaders Today<br>26:27 The Role of Coaching in Personal Development<br>27:15 The Dynamics of Coaching Relationships<br>29:29 Prioritizing Personal Needs in Leadership<br>30:56 The Importance of Self-Awareness<br>33:20 Understanding Perceptions: The Portrait Analogy<br>39:20 The One, Two, Three Theory of Feedback<br>42:15 Embracing Growth and New Opportunities<br>44:13 Networking and Building Connections<br>46:19 Transforming Conflict into Connection</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Elissa Zylbershlag</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/elissazylbershlag/"><strong>https://www.linkedin.com/in/elissazylbershlag/</strong></a></li><li>Company / Affiliation<strong>: Work Wise Labs </strong><a href="https://www.workwiselabs.com/"><strong>https://www.workwiselabs.com/</strong></a></li><li>Guest's Bio: <strong>Elissa Zylbershlag, M.Ed.</strong> is the Founder of <strong>Work Wise Labs</strong> and a leadership development and team-building professional who helps nonprofits, universities, and small organizations create healthier, more connected workplaces. Through proactive coaching, interactive workshops, and culture-focused training, she works 1:1 with leaders and facilitates engaging group sessions that strengthen communication, trust, confidence, and collaboration—always with a focus on making work both productive and enjoyable. Through Work Wise Labs, Elissa equips organizations with practical tools to build supportive, mission-aligned cultures where people actually want to show up for work.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Different does not mean bad.</li><li>Focusing on strengths makes you happier and makes your life more meaningful.</li><li>Coaching is about possibility, what's possible, and it's about action plan.</li><li>The workplace is a hotbed of bias and discrimination.</li><li>Positive psychology looks at what's right with people, not what's wrong.</li><li>Coaching relationships can last from months to decades, depending on individual needs.</li><li>Self-awareness is crucial in leadership; it's about understanding how others perceive you.</li><li>Feedback from multiple sources can reveal patterns in behavior and perceptions.</li><li>Addressing conflict can improve relationships 75% of the time when done correctly.</li><li>Prioritizing your own needs is essential before helping others.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, host Heath Fletcher engages with Elissa Zylbershlag, Founder of Work Wise Labs, who specializes in proactive HR strategies and positive workplace environments. Elissa shares her journey from being an anti-bias educator to establishing her own business, emphasizing the importance of fostering a positive work culture. She explains the concept of anti-bias education, which aims to create a more just and equitable world, and how it connects to workplace dynamics. Alissa also introduces the principles of positive psychology, highlighting how focusing on strengths rather than weaknesses can lead to a more fulfilling and productive work life.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Elissa Zylbershlag and Work Wise Labs<br>01:23 Understanding Anti-Bias Education<br>07:06 The Shift to Positive Psychology<br>13:52 Work Wise Labs: Services and Offerings<br>20:41 The Journey to Entrepreneurship<br>22:10 Challenges Faced by Leaders Today<br>26:27 The Role of Coaching in Personal Development<br>27:15 The Dynamics of Coaching Relationships<br>29:29 Prioritizing Personal Needs in Leadership<br>30:56 The Importance of Self-Awareness<br>33:20 Understanding Perceptions: The Portrait Analogy<br>39:20 The One, Two, Three Theory of Feedback<br>42:15 Embracing Growth and New Opportunities<br>44:13 Networking and Building Connections<br>46:19 Transforming Conflict into Connection</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Elissa Zylbershlag</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/elissazylbershlag/"><strong>https://www.linkedin.com/in/elissazylbershlag/</strong></a></li><li>Company / Affiliation<strong>: Work Wise Labs </strong><a href="https://www.workwiselabs.com/"><strong>https://www.workwiselabs.com/</strong></a></li><li>Guest's Bio: <strong>Elissa Zylbershlag, M.Ed.</strong> is the Founder of <strong>Work Wise Labs</strong> and a leadership development and team-building professional who helps nonprofits, universities, and small organizations create healthier, more connected workplaces. Through proactive coaching, interactive workshops, and culture-focused training, she works 1:1 with leaders and facilitates engaging group sessions that strengthen communication, trust, confidence, and collaboration—always with a focus on making work both productive and enjoyable. Through Work Wise Labs, Elissa equips organizations with practical tools to build supportive, mission-aligned cultures where people actually want to show up for work.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Different does not mean bad.</li><li>Focusing on strengths makes you happier and makes your life more meaningful.</li><li>Coaching is about possibility, what's possible, and it's about action plan.</li><li>The workplace is a hotbed of bias and discrimination.</li><li>Positive psychology looks at what's right with people, not what's wrong.</li><li>Coaching relationships can last from months to decades, depending on individual needs.</li><li>Self-awareness is crucial in leadership; it's about understanding how others perceive you.</li><li>Feedback from multiple sources can reveal patterns in behavior and perceptions.</li><li>Addressing conflict can improve relationships 75% of the time when done correctly.</li><li>Prioritizing your own needs is essential before helping others.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Thu, 01 Jan 2026 06:05:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/a114cc64/43d7ef3e.mp3" length="75173912" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/0ZhUKUtg04jWRNVWFWV5-nsTRgSl9CnlHpcK1p11-qY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lODBj/ZmI3OGNiNTNkMzFl/ODQ0ZWNkZDlmY2Y2/OGZhZC5qcGc.jpg"/>
      <itunes:duration>3128</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, host Heath Fletcher engages with Elissa Zylbershlag, Founder of Work Wise Labs, who specializes in proactive HR strategies and positive workplace environments. Elissa shares her journey from being an anti-bias educator to establishing her own business, emphasizing the importance of fostering a positive work culture. She explains the concept of anti-bias education, which aims to create a more just and equitable world, and how it connects to workplace dynamics. Alissa also introduces the principles of positive psychology, highlighting how focusing on strengths rather than weaknesses can lead to a more fulfilling and productive work life.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Elissa Zylbershlag and Work Wise Labs<br>01:23 Understanding Anti-Bias Education<br>07:06 The Shift to Positive Psychology<br>13:52 Work Wise Labs: Services and Offerings<br>20:41 The Journey to Entrepreneurship<br>22:10 Challenges Faced by Leaders Today<br>26:27 The Role of Coaching in Personal Development<br>27:15 The Dynamics of Coaching Relationships<br>29:29 Prioritizing Personal Needs in Leadership<br>30:56 The Importance of Self-Awareness<br>33:20 Understanding Perceptions: The Portrait Analogy<br>39:20 The One, Two, Three Theory of Feedback<br>42:15 Embracing Growth and New Opportunities<br>44:13 Networking and Building Connections<br>46:19 Transforming Conflict into Connection</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Elissa Zylbershlag</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/elissazylbershlag/"><strong>https://www.linkedin.com/in/elissazylbershlag/</strong></a></li><li>Company / Affiliation<strong>: Work Wise Labs </strong><a href="https://www.workwiselabs.com/"><strong>https://www.workwiselabs.com/</strong></a></li><li>Guest's Bio: <strong>Elissa Zylbershlag, M.Ed.</strong> is the Founder of <strong>Work Wise Labs</strong> and a leadership development and team-building professional who helps nonprofits, universities, and small organizations create healthier, more connected workplaces. Through proactive coaching, interactive workshops, and culture-focused training, she works 1:1 with leaders and facilitates engaging group sessions that strengthen communication, trust, confidence, and collaboration—always with a focus on making work both productive and enjoyable. Through Work Wise Labs, Elissa equips organizations with practical tools to build supportive, mission-aligned cultures where people actually want to show up for work.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Different does not mean bad.</li><li>Focusing on strengths makes you happier and makes your life more meaningful.</li><li>Coaching is about possibility, what's possible, and it's about action plan.</li><li>The workplace is a hotbed of bias and discrimination.</li><li>Positive psychology looks at what's right with people, not what's wrong.</li><li>Coaching relationships can last from months to decades, depending on individual needs.</li><li>Self-awareness is crucial in leadership; it's about understanding how others perceive you.</li><li>Feedback from multiple sources can reveal patterns in behavior and perceptions.</li><li>Addressing conflict can improve relationships 75% of the time when done correctly.</li><li>Prioritizing your own needs is essential before helping others.</li></ul><p><strong><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>HR strategies, positive psychology, anti-bias education, workplace culture, leadership development, team building, coaching, WorkWise Labs, employee engagement, organizational health, coaching, self-awareness, leadership, conflict resolution, personal growth, workplace culture, feedback, coaching relationships, prioritizing needs, positive psychology</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Guest" href="https://www.workwiselabs.com/" img="https://img.transistorcdn.com/Kd0XkDSnDgR2I5HOeyrUjWRaUadu-3C7j-Srj4e_hQ8/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NGJl/ZDcxOWJmZTZlN2Q2/YzgyYmNjYmE0YjQ2/ZGE2My5qcGVn.jpg">Elissa Zylbershlag</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/a114cc64/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>AI Teammates in Action: Streamlining Care and Reducing Denials with Katie Saindon</title>
      <itunes:episode>66</itunes:episode>
      <podcast:episode>66</podcast:episode>
      <itunes:title>AI Teammates in Action: Streamlining Care and Reducing Denials with Katie Saindon</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c98ec90a-9b62-40e8-ade9-23dd6d9e1747</guid>
      <link>https://share.transistor.fm/s/71106926</link>
      <description>
        <![CDATA[<p>In this episode, Katie Saindon, Senior Director of Product at Qventus, discusses her journey in product management and the innovative solutions Qventus provides to healthcare systems. The conversation covers the challenges faced by health systems, the role of AI in automating care operations, and the importance of seamless integration with existing workflows. Katie shares insights on the impact their platform can make on patient discharge processes and surgical operations. The discussion highlights the collaborative approach they take with clients to develop tailored solutions that enhance patient care and operational efficiency.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Katie Saindon and Qventus<br>02:53 Katie's Journey into Product Management<br>05:45 Understanding Qventus and Its Solutions<br>09:01 The Impact of Qventus on Patient Discharge<br>12:00 AI as a Teammate in Healthcare<br>15:09 Optimizing Surgical Operations with Qventus<br>17:51 Integration Challenges and Solutions<br>21:05 Growth and Funding Stages of Qventus<br>24:09 Competitive Landscape and Client Partnerships<br>26:59 Innovative Solutions and Case Studies<br>30:08 Marketing and Outreach Strategies<br>32:55 Future of Qventus and Healthcare Technology</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Katie Saindon</strong></li><li>Guest's Title/Position:<strong>  Senior Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/katie-saindon/"><strong>https://www.linkedin.com/in/katie-saindon/</strong></a></li><li>Company / Affiliation<strong>: Qventus </strong><a href="https://www.qventus.com/"><strong>https://www.qventus.com/</strong></a></li><li>Guest's Bio: <strong>Katie Saindon</strong> is <strong>Senior Director of Product Management at Qventus</strong>, where she leads product strategy and execution for AI-driven healthcare solutions. An intrinsically motivated and passionate product leader, Katie brings global experience driving vision, roadmap, and delivery to generate revenue and elevate customer satisfaction. She’s known for balancing short- and long-term priorities with radical clarity—keeping outcomes front and center to deliver meaningful value for both customers and the business.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Katie Saindon is the Senior Director of Product at Qventus.</li><li>Qventus automates care operations across the entire patient journey.</li><li>The company helps alleviate administrative burdens on healthcare staff.</li><li>AI is positioned as a teammate to support healthcare professionals.</li><li>Qventus aims to optimize patient discharge processes.</li><li>The integration of Qventus solutions with existing EHR systems is crucial.</li><li>The company is in a Series D funding stage, indicating rapid growth.</li><li>Client partnerships are key to developing innovative solutions.</li><li>Qventus has seen significant reductions in patient wait times and denials.</li><li>The future of healthcare technology is focused on collaboration and integration.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Katie Saindon, Senior Director of Product at Qventus, discusses her journey in product management and the innovative solutions Qventus provides to healthcare systems. The conversation covers the challenges faced by health systems, the role of AI in automating care operations, and the importance of seamless integration with existing workflows. Katie shares insights on the impact their platform can make on patient discharge processes and surgical operations. The discussion highlights the collaborative approach they take with clients to develop tailored solutions that enhance patient care and operational efficiency.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Katie Saindon and Qventus<br>02:53 Katie's Journey into Product Management<br>05:45 Understanding Qventus and Its Solutions<br>09:01 The Impact of Qventus on Patient Discharge<br>12:00 AI as a Teammate in Healthcare<br>15:09 Optimizing Surgical Operations with Qventus<br>17:51 Integration Challenges and Solutions<br>21:05 Growth and Funding Stages of Qventus<br>24:09 Competitive Landscape and Client Partnerships<br>26:59 Innovative Solutions and Case Studies<br>30:08 Marketing and Outreach Strategies<br>32:55 Future of Qventus and Healthcare Technology</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Katie Saindon</strong></li><li>Guest's Title/Position:<strong>  Senior Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/katie-saindon/"><strong>https://www.linkedin.com/in/katie-saindon/</strong></a></li><li>Company / Affiliation<strong>: Qventus </strong><a href="https://www.qventus.com/"><strong>https://www.qventus.com/</strong></a></li><li>Guest's Bio: <strong>Katie Saindon</strong> is <strong>Senior Director of Product Management at Qventus</strong>, where she leads product strategy and execution for AI-driven healthcare solutions. An intrinsically motivated and passionate product leader, Katie brings global experience driving vision, roadmap, and delivery to generate revenue and elevate customer satisfaction. She’s known for balancing short- and long-term priorities with radical clarity—keeping outcomes front and center to deliver meaningful value for both customers and the business.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Katie Saindon is the Senior Director of Product at Qventus.</li><li>Qventus automates care operations across the entire patient journey.</li><li>The company helps alleviate administrative burdens on healthcare staff.</li><li>AI is positioned as a teammate to support healthcare professionals.</li><li>Qventus aims to optimize patient discharge processes.</li><li>The integration of Qventus solutions with existing EHR systems is crucial.</li><li>The company is in a Series D funding stage, indicating rapid growth.</li><li>Client partnerships are key to developing innovative solutions.</li><li>Qventus has seen significant reductions in patient wait times and denials.</li><li>The future of healthcare technology is focused on collaboration and integration.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 30 Dec 2025 11:13:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/71106926/60ee6bc2.mp3" length="63862137" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Y50YoX-3pk5Sxhw4UlALtD1Kvk3eU4KDCttZ4lr1Da4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80OWZk/MzhlM2Y5YjM4ZjQ2/ZWMyZmM5NjU0MjQ2/ODFhZC5qcGc.jpg"/>
      <itunes:duration>2656</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Katie Saindon, Senior Director of Product at Qventus, discusses her journey in product management and the innovative solutions Qventus provides to healthcare systems. The conversation covers the challenges faced by health systems, the role of AI in automating care operations, and the importance of seamless integration with existing workflows. Katie shares insights on the impact their platform can make on patient discharge processes and surgical operations. The discussion highlights the collaborative approach they take with clients to develop tailored solutions that enhance patient care and operational efficiency.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Katie Saindon and Qventus<br>02:53 Katie's Journey into Product Management<br>05:45 Understanding Qventus and Its Solutions<br>09:01 The Impact of Qventus on Patient Discharge<br>12:00 AI as a Teammate in Healthcare<br>15:09 Optimizing Surgical Operations with Qventus<br>17:51 Integration Challenges and Solutions<br>21:05 Growth and Funding Stages of Qventus<br>24:09 Competitive Landscape and Client Partnerships<br>26:59 Innovative Solutions and Case Studies<br>30:08 Marketing and Outreach Strategies<br>32:55 Future of Qventus and Healthcare Technology</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Katie Saindon</strong></li><li>Guest's Title/Position:<strong>  Senior Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/katie-saindon/"><strong>https://www.linkedin.com/in/katie-saindon/</strong></a></li><li>Company / Affiliation<strong>: Qventus </strong><a href="https://www.qventus.com/"><strong>https://www.qventus.com/</strong></a></li><li>Guest's Bio: <strong>Katie Saindon</strong> is <strong>Senior Director of Product Management at Qventus</strong>, where she leads product strategy and execution for AI-driven healthcare solutions. An intrinsically motivated and passionate product leader, Katie brings global experience driving vision, roadmap, and delivery to generate revenue and elevate customer satisfaction. She’s known for balancing short- and long-term priorities with radical clarity—keeping outcomes front and center to deliver meaningful value for both customers and the business.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Katie Saindon is the Senior Director of Product at Qventus.</li><li>Qventus automates care operations across the entire patient journey.</li><li>The company helps alleviate administrative burdens on healthcare staff.</li><li>AI is positioned as a teammate to support healthcare professionals.</li><li>Qventus aims to optimize patient discharge processes.</li><li>The integration of Qventus solutions with existing EHR systems is crucial.</li><li>The company is in a Series D funding stage, indicating rapid growth.</li><li>Client partnerships are key to developing innovative solutions.</li><li>Qventus has seen significant reductions in patient wait times and denials.</li><li>The future of healthcare technology is focused on collaboration and integration.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Qventus, healthcare technology, AI in healthcare, patient care, product management, automation, surgical operations, healthcare solutions, client partnerships, innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.qventus.com/" img="https://img.transistorcdn.com/ifiZEZY56QjN07833gs6IqhdUWh1nxSW-ijkfFu0JuE/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wZGEz/MmY2MjQwNDU0ZTc0/YTBlNWM0MTVjYWU0/MTQyMC5qcGVn.jpg">Katie Saindon</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/71106926/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Biotech Meets Big Data: The Future of Data Storage is in Our DNA with T.K. Martin Tsui</title>
      <itunes:episode>65</itunes:episode>
      <podcast:episode>65</podcast:episode>
      <itunes:title>Biotech Meets Big Data: The Future of Data Storage is in Our DNA with T.K. Martin Tsui</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">995a34fb-4229-4c37-9c7c-54377520f6d0</guid>
      <link>https://share.transistor.fm/s/71550e74</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, guest Martin Tsui shares his journey from scientist to entrepreneur and the founding of his biotech startup, ncrspt. The conversation explores how CRISPR technology can be used for DNA-based data storage, offering a radically new approach to long-term, secure data preservation. Tsui breaks down the science behind CRISPR in accessible terms, discusses the fundraising challenges faced by deep-tech biotech startups, and highlights potential applications of DNA data storage—particularly in healthcare. The episode also examines the growing role of AI in data management, the future of data preservation, and why biological systems may hold the key to storing information at unprecedented scale and durability.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Martin Tsui and ncrspt<br>02:52 Martin's Journey in Science and Technology<br>05:59 The Birth of ncrspt<br>08:48 Understanding CRISPR Technology<br>12:03 Current Stage of ncrspt and Challenges<br>15:01 Innovative Data Storage Solutions<br>18:02 The Science Behind DNA Data Storage<br>20:56 Applications of DNA Data Storage<br>23:51 Navigating the Investment Landscape<br>27:04 Future Prospects and Applications of ncrspt<br>29:57 The Challenges of DNA Data Storage<br>32:56 The Process of Storing Data in DNA<br>36:54 The Future of Data Centers<br>38:00 Applications in Healthcare and Beyond<br>40:32 The Role of AI in Data Storage<br>42:24 Innovative Data Transfer Methods<br>45:03 The Future of Data Preservation<br>48:40 The Vision for Data Storage Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong>Martin Tsui</li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/t-k-martin-tsui/"><strong>https://www.linkedin.com/in/t-k-martin-tsui/</strong></a></li><li>Company / Affiliation<strong>: ncrspt </strong><a href="https://www.ncrspt.com/"><strong>https://www.ncrspt.com/</strong></a></li><li>Guest's Bio: <strong>T.K. Martin Tsui</strong> is the <strong>Founder &amp; CEO of ncrspt</strong>, a biotech platform pioneering the preservation of digital data in living cells using DNA-based storage technology. Under his leadership, ncrspt is developing proprietary methods to encode any digital format into biological systems for secure, long-term archiving across industries including healthcare, government, and enterprise. Tsui has a background in structural biochemistry and CRISPR research, with a Ph.D. in Molecular Biophysics and experience applying cutting-edge molecular biology techniques to solve complex scientific challenges before turning to deep tech entrepreneurship.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Martin Tsui is the founder and CEO of ncrspt.</li><li>ncrspt focuses on using CRISPR technology for data storage.</li><li>CRISPR technology has applications in genome engineering and beyond.</li><li>The startup was born out of a layoff experience at Amazon.</li><li>Investors are often hesitant to fund biotech startups due to perceived risks.</li><li>DNA can store vast amounts of data in a small volume.</li><li>The density of DNA data storage is significantly higher than traditional methods.</li><li>ncrspt aims to keep data for decades or centuries.</li><li>The company is currently in the process of fundraising and developing prototypes.</li><li>Understanding the science behind CRISPR is crucial for its applications.  </li><li>The technology requires cutting DNA into smaller pieces for storage.</li><li>Quality control is essential in the DNA data storage process.</li><li>Storing data in DNA can provide a secure backup solution.</li><li>The process involves converting files into DNA sequences.</li><li>Genome engineering tools like CRISPR are used in data insertion.</li><li>Data can be preserved for long periods using biological methods.</li><li>AI currently cannot access data stored in DNA.</li><li>Innovative methods for data transfer can include space travel.</li><li>The technology has potential applications in healthcare and national security.</li><li>Raising awareness about DNA data storage is crucial for its adoption.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, guest Martin Tsui shares his journey from scientist to entrepreneur and the founding of his biotech startup, ncrspt. The conversation explores how CRISPR technology can be used for DNA-based data storage, offering a radically new approach to long-term, secure data preservation. Tsui breaks down the science behind CRISPR in accessible terms, discusses the fundraising challenges faced by deep-tech biotech startups, and highlights potential applications of DNA data storage—particularly in healthcare. The episode also examines the growing role of AI in data management, the future of data preservation, and why biological systems may hold the key to storing information at unprecedented scale and durability.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Martin Tsui and ncrspt<br>02:52 Martin's Journey in Science and Technology<br>05:59 The Birth of ncrspt<br>08:48 Understanding CRISPR Technology<br>12:03 Current Stage of ncrspt and Challenges<br>15:01 Innovative Data Storage Solutions<br>18:02 The Science Behind DNA Data Storage<br>20:56 Applications of DNA Data Storage<br>23:51 Navigating the Investment Landscape<br>27:04 Future Prospects and Applications of ncrspt<br>29:57 The Challenges of DNA Data Storage<br>32:56 The Process of Storing Data in DNA<br>36:54 The Future of Data Centers<br>38:00 Applications in Healthcare and Beyond<br>40:32 The Role of AI in Data Storage<br>42:24 Innovative Data Transfer Methods<br>45:03 The Future of Data Preservation<br>48:40 The Vision for Data Storage Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong>Martin Tsui</li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/t-k-martin-tsui/"><strong>https://www.linkedin.com/in/t-k-martin-tsui/</strong></a></li><li>Company / Affiliation<strong>: ncrspt </strong><a href="https://www.ncrspt.com/"><strong>https://www.ncrspt.com/</strong></a></li><li>Guest's Bio: <strong>T.K. Martin Tsui</strong> is the <strong>Founder &amp; CEO of ncrspt</strong>, a biotech platform pioneering the preservation of digital data in living cells using DNA-based storage technology. Under his leadership, ncrspt is developing proprietary methods to encode any digital format into biological systems for secure, long-term archiving across industries including healthcare, government, and enterprise. Tsui has a background in structural biochemistry and CRISPR research, with a Ph.D. in Molecular Biophysics and experience applying cutting-edge molecular biology techniques to solve complex scientific challenges before turning to deep tech entrepreneurship.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Martin Tsui is the founder and CEO of ncrspt.</li><li>ncrspt focuses on using CRISPR technology for data storage.</li><li>CRISPR technology has applications in genome engineering and beyond.</li><li>The startup was born out of a layoff experience at Amazon.</li><li>Investors are often hesitant to fund biotech startups due to perceived risks.</li><li>DNA can store vast amounts of data in a small volume.</li><li>The density of DNA data storage is significantly higher than traditional methods.</li><li>ncrspt aims to keep data for decades or centuries.</li><li>The company is currently in the process of fundraising and developing prototypes.</li><li>Understanding the science behind CRISPR is crucial for its applications.  </li><li>The technology requires cutting DNA into smaller pieces for storage.</li><li>Quality control is essential in the DNA data storage process.</li><li>Storing data in DNA can provide a secure backup solution.</li><li>The process involves converting files into DNA sequences.</li><li>Genome engineering tools like CRISPR are used in data insertion.</li><li>Data can be preserved for long periods using biological methods.</li><li>AI currently cannot access data stored in DNA.</li><li>Innovative methods for data transfer can include space travel.</li><li>The technology has potential applications in healthcare and national security.</li><li>Raising awareness about DNA data storage is crucial for its adoption.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Mon, 29 Dec 2025 09:15:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/71550e74/c820ea33.mp3" length="78960329" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/7BuYugKLZ_6NV4kwDfPQvE7b_4SibsVsJSMZUCRCiBs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85Nzk4/ZjY5YTYwYTQ0MjY2/NjgxNjAyOGJmZTQ3/YTQ5Ni5qcGc.jpg"/>
      <itunes:duration>3286</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, guest Martin Tsui shares his journey from scientist to entrepreneur and the founding of his biotech startup, ncrspt. The conversation explores how CRISPR technology can be used for DNA-based data storage, offering a radically new approach to long-term, secure data preservation. Tsui breaks down the science behind CRISPR in accessible terms, discusses the fundraising challenges faced by deep-tech biotech startups, and highlights potential applications of DNA data storage—particularly in healthcare. The episode also examines the growing role of AI in data management, the future of data preservation, and why biological systems may hold the key to storing information at unprecedented scale and durability.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Martin Tsui and ncrspt<br>02:52 Martin's Journey in Science and Technology<br>05:59 The Birth of ncrspt<br>08:48 Understanding CRISPR Technology<br>12:03 Current Stage of ncrspt and Challenges<br>15:01 Innovative Data Storage Solutions<br>18:02 The Science Behind DNA Data Storage<br>20:56 Applications of DNA Data Storage<br>23:51 Navigating the Investment Landscape<br>27:04 Future Prospects and Applications of ncrspt<br>29:57 The Challenges of DNA Data Storage<br>32:56 The Process of Storing Data in DNA<br>36:54 The Future of Data Centers<br>38:00 Applications in Healthcare and Beyond<br>40:32 The Role of AI in Data Storage<br>42:24 Innovative Data Transfer Methods<br>45:03 The Future of Data Preservation<br>48:40 The Vision for Data Storage Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong>Martin Tsui</li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/t-k-martin-tsui/"><strong>https://www.linkedin.com/in/t-k-martin-tsui/</strong></a></li><li>Company / Affiliation<strong>: ncrspt </strong><a href="https://www.ncrspt.com/"><strong>https://www.ncrspt.com/</strong></a></li><li>Guest's Bio: <strong>T.K. Martin Tsui</strong> is the <strong>Founder &amp; CEO of ncrspt</strong>, a biotech platform pioneering the preservation of digital data in living cells using DNA-based storage technology. Under his leadership, ncrspt is developing proprietary methods to encode any digital format into biological systems for secure, long-term archiving across industries including healthcare, government, and enterprise. Tsui has a background in structural biochemistry and CRISPR research, with a Ph.D. in Molecular Biophysics and experience applying cutting-edge molecular biology techniques to solve complex scientific challenges before turning to deep tech entrepreneurship.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Martin Tsui is the founder and CEO of ncrspt.</li><li>ncrspt focuses on using CRISPR technology for data storage.</li><li>CRISPR technology has applications in genome engineering and beyond.</li><li>The startup was born out of a layoff experience at Amazon.</li><li>Investors are often hesitant to fund biotech startups due to perceived risks.</li><li>DNA can store vast amounts of data in a small volume.</li><li>The density of DNA data storage is significantly higher than traditional methods.</li><li>ncrspt aims to keep data for decades or centuries.</li><li>The company is currently in the process of fundraising and developing prototypes.</li><li>Understanding the science behind CRISPR is crucial for its applications.  </li><li>The technology requires cutting DNA into smaller pieces for storage.</li><li>Quality control is essential in the DNA data storage process.</li><li>Storing data in DNA can provide a secure backup solution.</li><li>The process involves converting files into DNA sequences.</li><li>Genome engineering tools like CRISPR are used in data insertion.</li><li>Data can be preserved for long periods using biological methods.</li><li>AI currently cannot access data stored in DNA.</li><li>Innovative methods for data transfer can include space travel.</li><li>The technology has potential applications in healthcare and national security.</li><li>Raising awareness about DNA data storage is crucial for its adoption.<p></p></li></ul><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>CRISPR, biotechnology, data storage, DNA, ncrspt, Martin Tsui, genome engineering, startup, investment, healthcare, DNA data storage, biotechnology, data preservation, healthcare applications, CRISPR, data security, innovative technology, future of data, AI in data storage, data transfer methods</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.ncrspt.com/" img="https://img.transistorcdn.com/drds64Z6cDTUirnhG2VCK4wkSouceM7YMMIsTDewqjU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lZGFl/MDlmODAzMTQ5NmE4/NTRiNWY2ZDk3ZmQ4/NTM0YS5qcGVn.jpg">T.K. Martin Tsui</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/71550e74/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Rest, Resilience, and Reinvention: Helping Women Rise Before Burnout Hits with Annie Stephanos</title>
      <itunes:episode>64</itunes:episode>
      <podcast:episode>64</podcast:episode>
      <itunes:title>Rest, Resilience, and Reinvention: Helping Women Rise Before Burnout Hits with Annie Stephanos</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0ecfa822-fd99-46d5-b4f0-46de8d1c1e33</guid>
      <link>https://share.transistor.fm/s/703840be</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Annie Stephanos shares her journey from burnout to becoming a certified life, mental health, and wellness coach. She discusses the realities of burnout, the difference between coaching and therapy, and how women can build sustainable routines, set healthy boundaries, and prioritize self-care. Annie also reflects on her entrepreneurial path with Highroads Coaching and offers practical tools for creating meaningful, lasting change.</p><p>Chapters:<br>00:00 Introduction to Highroads Coaching<br>02:54 The Journey to Coaching<br>06:44 Understanding Burnout<br>10:34 The Layers of Burnout<br>15:31 Preventing Burnout<br>19:18 The Importance of Rest<br>22:01 Coaching vs. Therapy<br>30:27 The Reward of Coaching<br>31:52 The Importance of Coaching for Coaches<br>34:47 Navigating the Entrepreneurial Journey<br>39:54 Marketing Strategies in a Saturated Market<br>44:22 Leveraging Technology and AI in Coaching<br>49:04 Advice for Aspiring Coaches and Those Facing Burnout</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Annie Stephanos</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/highroadscoaching/"><strong>https://www.linkedin.com/in/highroadscoaching/</strong></a></li><li>Company / Affiliation: <strong>Highroads Coaching </strong><a href="https://highroadscoaching.com/"><strong>https://highroadscoaching.com/</strong></a></li><li>Guest's Bio: <strong>Annie Stephanos, M.Ed., CMHC, CPLC</strong> is a life, mental health, and wellness coach who helps individuals reconnect with themselves and build sustainable paths to balance and well-being. A former educational coach and <strong>Founder of Highroads Coaching</strong>, she empowers clients to recognize that the capacity for meaningful change has been within them all along. Annie brings a deep passion for guiding people toward their goals, grounded in her core values of hope, trust, and compassion, shaped by her own journey through burnout and PTSD. </li></ul><p>Takeaways:</p><ul><li>Annie Stefanos is a certified mental health and wellness coach.</li><li>She helps high-achieving women recover from burnout.</li><li>Burnout can stem from various sources, including workplace stress and societal pressures.</li><li>Support systems are crucial for recovery from burnout.</li><li>Coaching focuses on future goals, while therapy often addresses past issues.</li><li>Setting healthy boundaries is essential for mental well-being.</li><li>Rest is often undervalued in a productivity-driven society.</li><li>Women need to be heard and supported in their struggles with burnout.</li><li>Creating sustainable routines can help prevent burnout.</li><li>Every client has unique needs, and coaching should be tailored to them. </li><li>Never think you can do it all alone; it takes a village.</li><li>Continuous learning and feedback are essential in coaching.</li><li>Starting a business can be easier with the right support.</li><li>Standing out in a saturated market requires a unique story.</li><li>Word of mouth is the most effective marketing strategy.</li><li>Coaching is a valuable investment in oneself.</li><li>Don't wait for burnout to seek help; reach out early.</li><li>Having a niche helps in establishing a coaching business.</li><li>Coaching provides actionable tools for immediate change.</li><li>You are worth investing in your mental health and well-being.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Annie Stephanos shares her journey from burnout to becoming a certified life, mental health, and wellness coach. She discusses the realities of burnout, the difference between coaching and therapy, and how women can build sustainable routines, set healthy boundaries, and prioritize self-care. Annie also reflects on her entrepreneurial path with Highroads Coaching and offers practical tools for creating meaningful, lasting change.</p><p>Chapters:<br>00:00 Introduction to Highroads Coaching<br>02:54 The Journey to Coaching<br>06:44 Understanding Burnout<br>10:34 The Layers of Burnout<br>15:31 Preventing Burnout<br>19:18 The Importance of Rest<br>22:01 Coaching vs. Therapy<br>30:27 The Reward of Coaching<br>31:52 The Importance of Coaching for Coaches<br>34:47 Navigating the Entrepreneurial Journey<br>39:54 Marketing Strategies in a Saturated Market<br>44:22 Leveraging Technology and AI in Coaching<br>49:04 Advice for Aspiring Coaches and Those Facing Burnout</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Annie Stephanos</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/highroadscoaching/"><strong>https://www.linkedin.com/in/highroadscoaching/</strong></a></li><li>Company / Affiliation: <strong>Highroads Coaching </strong><a href="https://highroadscoaching.com/"><strong>https://highroadscoaching.com/</strong></a></li><li>Guest's Bio: <strong>Annie Stephanos, M.Ed., CMHC, CPLC</strong> is a life, mental health, and wellness coach who helps individuals reconnect with themselves and build sustainable paths to balance and well-being. A former educational coach and <strong>Founder of Highroads Coaching</strong>, she empowers clients to recognize that the capacity for meaningful change has been within them all along. Annie brings a deep passion for guiding people toward their goals, grounded in her core values of hope, trust, and compassion, shaped by her own journey through burnout and PTSD. </li></ul><p>Takeaways:</p><ul><li>Annie Stefanos is a certified mental health and wellness coach.</li><li>She helps high-achieving women recover from burnout.</li><li>Burnout can stem from various sources, including workplace stress and societal pressures.</li><li>Support systems are crucial for recovery from burnout.</li><li>Coaching focuses on future goals, while therapy often addresses past issues.</li><li>Setting healthy boundaries is essential for mental well-being.</li><li>Rest is often undervalued in a productivity-driven society.</li><li>Women need to be heard and supported in their struggles with burnout.</li><li>Creating sustainable routines can help prevent burnout.</li><li>Every client has unique needs, and coaching should be tailored to them. </li><li>Never think you can do it all alone; it takes a village.</li><li>Continuous learning and feedback are essential in coaching.</li><li>Starting a business can be easier with the right support.</li><li>Standing out in a saturated market requires a unique story.</li><li>Word of mouth is the most effective marketing strategy.</li><li>Coaching is a valuable investment in oneself.</li><li>Don't wait for burnout to seek help; reach out early.</li><li>Having a niche helps in establishing a coaching business.</li><li>Coaching provides actionable tools for immediate change.</li><li>You are worth investing in your mental health and well-being.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Sun, 28 Dec 2025 16:19:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/703840be/5c551aa3.mp3" length="87328852" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/nhJhXeH1KXF_dAyIw1oHNZJ7fbHhd7ftnLEcXFni-5E/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZjAw/MTA5MzdjZGEwMDM1/OWQ3MmE3Y2I1NmNl/ZTAzNC5qcGc.jpg"/>
      <itunes:duration>3634</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Annie Stephanos shares her journey from burnout to becoming a certified life, mental health, and wellness coach. She discusses the realities of burnout, the difference between coaching and therapy, and how women can build sustainable routines, set healthy boundaries, and prioritize self-care. Annie also reflects on her entrepreneurial path with Highroads Coaching and offers practical tools for creating meaningful, lasting change.</p><p>Chapters:<br>00:00 Introduction to Highroads Coaching<br>02:54 The Journey to Coaching<br>06:44 Understanding Burnout<br>10:34 The Layers of Burnout<br>15:31 Preventing Burnout<br>19:18 The Importance of Rest<br>22:01 Coaching vs. Therapy<br>30:27 The Reward of Coaching<br>31:52 The Importance of Coaching for Coaches<br>34:47 Navigating the Entrepreneurial Journey<br>39:54 Marketing Strategies in a Saturated Market<br>44:22 Leveraging Technology and AI in Coaching<br>49:04 Advice for Aspiring Coaches and Those Facing Burnout</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Annie Stephanos</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/highroadscoaching/"><strong>https://www.linkedin.com/in/highroadscoaching/</strong></a></li><li>Company / Affiliation: <strong>Highroads Coaching </strong><a href="https://highroadscoaching.com/"><strong>https://highroadscoaching.com/</strong></a></li><li>Guest's Bio: <strong>Annie Stephanos, M.Ed., CMHC, CPLC</strong> is a life, mental health, and wellness coach who helps individuals reconnect with themselves and build sustainable paths to balance and well-being. A former educational coach and <strong>Founder of Highroads Coaching</strong>, she empowers clients to recognize that the capacity for meaningful change has been within them all along. Annie brings a deep passion for guiding people toward their goals, grounded in her core values of hope, trust, and compassion, shaped by her own journey through burnout and PTSD. </li></ul><p>Takeaways:</p><ul><li>Annie Stefanos is a certified mental health and wellness coach.</li><li>She helps high-achieving women recover from burnout.</li><li>Burnout can stem from various sources, including workplace stress and societal pressures.</li><li>Support systems are crucial for recovery from burnout.</li><li>Coaching focuses on future goals, while therapy often addresses past issues.</li><li>Setting healthy boundaries is essential for mental well-being.</li><li>Rest is often undervalued in a productivity-driven society.</li><li>Women need to be heard and supported in their struggles with burnout.</li><li>Creating sustainable routines can help prevent burnout.</li><li>Every client has unique needs, and coaching should be tailored to them. </li><li>Never think you can do it all alone; it takes a village.</li><li>Continuous learning and feedback are essential in coaching.</li><li>Starting a business can be easier with the right support.</li><li>Standing out in a saturated market requires a unique story.</li><li>Word of mouth is the most effective marketing strategy.</li><li>Coaching is a valuable investment in oneself.</li><li>Don't wait for burnout to seek help; reach out early.</li><li>Having a niche helps in establishing a coaching business.</li><li>Coaching provides actionable tools for immediate change.</li><li>You are worth investing in your mental health and well-being.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>highroads coaching, burnout, mental health, wellness, women empowerment, self-care, support systems, therapy, emotional well-being, personal growth, coaching, burnout, entrepreneurship, community, marketing, self-care, mental health, women empowerment, personal development, life coaching</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://highroadscoaching.com/" img="https://img.transistorcdn.com/JgSPsnTb_TmeT6NbkH4_Otml_G_W_eE69Z2_1IkLVlU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NTBh/ZDg5YmU1ZWI2MDRl/NDY4ODFjZWM1NGZj/ZWUzNC5QTkc.jpg">Annie Stephanos</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/703840be/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Transforming Senior Living: Bridging Generations thru Community-Centric Care with Dr. Merle Griff</title>
      <itunes:episode>63</itunes:episode>
      <podcast:episode>63</podcast:episode>
      <itunes:title>Transforming Senior Living: Bridging Generations thru Community-Centric Care with Dr. Merle Griff</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">782cd005-724d-48cf-ae9c-81790da34c14</guid>
      <link>https://share.transistor.fm/s/903a80c6</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Dr. Merle Griff, Founder and CEO of SarahCare Senior Solutions, shares her journey in senior care and the evolution of adult day health services. She explores the value of intergenerational programs, lessons from caregiving during COVID-19, and the leadership challenges of scaling a franchise model. Dr. Griff also discusses restorative nursing, technology-enabled care, regulatory realities, and insights from her book <em>Solace in the Storm</em>, offering practical guidance for family caregivers.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Senior Care Solutions<br>01:47 The Journey of a Caregiver<br>04:50 Changing Perspectives on Senior Care<br>06:55 The Impact of COVID-19 on Caregiving<br>10:27 Intergenerational Connections in Care<br>16:01 Franchising Senior Care Services<br>24:41 Evolving Leadership in Senior Care<br>27:05 Restorative Nursing and Its Impact<br>28:46 Franchise Model and Business Philosophy<br>30:42 Community and Support Among Franchisees<br>32:15 Innovation and Technology in Care<br>34:40 Growth and Expansion Plans<br>37:39 Attracting Franchisees and Market Viability<br>40:15 Navigating Regulations and Technology Challenges<br>42:11 Advice for Aspiring Franchisees<br>45:49 Introduction to 'Solace in the Storm' Book<br>49:55 Closing Thoughts and Resources</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Merle Griff</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drmerlegriff/"><strong>https://www.linkedin.com/in/drmerlegriff/</strong></a></li><li>Company / Affiliation: <strong>SarahCare Senior Solutions</strong>  <a href="https://sarahcare.com/"><strong>https://sarahcare.com/ </strong></a></li><li>Guest's Bio: <strong>Merle D. Griff, Ph.D.</strong> is the Founder &amp; CEO of <strong>SarahCare</strong> and one of the leading authorities on senior care in the United States. She has served in national leadership roles including Past Chair of the <strong>National Adult Day Services Association (NADSA)</strong>, member of <strong>CARF’s International Advisory Board</strong>, and as a federal task force contributor to the U.S. Department of Aging. A former play therapist, Dr. Griff developed widely adopted <strong>Family Play Therapy</strong> and <strong>Intergenerational Play Therapy</strong> models and is the author of <em>Linkages</em>, along with numerous scholarly publications. She also hosts the podcast <strong>Caught Between Generations</strong>, focused on the challenges facing caregivers in the sandwich generation.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Merle Griff emphasizes the importance of community in senior care.</li><li>Caregiving experience provides valuable insights into the needs of seniors.</li><li>COVID-19 has shifted perceptions about home-based care.</li><li>Intergenerational programs foster relationships between seniors and children.</li><li>Franchising allows for the expansion of high-quality senior care services.</li><li>Staffing in adult day care is often easier than in nursing homes.</li><li>Caregivers need respite to maintain their health and well-being.</li><li>Engagement in activities significantly improves seniors' quality of life.</li><li>The role of family caregivers is evolving with younger generations taking charge.</li><li>Building relationships with families enhances the caregiving experience. </li><li>Restorative nursing helps patients make progress at a slower rate.</li><li>The franchise model allows for high standards of care across multiple locations.</li><li>Franchisees benefit from a supportive community and shared experiences.</li><li>Technology plays a crucial role in modernizing care practices.</li><li>Growth in adult day health is expected as demand increases post-COVID.</li><li>Studio 55 caters to active seniors needing social engagement.</li><li>Franchisees are attracted through online portals and demographic analysis.</li><li>Navigating state regulations is essential for successful expansion.</li><li>Financial literacy is critical for franchisee success.</li><li>'Solace in the Storm' provides practical tips for family caregivers.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Dr. Merle Griff, Founder and CEO of SarahCare Senior Solutions, shares her journey in senior care and the evolution of adult day health services. She explores the value of intergenerational programs, lessons from caregiving during COVID-19, and the leadership challenges of scaling a franchise model. Dr. Griff also discusses restorative nursing, technology-enabled care, regulatory realities, and insights from her book <em>Solace in the Storm</em>, offering practical guidance for family caregivers.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Senior Care Solutions<br>01:47 The Journey of a Caregiver<br>04:50 Changing Perspectives on Senior Care<br>06:55 The Impact of COVID-19 on Caregiving<br>10:27 Intergenerational Connections in Care<br>16:01 Franchising Senior Care Services<br>24:41 Evolving Leadership in Senior Care<br>27:05 Restorative Nursing and Its Impact<br>28:46 Franchise Model and Business Philosophy<br>30:42 Community and Support Among Franchisees<br>32:15 Innovation and Technology in Care<br>34:40 Growth and Expansion Plans<br>37:39 Attracting Franchisees and Market Viability<br>40:15 Navigating Regulations and Technology Challenges<br>42:11 Advice for Aspiring Franchisees<br>45:49 Introduction to 'Solace in the Storm' Book<br>49:55 Closing Thoughts and Resources</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Merle Griff</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drmerlegriff/"><strong>https://www.linkedin.com/in/drmerlegriff/</strong></a></li><li>Company / Affiliation: <strong>SarahCare Senior Solutions</strong>  <a href="https://sarahcare.com/"><strong>https://sarahcare.com/ </strong></a></li><li>Guest's Bio: <strong>Merle D. Griff, Ph.D.</strong> is the Founder &amp; CEO of <strong>SarahCare</strong> and one of the leading authorities on senior care in the United States. She has served in national leadership roles including Past Chair of the <strong>National Adult Day Services Association (NADSA)</strong>, member of <strong>CARF’s International Advisory Board</strong>, and as a federal task force contributor to the U.S. Department of Aging. A former play therapist, Dr. Griff developed widely adopted <strong>Family Play Therapy</strong> and <strong>Intergenerational Play Therapy</strong> models and is the author of <em>Linkages</em>, along with numerous scholarly publications. She also hosts the podcast <strong>Caught Between Generations</strong>, focused on the challenges facing caregivers in the sandwich generation.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Merle Griff emphasizes the importance of community in senior care.</li><li>Caregiving experience provides valuable insights into the needs of seniors.</li><li>COVID-19 has shifted perceptions about home-based care.</li><li>Intergenerational programs foster relationships between seniors and children.</li><li>Franchising allows for the expansion of high-quality senior care services.</li><li>Staffing in adult day care is often easier than in nursing homes.</li><li>Caregivers need respite to maintain their health and well-being.</li><li>Engagement in activities significantly improves seniors' quality of life.</li><li>The role of family caregivers is evolving with younger generations taking charge.</li><li>Building relationships with families enhances the caregiving experience. </li><li>Restorative nursing helps patients make progress at a slower rate.</li><li>The franchise model allows for high standards of care across multiple locations.</li><li>Franchisees benefit from a supportive community and shared experiences.</li><li>Technology plays a crucial role in modernizing care practices.</li><li>Growth in adult day health is expected as demand increases post-COVID.</li><li>Studio 55 caters to active seniors needing social engagement.</li><li>Franchisees are attracted through online portals and demographic analysis.</li><li>Navigating state regulations is essential for successful expansion.</li><li>Financial literacy is critical for franchisee success.</li><li>'Solace in the Storm' provides practical tips for family caregivers.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Sat, 27 Dec 2025 12:41:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/903a80c6/8814482b.mp3" length="76011364" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/tVVFaLTzdTzjrcxmBZ8DmYnAl5mTB83iEKmWBoDe9Xg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lMWI1/OWU5M2JlNTFiMDZh/NTNlOGI4ZTNkNGJl/YjJkZi5qcGc.jpg"/>
      <itunes:duration>3162</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Dr. Merle Griff, Founder and CEO of SarahCare Senior Solutions, shares her journey in senior care and the evolution of adult day health services. She explores the value of intergenerational programs, lessons from caregiving during COVID-19, and the leadership challenges of scaling a franchise model. Dr. Griff also discusses restorative nursing, technology-enabled care, regulatory realities, and insights from her book <em>Solace in the Storm</em>, offering practical guidance for family caregivers.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Senior Care Solutions<br>01:47 The Journey of a Caregiver<br>04:50 Changing Perspectives on Senior Care<br>06:55 The Impact of COVID-19 on Caregiving<br>10:27 Intergenerational Connections in Care<br>16:01 Franchising Senior Care Services<br>24:41 Evolving Leadership in Senior Care<br>27:05 Restorative Nursing and Its Impact<br>28:46 Franchise Model and Business Philosophy<br>30:42 Community and Support Among Franchisees<br>32:15 Innovation and Technology in Care<br>34:40 Growth and Expansion Plans<br>37:39 Attracting Franchisees and Market Viability<br>40:15 Navigating Regulations and Technology Challenges<br>42:11 Advice for Aspiring Franchisees<br>45:49 Introduction to 'Solace in the Storm' Book<br>49:55 Closing Thoughts and Resources</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Merle Griff</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drmerlegriff/"><strong>https://www.linkedin.com/in/drmerlegriff/</strong></a></li><li>Company / Affiliation: <strong>SarahCare Senior Solutions</strong>  <a href="https://sarahcare.com/"><strong>https://sarahcare.com/ </strong></a></li><li>Guest's Bio: <strong>Merle D. Griff, Ph.D.</strong> is the Founder &amp; CEO of <strong>SarahCare</strong> and one of the leading authorities on senior care in the United States. She has served in national leadership roles including Past Chair of the <strong>National Adult Day Services Association (NADSA)</strong>, member of <strong>CARF’s International Advisory Board</strong>, and as a federal task force contributor to the U.S. Department of Aging. A former play therapist, Dr. Griff developed widely adopted <strong>Family Play Therapy</strong> and <strong>Intergenerational Play Therapy</strong> models and is the author of <em>Linkages</em>, along with numerous scholarly publications. She also hosts the podcast <strong>Caught Between Generations</strong>, focused on the challenges facing caregivers in the sandwich generation.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Merle Griff emphasizes the importance of community in senior care.</li><li>Caregiving experience provides valuable insights into the needs of seniors.</li><li>COVID-19 has shifted perceptions about home-based care.</li><li>Intergenerational programs foster relationships between seniors and children.</li><li>Franchising allows for the expansion of high-quality senior care services.</li><li>Staffing in adult day care is often easier than in nursing homes.</li><li>Caregivers need respite to maintain their health and well-being.</li><li>Engagement in activities significantly improves seniors' quality of life.</li><li>The role of family caregivers is evolving with younger generations taking charge.</li><li>Building relationships with families enhances the caregiving experience. </li><li>Restorative nursing helps patients make progress at a slower rate.</li><li>The franchise model allows for high standards of care across multiple locations.</li><li>Franchisees benefit from a supportive community and shared experiences.</li><li>Technology plays a crucial role in modernizing care practices.</li><li>Growth in adult day health is expected as demand increases post-COVID.</li><li>Studio 55 caters to active seniors needing social engagement.</li><li>Franchisees are attracted through online portals and demographic analysis.</li><li>Navigating state regulations is essential for successful expansion.</li><li>Financial literacy is critical for franchisee success.</li><li>'Solace in the Storm' provides practical tips for family caregivers.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>senior care, caregiving, intergenerational programs, adult day care, family caregivers, COVID-19 impact, mental health, franchising, community support, health care, Restorative nursing, franchise model, community support, innovation in care, growth strategies, attracting franchisees, regulations in healthcare, family caregiving, Solace in the Storm, senior care</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://sarahcare.com/" img="https://img.transistorcdn.com/gp7T47hoGBY1XNtE5Rsm3PZF2JH0ItHZK8bB2n8j0tE/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85OTAx/NjJjNzQzMDg0N2Jh/OGEyOGZlODg3OTcz/NWM0MS5qcGVn.jpg">Dr. Merle Griff</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/903a80c6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Transforming Pharma Workflows: AI-Driven Quality &amp; Compliance with Chris Dayton</title>
      <itunes:episode>62</itunes:episode>
      <podcast:episode>62</podcast:episode>
      <itunes:title>Transforming Pharma Workflows: AI-Driven Quality &amp; Compliance with Chris Dayton</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">77951139-a188-4623-93fa-aa74f36424fe</guid>
      <link>https://share.transistor.fm/s/c97ae0d4</link>
      <description>
        <![CDATA[<p>Chris Dayton, Co-Founder &amp; CEO of Quality Assured AI, explores how AI is being responsibly integrated into the pharmaceutical industry, with a focus on quality management, regulatory compliance, and data security. He discusses the use of closed systems and air-gapped architectures to protect sensitive data, the challenges of deploying AI in regulated environments, and the importance of mitigating hallucinations in AI models. Chris also shares lessons from launching and scaling the platform, transitioning into the CEO role, and building AI literacy within organizations—highlighting how thoughtful AI adoption can drive innovation while reducing operational strain and burnout.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Quality Assured AI<br>02:51 The Role of AI in Pharmaceuticals<br>06:02 Understanding AI Implementation Challenges<br>09:04 The Importance of Data Security<br>11:50 Navigating Regulatory Compliance<br>15:00 The Evolution of AI in Quality Management<br>17:59 The Human Element in AI Integration<br>20:56 Client Onboarding and Customization<br>23:49 Feedback and Market Reception<br>26:59 Future Growth and Scalability<br>29:50 Parting Thoughts and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chris Dayton</strong></li><li>Guest's Title/Position:<strong>  Co-Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/chris-dayton-b414bb57/"><strong>https://www.linkedin.com/in/chris-dayton-b414bb57/</strong></a></li><li>Company / Affiliation: <strong>Quality Assured AI  </strong><a href="https://www.qualityassured.ai/"><strong>https://www.qualityassured.ai/</strong></a></li><li>Guest's Bio:<strong> Chris Dayton</strong> is the <strong>Co-Founder and CEO of Quality Assured Ai</strong>, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He has consulted with top-25 global pharmaceutical companies on GxP-aligned AI pilots and is a recognized thought leader in AI governance for life sciences, speaking at PDA events and leading AI literacy initiatives for QA and regulatory professionals.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Quality Assured AI focuses on the quality and regulatory side of pharmaceuticals.</li><li>AI can significantly reduce the time needed for documentation in the pharmaceutical industry.</li><li>Closed system deployments ensure data security and compliance with regulations.</li><li>Understanding and addressing hallucinations in AI is crucial for reliability.</li><li>AI should not continuously learn from user interactions in regulated environments.</li><li>Effective training and onboarding are essential for successful AI integration.</li><li>Feedback from users highlights the practical benefits of AI in quality management.</li><li>Collaboration with consulting groups enhances scalability and deployment efficiency.</li><li>AI literacy is vital for stakeholders in the pharmaceutical industry.</li><li>Future growth includes expanding AI capabilities to automate more processes. </li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Chris Dayton, Co-Founder &amp; CEO of Quality Assured AI, explores how AI is being responsibly integrated into the pharmaceutical industry, with a focus on quality management, regulatory compliance, and data security. He discusses the use of closed systems and air-gapped architectures to protect sensitive data, the challenges of deploying AI in regulated environments, and the importance of mitigating hallucinations in AI models. Chris also shares lessons from launching and scaling the platform, transitioning into the CEO role, and building AI literacy within organizations—highlighting how thoughtful AI adoption can drive innovation while reducing operational strain and burnout.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Quality Assured AI<br>02:51 The Role of AI in Pharmaceuticals<br>06:02 Understanding AI Implementation Challenges<br>09:04 The Importance of Data Security<br>11:50 Navigating Regulatory Compliance<br>15:00 The Evolution of AI in Quality Management<br>17:59 The Human Element in AI Integration<br>20:56 Client Onboarding and Customization<br>23:49 Feedback and Market Reception<br>26:59 Future Growth and Scalability<br>29:50 Parting Thoughts and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chris Dayton</strong></li><li>Guest's Title/Position:<strong>  Co-Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/chris-dayton-b414bb57/"><strong>https://www.linkedin.com/in/chris-dayton-b414bb57/</strong></a></li><li>Company / Affiliation: <strong>Quality Assured AI  </strong><a href="https://www.qualityassured.ai/"><strong>https://www.qualityassured.ai/</strong></a></li><li>Guest's Bio:<strong> Chris Dayton</strong> is the <strong>Co-Founder and CEO of Quality Assured Ai</strong>, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He has consulted with top-25 global pharmaceutical companies on GxP-aligned AI pilots and is a recognized thought leader in AI governance for life sciences, speaking at PDA events and leading AI literacy initiatives for QA and regulatory professionals.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Quality Assured AI focuses on the quality and regulatory side of pharmaceuticals.</li><li>AI can significantly reduce the time needed for documentation in the pharmaceutical industry.</li><li>Closed system deployments ensure data security and compliance with regulations.</li><li>Understanding and addressing hallucinations in AI is crucial for reliability.</li><li>AI should not continuously learn from user interactions in regulated environments.</li><li>Effective training and onboarding are essential for successful AI integration.</li><li>Feedback from users highlights the practical benefits of AI in quality management.</li><li>Collaboration with consulting groups enhances scalability and deployment efficiency.</li><li>AI literacy is vital for stakeholders in the pharmaceutical industry.</li><li>Future growth includes expanding AI capabilities to automate more processes. </li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 23 Dec 2025 13:39:00 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/c97ae0d4/55d8bab6.mp3" length="68982976" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/IoLmKJoJ_C9Oo-m8YrJTJkWcfpqWs3HTddAklHnyO7E/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82ZmI4/MWVhZTBhNTJiMDJh/MjhhY2YzOWEyYjU5/ZGMzOC5qcGc.jpg"/>
      <itunes:duration>2869</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Chris Dayton, Co-Founder &amp; CEO of Quality Assured AI, explores how AI is being responsibly integrated into the pharmaceutical industry, with a focus on quality management, regulatory compliance, and data security. He discusses the use of closed systems and air-gapped architectures to protect sensitive data, the challenges of deploying AI in regulated environments, and the importance of mitigating hallucinations in AI models. Chris also shares lessons from launching and scaling the platform, transitioning into the CEO role, and building AI literacy within organizations—highlighting how thoughtful AI adoption can drive innovation while reducing operational strain and burnout.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Quality Assured AI<br>02:51 The Role of AI in Pharmaceuticals<br>06:02 Understanding AI Implementation Challenges<br>09:04 The Importance of Data Security<br>11:50 Navigating Regulatory Compliance<br>15:00 The Evolution of AI in Quality Management<br>17:59 The Human Element in AI Integration<br>20:56 Client Onboarding and Customization<br>23:49 Feedback and Market Reception<br>26:59 Future Growth and Scalability<br>29:50 Parting Thoughts and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Chris Dayton</strong></li><li>Guest's Title/Position:<strong>  Co-Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/chris-dayton-b414bb57/"><strong>https://www.linkedin.com/in/chris-dayton-b414bb57/</strong></a></li><li>Company / Affiliation: <strong>Quality Assured AI  </strong><a href="https://www.qualityassured.ai/"><strong>https://www.qualityassured.ai/</strong></a></li><li>Guest's Bio:<strong> Chris Dayton</strong> is the <strong>Co-Founder and CEO of Quality Assured Ai</strong>, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He has consulted with top-25 global pharmaceutical companies on GxP-aligned AI pilots and is a recognized thought leader in AI governance for life sciences, speaking at PDA events and leading AI literacy initiatives for QA and regulatory professionals.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Quality Assured AI focuses on the quality and regulatory side of pharmaceuticals.</li><li>AI can significantly reduce the time needed for documentation in the pharmaceutical industry.</li><li>Closed system deployments ensure data security and compliance with regulations.</li><li>Understanding and addressing hallucinations in AI is crucial for reliability.</li><li>AI should not continuously learn from user interactions in regulated environments.</li><li>Effective training and onboarding are essential for successful AI integration.</li><li>Feedback from users highlights the practical benefits of AI in quality management.</li><li>Collaboration with consulting groups enhances scalability and deployment efficiency.</li><li>AI literacy is vital for stakeholders in the pharmaceutical industry.</li><li>Future growth includes expanding AI capabilities to automate more processes. </li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>AI, pharmaceuticals, quality management, regulatory compliance, language models, closed systems, air gapping, hallucinations, customization, client feedback, AI, pharmaceutical industry, data security, compliance, burnout, leadership, scalability, marketing, education, innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.qualityassured.ai/" img="https://img.transistorcdn.com/sLVusXf1owIF03VjJgy9dYdYlcBZj-v8MwjjnjVDrg0/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mYzQ1/NjI3NDk1NmI1YzVk/OGNlZTIyNWUyMTBk/N2EwYy5qcGVn.jpg">Chris Dayton</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/c97ae0d4/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/c97ae0d4/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/c97ae0d4/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/c97ae0d4/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/c97ae0d4/transcription" type="text/html"/>
    </item>
    <item>
      <title>Inside Modern Recruitment: Navigating AI, Attrition, and Human Connection with Larry L. Chism</title>
      <itunes:episode>61</itunes:episode>
      <podcast:episode>61</podcast:episode>
      <itunes:title>Inside Modern Recruitment: Navigating AI, Attrition, and Human Connection with Larry L. Chism</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8b19c0c0-c303-4664-a492-31c844bf1b06</guid>
      <link>https://share.transistor.fm/s/0a2fd806</link>
      <description>
        <![CDATA[<p>In this episode of the Helping Enterprise podcast, host Heath Fletcher speaks with Larry Chism, a seasoned talent acquisition executive, about the evolving landscape of recruitment. They discuss the impact of technology, particularly AI, on hiring processes, the importance of human connection in recruitment, and the challenges faced by both job seekers and employers in today's market. Larry shares insights on bridging the gap between retiring professionals and new graduates, as well as the unique challenges within the healthcare sector. The conversation emphasizes the need for adaptability, networking, and maintaining a positive outlook in the face of change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Talent Acquisition and Larry Chism<br>04:03 The Evolution of Recruitment: Challenges and Opportunities<br>09:09 The Role of AI in Recruitment<br>15:14 Headhunting vs. Passive Recruitment<br>18:34 Bridging the Gap: Workforce Attrition and New Graduates<br>30:48 Challenges in the Healthcare Recruitment Landscape<br>35:21 Quality of Life and the Future of Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>  Larry L. Chism</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/larrylchism/"><strong> https://www.linkedin.com/in/larrylchism/</strong></a></li><li>Company / Affiliation:  <strong>Quantus Management Resources </strong><a href="https://www.qmrconsultants.com/"><strong>https://www.qmrconsultants.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Larry L. Chism is a Senior Talent Acquisition Executive and entrepreneur with 25+ years of experience in full-cycle recruiting and strategic growth talent solutions. Throughout his career, Larry has placed hundreds of high-impact professionals—from junior contributors to C-suite leaders—across startups, Fortune 100 companies, and the biopharmaceutical and life sciences sectors. Notably, he has served in talent acquisition leadership roles supporting biopharma organizations, including Talent Acquisition at Rentschler Biopharma, where he focused on sourcing exceptional scientific, technical, and commercial talent in a highly competitive market.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Larry Chism has over 25 years of experience in recruitment.</li><li>AI is significantly changing how resumes are screened.</li><li>Headhunting is becoming more essential for higher-level positions.</li><li>There is a notable gap between retiring professionals and new graduates.</li><li>Quality of life considerations are increasingly important for job seekers.</li><li>Networking and mentorship are crucial for career advancement.</li><li>Internships provide valuable experience for new graduates.</li><li>The reliance on technology can create challenges in recruitment.</li><li>Maintaining a positive attitude is essential for job seekers.</li><li>Adaptability is key in the evolving job market.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Helping Enterprise podcast, host Heath Fletcher speaks with Larry Chism, a seasoned talent acquisition executive, about the evolving landscape of recruitment. They discuss the impact of technology, particularly AI, on hiring processes, the importance of human connection in recruitment, and the challenges faced by both job seekers and employers in today's market. Larry shares insights on bridging the gap between retiring professionals and new graduates, as well as the unique challenges within the healthcare sector. The conversation emphasizes the need for adaptability, networking, and maintaining a positive outlook in the face of change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Talent Acquisition and Larry Chism<br>04:03 The Evolution of Recruitment: Challenges and Opportunities<br>09:09 The Role of AI in Recruitment<br>15:14 Headhunting vs. Passive Recruitment<br>18:34 Bridging the Gap: Workforce Attrition and New Graduates<br>30:48 Challenges in the Healthcare Recruitment Landscape<br>35:21 Quality of Life and the Future of Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>  Larry L. Chism</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/larrylchism/"><strong> https://www.linkedin.com/in/larrylchism/</strong></a></li><li>Company / Affiliation:  <strong>Quantus Management Resources </strong><a href="https://www.qmrconsultants.com/"><strong>https://www.qmrconsultants.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Larry L. Chism is a Senior Talent Acquisition Executive and entrepreneur with 25+ years of experience in full-cycle recruiting and strategic growth talent solutions. Throughout his career, Larry has placed hundreds of high-impact professionals—from junior contributors to C-suite leaders—across startups, Fortune 100 companies, and the biopharmaceutical and life sciences sectors. Notably, he has served in talent acquisition leadership roles supporting biopharma organizations, including Talent Acquisition at Rentschler Biopharma, where he focused on sourcing exceptional scientific, technical, and commercial talent in a highly competitive market.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Larry Chism has over 25 years of experience in recruitment.</li><li>AI is significantly changing how resumes are screened.</li><li>Headhunting is becoming more essential for higher-level positions.</li><li>There is a notable gap between retiring professionals and new graduates.</li><li>Quality of life considerations are increasingly important for job seekers.</li><li>Networking and mentorship are crucial for career advancement.</li><li>Internships provide valuable experience for new graduates.</li><li>The reliance on technology can create challenges in recruitment.</li><li>Maintaining a positive attitude is essential for job seekers.</li><li>Adaptability is key in the evolving job market.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Mon, 22 Dec 2025 13:57:15 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/0a2fd806/f5834345.mp3" length="61244721" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/S-rv2c2atKsUWJv4l-JOUaj7i3IckVGSQ4QN7-MMU4I/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iMjQx/NDRmMjg4MDhkNTQw/ZWM3ZWM5Yjg0Mzgz/NzI2OS5qcGc.jpg"/>
      <itunes:duration>2544</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Helping Enterprise podcast, host Heath Fletcher speaks with Larry Chism, a seasoned talent acquisition executive, about the evolving landscape of recruitment. They discuss the impact of technology, particularly AI, on hiring processes, the importance of human connection in recruitment, and the challenges faced by both job seekers and employers in today's market. Larry shares insights on bridging the gap between retiring professionals and new graduates, as well as the unique challenges within the healthcare sector. The conversation emphasizes the need for adaptability, networking, and maintaining a positive outlook in the face of change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Talent Acquisition and Larry Chism<br>04:03 The Evolution of Recruitment: Challenges and Opportunities<br>09:09 The Role of AI in Recruitment<br>15:14 Headhunting vs. Passive Recruitment<br>18:34 Bridging the Gap: Workforce Attrition and New Graduates<br>30:48 Challenges in the Healthcare Recruitment Landscape<br>35:21 Quality of Life and the Future of Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>  Larry L. Chism</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/larrylchism/"><strong> https://www.linkedin.com/in/larrylchism/</strong></a></li><li>Company / Affiliation:  <strong>Quantus Management Resources </strong><a href="https://www.qmrconsultants.com/"><strong>https://www.qmrconsultants.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Larry L. Chism is a Senior Talent Acquisition Executive and entrepreneur with 25+ years of experience in full-cycle recruiting and strategic growth talent solutions. Throughout his career, Larry has placed hundreds of high-impact professionals—from junior contributors to C-suite leaders—across startups, Fortune 100 companies, and the biopharmaceutical and life sciences sectors. Notably, he has served in talent acquisition leadership roles supporting biopharma organizations, including Talent Acquisition at Rentschler Biopharma, where he focused on sourcing exceptional scientific, technical, and commercial talent in a highly competitive market.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Larry Chism has over 25 years of experience in recruitment.</li><li>AI is significantly changing how resumes are screened.</li><li>Headhunting is becoming more essential for higher-level positions.</li><li>There is a notable gap between retiring professionals and new graduates.</li><li>Quality of life considerations are increasingly important for job seekers.</li><li>Networking and mentorship are crucial for career advancement.</li><li>Internships provide valuable experience for new graduates.</li><li>The reliance on technology can create challenges in recruitment.</li><li>Maintaining a positive attitude is essential for job seekers.</li><li>Adaptability is key in the evolving job market.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>talent acquisition, recruitment, AI in hiring, workforce development, healthcare staffing, headhunting, job market trends, career coaching, workforce gaps, quality of life</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Guest" href="https://www.qmrconsultants.com/" img="https://img.transistorcdn.com/10T5P7BklondZuE_iDlK0NR3kesydpd9EEGBwJmpc54/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mYzU1/Y2M5NjI1OTRmMDk3/M2ZlZWM1OWI2MmI5/N2RiYS5qcGVn.jpg"> Larry L. Chism</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/0a2fd806/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Beyond the Microscope: Light, Data, and the Future of Biomedical Imaging with Georg Draude</title>
      <itunes:episode>60</itunes:episode>
      <podcast:episode>60</podcast:episode>
      <itunes:title>Beyond the Microscope: Light, Data, and the Future of Biomedical Imaging with Georg Draude</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e2b6bd5a-b364-4aa9-9619-42714186ca37</guid>
      <link>https://share.transistor.fm/s/c662f081</link>
      <description>
        <![CDATA[<p>In this episode of the Healthy Enterprise Podcast, Georg Draude, General Manager of Chroma Technology, discusses the company's innovative work in optical filters and imaging solutions. With a background in biomedical sciences, Georg shares insights into the role of optical filters in biomedical research, advancements in microscopy technology, and the intersection of micro and macro perspectives in science. He also reflects on his transition from academia to industry, the future challenges and opportunities for Chroma, and the potential role of AI in enhancing research capabilities.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Chroma Technology and Georg Draude<br>05:59 The Role of Optical Filters in Biomedical Research<br>12:00 Advancements in Microscopy and Imaging Technology<br>18:13 The Intersection of Micro and Macro: Space and Microscopy<br>24:04 Transitioning from Academia to Industry<br>30:09 Future Challenges and Opportunities for Chroma Technology<br>36:04 The Role of AI in Optical Filter Design and Research</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Georg Draude</strong></li><li>Guest's Title/Position:<strong>  General Manager</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/georg-draude/"><strong>https://www.linkedin.com/in/georg-draude/</strong></a></li><li>Company / Affiliation: <strong>Chroma Technology </strong><a href="https://www.chroma.com/"><strong>https://www.chroma.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Georg Draude is a seasoned leader at the intersection of photonics, biotechnology, and advanced imaging. He currently serves as General Manager at Chroma Technology GmbH, where he has led commercial and market strategy since 2010. With a background spanning sales leadership, high-end imaging systems, and biomedical research, Georg brings a rare blend of scientific depth and market insight. He holds a doctorate in medical sciences from Ludwig-Maximilians-Universität München and has built his career translating complex technologies into real-world impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Chroma Technology specializes in producing optical filters for microscopy applications.</li><li>The company collaborates closely with researchers to develop specific filter sets for their experiments.</li><li>Advancements in camera technology have significantly improved microscopy capabilities.</li><li>There is a growing trend towards miniaturization in biomedical devices.</li><li>AI can assist in analyzing large datasets generated by modern microscopy techniques.</li><li>Georg's transition from academia to industry highlights the importance of networking.</li><li>Effective communication is key in translating complex scientific concepts to broader audiences.</li><li>Chroma's independence in the market allows for innovative and flexible solutions.</li><li>The company is involved in various industries beyond biomedical research, including astronomy.</li><li>Collaboration in the scientific community transcends borders and backgrounds.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Healthy Enterprise Podcast, Georg Draude, General Manager of Chroma Technology, discusses the company's innovative work in optical filters and imaging solutions. With a background in biomedical sciences, Georg shares insights into the role of optical filters in biomedical research, advancements in microscopy technology, and the intersection of micro and macro perspectives in science. He also reflects on his transition from academia to industry, the future challenges and opportunities for Chroma, and the potential role of AI in enhancing research capabilities.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Chroma Technology and Georg Draude<br>05:59 The Role of Optical Filters in Biomedical Research<br>12:00 Advancements in Microscopy and Imaging Technology<br>18:13 The Intersection of Micro and Macro: Space and Microscopy<br>24:04 Transitioning from Academia to Industry<br>30:09 Future Challenges and Opportunities for Chroma Technology<br>36:04 The Role of AI in Optical Filter Design and Research</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Georg Draude</strong></li><li>Guest's Title/Position:<strong>  General Manager</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/georg-draude/"><strong>https://www.linkedin.com/in/georg-draude/</strong></a></li><li>Company / Affiliation: <strong>Chroma Technology </strong><a href="https://www.chroma.com/"><strong>https://www.chroma.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Georg Draude is a seasoned leader at the intersection of photonics, biotechnology, and advanced imaging. He currently serves as General Manager at Chroma Technology GmbH, where he has led commercial and market strategy since 2010. With a background spanning sales leadership, high-end imaging systems, and biomedical research, Georg brings a rare blend of scientific depth and market insight. He holds a doctorate in medical sciences from Ludwig-Maximilians-Universität München and has built his career translating complex technologies into real-world impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Chroma Technology specializes in producing optical filters for microscopy applications.</li><li>The company collaborates closely with researchers to develop specific filter sets for their experiments.</li><li>Advancements in camera technology have significantly improved microscopy capabilities.</li><li>There is a growing trend towards miniaturization in biomedical devices.</li><li>AI can assist in analyzing large datasets generated by modern microscopy techniques.</li><li>Georg's transition from academia to industry highlights the importance of networking.</li><li>Effective communication is key in translating complex scientific concepts to broader audiences.</li><li>Chroma's independence in the market allows for innovative and flexible solutions.</li><li>The company is involved in various industries beyond biomedical research, including astronomy.</li><li>Collaboration in the scientific community transcends borders and backgrounds.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 19 Dec 2025 11:00:18 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/c662f081/02b05ef1.mp3" length="59701209" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/_e6xprxvFG7acF_Zuez9Tlt3Cdxb3heoJuD8_laCSkk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZTVh/YmZhNzk1ODA0Zjcz/MWViZWExZTFkNDFj/NTc3Ny5qcGc.jpg"/>
      <itunes:duration>2483</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Healthy Enterprise Podcast, Georg Draude, General Manager of Chroma Technology, discusses the company's innovative work in optical filters and imaging solutions. With a background in biomedical sciences, Georg shares insights into the role of optical filters in biomedical research, advancements in microscopy technology, and the intersection of micro and macro perspectives in science. He also reflects on his transition from academia to industry, the future challenges and opportunities for Chroma, and the potential role of AI in enhancing research capabilities.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Chroma Technology and Georg Draude<br>05:59 The Role of Optical Filters in Biomedical Research<br>12:00 Advancements in Microscopy and Imaging Technology<br>18:13 The Intersection of Micro and Macro: Space and Microscopy<br>24:04 Transitioning from Academia to Industry<br>30:09 Future Challenges and Opportunities for Chroma Technology<br>36:04 The Role of AI in Optical Filter Design and Research</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Georg Draude</strong></li><li>Guest's Title/Position:<strong>  General Manager</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/georg-draude/"><strong>https://www.linkedin.com/in/georg-draude/</strong></a></li><li>Company / Affiliation: <strong>Chroma Technology </strong><a href="https://www.chroma.com/"><strong>https://www.chroma.com/</strong></a></li><li>Guest's Bio:<strong>  </strong>Georg Draude is a seasoned leader at the intersection of photonics, biotechnology, and advanced imaging. He currently serves as General Manager at Chroma Technology GmbH, where he has led commercial and market strategy since 2010. With a background spanning sales leadership, high-end imaging systems, and biomedical research, Georg brings a rare blend of scientific depth and market insight. He holds a doctorate in medical sciences from Ludwig-Maximilians-Universität München and has built his career translating complex technologies into real-world impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Chroma Technology specializes in producing optical filters for microscopy applications.</li><li>The company collaborates closely with researchers to develop specific filter sets for their experiments.</li><li>Advancements in camera technology have significantly improved microscopy capabilities.</li><li>There is a growing trend towards miniaturization in biomedical devices.</li><li>AI can assist in analyzing large datasets generated by modern microscopy techniques.</li><li>Georg's transition from academia to industry highlights the importance of networking.</li><li>Effective communication is key in translating complex scientific concepts to broader audiences.</li><li>Chroma's independence in the market allows for innovative and flexible solutions.</li><li>The company is involved in various industries beyond biomedical research, including astronomy.</li><li>Collaboration in the scientific community transcends borders and backgrounds.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Chroma Technology, optical filters, biomedical research, microscopy, imaging solutions, Georg Draude, light manipulation, AI in research, industry transition, scientific collaboration</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.chroma.com/" img="https://img.transistorcdn.com/jDFPM0R2K0MUWI_9y7lpsAlhTDle7sK2ikxYrEhjB6s/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80MjU2/YzU4ZjQyMjZkZDQ5/ZDUxN2VkMWY5Y2Ni/ZjFlNi5qcGVn.jpg">Georg Draude</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/c662f081/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Holistic Mental Health: Bridging Mind, Body, and Community with Dr. Psyche Young</title>
      <itunes:episode>59</itunes:episode>
      <podcast:episode>59</podcast:episode>
      <itunes:title>Holistic Mental Health: Bridging Mind, Body, and Community with Dr. Psyche Young</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">098cefe0-52e3-4129-a85d-63b03d5c7dde</guid>
      <link>https://share.transistor.fm/s/2ed830c0</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. Psyche Young, a licensed professional counselor and trauma-informed therapist, shares her path into mental health and the values that guide her work. She explores the importance of transparency in therapy, work-life balance, and an integrative model of care that honors the mind-body-spirit connection. Dr. Young also unpacks the realities of modern mental health care — from insurance challenges and the rise of telehealth to the growing role of technology and psychoeducation in prevention. The conversation offers thoughtful insight and practical advice for both clients and aspiring therapists navigating today’s mental health landscape.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. Psyche Young<br>02:24 Journey into Mental Health<br>03:36 Specializations in Therapy<br>05:03 Balancing Life and Business<br>06:10 Understanding Stress and Work-Life Balance<br>09:02 The Importance of Transparency in Therapy<br>10:30 Core Values and Purpose<br>14:11 Integrative Care in Mental Health<br>17:12 Mind-Body-Spirit Connection<br>19:22 Building Therapeutic Relationships<br>21:45 The Ripple Effect of Therapy<br>23:05 Navigating Insurance and Payment Disparities<br>24:10 The Role of Technology in Therapy<br>25:24 The Human Element in Telehealth<br>28:41 Expanding Reach Through Speaking Engagements<br>33:05 Supporting Healthcare Professionals<br>36:50 The Importance of Psychoeducation<br>39:28 Future Projects and Growth<br>40:41 Advice for Aspiring Therapists</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Psyche Young</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/"><strong>https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/</strong></a></li><li>Company / Affiliation: <strong>YaH Vision Counseling &amp; Wellness   </strong><a href="https://www.yahvisioncw.com"><strong>https://www.yahvisioncw.com</strong></a><strong>  |  </strong><a href="https://www.instagram.com/yahvisioncounseling/"><strong>https://www.instagram.com/yahvisioncounseling/</strong></a><strong>  |  </strong><a href="https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/"><strong>https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/</strong></a></li><li>Guest's Bio:<strong> Psyche Young, Ph.D., LPC</strong> is a licensed psychotherapist, consultant, and public speaker with over a decade of clinical experience supporting individuals, couples, and families. She is the Owner and CEO of <strong>YaH Vision Counseling &amp; Wellness LLC</strong> and Co-Founder of YaH Vision Productions, with a particular focus on marriage and family therapy and working with military families navigating complex life transitions. A recognized thought leader in mental health, Dr. Young empowers clients to overcome barriers to personal and professional growth while building emotional resilience and sustainable wellness strategies. She is an engaging speaker and trusted consultant known for blending clinical expertise with real-world application. Dr. Young is a member of the American Association for Marriage and Family Therapy (AAMFT) and the American Counseling Association (ACA) and is guided by a core belief that wellness is not a privilege — it’s a human right.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Psyche Young has over 20 years of experience in mental health.</li><li>She specializes in marriage and family therapy, particularly with military families.</li><li>Work-life balance is crucial for mental health and well-being.</li><li>Stress often indicates a lack of balance in life.</li><li>Transparency in therapy is essential for effective treatment.</li><li>Core values play a significant role in personal fulfillment.</li><li>Mental health is interconnected with physical and social health.</li><li>Integrative care models are becoming more common in healthcare.</li><li>Building rapport with clients is vital for therapeutic success.</li><li>The ripple effect of therapy can lead to healthier families and communities. </li><li>Insurance disparities affect access to mental health care.</li><li>Telehealth offers convenience but lacks the human touch.</li><li>Healthcare professionals are increasingly prioritizing their mental health.</li><li>Psychoeducation is vital for understanding mental health experiences.</li><li>Proactive approaches are better than reactive ones in mental health care.</li><li>The body’s chemical responses play a role in mental health.</li><li>Networking is essential for growth in the mental health field.</li><li>Support is available for those seeking help.</li><li>Self-care is crucial for healthcare providers.</li><li>Future projects can enhance community support and outreach.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. Psyche Young, a licensed professional counselor and trauma-informed therapist, shares her path into mental health and the values that guide her work. She explores the importance of transparency in therapy, work-life balance, and an integrative model of care that honors the mind-body-spirit connection. Dr. Young also unpacks the realities of modern mental health care — from insurance challenges and the rise of telehealth to the growing role of technology and psychoeducation in prevention. The conversation offers thoughtful insight and practical advice for both clients and aspiring therapists navigating today’s mental health landscape.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. Psyche Young<br>02:24 Journey into Mental Health<br>03:36 Specializations in Therapy<br>05:03 Balancing Life and Business<br>06:10 Understanding Stress and Work-Life Balance<br>09:02 The Importance of Transparency in Therapy<br>10:30 Core Values and Purpose<br>14:11 Integrative Care in Mental Health<br>17:12 Mind-Body-Spirit Connection<br>19:22 Building Therapeutic Relationships<br>21:45 The Ripple Effect of Therapy<br>23:05 Navigating Insurance and Payment Disparities<br>24:10 The Role of Technology in Therapy<br>25:24 The Human Element in Telehealth<br>28:41 Expanding Reach Through Speaking Engagements<br>33:05 Supporting Healthcare Professionals<br>36:50 The Importance of Psychoeducation<br>39:28 Future Projects and Growth<br>40:41 Advice for Aspiring Therapists</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Psyche Young</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/"><strong>https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/</strong></a></li><li>Company / Affiliation: <strong>YaH Vision Counseling &amp; Wellness   </strong><a href="https://www.yahvisioncw.com"><strong>https://www.yahvisioncw.com</strong></a><strong>  |  </strong><a href="https://www.instagram.com/yahvisioncounseling/"><strong>https://www.instagram.com/yahvisioncounseling/</strong></a><strong>  |  </strong><a href="https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/"><strong>https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/</strong></a></li><li>Guest's Bio:<strong> Psyche Young, Ph.D., LPC</strong> is a licensed psychotherapist, consultant, and public speaker with over a decade of clinical experience supporting individuals, couples, and families. She is the Owner and CEO of <strong>YaH Vision Counseling &amp; Wellness LLC</strong> and Co-Founder of YaH Vision Productions, with a particular focus on marriage and family therapy and working with military families navigating complex life transitions. A recognized thought leader in mental health, Dr. Young empowers clients to overcome barriers to personal and professional growth while building emotional resilience and sustainable wellness strategies. She is an engaging speaker and trusted consultant known for blending clinical expertise with real-world application. Dr. Young is a member of the American Association for Marriage and Family Therapy (AAMFT) and the American Counseling Association (ACA) and is guided by a core belief that wellness is not a privilege — it’s a human right.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Psyche Young has over 20 years of experience in mental health.</li><li>She specializes in marriage and family therapy, particularly with military families.</li><li>Work-life balance is crucial for mental health and well-being.</li><li>Stress often indicates a lack of balance in life.</li><li>Transparency in therapy is essential for effective treatment.</li><li>Core values play a significant role in personal fulfillment.</li><li>Mental health is interconnected with physical and social health.</li><li>Integrative care models are becoming more common in healthcare.</li><li>Building rapport with clients is vital for therapeutic success.</li><li>The ripple effect of therapy can lead to healthier families and communities. </li><li>Insurance disparities affect access to mental health care.</li><li>Telehealth offers convenience but lacks the human touch.</li><li>Healthcare professionals are increasingly prioritizing their mental health.</li><li>Psychoeducation is vital for understanding mental health experiences.</li><li>Proactive approaches are better than reactive ones in mental health care.</li><li>The body’s chemical responses play a role in mental health.</li><li>Networking is essential for growth in the mental health field.</li><li>Support is available for those seeking help.</li><li>Self-care is crucial for healthcare providers.</li><li>Future projects can enhance community support and outreach.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 16 Dec 2025 14:41:01 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/2ed830c0/e515f937.mp3" length="64099364" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ylJrGdxX8vsKxfEHa6Z-65CXY-KEhGuNKzsGrZEMVWM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80Yjg4/YzM5MDYxM2Y2YjZm/ZGQyNWRhZGVlYzMw/Zjc0ZS5qcGc.jpg"/>
      <itunes:duration>2664</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. Psyche Young, a licensed professional counselor and trauma-informed therapist, shares her path into mental health and the values that guide her work. She explores the importance of transparency in therapy, work-life balance, and an integrative model of care that honors the mind-body-spirit connection. Dr. Young also unpacks the realities of modern mental health care — from insurance challenges and the rise of telehealth to the growing role of technology and psychoeducation in prevention. The conversation offers thoughtful insight and practical advice for both clients and aspiring therapists navigating today’s mental health landscape.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. Psyche Young<br>02:24 Journey into Mental Health<br>03:36 Specializations in Therapy<br>05:03 Balancing Life and Business<br>06:10 Understanding Stress and Work-Life Balance<br>09:02 The Importance of Transparency in Therapy<br>10:30 Core Values and Purpose<br>14:11 Integrative Care in Mental Health<br>17:12 Mind-Body-Spirit Connection<br>19:22 Building Therapeutic Relationships<br>21:45 The Ripple Effect of Therapy<br>23:05 Navigating Insurance and Payment Disparities<br>24:10 The Role of Technology in Therapy<br>25:24 The Human Element in Telehealth<br>28:41 Expanding Reach Through Speaking Engagements<br>33:05 Supporting Healthcare Professionals<br>36:50 The Importance of Psychoeducation<br>39:28 Future Projects and Growth<br>40:41 Advice for Aspiring Therapists</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Psyche Young</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/"><strong>https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/</strong></a></li><li>Company / Affiliation: <strong>YaH Vision Counseling &amp; Wellness   </strong><a href="https://www.yahvisioncw.com"><strong>https://www.yahvisioncw.com</strong></a><strong>  |  </strong><a href="https://www.instagram.com/yahvisioncounseling/"><strong>https://www.instagram.com/yahvisioncounseling/</strong></a><strong>  |  </strong><a href="https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/"><strong>https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/</strong></a></li><li>Guest's Bio:<strong> Psyche Young, Ph.D., LPC</strong> is a licensed psychotherapist, consultant, and public speaker with over a decade of clinical experience supporting individuals, couples, and families. She is the Owner and CEO of <strong>YaH Vision Counseling &amp; Wellness LLC</strong> and Co-Founder of YaH Vision Productions, with a particular focus on marriage and family therapy and working with military families navigating complex life transitions. A recognized thought leader in mental health, Dr. Young empowers clients to overcome barriers to personal and professional growth while building emotional resilience and sustainable wellness strategies. She is an engaging speaker and trusted consultant known for blending clinical expertise with real-world application. Dr. Young is a member of the American Association for Marriage and Family Therapy (AAMFT) and the American Counseling Association (ACA) and is guided by a core belief that wellness is not a privilege — it’s a human right.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Dr. Psyche Young has over 20 years of experience in mental health.</li><li>She specializes in marriage and family therapy, particularly with military families.</li><li>Work-life balance is crucial for mental health and well-being.</li><li>Stress often indicates a lack of balance in life.</li><li>Transparency in therapy is essential for effective treatment.</li><li>Core values play a significant role in personal fulfillment.</li><li>Mental health is interconnected with physical and social health.</li><li>Integrative care models are becoming more common in healthcare.</li><li>Building rapport with clients is vital for therapeutic success.</li><li>The ripple effect of therapy can lead to healthier families and communities. </li><li>Insurance disparities affect access to mental health care.</li><li>Telehealth offers convenience but lacks the human touch.</li><li>Healthcare professionals are increasingly prioritizing their mental health.</li><li>Psychoeducation is vital for understanding mental health experiences.</li><li>Proactive approaches are better than reactive ones in mental health care.</li><li>The body’s chemical responses play a role in mental health.</li><li>Networking is essential for growth in the mental health field.</li><li>Support is available for those seeking help.</li><li>Self-care is crucial for healthcare providers.</li><li>Future projects can enhance community support and outreach.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>mental health, therapy, work-life balance, stress management, core values, integrative care, holistic approach, transparency, family therapy, counseling, mental health, therapy, telehealth, psychoeducation, healthcare professionals, insurance disparities, technology in therapy, speaking engagements, self-care, future projects</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.yahvisioncw.com/" img="https://img.transistorcdn.com/NZBpi05QI2IBqC0_FyX0ZcW9iFOvmQPM_BYvgDMNHF4/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xYjgy/MzE4YmMxMmIzODc0/MTg4NGI3NDkyNDJl/ZTBlMC5qcGVn.jpg">Dr. Psyche Young</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/2ed830c0/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Connecting Care to Communities: Partnerships for Mental &amp; Public Health Access with April Joy Damian</title>
      <itunes:episode>58</itunes:episode>
      <podcast:episode>58</podcast:episode>
      <itunes:title>Connecting Care to Communities: Partnerships for Mental &amp; Public Health Access with April Joy Damian</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9b4030d9-e09e-4f3b-9d5c-95879759beb1</guid>
      <link>https://share.transistor.fm/s/9fb0dde6</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. April Joy Damian,  Chief Scientific Officer and Director of the Weitzman Institute, explores how health equity and social determinants of health shape the future of care for vulnerable populations. She discusses the institute’s mission across research, education, and policy, its partnerships with federally qualified health centers, and the real-world impact of community-driven programs. Dr. Damian highlights the power of storytelling in measuring outcomes, the role of coaching and leadership in building strong teams, and her vision for advancing innovation while training the next generation of healthcare leaders.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. April Joy Damian and the Weitzman Institute<br>03:03 The Mission and Impact of the Weitzman Institute<br>06:09 Partnerships and Community Engagement<br>09:04 Personal Motivation and Organizational Culture<br>12:04 Stories of Impact and Change<br>15:00 Addressing Childhood Trauma and Community Needs<br>18:08 Intergenerational Trauma and Community Solutions<br>21:02 The Role of Storytelling in Healthcare<br>23:54 The Importance of Continuous Improvement<br>26:49 Impactful Stories in Healthcare<br>29:25 Exponential Leadership and Team Empowerment<br>33:54 Finding Meaning and Joy in Work<br>36:45 The Value of Coaching in Leadership<br>41:31 Trusting the Process and Embracing Change<br>44:48 Innovation in Health Centers<br>46:55 Future Growth and Training the Next Generation</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. April Joy Damian</strong></li><li>Guest's Title/Position:<strong>  Chief Scientific Officer and Director</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/apriljoydamian/"><strong> https://www.linkedin.com/in/apriljoydamian/</strong></a></li><li>Company / Affiliation: <strong>Weitzman Institute </strong><a href="https://www.weitzmaninstitute.org/"><strong>https://www.weitzmaninstitute.org/</strong></a></li><li>Guest's Bio: <strong>Dr. April Joy Damian</strong> is an epidemiologist and health services researcher specializing in health equity, social determinants of health, and psychiatric epidemiology. She serves as <strong>Chief Scientific Officer and Director of the Weitzman Institute</strong>, leading research, education, and policy efforts to advance quality improvement and primary care transformation for vulnerable populations. Dr. Damian is also a Senior Scholar for Health Equity at Academy Health and holds faculty appointments at Johns Hopkins Bloomberg School of Public Health and Wesleyan University. A national thought leader, she contributes to multiple advisory boards and committees, including the National Academies and NIH’s RECOVER initiative. Previously, she directed Quality Innovation at the National Quality Forum, expanding efforts around social determinants of health measurement. Dr. Damian earned her PhD from Johns Hopkins, a master’s from Harvard Medical School, and her bachelor’s degree with highest honors from UC Berkeley.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Dr. April Joy Damian is an expert in health equity and psychiatric epidemiology.</li><li>The Weitzman Institute focuses on transforming primary care for vulnerable populations.</li><li>Partnerships with federally qualified health centers are crucial for community health.</li><li>The mission of alleviating human suffering drives Dr. Damian's work.</li><li>Stories from patients and providers highlight the impact of healthcare initiatives.</li><li>Intergenerational trauma is a significant focus of their programs.</li><li>Practice-based research informs the needs of the communities served.</li><li>Continuous quality improvement is essential for effective healthcare delivery.</li><li>The importance of emotional regulation and social skills in youth programs.</li><li>Storytelling is a powerful tool for understanding healthcare impact. </li><li>Stories validate and demystify what's going on out there.</li><li>It's important to understand that everyone receives information differently.</li><li>Exponential leadership creates a ripple effect.</li><li>Finding meaning in work leads to unwavering commitment.</li><li>Caring without attachment is a powerful lesson.</li><li>Innovation is born when your back is against the wall.</li><li>We are training the next generation of leaders.</li><li>The work is more important than any individual.</li><li>Everyone has a different way of absorbing information.</li><li>Trusting that it will work out is essential.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. April Joy Damian,  Chief Scientific Officer and Director of the Weitzman Institute, explores how health equity and social determinants of health shape the future of care for vulnerable populations. She discusses the institute’s mission across research, education, and policy, its partnerships with federally qualified health centers, and the real-world impact of community-driven programs. Dr. Damian highlights the power of storytelling in measuring outcomes, the role of coaching and leadership in building strong teams, and her vision for advancing innovation while training the next generation of healthcare leaders.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. April Joy Damian and the Weitzman Institute<br>03:03 The Mission and Impact of the Weitzman Institute<br>06:09 Partnerships and Community Engagement<br>09:04 Personal Motivation and Organizational Culture<br>12:04 Stories of Impact and Change<br>15:00 Addressing Childhood Trauma and Community Needs<br>18:08 Intergenerational Trauma and Community Solutions<br>21:02 The Role of Storytelling in Healthcare<br>23:54 The Importance of Continuous Improvement<br>26:49 Impactful Stories in Healthcare<br>29:25 Exponential Leadership and Team Empowerment<br>33:54 Finding Meaning and Joy in Work<br>36:45 The Value of Coaching in Leadership<br>41:31 Trusting the Process and Embracing Change<br>44:48 Innovation in Health Centers<br>46:55 Future Growth and Training the Next Generation</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. April Joy Damian</strong></li><li>Guest's Title/Position:<strong>  Chief Scientific Officer and Director</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/apriljoydamian/"><strong> https://www.linkedin.com/in/apriljoydamian/</strong></a></li><li>Company / Affiliation: <strong>Weitzman Institute </strong><a href="https://www.weitzmaninstitute.org/"><strong>https://www.weitzmaninstitute.org/</strong></a></li><li>Guest's Bio: <strong>Dr. April Joy Damian</strong> is an epidemiologist and health services researcher specializing in health equity, social determinants of health, and psychiatric epidemiology. She serves as <strong>Chief Scientific Officer and Director of the Weitzman Institute</strong>, leading research, education, and policy efforts to advance quality improvement and primary care transformation for vulnerable populations. Dr. Damian is also a Senior Scholar for Health Equity at Academy Health and holds faculty appointments at Johns Hopkins Bloomberg School of Public Health and Wesleyan University. A national thought leader, she contributes to multiple advisory boards and committees, including the National Academies and NIH’s RECOVER initiative. Previously, she directed Quality Innovation at the National Quality Forum, expanding efforts around social determinants of health measurement. Dr. Damian earned her PhD from Johns Hopkins, a master’s from Harvard Medical School, and her bachelor’s degree with highest honors from UC Berkeley.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Dr. April Joy Damian is an expert in health equity and psychiatric epidemiology.</li><li>The Weitzman Institute focuses on transforming primary care for vulnerable populations.</li><li>Partnerships with federally qualified health centers are crucial for community health.</li><li>The mission of alleviating human suffering drives Dr. Damian's work.</li><li>Stories from patients and providers highlight the impact of healthcare initiatives.</li><li>Intergenerational trauma is a significant focus of their programs.</li><li>Practice-based research informs the needs of the communities served.</li><li>Continuous quality improvement is essential for effective healthcare delivery.</li><li>The importance of emotional regulation and social skills in youth programs.</li><li>Storytelling is a powerful tool for understanding healthcare impact. </li><li>Stories validate and demystify what's going on out there.</li><li>It's important to understand that everyone receives information differently.</li><li>Exponential leadership creates a ripple effect.</li><li>Finding meaning in work leads to unwavering commitment.</li><li>Caring without attachment is a powerful lesson.</li><li>Innovation is born when your back is against the wall.</li><li>We are training the next generation of leaders.</li><li>The work is more important than any individual.</li><li>Everyone has a different way of absorbing information.</li><li>Trusting that it will work out is essential.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </content:encoded>
      <pubDate>Thu, 11 Dec 2025 09:15:47 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/9fb0dde6/d1ff6ad9.mp3" length="72793506" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/kQ2-fGlIKbIdJcf29MKFBN6Vd-rIGitDk9ldj17aAkk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hY2Vi/NDRjNjk5ZDUzMjhh/MzgyZDgxY2EyZDc4/NjdmNy5qcGc.jpg"/>
      <itunes:duration>3028</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Dr. April Joy Damian,  Chief Scientific Officer and Director of the Weitzman Institute, explores how health equity and social determinants of health shape the future of care for vulnerable populations. She discusses the institute’s mission across research, education, and policy, its partnerships with federally qualified health centers, and the real-world impact of community-driven programs. Dr. Damian highlights the power of storytelling in measuring outcomes, the role of coaching and leadership in building strong teams, and her vision for advancing innovation while training the next generation of healthcare leaders.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Dr. April Joy Damian and the Weitzman Institute<br>03:03 The Mission and Impact of the Weitzman Institute<br>06:09 Partnerships and Community Engagement<br>09:04 Personal Motivation and Organizational Culture<br>12:04 Stories of Impact and Change<br>15:00 Addressing Childhood Trauma and Community Needs<br>18:08 Intergenerational Trauma and Community Solutions<br>21:02 The Role of Storytelling in Healthcare<br>23:54 The Importance of Continuous Improvement<br>26:49 Impactful Stories in Healthcare<br>29:25 Exponential Leadership and Team Empowerment<br>33:54 Finding Meaning and Joy in Work<br>36:45 The Value of Coaching in Leadership<br>41:31 Trusting the Process and Embracing Change<br>44:48 Innovation in Health Centers<br>46:55 Future Growth and Training the Next Generation</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. April Joy Damian</strong></li><li>Guest's Title/Position:<strong>  Chief Scientific Officer and Director</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/apriljoydamian/"><strong> https://www.linkedin.com/in/apriljoydamian/</strong></a></li><li>Company / Affiliation: <strong>Weitzman Institute </strong><a href="https://www.weitzmaninstitute.org/"><strong>https://www.weitzmaninstitute.org/</strong></a></li><li>Guest's Bio: <strong>Dr. April Joy Damian</strong> is an epidemiologist and health services researcher specializing in health equity, social determinants of health, and psychiatric epidemiology. She serves as <strong>Chief Scientific Officer and Director of the Weitzman Institute</strong>, leading research, education, and policy efforts to advance quality improvement and primary care transformation for vulnerable populations. Dr. Damian is also a Senior Scholar for Health Equity at Academy Health and holds faculty appointments at Johns Hopkins Bloomberg School of Public Health and Wesleyan University. A national thought leader, she contributes to multiple advisory boards and committees, including the National Academies and NIH’s RECOVER initiative. Previously, she directed Quality Innovation at the National Quality Forum, expanding efforts around social determinants of health measurement. Dr. Damian earned her PhD from Johns Hopkins, a master’s from Harvard Medical School, and her bachelor’s degree with highest honors from UC Berkeley.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Dr. April Joy Damian is an expert in health equity and psychiatric epidemiology.</li><li>The Weitzman Institute focuses on transforming primary care for vulnerable populations.</li><li>Partnerships with federally qualified health centers are crucial for community health.</li><li>The mission of alleviating human suffering drives Dr. Damian's work.</li><li>Stories from patients and providers highlight the impact of healthcare initiatives.</li><li>Intergenerational trauma is a significant focus of their programs.</li><li>Practice-based research informs the needs of the communities served.</li><li>Continuous quality improvement is essential for effective healthcare delivery.</li><li>The importance of emotional regulation and social skills in youth programs.</li><li>Storytelling is a powerful tool for understanding healthcare impact. </li><li>Stories validate and demystify what's going on out there.</li><li>It's important to understand that everyone receives information differently.</li><li>Exponential leadership creates a ripple effect.</li><li>Finding meaning in work leads to unwavering commitment.</li><li>Caring without attachment is a powerful lesson.</li><li>Innovation is born when your back is against the wall.</li><li>We are training the next generation of leaders.</li><li>The work is more important than any individual.</li><li>Everyone has a different way of absorbing information.</li><li>Trusting that it will work out is essential.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>health equity, mental health, Weitzman Institute, community health, partnerships, intergenerational trauma, storytelling, healthcare innovation, public health, patient care, storytelling, leadership, coaching, health innovation, workforce development, community health, mental health, public health, Weizmann Institute, exponential growth</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.weitzmaninstitute.org/" img="https://img.transistorcdn.com/IIL_f6r0yxu8Sl_VHHBjQrrYLxV99orxiFYi-RYShl4/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jYTNh/MmM4MWVlMDc5YmU4/MmI1ZTRlOTQxMWI2/MDllNy5qcGVn.jpg"> Dr. April Joy Damian</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/9fb0dde6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Primary Care Innovation: Reinventing the Patient Care Experience with Laurence Bauer</title>
      <itunes:episode>57</itunes:episode>
      <podcast:episode>57</podcast:episode>
      <itunes:title>Primary Care Innovation: Reinventing the Patient Care Experience with Laurence Bauer</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">996a6c03-dc6f-4ccd-b5bf-f236aeefa6b1</guid>
      <link>https://share.transistor.fm/s/a3febafa</link>
      <description>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Laurence Bauer discusses his extensive experience in family medicine education and primary care workforce development. He shares insights on the importance of primary care, the innovations emerging in the field, and the challenges faced by the healthcare system. Laurence emphasizes the need for interpersonal skills in healthcare and the role of family physicians in community health. He also highlights the impact of telehealth and the significance of the Primary Care Innovators Network in fostering innovation. The conversation concludes with reflections on the future of primary care and the importance of building trust and relationships in healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Laurence Bauer and His Journey<br>06:07 Innovations in Primary Care<br>11:48 The Importance of Primary Care<br>17:57 Challenges in the Healthcare System<br>23:51 The Role of Telehealth<br>29:51 The Primary Care Innovators Network<br>35:57 The Future of Primary Care and Innovations<br>41:58 Interpersonal Skills in Healthcare<br>47:55 Conclusion and Final Thoughts</p><p><br><strong>Guest Information:</strong></p><ul><li><strong>Guest's Name: </strong>Laurence Bauer </li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/laurence-bauer-70a6746/"><strong>https://www.linkedin.com/in/laurence-bauer-70a6746/</strong></a></li><li>Company / Affiliation:  <strong>Primary Care Innovators Network  </strong><a href="https://thepcin.net/"><strong>https://thepcin.net/ </strong></a></li><li>Guest's Bio: <strong>Laurence C. Bauer, M.S.W., M.Ed.</strong> is a longtime leader in family medicine education and primary care development. He served as CEO of the Family Medicine Education Consortium (1994–2021), advancing collaboration across academic and primary care communities in the Northeast. He also held leadership roles at the Center for Innovation in Family and Community Health and served as Associate Clinical Professor at Wright State University, with prior faculty development positions at The Ohio State University and Penn State College of Medicine. Now an active consultant, he remains dedicated to building a primary-care–driven U.S. healthcare system. Based in Hershey, PA, he enjoys time with family, pickleball, basketball, and gardening.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Laurence Bauer has a rich background in family medicine education.</li><li>Innovations in primary care often come from community-level practitioners.</li><li>A significant portion of healthcare spending is wasted due to lack of primary care.</li><li>Telehealth is improving accessibility to healthcare services.</li><li>There is a critical shortage of family physicians in the U.S.</li><li>Interpersonal skills are essential for effective patient care.</li><li>Healthcare is fundamentally about human relationships and trust.</li><li>The Primary Care Innovators Network fosters collaboration and innovation.</li><li>Curiosity and adventure drive Lawrence's approach to healthcare.</li><li>Creating healthy systems is vital for improving community health.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Laurence Bauer discusses his extensive experience in family medicine education and primary care workforce development. He shares insights on the importance of primary care, the innovations emerging in the field, and the challenges faced by the healthcare system. Laurence emphasizes the need for interpersonal skills in healthcare and the role of family physicians in community health. He also highlights the impact of telehealth and the significance of the Primary Care Innovators Network in fostering innovation. The conversation concludes with reflections on the future of primary care and the importance of building trust and relationships in healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Laurence Bauer and His Journey<br>06:07 Innovations in Primary Care<br>11:48 The Importance of Primary Care<br>17:57 Challenges in the Healthcare System<br>23:51 The Role of Telehealth<br>29:51 The Primary Care Innovators Network<br>35:57 The Future of Primary Care and Innovations<br>41:58 Interpersonal Skills in Healthcare<br>47:55 Conclusion and Final Thoughts</p><p><br><strong>Guest Information:</strong></p><ul><li><strong>Guest's Name: </strong>Laurence Bauer </li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/laurence-bauer-70a6746/"><strong>https://www.linkedin.com/in/laurence-bauer-70a6746/</strong></a></li><li>Company / Affiliation:  <strong>Primary Care Innovators Network  </strong><a href="https://thepcin.net/"><strong>https://thepcin.net/ </strong></a></li><li>Guest's Bio: <strong>Laurence C. Bauer, M.S.W., M.Ed.</strong> is a longtime leader in family medicine education and primary care development. He served as CEO of the Family Medicine Education Consortium (1994–2021), advancing collaboration across academic and primary care communities in the Northeast. He also held leadership roles at the Center for Innovation in Family and Community Health and served as Associate Clinical Professor at Wright State University, with prior faculty development positions at The Ohio State University and Penn State College of Medicine. Now an active consultant, he remains dedicated to building a primary-care–driven U.S. healthcare system. Based in Hershey, PA, he enjoys time with family, pickleball, basketball, and gardening.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Laurence Bauer has a rich background in family medicine education.</li><li>Innovations in primary care often come from community-level practitioners.</li><li>A significant portion of healthcare spending is wasted due to lack of primary care.</li><li>Telehealth is improving accessibility to healthcare services.</li><li>There is a critical shortage of family physicians in the U.S.</li><li>Interpersonal skills are essential for effective patient care.</li><li>Healthcare is fundamentally about human relationships and trust.</li><li>The Primary Care Innovators Network fosters collaboration and innovation.</li><li>Curiosity and adventure drive Lawrence's approach to healthcare.</li><li>Creating healthy systems is vital for improving community health.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Mon, 08 Dec 2025 22:10:30 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/a3febafa/08ef71b3.mp3" length="72881784" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ony3AuhU4IqMdMANoSBbIt-ci2IxvlF3pJneSP2GXEY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yOGE1/MmZhMjhhZGViZWQ2/ZDBjZmM1MzNmMTQ0/NjlkMS5qcGc.jpg"/>
      <itunes:duration>3033</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Laurence Bauer discusses his extensive experience in family medicine education and primary care workforce development. He shares insights on the importance of primary care, the innovations emerging in the field, and the challenges faced by the healthcare system. Laurence emphasizes the need for interpersonal skills in healthcare and the role of family physicians in community health. He also highlights the impact of telehealth and the significance of the Primary Care Innovators Network in fostering innovation. The conversation concludes with reflections on the future of primary care and the importance of building trust and relationships in healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Laurence Bauer and His Journey<br>06:07 Innovations in Primary Care<br>11:48 The Importance of Primary Care<br>17:57 Challenges in the Healthcare System<br>23:51 The Role of Telehealth<br>29:51 The Primary Care Innovators Network<br>35:57 The Future of Primary Care and Innovations<br>41:58 Interpersonal Skills in Healthcare<br>47:55 Conclusion and Final Thoughts</p><p><br><strong>Guest Information:</strong></p><ul><li><strong>Guest's Name: </strong>Laurence Bauer </li><li>Guest's Title/Position:<strong>  Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/laurence-bauer-70a6746/"><strong>https://www.linkedin.com/in/laurence-bauer-70a6746/</strong></a></li><li>Company / Affiliation:  <strong>Primary Care Innovators Network  </strong><a href="https://thepcin.net/"><strong>https://thepcin.net/ </strong></a></li><li>Guest's Bio: <strong>Laurence C. Bauer, M.S.W., M.Ed.</strong> is a longtime leader in family medicine education and primary care development. He served as CEO of the Family Medicine Education Consortium (1994–2021), advancing collaboration across academic and primary care communities in the Northeast. He also held leadership roles at the Center for Innovation in Family and Community Health and served as Associate Clinical Professor at Wright State University, with prior faculty development positions at The Ohio State University and Penn State College of Medicine. Now an active consultant, he remains dedicated to building a primary-care–driven U.S. healthcare system. Based in Hershey, PA, he enjoys time with family, pickleball, basketball, and gardening.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Laurence Bauer has a rich background in family medicine education.</li><li>Innovations in primary care often come from community-level practitioners.</li><li>A significant portion of healthcare spending is wasted due to lack of primary care.</li><li>Telehealth is improving accessibility to healthcare services.</li><li>There is a critical shortage of family physicians in the U.S.</li><li>Interpersonal skills are essential for effective patient care.</li><li>Healthcare is fundamentally about human relationships and trust.</li><li>The Primary Care Innovators Network fosters collaboration and innovation.</li><li>Curiosity and adventure drive Lawrence's approach to healthcare.</li><li>Creating healthy systems is vital for improving community health.</li></ul><p><br></p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>primary care, healthcare innovation, family medicine, telehealth, healthcare system, interpersonal skills, community health, healthcare challenges, medical education, healthcare workforce</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://thepcin.net/" img="https://img.transistorcdn.com/jn5gJ_6098bW3acvKnrO5N2f7Ra0pL4rWvWLyVJ4L10/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85MjU4/MGYyZDEyOWY5N2Zm/MmI3MGRmZWE4ODYz/N2Y2OC5qcGVn.jpg">Laurence Bauer</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/a3febafa/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/a3febafa/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/a3febafa/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/a3febafa/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/a3febafa/transcription" type="text/html"/>
    </item>
    <item>
      <title>Pain, Process, and Purpose: Enhancing Patient Outcomes in Therapy with Jeffrey Petersen</title>
      <itunes:episode>56</itunes:episode>
      <podcast:episode>56</podcast:episode>
      <itunes:title>Pain, Process, and Purpose: Enhancing Patient Outcomes in Therapy with Jeffrey Petersen</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ee449f29-1fb0-4167-88ec-ed5f1ba73fec</guid>
      <link>https://share.transistor.fm/s/cf1d96c6</link>
      <description>
        <![CDATA[<p>In this episode, Jeffrey Petersen shares lessons from nearly four decades in physical therapy, exploring the physical, emotional, and neurological dimensions of pain and advocating for whole-person care. He discusses growing a high-touch healthcare business, the importance of empathy and process in patient outcomes, and insights from his work on an upcoming book focused on understanding pain and purpose in healing.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Whole Person Care<br>03:02 The Evolution of Physical Therapy<br>05:47 Understanding Pain and Patient Care<br>08:46 The Emotional Experience of Pain<br>12:04 Pain as Information: A Neurological Perspective<br>15:03 The Role of Awareness in Pain Management<br>17:59 The Connection Between Emotional and Physical Pain<br>20:52 The Journey of Writing a Book on Pain<br>28:43 Finding Purpose in Suffering<br>31:05 The Role of Pain in Personal Growth<br>33:17 Expanding a Business: Challenges and Lessons<br>36:23 The Importance of Process in Business<br>40:10 Navigating Complexities in Patient Care<br>46:03 Marketing Strategies for Growth</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jeffrey Petersen</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/"><strong>https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/</strong></a></li><li>Company / Affiliation: <strong>Petersen Physical Therapy </strong><a href="https://petersenpt.com/"><strong>https://petersenpt.com/</strong></a></li><li>Guest's Bio: <strong>Jeffrey Petersen</strong> is the <strong>CEO and Founder of Petersen Physical Therapy</strong>, launched with a mission to help as many people as possible move better and live healthier lives. With nearly four decades of experience, Jeff is deeply committed to clinical excellence and to building a welcoming, patient-centered environment that meets people exactly where they are and helps them move forward. He brings a rare blend of hands-on clinical insight, long-term leadership, and a genuine passion for helping patients recover, rehabilitate, and thrive.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Physical therapy has evolved significantly over the decades.</li><li>Pain is often the primary reason people seek therapy.</li><li>The emotional experience of pain is crucial to understanding it.</li><li>Intensity of pain does not always correlate with severity of injury.</li><li>Pain serves as information rather than just a warning signal.</li><li>Awareness of one's body can aid in pain management.</li><li>Shame can hinder the learning process in pain management.</li><li>The connection between emotional and physical pain is profound.</li><li>The journey of writing a book can help consolidate knowledge.</li><li>Understanding pain can lead to better patient outcomes. </li><li>Finding purpose in suffering can help endure pain.</li><li>Pain provides contrast that enhances appreciation for well-being.</li><li>Building a supportive culture is essential for business growth.</li><li>Engaging in the process is more important than focusing solely on outcomes.</li><li>Effective marketing stems from treating patients well and fostering referrals.</li><li>Navigating patient care requires balancing multiple stakeholders' needs.</li><li>Empathy is crucial in patient relationships and care.</li><li>The importance of documenting processes for business efficiency.</li><li>AI can assist in organizing business processes and enhancing patient care.</li><li>Long-term relationships with patients are built on trust and effective communication.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Jeffrey Petersen shares lessons from nearly four decades in physical therapy, exploring the physical, emotional, and neurological dimensions of pain and advocating for whole-person care. He discusses growing a high-touch healthcare business, the importance of empathy and process in patient outcomes, and insights from his work on an upcoming book focused on understanding pain and purpose in healing.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Whole Person Care<br>03:02 The Evolution of Physical Therapy<br>05:47 Understanding Pain and Patient Care<br>08:46 The Emotional Experience of Pain<br>12:04 Pain as Information: A Neurological Perspective<br>15:03 The Role of Awareness in Pain Management<br>17:59 The Connection Between Emotional and Physical Pain<br>20:52 The Journey of Writing a Book on Pain<br>28:43 Finding Purpose in Suffering<br>31:05 The Role of Pain in Personal Growth<br>33:17 Expanding a Business: Challenges and Lessons<br>36:23 The Importance of Process in Business<br>40:10 Navigating Complexities in Patient Care<br>46:03 Marketing Strategies for Growth</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jeffrey Petersen</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/"><strong>https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/</strong></a></li><li>Company / Affiliation: <strong>Petersen Physical Therapy </strong><a href="https://petersenpt.com/"><strong>https://petersenpt.com/</strong></a></li><li>Guest's Bio: <strong>Jeffrey Petersen</strong> is the <strong>CEO and Founder of Petersen Physical Therapy</strong>, launched with a mission to help as many people as possible move better and live healthier lives. With nearly four decades of experience, Jeff is deeply committed to clinical excellence and to building a welcoming, patient-centered environment that meets people exactly where they are and helps them move forward. He brings a rare blend of hands-on clinical insight, long-term leadership, and a genuine passion for helping patients recover, rehabilitate, and thrive.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Physical therapy has evolved significantly over the decades.</li><li>Pain is often the primary reason people seek therapy.</li><li>The emotional experience of pain is crucial to understanding it.</li><li>Intensity of pain does not always correlate with severity of injury.</li><li>Pain serves as information rather than just a warning signal.</li><li>Awareness of one's body can aid in pain management.</li><li>Shame can hinder the learning process in pain management.</li><li>The connection between emotional and physical pain is profound.</li><li>The journey of writing a book can help consolidate knowledge.</li><li>Understanding pain can lead to better patient outcomes. </li><li>Finding purpose in suffering can help endure pain.</li><li>Pain provides contrast that enhances appreciation for well-being.</li><li>Building a supportive culture is essential for business growth.</li><li>Engaging in the process is more important than focusing solely on outcomes.</li><li>Effective marketing stems from treating patients well and fostering referrals.</li><li>Navigating patient care requires balancing multiple stakeholders' needs.</li><li>Empathy is crucial in patient relationships and care.</li><li>The importance of documenting processes for business efficiency.</li><li>AI can assist in organizing business processes and enhancing patient care.</li><li>Long-term relationships with patients are built on trust and effective communication.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </content:encoded>
      <pubDate>Wed, 03 Dec 2025 17:58:24 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/cf1d96c6/bb3e8458.mp3" length="74634646" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/YWPbpWe6Vl_Hw2RbDR1sXIRfL1dHpIFsxhLm1DDvVsI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81N2Yy/ZDJmNDQ0NjMxYWJk/MjJmZjBhYjAyNWM0/NTRkNS5qcGc.jpg"/>
      <itunes:duration>3106</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Jeffrey Petersen shares lessons from nearly four decades in physical therapy, exploring the physical, emotional, and neurological dimensions of pain and advocating for whole-person care. He discusses growing a high-touch healthcare business, the importance of empathy and process in patient outcomes, and insights from his work on an upcoming book focused on understanding pain and purpose in healing.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Whole Person Care<br>03:02 The Evolution of Physical Therapy<br>05:47 Understanding Pain and Patient Care<br>08:46 The Emotional Experience of Pain<br>12:04 Pain as Information: A Neurological Perspective<br>15:03 The Role of Awareness in Pain Management<br>17:59 The Connection Between Emotional and Physical Pain<br>20:52 The Journey of Writing a Book on Pain<br>28:43 Finding Purpose in Suffering<br>31:05 The Role of Pain in Personal Growth<br>33:17 Expanding a Business: Challenges and Lessons<br>36:23 The Importance of Process in Business<br>40:10 Navigating Complexities in Patient Care<br>46:03 Marketing Strategies for Growth</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jeffrey Petersen</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/"><strong>https://www.linkedin.com/in/jeffrey-petersen-pt-9b467558/</strong></a></li><li>Company / Affiliation: <strong>Petersen Physical Therapy </strong><a href="https://petersenpt.com/"><strong>https://petersenpt.com/</strong></a></li><li>Guest's Bio: <strong>Jeffrey Petersen</strong> is the <strong>CEO and Founder of Petersen Physical Therapy</strong>, launched with a mission to help as many people as possible move better and live healthier lives. With nearly four decades of experience, Jeff is deeply committed to clinical excellence and to building a welcoming, patient-centered environment that meets people exactly where they are and helps them move forward. He brings a rare blend of hands-on clinical insight, long-term leadership, and a genuine passion for helping patients recover, rehabilitate, and thrive.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Physical therapy has evolved significantly over the decades.</li><li>Pain is often the primary reason people seek therapy.</li><li>The emotional experience of pain is crucial to understanding it.</li><li>Intensity of pain does not always correlate with severity of injury.</li><li>Pain serves as information rather than just a warning signal.</li><li>Awareness of one's body can aid in pain management.</li><li>Shame can hinder the learning process in pain management.</li><li>The connection between emotional and physical pain is profound.</li><li>The journey of writing a book can help consolidate knowledge.</li><li>Understanding pain can lead to better patient outcomes. </li><li>Finding purpose in suffering can help endure pain.</li><li>Pain provides contrast that enhances appreciation for well-being.</li><li>Building a supportive culture is essential for business growth.</li><li>Engaging in the process is more important than focusing solely on outcomes.</li><li>Effective marketing stems from treating patients well and fostering referrals.</li><li>Navigating patient care requires balancing multiple stakeholders' needs.</li><li>Empathy is crucial in patient relationships and care.</li><li>The importance of documenting processes for business efficiency.</li><li>AI can assist in organizing business processes and enhancing patient care.</li><li>Long-term relationships with patients are built on trust and effective communication.</li></ul><p><br><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>physical therapy, pain management, emotional pain, whole person care, healthcare evolution, patient care, pain awareness, manual therapy, Jeff Peterson, healthcare podcast, purpose, suffering, pain, personal growth, business expansion, process, patient care, marketing strategies, empathy, healing</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://petersenpt.com/" img="https://img.transistorcdn.com/Yo7R1Hf8KS15y9QRaSYSv8aGX-aEmvkzNl4bt6vN5KM/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mODQ2/MmVkNTI3NjhjYzE2/OTY0Y2M0YWJkN2Y0/Yjg5NC5qcGVn.jpg">Jeffrey Petersen </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/cf1d96c6/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/cf1d96c6/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/cf1d96c6/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/cf1d96c6/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/cf1d96c6/transcription" type="text/html"/>
    </item>
    <item>
      <title>Bridging Science &amp; Strategy: Leading High-Performing Teams in Biotech with Patti Aha</title>
      <itunes:episode>55</itunes:episode>
      <podcast:episode>55</podcast:episode>
      <itunes:title>Bridging Science &amp; Strategy: Leading High-Performing Teams in Biotech with Patti Aha</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">68191a35-b522-4bc1-896b-d576449bba5d</guid>
      <link>https://share.transistor.fm/s/8d9cc755</link>
      <description>
        <![CDATA[<p>In this episode of the <em>Healthy Enterprise</em> podcast, Patti Aha shares her journey from research scientist to project manager and consultant in the biotech and diagnostics space. She discusses the importance of collaboration, innovation, and mentorship in driving drug development, while exploring the challenges and opportunities within the industry. Patti reflects on the potential of AI to accelerate discovery and the critical role of effective leadership, communication, organization, and emotional intelligence in managing scientific teams. The conversation also covers navigating project management challenges, building strong relationships, knowing when to pivot or stop a project, and transitioning from corporate roles to entrepreneurship, offering practical advice for aspiring biotech leaders.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Biotech Leadership<br>03:12 Patti Aha's Journey in Biotech<br>06:02 The Role of Project Management in Drug Development<br>09:02 Understanding Drug Targets and Assays<br>11:55 The Importance of Collaboration in Biotech<br>14:50 Navigating the Drug Development Pipeline<br>17:51 The Future of AI in Biotech<br>21:04 Consultancy and Leadership in Biotech<br>23:50 The Philosophy of Project Management<br>28:33 Essential Qualities of a Project Manager<br>31:46 Building Relationships in Project Management<br>34:49 Navigating Challenges in Biotech Projects<br>39:34 Advice for Aspiring Project Managers<br>42:51 Dream Projects and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Patti Aha </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/patti-aha-6a20114/"><strong>https://www.linkedin.com/in/patti-aha-6a20114/</strong></a></li><li>Company / Affiliation: <strong>Robin Hill Group LLC</strong> </li><li>Guest's Bio: <strong>Patti Aha</strong> is the <strong>CEO of the Robin Hill Group</strong> and a seasoned project management and business leader with a strong scientific foundation. With deep experience across operations, portfolio management, and process development, she excels at bringing structure, efficiency, and clarity to complex initiatives. Patti is passionate about effective leadership, transparent communication, and building collaborative teams that consistently deliver results. Her unique blend of scientific rigor and business acumen allows her to bridge the gap between technical and strategic domains, making her a trusted partner for organizations seeking operational excellence and sustainable growth. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Patti Aha has a long career in biotech and academia.</li><li>She emphasizes the importance of project management in drug development.</li><li>Collaboration between academia and industry is crucial for innovation.</li><li>Understanding drug targets and assays is fundamental in biotech.</li><li>The drug development process is lengthy and complex.</li><li>AI has the potential to significantly speed up drug discovery.</li><li>Effective leadership is essential for managing scientific teams.</li><li>Mentoring future leaders is a passion for Patti.</li><li>Not-for-profit biotech models face unique challenges.</li><li>Continuous improvement is necessary for growing biotech companies. </li><li>Project management serves the work and helps people communicate.</li><li>There is a fine line between necessary process and over-processing.</li><li>Good communication is essential for project managers.</li><li>Emotional intelligence is crucial in managing team dynamics.</li><li>Building relationships is a cornerstone of effective project management.</li><li>Conflict resolution is a key skill for project managers.</li><li>Defining success at the beginning of a project is vital.</li><li>Knowing when to stop a project can be a significant win.</li><li>Continuous education and networking are important for career growth.</li><li>The biotech field offers exciting opportunities for innovation.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the <em>Healthy Enterprise</em> podcast, Patti Aha shares her journey from research scientist to project manager and consultant in the biotech and diagnostics space. She discusses the importance of collaboration, innovation, and mentorship in driving drug development, while exploring the challenges and opportunities within the industry. Patti reflects on the potential of AI to accelerate discovery and the critical role of effective leadership, communication, organization, and emotional intelligence in managing scientific teams. The conversation also covers navigating project management challenges, building strong relationships, knowing when to pivot or stop a project, and transitioning from corporate roles to entrepreneurship, offering practical advice for aspiring biotech leaders.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Biotech Leadership<br>03:12 Patti Aha's Journey in Biotech<br>06:02 The Role of Project Management in Drug Development<br>09:02 Understanding Drug Targets and Assays<br>11:55 The Importance of Collaboration in Biotech<br>14:50 Navigating the Drug Development Pipeline<br>17:51 The Future of AI in Biotech<br>21:04 Consultancy and Leadership in Biotech<br>23:50 The Philosophy of Project Management<br>28:33 Essential Qualities of a Project Manager<br>31:46 Building Relationships in Project Management<br>34:49 Navigating Challenges in Biotech Projects<br>39:34 Advice for Aspiring Project Managers<br>42:51 Dream Projects and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Patti Aha </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/patti-aha-6a20114/"><strong>https://www.linkedin.com/in/patti-aha-6a20114/</strong></a></li><li>Company / Affiliation: <strong>Robin Hill Group LLC</strong> </li><li>Guest's Bio: <strong>Patti Aha</strong> is the <strong>CEO of the Robin Hill Group</strong> and a seasoned project management and business leader with a strong scientific foundation. With deep experience across operations, portfolio management, and process development, she excels at bringing structure, efficiency, and clarity to complex initiatives. Patti is passionate about effective leadership, transparent communication, and building collaborative teams that consistently deliver results. Her unique blend of scientific rigor and business acumen allows her to bridge the gap between technical and strategic domains, making her a trusted partner for organizations seeking operational excellence and sustainable growth. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Patti Aha has a long career in biotech and academia.</li><li>She emphasizes the importance of project management in drug development.</li><li>Collaboration between academia and industry is crucial for innovation.</li><li>Understanding drug targets and assays is fundamental in biotech.</li><li>The drug development process is lengthy and complex.</li><li>AI has the potential to significantly speed up drug discovery.</li><li>Effective leadership is essential for managing scientific teams.</li><li>Mentoring future leaders is a passion for Patti.</li><li>Not-for-profit biotech models face unique challenges.</li><li>Continuous improvement is necessary for growing biotech companies. </li><li>Project management serves the work and helps people communicate.</li><li>There is a fine line between necessary process and over-processing.</li><li>Good communication is essential for project managers.</li><li>Emotional intelligence is crucial in managing team dynamics.</li><li>Building relationships is a cornerstone of effective project management.</li><li>Conflict resolution is a key skill for project managers.</li><li>Defining success at the beginning of a project is vital.</li><li>Knowing when to stop a project can be a significant win.</li><li>Continuous education and networking are important for career growth.</li><li>The biotech field offers exciting opportunities for innovation.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </content:encoded>
      <pubDate>Fri, 28 Nov 2025 19:06:30 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/8d9cc755/27d36c5b.mp3" length="65803992" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/796KBX0pckJyAZKfgNEO_3ia9j0otTvhOY4e_lbJ13w/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMzdj/YzY5MTk1OWEzMGVj/YjdkMjcxMjljZmUz/MjVhMC5qcGc.jpg"/>
      <itunes:duration>2737</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the <em>Healthy Enterprise</em> podcast, Patti Aha shares her journey from research scientist to project manager and consultant in the biotech and diagnostics space. She discusses the importance of collaboration, innovation, and mentorship in driving drug development, while exploring the challenges and opportunities within the industry. Patti reflects on the potential of AI to accelerate discovery and the critical role of effective leadership, communication, organization, and emotional intelligence in managing scientific teams. The conversation also covers navigating project management challenges, building strong relationships, knowing when to pivot or stop a project, and transitioning from corporate roles to entrepreneurship, offering practical advice for aspiring biotech leaders.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Biotech Leadership<br>03:12 Patti Aha's Journey in Biotech<br>06:02 The Role of Project Management in Drug Development<br>09:02 Understanding Drug Targets and Assays<br>11:55 The Importance of Collaboration in Biotech<br>14:50 Navigating the Drug Development Pipeline<br>17:51 The Future of AI in Biotech<br>21:04 Consultancy and Leadership in Biotech<br>23:50 The Philosophy of Project Management<br>28:33 Essential Qualities of a Project Manager<br>31:46 Building Relationships in Project Management<br>34:49 Navigating Challenges in Biotech Projects<br>39:34 Advice for Aspiring Project Managers<br>42:51 Dream Projects and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Patti Aha </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/patti-aha-6a20114/"><strong>https://www.linkedin.com/in/patti-aha-6a20114/</strong></a></li><li>Company / Affiliation: <strong>Robin Hill Group LLC</strong> </li><li>Guest's Bio: <strong>Patti Aha</strong> is the <strong>CEO of the Robin Hill Group</strong> and a seasoned project management and business leader with a strong scientific foundation. With deep experience across operations, portfolio management, and process development, she excels at bringing structure, efficiency, and clarity to complex initiatives. Patti is passionate about effective leadership, transparent communication, and building collaborative teams that consistently deliver results. Her unique blend of scientific rigor and business acumen allows her to bridge the gap between technical and strategic domains, making her a trusted partner for organizations seeking operational excellence and sustainable growth. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Patti Aha has a long career in biotech and academia.</li><li>She emphasizes the importance of project management in drug development.</li><li>Collaboration between academia and industry is crucial for innovation.</li><li>Understanding drug targets and assays is fundamental in biotech.</li><li>The drug development process is lengthy and complex.</li><li>AI has the potential to significantly speed up drug discovery.</li><li>Effective leadership is essential for managing scientific teams.</li><li>Mentoring future leaders is a passion for Patti.</li><li>Not-for-profit biotech models face unique challenges.</li><li>Continuous improvement is necessary for growing biotech companies. </li><li>Project management serves the work and helps people communicate.</li><li>There is a fine line between necessary process and over-processing.</li><li>Good communication is essential for project managers.</li><li>Emotional intelligence is crucial in managing team dynamics.</li><li>Building relationships is a cornerstone of effective project management.</li><li>Conflict resolution is a key skill for project managers.</li><li>Defining success at the beginning of a project is vital.</li><li>Knowing when to stop a project can be a significant win.</li><li>Continuous education and networking are important for career growth.</li><li>The biotech field offers exciting opportunities for innovation.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </itunes:summary>
      <itunes:keywords>biotech, drug development, project management, innovation, leadership, collaboration, AI in biotech, mentoring, strategic partnerships, asset development, project management, biotech, communication, organization, emotional intelligence, relationships, challenges, advice, career, success</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/patti-aha" img="https://img.transistorcdn.com/bfqxLbdQGxNENyyrkixLtH25ERdRE5wiiXjw9RYVu-8/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85ZmNl/ZmMyODQ0MmJjODEw/YjU0Y2JhMTY0YjQ3/M2JlYy5qcGVn.jpg">Patti Aha</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/8d9cc755/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8d9cc755/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8d9cc755/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8d9cc755/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/8d9cc755/transcription" type="text/html"/>
    </item>
    <item>
      <title>Evolving Health Leaders: A Fresh Perspective to Achieving a Growth Mindset with Kimberly Cremers </title>
      <itunes:episode>54</itunes:episode>
      <podcast:episode>54</podcast:episode>
      <itunes:title>Evolving Health Leaders: A Fresh Perspective to Achieving a Growth Mindset with Kimberly Cremers </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">01aa1cad-72ea-4f4a-857c-fd5729fef21d</guid>
      <link>https://share.transistor.fm/s/28c5c213</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath talks with Kimberly Cremers, pharmacist, executive coach, and Founder &amp; CEO of Petrichor Medical Affairs Consulting, about her journey in the pharmaceutical industry and the evolving role of Medical Affairs. Kim shares insights on AI in drug development, her transition to consultancy, and the importance of effective communication, listening, and continuous learning in leadership. They explore the transformative power of coaching—recognizing when it’s needed, building trust, overcoming self-doubt, and embracing discomfort for growth—while also reflecting on entrepreneurship, career development, and the impact of a growth mindset on personal and professional success.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Kim Cremers and Her Journey<br>02:59 The Role of Medical Affairs in Pharma<br>06:00 Challenges in the Pharmaceutical Industry<br>09:04 The Impact of AI on Drug Development<br>12:00 Transitioning to Consultancy and Coaching<br>15:01 Executive Coaching: Challenges and Insights<br>17:57 Navigating Imposter Syndrome and Communication<br>20:58 The Importance of Listening in Leadership<br>22:20 The Importance of Coaching Relationships<br>25:01 Recognizing the Need for a Coach<br>26:30 Aha Moments in Personal Development<br>28:25 Signs It's Time for Career Coaching<br>30:01 Overcoming Self-Doubt in Career Changes<br>31:12 Embracing Discomfort for Growth<br>34:07 Navigating Entrepreneurial Challenges<br>37:43 Core Values in Coaching<br>41:06 The Power of a Growth Mindset</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kimberly Cremers</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kimberly-cremers-petrichor/"><strong>https://www.linkedin.com/in/kimberly-cremers-petrichor/ </strong></a></li><li>Company / Affiliation: <strong>Petrichor Medical Affairs Consulting</strong> <a href="https://www.petrichormaconsulting.com/"><strong>https://www.petrichormaconsulting.com/</strong></a></li><li>Guest's Bio: Kimberly Cremers is the Founder and CEO of Petrichor Medical Affairs Consulting, a licensed pharmacist, Certified Executive Coach, and Medical Affairs leader with over 25 years in pharma and biotech. She helps organizations build, optimize, and scale high-performing Medical Science Liaison teams—providing strategic guidance, tactical planning, onboarding, coaching, scientific exchange materials, and support for key initiatives like advisory boards and congresses.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Kim Cremers has over 25 years of experience in medical affairs.</li><li>Medical Affairs plays a crucial role in contextualizing clinical data for healthcare professionals.</li><li>Pharmacy students often lack awareness of career opportunities in the pharmaceutical industry.</li><li>The pharmaceutical industry faces challenges from geopolitical changes and regulatory environments.</li><li>AI has the potential to streamline drug development processes.</li><li>Consultancy allows Kim to focus on her passions, including teaching and coaching.</li><li>Executive coaching helps leaders navigate their challenges and optimize their impact.</li><li>Imposter syndrome affects executives, highlighting the need for supportive environments.</li><li>Effective listening is essential for leadership and understanding team dynamics.</li><li>Navigating the complexities of tech and pharma requires open-mindedness and collaboration. </li><li>Coaching relationships are essential for achieving personal and professional goals.</li><li>Recognizing the need for a coach often comes after a period of self-reflection or feedback.</li><li>Aha moments can empower individuals to take action and make significant changes in their careers.</li><li>Signs that it's time for career coaching include feelings of dread about work or a lack of motivation.</li><li>Self-doubt can hinder career advancement, especially among women.</li><li>Embracing discomfort is crucial for personal growth and development.</li><li>Navigating entrepreneurial challenges requires flexibility and a willingness to learn.</li><li>Core values such as authenticity and integrity are vital in coaching.</li><li>A growth mindset allows individuals to see challenges as opportunities for growth.</li><li>Investing in personal development, such as reading impactful books, can lead to significant insights.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath talks with Kimberly Cremers, pharmacist, executive coach, and Founder &amp; CEO of Petrichor Medical Affairs Consulting, about her journey in the pharmaceutical industry and the evolving role of Medical Affairs. Kim shares insights on AI in drug development, her transition to consultancy, and the importance of effective communication, listening, and continuous learning in leadership. They explore the transformative power of coaching—recognizing when it’s needed, building trust, overcoming self-doubt, and embracing discomfort for growth—while also reflecting on entrepreneurship, career development, and the impact of a growth mindset on personal and professional success.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Kim Cremers and Her Journey<br>02:59 The Role of Medical Affairs in Pharma<br>06:00 Challenges in the Pharmaceutical Industry<br>09:04 The Impact of AI on Drug Development<br>12:00 Transitioning to Consultancy and Coaching<br>15:01 Executive Coaching: Challenges and Insights<br>17:57 Navigating Imposter Syndrome and Communication<br>20:58 The Importance of Listening in Leadership<br>22:20 The Importance of Coaching Relationships<br>25:01 Recognizing the Need for a Coach<br>26:30 Aha Moments in Personal Development<br>28:25 Signs It's Time for Career Coaching<br>30:01 Overcoming Self-Doubt in Career Changes<br>31:12 Embracing Discomfort for Growth<br>34:07 Navigating Entrepreneurial Challenges<br>37:43 Core Values in Coaching<br>41:06 The Power of a Growth Mindset</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kimberly Cremers</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kimberly-cremers-petrichor/"><strong>https://www.linkedin.com/in/kimberly-cremers-petrichor/ </strong></a></li><li>Company / Affiliation: <strong>Petrichor Medical Affairs Consulting</strong> <a href="https://www.petrichormaconsulting.com/"><strong>https://www.petrichormaconsulting.com/</strong></a></li><li>Guest's Bio: Kimberly Cremers is the Founder and CEO of Petrichor Medical Affairs Consulting, a licensed pharmacist, Certified Executive Coach, and Medical Affairs leader with over 25 years in pharma and biotech. She helps organizations build, optimize, and scale high-performing Medical Science Liaison teams—providing strategic guidance, tactical planning, onboarding, coaching, scientific exchange materials, and support for key initiatives like advisory boards and congresses.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Kim Cremers has over 25 years of experience in medical affairs.</li><li>Medical Affairs plays a crucial role in contextualizing clinical data for healthcare professionals.</li><li>Pharmacy students often lack awareness of career opportunities in the pharmaceutical industry.</li><li>The pharmaceutical industry faces challenges from geopolitical changes and regulatory environments.</li><li>AI has the potential to streamline drug development processes.</li><li>Consultancy allows Kim to focus on her passions, including teaching and coaching.</li><li>Executive coaching helps leaders navigate their challenges and optimize their impact.</li><li>Imposter syndrome affects executives, highlighting the need for supportive environments.</li><li>Effective listening is essential for leadership and understanding team dynamics.</li><li>Navigating the complexities of tech and pharma requires open-mindedness and collaboration. </li><li>Coaching relationships are essential for achieving personal and professional goals.</li><li>Recognizing the need for a coach often comes after a period of self-reflection or feedback.</li><li>Aha moments can empower individuals to take action and make significant changes in their careers.</li><li>Signs that it's time for career coaching include feelings of dread about work or a lack of motivation.</li><li>Self-doubt can hinder career advancement, especially among women.</li><li>Embracing discomfort is crucial for personal growth and development.</li><li>Navigating entrepreneurial challenges requires flexibility and a willingness to learn.</li><li>Core values such as authenticity and integrity are vital in coaching.</li><li>A growth mindset allows individuals to see challenges as opportunities for growth.</li><li>Investing in personal development, such as reading impactful books, can lead to significant insights.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </content:encoded>
      <pubDate>Wed, 26 Nov 2025 15:25:22 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/28c5c213/57e1443f.mp3" length="64534161" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/2lHM9kFQo0ub_ukpJ8IM1WaO4W6bWI2Fnzg7Xu-45hQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNDdk/NjkxM2FkYThlNDRh/MDdkYTc4ZGIyYTYz/ZDRhNy5qcGc.jpg"/>
      <itunes:duration>2684</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath talks with Kimberly Cremers, pharmacist, executive coach, and Founder &amp; CEO of Petrichor Medical Affairs Consulting, about her journey in the pharmaceutical industry and the evolving role of Medical Affairs. Kim shares insights on AI in drug development, her transition to consultancy, and the importance of effective communication, listening, and continuous learning in leadership. They explore the transformative power of coaching—recognizing when it’s needed, building trust, overcoming self-doubt, and embracing discomfort for growth—while also reflecting on entrepreneurship, career development, and the impact of a growth mindset on personal and professional success.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Kim Cremers and Her Journey<br>02:59 The Role of Medical Affairs in Pharma<br>06:00 Challenges in the Pharmaceutical Industry<br>09:04 The Impact of AI on Drug Development<br>12:00 Transitioning to Consultancy and Coaching<br>15:01 Executive Coaching: Challenges and Insights<br>17:57 Navigating Imposter Syndrome and Communication<br>20:58 The Importance of Listening in Leadership<br>22:20 The Importance of Coaching Relationships<br>25:01 Recognizing the Need for a Coach<br>26:30 Aha Moments in Personal Development<br>28:25 Signs It's Time for Career Coaching<br>30:01 Overcoming Self-Doubt in Career Changes<br>31:12 Embracing Discomfort for Growth<br>34:07 Navigating Entrepreneurial Challenges<br>37:43 Core Values in Coaching<br>41:06 The Power of a Growth Mindset</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kimberly Cremers</strong></li><li>Guest's Title/Position:<strong>  Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kimberly-cremers-petrichor/"><strong>https://www.linkedin.com/in/kimberly-cremers-petrichor/ </strong></a></li><li>Company / Affiliation: <strong>Petrichor Medical Affairs Consulting</strong> <a href="https://www.petrichormaconsulting.com/"><strong>https://www.petrichormaconsulting.com/</strong></a></li><li>Guest's Bio: Kimberly Cremers is the Founder and CEO of Petrichor Medical Affairs Consulting, a licensed pharmacist, Certified Executive Coach, and Medical Affairs leader with over 25 years in pharma and biotech. She helps organizations build, optimize, and scale high-performing Medical Science Liaison teams—providing strategic guidance, tactical planning, onboarding, coaching, scientific exchange materials, and support for key initiatives like advisory boards and congresses.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Kim Cremers has over 25 years of experience in medical affairs.</li><li>Medical Affairs plays a crucial role in contextualizing clinical data for healthcare professionals.</li><li>Pharmacy students often lack awareness of career opportunities in the pharmaceutical industry.</li><li>The pharmaceutical industry faces challenges from geopolitical changes and regulatory environments.</li><li>AI has the potential to streamline drug development processes.</li><li>Consultancy allows Kim to focus on her passions, including teaching and coaching.</li><li>Executive coaching helps leaders navigate their challenges and optimize their impact.</li><li>Imposter syndrome affects executives, highlighting the need for supportive environments.</li><li>Effective listening is essential for leadership and understanding team dynamics.</li><li>Navigating the complexities of tech and pharma requires open-mindedness and collaboration. </li><li>Coaching relationships are essential for achieving personal and professional goals.</li><li>Recognizing the need for a coach often comes after a period of self-reflection or feedback.</li><li>Aha moments can empower individuals to take action and make significant changes in their careers.</li><li>Signs that it's time for career coaching include feelings of dread about work or a lack of motivation.</li><li>Self-doubt can hinder career advancement, especially among women.</li><li>Embracing discomfort is crucial for personal growth and development.</li><li>Navigating entrepreneurial challenges requires flexibility and a willingness to learn.</li><li>Core values such as authenticity and integrity are vital in coaching.</li><li>A growth mindset allows individuals to see challenges as opportunities for growth.</li><li>Investing in personal development, such as reading impactful books, can lead to significant insights.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </itunes:summary>
      <itunes:keywords>pharmaceutical industry, medical affairs, executive coaching, AI in healthcare, drug development, imposter syndrome, leadership, healthcare professionals, consultancy, pharmacy education, coaching, personal development, career coaching, growth mindset, professional success, self-reflection, mentoring, overcoming self-doubt, entrepreneurial challenges, aha moments</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.petrichormaconsulting.com/" img="https://img.transistorcdn.com/vx4np3wWTXhQbnYuiuy_hp3NV58mZno48nXkBSkEMK0/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMzU3/MzhmNjU4MGFiYzFj/ZDIxNDM2ZjczYzUy/M2IyYS5qcGVn.jpg">Kimberly Cremers</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/28c5c213/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/28c5c213/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/28c5c213/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/28c5c213/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/28c5c213/transcription" type="text/html"/>
    </item>
    <item>
      <title> Innovation Meets Inequity: Building Solutions in Emerging Markets with Sona Shah</title>
      <itunes:episode>53</itunes:episode>
      <podcast:episode>53</podcast:episode>
      <itunes:title> Innovation Meets Inequity: Building Solutions in Emerging Markets with Sona Shah</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1186ddd3-7f0c-4eb4-8fef-d2903aa3aea2</guid>
      <link>https://share.transistor.fm/s/6e194560</link>
      <description>
        <![CDATA[<p>In this episode, Sona Shah, and Co-Founder and CEO  of Neopenda, shares her journey from engineering to healthcare innovation. She discusses the challenges of healthcare inequities in emerging markets and how Neopenda's flagship product, NeoGuard, aims to address these issues by providing vital signs monitoring in under-resourced hospitals. Sona highlights the importance of understanding customer needs, the challenges of product adoption, and the innovative approaches taken to ensure sustainability and growth in the healthcare sector. In this conversation, Sona Shah discusses the importance of data collection in underserved communities, the evolution of her leadership style over the past decade, and the balance between personal and professional life as a founder. She also shares insights on the growth phase of her company, Neopenda, and the strategies for fundraising and scaling operations to meet the needs of patients globally.</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sona Shah</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sonarshah/"><strong>https://www.linkedin.com/in/sonarshah/ </strong></a></li><li>Company / Affiliation: <strong>Neopenda </strong><a href="https://www.neopenda.com/"><strong>https://www.neopenda.com/</strong></a></li><li>Guest's Bio: <strong>Sona Shah </strong>is the<strong> Co-Founder and CEO</strong>  of <strong>Neopenda</strong>, where she leads the development of innovative medical technologies designed for low-resource healthcare settings. Inspired by her time teaching in Kenya and her background in biomedical engineering, Sona co-founded Neopenda in 2015 to help close critical gaps in care across emerging markets. Today, she and her team are bringing solutions like the neoGuard monitoring system to countries such as Kenya, Uganda, and Ghana—advancing accessible, tech-driven healthcare for the next billion people.</li></ul><p><br><strong>Chapters:</strong><br>00:00 Introduction to Neopenda and Sona Shah<br>01:22 Sona's Journey: From Engineering to Healthcare<br>05:43 Identifying Healthcare Inequities in Emerging Markets<br>10:06 The Birth of Neopenda: Addressing Global Health Challenges<br>12:50 Innovating Medical Technology: The NeoGuard Device<br>18:15 Challenges in Adoption and Customer Feedback<br>21:53 Sustaining Innovation: Revenue Models and Future Plans<br>25:23 Data Collection in Underserved Communities<br>30:32 Leadership and Team Dynamics<br>37:00 Balancing Personal and Professional Life<br>41:52 Growth and Fundraising Strategies</p><p><br><strong>Takeaways:</strong></p><ul><li>Sona Shah's journey reflects a passion for addressing healthcare inequities.</li><li>Neopenda was founded to tackle the lack of medical technology in emerging markets.</li><li>The NeoGuard device is designed for low-resource settings, providing essential monitoring.</li><li>Understanding the local healthcare environment is crucial for product adoption.</li><li>Customer feedback is vital for improving product performance and satisfaction.</li><li>Sustaining innovation requires a balance between product sales and customer support.</li><li>The healthcare market in emerging countries is often misunderstood regarding affordability.</li><li>Data collection from NeoGuard can provide valuable insights for healthcare providers.</li><li>Training and support are essential for successful technology adoption in hospitals.</li><li>Future plans include introducing a data-driven revenue model with NeoCloud. </li><li>Data collection is crucial for understanding health in underserved communities.</li><li>Leadership involves trusting and empowering your team.</li><li>Balancing personal life with professional responsibilities is essential for well-being.</li><li>Growth opportunities must be approached strategically to avoid pitfalls.</li><li>The healthcare sector requires innovative solutions tailored to specific populations.</li><li>Mental health support is vital for founders managing stress and responsibilities.</li><li>Community investment can enhance growth and bring diverse expertise.</li><li>Celebrating small wins is important for maintaining morale in a startup.</li><li>Nature and personal time can rejuvenate and provide clarity.</li><li>The journey of a founder is filled with challenges but also immense rewards.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Sona Shah, and Co-Founder and CEO  of Neopenda, shares her journey from engineering to healthcare innovation. She discusses the challenges of healthcare inequities in emerging markets and how Neopenda's flagship product, NeoGuard, aims to address these issues by providing vital signs monitoring in under-resourced hospitals. Sona highlights the importance of understanding customer needs, the challenges of product adoption, and the innovative approaches taken to ensure sustainability and growth in the healthcare sector. In this conversation, Sona Shah discusses the importance of data collection in underserved communities, the evolution of her leadership style over the past decade, and the balance between personal and professional life as a founder. She also shares insights on the growth phase of her company, Neopenda, and the strategies for fundraising and scaling operations to meet the needs of patients globally.</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sona Shah</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sonarshah/"><strong>https://www.linkedin.com/in/sonarshah/ </strong></a></li><li>Company / Affiliation: <strong>Neopenda </strong><a href="https://www.neopenda.com/"><strong>https://www.neopenda.com/</strong></a></li><li>Guest's Bio: <strong>Sona Shah </strong>is the<strong> Co-Founder and CEO</strong>  of <strong>Neopenda</strong>, where she leads the development of innovative medical technologies designed for low-resource healthcare settings. Inspired by her time teaching in Kenya and her background in biomedical engineering, Sona co-founded Neopenda in 2015 to help close critical gaps in care across emerging markets. Today, she and her team are bringing solutions like the neoGuard monitoring system to countries such as Kenya, Uganda, and Ghana—advancing accessible, tech-driven healthcare for the next billion people.</li></ul><p><br><strong>Chapters:</strong><br>00:00 Introduction to Neopenda and Sona Shah<br>01:22 Sona's Journey: From Engineering to Healthcare<br>05:43 Identifying Healthcare Inequities in Emerging Markets<br>10:06 The Birth of Neopenda: Addressing Global Health Challenges<br>12:50 Innovating Medical Technology: The NeoGuard Device<br>18:15 Challenges in Adoption and Customer Feedback<br>21:53 Sustaining Innovation: Revenue Models and Future Plans<br>25:23 Data Collection in Underserved Communities<br>30:32 Leadership and Team Dynamics<br>37:00 Balancing Personal and Professional Life<br>41:52 Growth and Fundraising Strategies</p><p><br><strong>Takeaways:</strong></p><ul><li>Sona Shah's journey reflects a passion for addressing healthcare inequities.</li><li>Neopenda was founded to tackle the lack of medical technology in emerging markets.</li><li>The NeoGuard device is designed for low-resource settings, providing essential monitoring.</li><li>Understanding the local healthcare environment is crucial for product adoption.</li><li>Customer feedback is vital for improving product performance and satisfaction.</li><li>Sustaining innovation requires a balance between product sales and customer support.</li><li>The healthcare market in emerging countries is often misunderstood regarding affordability.</li><li>Data collection from NeoGuard can provide valuable insights for healthcare providers.</li><li>Training and support are essential for successful technology adoption in hospitals.</li><li>Future plans include introducing a data-driven revenue model with NeoCloud. </li><li>Data collection is crucial for understanding health in underserved communities.</li><li>Leadership involves trusting and empowering your team.</li><li>Balancing personal life with professional responsibilities is essential for well-being.</li><li>Growth opportunities must be approached strategically to avoid pitfalls.</li><li>The healthcare sector requires innovative solutions tailored to specific populations.</li><li>Mental health support is vital for founders managing stress and responsibilities.</li><li>Community investment can enhance growth and bring diverse expertise.</li><li>Celebrating small wins is important for maintaining morale in a startup.</li><li>Nature and personal time can rejuvenate and provide clarity.</li><li>The journey of a founder is filled with challenges but also immense rewards.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </content:encoded>
      <pubDate>Mon, 24 Nov 2025 13:26:58 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/6e194560/96f85a77.mp3" length="69851531" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/H1ehyCL-e4X5hhqk_23JrYC9RPyUAWX-eWGgo-v9x2w/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZDk2/ZGVkYWEwOTI5NDA0/NGVkMmU5MDFkNGI3/OGNjYS5qcGc.jpg"/>
      <itunes:duration>2904</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Sona Shah, and Co-Founder and CEO  of Neopenda, shares her journey from engineering to healthcare innovation. She discusses the challenges of healthcare inequities in emerging markets and how Neopenda's flagship product, NeoGuard, aims to address these issues by providing vital signs monitoring in under-resourced hospitals. Sona highlights the importance of understanding customer needs, the challenges of product adoption, and the innovative approaches taken to ensure sustainability and growth in the healthcare sector. In this conversation, Sona Shah discusses the importance of data collection in underserved communities, the evolution of her leadership style over the past decade, and the balance between personal and professional life as a founder. She also shares insights on the growth phase of her company, Neopenda, and the strategies for fundraising and scaling operations to meet the needs of patients globally.</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sona Shah</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sonarshah/"><strong>https://www.linkedin.com/in/sonarshah/ </strong></a></li><li>Company / Affiliation: <strong>Neopenda </strong><a href="https://www.neopenda.com/"><strong>https://www.neopenda.com/</strong></a></li><li>Guest's Bio: <strong>Sona Shah </strong>is the<strong> Co-Founder and CEO</strong>  of <strong>Neopenda</strong>, where she leads the development of innovative medical technologies designed for low-resource healthcare settings. Inspired by her time teaching in Kenya and her background in biomedical engineering, Sona co-founded Neopenda in 2015 to help close critical gaps in care across emerging markets. Today, she and her team are bringing solutions like the neoGuard monitoring system to countries such as Kenya, Uganda, and Ghana—advancing accessible, tech-driven healthcare for the next billion people.</li></ul><p><br><strong>Chapters:</strong><br>00:00 Introduction to Neopenda and Sona Shah<br>01:22 Sona's Journey: From Engineering to Healthcare<br>05:43 Identifying Healthcare Inequities in Emerging Markets<br>10:06 The Birth of Neopenda: Addressing Global Health Challenges<br>12:50 Innovating Medical Technology: The NeoGuard Device<br>18:15 Challenges in Adoption and Customer Feedback<br>21:53 Sustaining Innovation: Revenue Models and Future Plans<br>25:23 Data Collection in Underserved Communities<br>30:32 Leadership and Team Dynamics<br>37:00 Balancing Personal and Professional Life<br>41:52 Growth and Fundraising Strategies</p><p><br><strong>Takeaways:</strong></p><ul><li>Sona Shah's journey reflects a passion for addressing healthcare inequities.</li><li>Neopenda was founded to tackle the lack of medical technology in emerging markets.</li><li>The NeoGuard device is designed for low-resource settings, providing essential monitoring.</li><li>Understanding the local healthcare environment is crucial for product adoption.</li><li>Customer feedback is vital for improving product performance and satisfaction.</li><li>Sustaining innovation requires a balance between product sales and customer support.</li><li>The healthcare market in emerging countries is often misunderstood regarding affordability.</li><li>Data collection from NeoGuard can provide valuable insights for healthcare providers.</li><li>Training and support are essential for successful technology adoption in hospitals.</li><li>Future plans include introducing a data-driven revenue model with NeoCloud. </li><li>Data collection is crucial for understanding health in underserved communities.</li><li>Leadership involves trusting and empowering your team.</li><li>Balancing personal life with professional responsibilities is essential for well-being.</li><li>Growth opportunities must be approached strategically to avoid pitfalls.</li><li>The healthcare sector requires innovative solutions tailored to specific populations.</li><li>Mental health support is vital for founders managing stress and responsibilities.</li><li>Community investment can enhance growth and bring diverse expertise.</li><li>Celebrating small wins is important for maintaining morale in a startup.</li><li>Nature and personal time can rejuvenate and provide clarity.</li><li>The journey of a founder is filled with challenges but also immense rewards.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </itunes:summary>
      <itunes:keywords>Neopenda, Sona Shah, healthcare inequities, medical technology, NeoGuard, emerging markets, innovation, startup journey, healthcare solutions, biomedical engineering, healthcare innovation, data collection, leadership, personal growth, fundraising, medical devices, global health, team dynamics, startup challenges, work-life balance</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.neopenda.com/" img="https://img.transistorcdn.com/D4zhZp-f9DUItrHqilChanAjNiknVcFf_NJ2Bsf8N4k/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNzlk/NGY5Yjg3N2Q5M2Rm/NGU5YzQ2YmMzYzlm/MzBhMC5qcGVn.jpg">Sona Shah</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/6e194560/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e194560/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e194560/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e194560/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e194560/transcription" type="text/html"/>
    </item>
    <item>
      <title>The Future of Optometry: The Challenges, Trends, and Opportunities with John D. Marvin </title>
      <itunes:episode>52</itunes:episode>
      <podcast:episode>52</podcast:episode>
      <itunes:title>The Future of Optometry: The Challenges, Trends, and Opportunities with John D. Marvin </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">010adbe3-7735-4ae1-91a1-c8930cd605d0</guid>
      <link>https://share.transistor.fm/s/0ef7e410</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, John D. Marvin reflects on his leadership journey in the optometry industry—from his marketing roots to becoming president of Texas State Optical. He discusses navigating major industry shifts, driving mindset change, and adapting to evolving consumer expectations. John explores the complexities of leading a member-owned cooperative, the growing influence of private equity, and the need for localized, community-focused eye-care services. He also offers insights on effective marketing, the challenges posed by e-commerce, and the importance of cultivating strong leadership within optometry. </p><p><strong>Chapters:</strong><br>00:00 Introduction to John D. Marvin and His Journey<br>10:47 Navigating Change in Leadership<br>20:02 Challenges of Mindset and Adaptation<br>30:05 The Evolution of Optometry and Business Models<br>31:16 Marketing Strategies for Community Engagement<br>32:08 Navigating E-commerce in Eye Care<br>36:34 Developing Leadership in Optometry Practices<br>40:53 The Importance of Personal Growth<br>44:43 Fusing Faith and Business Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>John D. Marvin</strong> </li><li>Guest's Title/Position:<strong>  Former President &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jdmarvin/"><strong>https://www.linkedin.com/in/jdmarvin/</strong></a></li><li>Company / Affiliation: <strong>Texas State Optical</strong>  <a href="https://tso.com/"><strong>https://tso.com/</strong></a></li><li>Guest's Bio: <strong>John D. Marvin</strong> is a seasoned executive leader with more than three decades of experience developing people and organizations through intentional leadership, effective communication, and mindset-driven growth. As the former President and CEO of Texas State Optical, he guided one of the nation’s largest networks of independent optometric practices, steering the organization through industry change with strategic clarity, operational excellence, and a people-first approach. He believes the only limits we face are the ones we place on ourselves—and his mission is to help others rise above them, lead with purpose, and carry that belief forward. <a href="https://themarvingroup.net/"><strong>https://themarvingroup.net/</strong></a></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>John Marvin has over three decades of experience in leadership.</li><li>He emphasizes the importance of mindset in business adaptation.</li><li>Fear of change can paralyze organizations from making necessary decisions.</li><li>Consumer behavior is a critical factor in business strategy.</li><li>The optometry industry is facing significant shifts in ownership dynamics.</li><li>Younger optometrists are less interested in private practice ownership.</li><li>The pandemic accelerated changes in consumer preferences.</li><li>A hybrid business model may be necessary for future growth.</li><li>Marketing encompasses more than just advertising; product quality is key.</li><li>Leadership requires balancing individual and corporate interests.  </li><li>The delivery of eye care services is a local community service.</li><li>Marketing efforts should focus within a three-mile radius of each location.</li><li>E-commerce has changed consumer behavior in the eyewear market.</li><li>Third-party payers complicate the relationship between consumers and eye care providers.</li><li>Leadership is about influence and personal growth is essential for effective leadership.</li><li>Community involvement can enhance practice visibility and patient loyalty.</li><li>Personal growth should be a self-directed journey.</li><li>Integrating faith into business can enrich the workplace experience.</li><li>Effective marketing requires understanding local consumer behavior.</li><li>Leadership development is crucial for franchise owners in the optometry field.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, John D. Marvin reflects on his leadership journey in the optometry industry—from his marketing roots to becoming president of Texas State Optical. He discusses navigating major industry shifts, driving mindset change, and adapting to evolving consumer expectations. John explores the complexities of leading a member-owned cooperative, the growing influence of private equity, and the need for localized, community-focused eye-care services. He also offers insights on effective marketing, the challenges posed by e-commerce, and the importance of cultivating strong leadership within optometry. </p><p><strong>Chapters:</strong><br>00:00 Introduction to John D. Marvin and His Journey<br>10:47 Navigating Change in Leadership<br>20:02 Challenges of Mindset and Adaptation<br>30:05 The Evolution of Optometry and Business Models<br>31:16 Marketing Strategies for Community Engagement<br>32:08 Navigating E-commerce in Eye Care<br>36:34 Developing Leadership in Optometry Practices<br>40:53 The Importance of Personal Growth<br>44:43 Fusing Faith and Business Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>John D. Marvin</strong> </li><li>Guest's Title/Position:<strong>  Former President &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jdmarvin/"><strong>https://www.linkedin.com/in/jdmarvin/</strong></a></li><li>Company / Affiliation: <strong>Texas State Optical</strong>  <a href="https://tso.com/"><strong>https://tso.com/</strong></a></li><li>Guest's Bio: <strong>John D. Marvin</strong> is a seasoned executive leader with more than three decades of experience developing people and organizations through intentional leadership, effective communication, and mindset-driven growth. As the former President and CEO of Texas State Optical, he guided one of the nation’s largest networks of independent optometric practices, steering the organization through industry change with strategic clarity, operational excellence, and a people-first approach. He believes the only limits we face are the ones we place on ourselves—and his mission is to help others rise above them, lead with purpose, and carry that belief forward. <a href="https://themarvingroup.net/"><strong>https://themarvingroup.net/</strong></a></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>John Marvin has over three decades of experience in leadership.</li><li>He emphasizes the importance of mindset in business adaptation.</li><li>Fear of change can paralyze organizations from making necessary decisions.</li><li>Consumer behavior is a critical factor in business strategy.</li><li>The optometry industry is facing significant shifts in ownership dynamics.</li><li>Younger optometrists are less interested in private practice ownership.</li><li>The pandemic accelerated changes in consumer preferences.</li><li>A hybrid business model may be necessary for future growth.</li><li>Marketing encompasses more than just advertising; product quality is key.</li><li>Leadership requires balancing individual and corporate interests.  </li><li>The delivery of eye care services is a local community service.</li><li>Marketing efforts should focus within a three-mile radius of each location.</li><li>E-commerce has changed consumer behavior in the eyewear market.</li><li>Third-party payers complicate the relationship between consumers and eye care providers.</li><li>Leadership is about influence and personal growth is essential for effective leadership.</li><li>Community involvement can enhance practice visibility and patient loyalty.</li><li>Personal growth should be a self-directed journey.</li><li>Integrating faith into business can enrich the workplace experience.</li><li>Effective marketing requires understanding local consumer behavior.</li><li>Leadership development is crucial for franchise owners in the optometry field.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </content:encoded>
      <pubDate>Thu, 20 Nov 2025 10:48:45 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/0ef7e410/785097ef.mp3" length="77258423" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/d4FrFJgd29HcKgK59o6lNV1g70rl1D2_ovuFyU3XBjY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mODFi/YmIyMzg1YWQ2MGYz/ZmNjZmM2YTBmMGE2/NjI4MS5qcGc.jpg"/>
      <itunes:duration>3214</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, John D. Marvin reflects on his leadership journey in the optometry industry—from his marketing roots to becoming president of Texas State Optical. He discusses navigating major industry shifts, driving mindset change, and adapting to evolving consumer expectations. John explores the complexities of leading a member-owned cooperative, the growing influence of private equity, and the need for localized, community-focused eye-care services. He also offers insights on effective marketing, the challenges posed by e-commerce, and the importance of cultivating strong leadership within optometry. </p><p><strong>Chapters:</strong><br>00:00 Introduction to John D. Marvin and His Journey<br>10:47 Navigating Change in Leadership<br>20:02 Challenges of Mindset and Adaptation<br>30:05 The Evolution of Optometry and Business Models<br>31:16 Marketing Strategies for Community Engagement<br>32:08 Navigating E-commerce in Eye Care<br>36:34 Developing Leadership in Optometry Practices<br>40:53 The Importance of Personal Growth<br>44:43 Fusing Faith and Business Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>John D. Marvin</strong> </li><li>Guest's Title/Position:<strong>  Former President &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jdmarvin/"><strong>https://www.linkedin.com/in/jdmarvin/</strong></a></li><li>Company / Affiliation: <strong>Texas State Optical</strong>  <a href="https://tso.com/"><strong>https://tso.com/</strong></a></li><li>Guest's Bio: <strong>John D. Marvin</strong> is a seasoned executive leader with more than three decades of experience developing people and organizations through intentional leadership, effective communication, and mindset-driven growth. As the former President and CEO of Texas State Optical, he guided one of the nation’s largest networks of independent optometric practices, steering the organization through industry change with strategic clarity, operational excellence, and a people-first approach. He believes the only limits we face are the ones we place on ourselves—and his mission is to help others rise above them, lead with purpose, and carry that belief forward. <a href="https://themarvingroup.net/"><strong>https://themarvingroup.net/</strong></a></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>John Marvin has over three decades of experience in leadership.</li><li>He emphasizes the importance of mindset in business adaptation.</li><li>Fear of change can paralyze organizations from making necessary decisions.</li><li>Consumer behavior is a critical factor in business strategy.</li><li>The optometry industry is facing significant shifts in ownership dynamics.</li><li>Younger optometrists are less interested in private practice ownership.</li><li>The pandemic accelerated changes in consumer preferences.</li><li>A hybrid business model may be necessary for future growth.</li><li>Marketing encompasses more than just advertising; product quality is key.</li><li>Leadership requires balancing individual and corporate interests.  </li><li>The delivery of eye care services is a local community service.</li><li>Marketing efforts should focus within a three-mile radius of each location.</li><li>E-commerce has changed consumer behavior in the eyewear market.</li><li>Third-party payers complicate the relationship between consumers and eye care providers.</li><li>Leadership is about influence and personal growth is essential for effective leadership.</li><li>Community involvement can enhance practice visibility and patient loyalty.</li><li>Personal growth should be a self-directed journey.</li><li>Integrating faith into business can enrich the workplace experience.</li><li>Effective marketing requires understanding local consumer behavior.</li><li>Leadership development is crucial for franchise owners in the optometry field.</li></ul><p><br>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </itunes:summary>
      <itunes:keywords>leadership, change management, optometry, business strategy, consumer behavior, marketing, healthcare, entrepreneurship, mindset, innovation, eye care, optometry, local marketing, e-commerce, leadership, personal growth, community engagement, John Maxwell, healthcare, business strategy</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://themarvingroup.net/" img="https://img.transistorcdn.com/i4cP7HsDio8574ifRj91HsBjGT8sdzcu3HgDyMQFTJ4/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ZjQ2/YTlkM2ZkMjdjYTBk/MmRmM2E3MWQ0MTUw/Y2JiMS5qcGVn.jpg">John D. Marvin</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/0ef7e410/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Revolutionizing Drug Discovery: Quantum Modeling and the Future of Pharma with Adityo Prakash</title>
      <itunes:episode>51</itunes:episode>
      <podcast:episode>51</podcast:episode>
      <itunes:title>Revolutionizing Drug Discovery: Quantum Modeling and the Future of Pharma with Adityo Prakash</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2de83727-1af6-4573-b911-0757e8c511ae</guid>
      <link>https://share.transistor.fm/s/114ff885</link>
      <description>
        <![CDATA[<p>In this episode, Adityo Prakash, founder and CEO of Verseon, shares how his company is transforming drug discovery through deep quantum modeling and advanced computational science. He discusses the challenges of traditional drug development, the limitations of current AI approaches, and how Verseon’s technology is redefining how we tackle complex diseases like diabetes and cancer. Adityo also reflects on the company’s mission-driven culture, its focus on addressing root causes rather than symptoms, and the importance of building a scientific community to accelerate truly transformative medicine.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Verseon and Adityo Prakash<br>03:07 The Journey of Drug Discovery and Innovation<br>06:03 Challenges in Current Drug Development Models<br>08:57 The Role of AI in Drug Discovery<br>11:58 Deep Quantum Modeling: A New Frontier<br>15:11 Transforming Drug Development Processes<br>18:07 Real-World Applications and Success Stories<br>27:13 Innovations in Diabetes Treatment<br>30:03 Advancements in Cancer Therapies<br>32:09 The Vision Behind the Company<br>35:02 Navigating Challenges in Drug Development<br>35:58 The Role of Quantum Computing in Drug Discovery<br>38:49 Choosing Disease Targets for Drug Development<br>42:59 Leadership Evolution and Company Culture<br>45:46 Attracting Investors and Building Community</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Adityo Prakash</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/adityo-prakash-3a5b928/"><strong>https://www.linkedin.com/in/adityo-prakash-3a5b928/</strong></a> </li><li>Company / Affiliation: <strong>Verseon </strong><a href="https://www.verseon.com/"><strong>https://www.verseon.com/</strong></a></li><li>Guest's Bio: <strong>Adityo Prakash</strong> is a scientist-entrepreneur and the <strong>Founder &amp; CEO of Verseon</strong>, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Verseon aims to redefine drug discovery through AI and quantum modeling.</li><li>The journey of drug discovery has been long and challenging.</li><li>Current drug development models are outdated and inefficient.</li><li>AI's role in drug discovery is often limited to existing data.</li><li>Deep quantum modeling offers a new approach to drug design.</li><li>The pharmaceutical industry faces dismal odds in drug development.</li><li>Innovative drugs can change treatment paradigms for major diseases.</li><li>Real-world applications of new drugs show promising results.</li><li>The need for systematic approaches in drug discovery is critical.</li><li>Verseon's mission is to create new medicines for previously untreatable diseases. </li><li>The shift from monthly to bi-monthly injections for diabetes treatment is still inadequate.</li><li>Current diabetes treatments often fail to address root causes, focusing instead on symptoms.</li><li>Innovative drugs can reverse diabetes in early stages with oral administration.</li><li>The company is developing multiple cancer therapies that target metastasis and immune response.</li><li>New chemotherapy agents are being created to remain effective even as tumors mutate.</li><li>The founders aimed to revolutionize drug discovery to better treat diseases.</li><li>External factors like economic downturns can significantly impact drug development timelines.</li><li>The integration of quantum computing is crucial for simulating complex biological systems.</li><li>Choosing disease targets is based on large unmet medical needs and well-understood biology.</li><li>Leadership involves continuous learning and adapting to foster a culture of innovation.<p></p></li></ul><p>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Adityo Prakash, founder and CEO of Verseon, shares how his company is transforming drug discovery through deep quantum modeling and advanced computational science. He discusses the challenges of traditional drug development, the limitations of current AI approaches, and how Verseon’s technology is redefining how we tackle complex diseases like diabetes and cancer. Adityo also reflects on the company’s mission-driven culture, its focus on addressing root causes rather than symptoms, and the importance of building a scientific community to accelerate truly transformative medicine.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Verseon and Adityo Prakash<br>03:07 The Journey of Drug Discovery and Innovation<br>06:03 Challenges in Current Drug Development Models<br>08:57 The Role of AI in Drug Discovery<br>11:58 Deep Quantum Modeling: A New Frontier<br>15:11 Transforming Drug Development Processes<br>18:07 Real-World Applications and Success Stories<br>27:13 Innovations in Diabetes Treatment<br>30:03 Advancements in Cancer Therapies<br>32:09 The Vision Behind the Company<br>35:02 Navigating Challenges in Drug Development<br>35:58 The Role of Quantum Computing in Drug Discovery<br>38:49 Choosing Disease Targets for Drug Development<br>42:59 Leadership Evolution and Company Culture<br>45:46 Attracting Investors and Building Community</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Adityo Prakash</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/adityo-prakash-3a5b928/"><strong>https://www.linkedin.com/in/adityo-prakash-3a5b928/</strong></a> </li><li>Company / Affiliation: <strong>Verseon </strong><a href="https://www.verseon.com/"><strong>https://www.verseon.com/</strong></a></li><li>Guest's Bio: <strong>Adityo Prakash</strong> is a scientist-entrepreneur and the <strong>Founder &amp; CEO of Verseon</strong>, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Verseon aims to redefine drug discovery through AI and quantum modeling.</li><li>The journey of drug discovery has been long and challenging.</li><li>Current drug development models are outdated and inefficient.</li><li>AI's role in drug discovery is often limited to existing data.</li><li>Deep quantum modeling offers a new approach to drug design.</li><li>The pharmaceutical industry faces dismal odds in drug development.</li><li>Innovative drugs can change treatment paradigms for major diseases.</li><li>Real-world applications of new drugs show promising results.</li><li>The need for systematic approaches in drug discovery is critical.</li><li>Verseon's mission is to create new medicines for previously untreatable diseases. </li><li>The shift from monthly to bi-monthly injections for diabetes treatment is still inadequate.</li><li>Current diabetes treatments often fail to address root causes, focusing instead on symptoms.</li><li>Innovative drugs can reverse diabetes in early stages with oral administration.</li><li>The company is developing multiple cancer therapies that target metastasis and immune response.</li><li>New chemotherapy agents are being created to remain effective even as tumors mutate.</li><li>The founders aimed to revolutionize drug discovery to better treat diseases.</li><li>External factors like economic downturns can significantly impact drug development timelines.</li><li>The integration of quantum computing is crucial for simulating complex biological systems.</li><li>Choosing disease targets is based on large unmet medical needs and well-understood biology.</li><li>Leadership involves continuous learning and adapting to foster a culture of innovation.<p></p></li></ul><p>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </content:encoded>
      <pubDate>Tue, 18 Nov 2025 10:49:48 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/114ff885/7a0ecc55.mp3" length="74768276" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/nGmVyyXG67OTwZiulrM4nAne4yP0ktGYAhjM31C5aJA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jZjM2/YjEzZTY0ODhiMWUy/YWRhYmZhNTY2NTE2/M2IxYS5qcGc.jpg"/>
      <itunes:duration>3109</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Adityo Prakash, founder and CEO of Verseon, shares how his company is transforming drug discovery through deep quantum modeling and advanced computational science. He discusses the challenges of traditional drug development, the limitations of current AI approaches, and how Verseon’s technology is redefining how we tackle complex diseases like diabetes and cancer. Adityo also reflects on the company’s mission-driven culture, its focus on addressing root causes rather than symptoms, and the importance of building a scientific community to accelerate truly transformative medicine.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Verseon and Adityo Prakash<br>03:07 The Journey of Drug Discovery and Innovation<br>06:03 Challenges in Current Drug Development Models<br>08:57 The Role of AI in Drug Discovery<br>11:58 Deep Quantum Modeling: A New Frontier<br>15:11 Transforming Drug Development Processes<br>18:07 Real-World Applications and Success Stories<br>27:13 Innovations in Diabetes Treatment<br>30:03 Advancements in Cancer Therapies<br>32:09 The Vision Behind the Company<br>35:02 Navigating Challenges in Drug Development<br>35:58 The Role of Quantum Computing in Drug Discovery<br>38:49 Choosing Disease Targets for Drug Development<br>42:59 Leadership Evolution and Company Culture<br>45:46 Attracting Investors and Building Community</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Adityo Prakash</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/adityo-prakash-3a5b928/"><strong>https://www.linkedin.com/in/adityo-prakash-3a5b928/</strong></a> </li><li>Company / Affiliation: <strong>Verseon </strong><a href="https://www.verseon.com/"><strong>https://www.verseon.com/</strong></a></li><li>Guest's Bio: <strong>Adityo Prakash</strong> is a scientist-entrepreneur and the <strong>Founder &amp; CEO of Verseon</strong>, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Verseon aims to redefine drug discovery through AI and quantum modeling.</li><li>The journey of drug discovery has been long and challenging.</li><li>Current drug development models are outdated and inefficient.</li><li>AI's role in drug discovery is often limited to existing data.</li><li>Deep quantum modeling offers a new approach to drug design.</li><li>The pharmaceutical industry faces dismal odds in drug development.</li><li>Innovative drugs can change treatment paradigms for major diseases.</li><li>Real-world applications of new drugs show promising results.</li><li>The need for systematic approaches in drug discovery is critical.</li><li>Verseon's mission is to create new medicines for previously untreatable diseases. </li><li>The shift from monthly to bi-monthly injections for diabetes treatment is still inadequate.</li><li>Current diabetes treatments often fail to address root causes, focusing instead on symptoms.</li><li>Innovative drugs can reverse diabetes in early stages with oral administration.</li><li>The company is developing multiple cancer therapies that target metastasis and immune response.</li><li>New chemotherapy agents are being created to remain effective even as tumors mutate.</li><li>The founders aimed to revolutionize drug discovery to better treat diseases.</li><li>External factors like economic downturns can significantly impact drug development timelines.</li><li>The integration of quantum computing is crucial for simulating complex biological systems.</li><li>Choosing disease targets is based on large unmet medical needs and well-understood biology.</li><li>Leadership involves continuous learning and adapting to foster a culture of innovation.<p></p></li></ul><p>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/</p>]]>
      </itunes:summary>
      <itunes:keywords>drug discovery, AI, quantum modeling, biotechnology, healthcare innovation, pharmaceutical industry, Aditya Prakash, Version, healthcare solutions, novel drugs, diabetes treatment, cancer therapies, drug development, quantum computing, leadership, innovation, healthcare, biotechnology, drug discovery, medical advancements</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.verseon.com/" img="https://img.transistorcdn.com/ViwBxmU74yN3I6g2Ghs839Cd9Gr3l4zpeBStiYR3r5k/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80NWI5/NTlmOTQ3MzQ2NjNh/ZGI4MDJhNmQyZWJi/N2U0MC5qcGVn.jpg">Adityo Prakash</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/114ff885/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Power of Partnership: Choosing to Adapt, Evolve &amp; Drive Growth with Meghna Deshraj</title>
      <itunes:episode>50</itunes:episode>
      <podcast:episode>50</podcast:episode>
      <itunes:title>The Power of Partnership: Choosing to Adapt, Evolve &amp; Drive Growth with Meghna Deshraj</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8e5c7add-53b8-4471-ae27-b459bc4613ba</guid>
      <link>https://share.transistor.fm/s/6542d038</link>
      <description>
        <![CDATA[<p>In this milestone 50th episode of <em>The Healthy Enterprise</em>, Bullzeye CEO Meghna Deshraj shares the personal journey behind building a business rooted in intention, resilience, and alignment. From leaving a stable corporate path to becoming an entrepreneur, angel investor, and global growth strategist, Meghna reflects on how marketing, healthcare, and human-centered partnership have shaped her leadership. She explains why real growth isn’t driven by louder campaigns, but by clarity, adaptation, and staying close to the people you serve. Her story captures what it truly means to be a modern growth partner—walking shoulder to shoulder with founders, helping them navigate complexity, and championing bold, meaningful progress, especially for women in business.</p><p><br><strong>Chapters:</strong><br>00:00 Celebrating Milestones: The 50th Episode<br>02:05 Meghna's Journey: From Corporate to Entrepreneur<br>05:47 The Evolution of Marketing: A Unique Approach<br>12:00 Healthcare: A Personal Connection and Professional Focus<br>18:06 Global Growth: Expanding Bullzeye's Reach<br>24:01 The Healthy Enterprise Podcast: Bridging Gaps in Healthcare<br>30:07 Investing in the Future: Meghna's Role as an Angel Investor<br>35:48 Overcoming Challenges: The Power of Adaptation<br>41:59 Final Thoughts: Embracing Change and Growth</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Meghna Deshraj</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/meghna-deshraj/"><strong> https://www.linkedin.com/in/meghna-deshraj/</strong></a></li><li>Company / Affiliation: <strong>Bullzeye Global Growth Partners</strong> <a href="https://bullzeyeglobal.com/"><strong> https://bullzeyeglobal.com/</strong></a></li><li>Guest's Bio:  <strong>Meghna Deshraj</strong> is the <strong>Founder &amp; CEO </strong>of Bullzeye Global Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships.</li></ul><p><br><strong>Takeaways:</strong><br>-Meghna Deshraj is the CEO and founder of Bullzeye Global Growth Partners.<br>-She transitioned from a corporate career to entrepreneurship through her passion for marketing.<br>-Marketing is essential for every business, regardless of product quality.<br>-A unique approach to marketing involves understanding client goals and needs.<br>-Healthcare is a personal passion for Meghna, influenced by her family's background.<br>-Global growth for Bullzeye was driven by client demand in international markets.<br>-The Healthy Enterprise Podcast aims to bridge gaps in healthcare knowledge.<br>-Meghna has been an angel investor for over 15 years, focusing on healthcare innovations.<br>-Adapting and evolving are crucial for overcoming challenges in business.<br>-Women should take bold steps and not let setbacks hold them back.</p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a><strong><br></strong><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this milestone 50th episode of <em>The Healthy Enterprise</em>, Bullzeye CEO Meghna Deshraj shares the personal journey behind building a business rooted in intention, resilience, and alignment. From leaving a stable corporate path to becoming an entrepreneur, angel investor, and global growth strategist, Meghna reflects on how marketing, healthcare, and human-centered partnership have shaped her leadership. She explains why real growth isn’t driven by louder campaigns, but by clarity, adaptation, and staying close to the people you serve. Her story captures what it truly means to be a modern growth partner—walking shoulder to shoulder with founders, helping them navigate complexity, and championing bold, meaningful progress, especially for women in business.</p><p><br><strong>Chapters:</strong><br>00:00 Celebrating Milestones: The 50th Episode<br>02:05 Meghna's Journey: From Corporate to Entrepreneur<br>05:47 The Evolution of Marketing: A Unique Approach<br>12:00 Healthcare: A Personal Connection and Professional Focus<br>18:06 Global Growth: Expanding Bullzeye's Reach<br>24:01 The Healthy Enterprise Podcast: Bridging Gaps in Healthcare<br>30:07 Investing in the Future: Meghna's Role as an Angel Investor<br>35:48 Overcoming Challenges: The Power of Adaptation<br>41:59 Final Thoughts: Embracing Change and Growth</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Meghna Deshraj</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/meghna-deshraj/"><strong> https://www.linkedin.com/in/meghna-deshraj/</strong></a></li><li>Company / Affiliation: <strong>Bullzeye Global Growth Partners</strong> <a href="https://bullzeyeglobal.com/"><strong> https://bullzeyeglobal.com/</strong></a></li><li>Guest's Bio:  <strong>Meghna Deshraj</strong> is the <strong>Founder &amp; CEO </strong>of Bullzeye Global Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships.</li></ul><p><br><strong>Takeaways:</strong><br>-Meghna Deshraj is the CEO and founder of Bullzeye Global Growth Partners.<br>-She transitioned from a corporate career to entrepreneurship through her passion for marketing.<br>-Marketing is essential for every business, regardless of product quality.<br>-A unique approach to marketing involves understanding client goals and needs.<br>-Healthcare is a personal passion for Meghna, influenced by her family's background.<br>-Global growth for Bullzeye was driven by client demand in international markets.<br>-The Healthy Enterprise Podcast aims to bridge gaps in healthcare knowledge.<br>-Meghna has been an angel investor for over 15 years, focusing on healthcare innovations.<br>-Adapting and evolving are crucial for overcoming challenges in business.<br>-Women should take bold steps and not let setbacks hold them back.</p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a><strong><br></strong><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 14 Nov 2025 11:11:31 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/6542d038/57fa18c0.mp3" length="65138623" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Do7nq2J3ZT84B4vYD1lV0CyKxsrb-0IESPCmEdzkQXw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wZDZm/Y2M4MDIwMGQwNGEw/YTI3NmNlYzFmNDE1/ZWIwNS5qcGc.jpg"/>
      <itunes:duration>2708</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this milestone 50th episode of <em>The Healthy Enterprise</em>, Bullzeye CEO Meghna Deshraj shares the personal journey behind building a business rooted in intention, resilience, and alignment. From leaving a stable corporate path to becoming an entrepreneur, angel investor, and global growth strategist, Meghna reflects on how marketing, healthcare, and human-centered partnership have shaped her leadership. She explains why real growth isn’t driven by louder campaigns, but by clarity, adaptation, and staying close to the people you serve. Her story captures what it truly means to be a modern growth partner—walking shoulder to shoulder with founders, helping them navigate complexity, and championing bold, meaningful progress, especially for women in business.</p><p><br><strong>Chapters:</strong><br>00:00 Celebrating Milestones: The 50th Episode<br>02:05 Meghna's Journey: From Corporate to Entrepreneur<br>05:47 The Evolution of Marketing: A Unique Approach<br>12:00 Healthcare: A Personal Connection and Professional Focus<br>18:06 Global Growth: Expanding Bullzeye's Reach<br>24:01 The Healthy Enterprise Podcast: Bridging Gaps in Healthcare<br>30:07 Investing in the Future: Meghna's Role as an Angel Investor<br>35:48 Overcoming Challenges: The Power of Adaptation<br>41:59 Final Thoughts: Embracing Change and Growth</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Meghna Deshraj</strong> </li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/meghna-deshraj/"><strong> https://www.linkedin.com/in/meghna-deshraj/</strong></a></li><li>Company / Affiliation: <strong>Bullzeye Global Growth Partners</strong> <a href="https://bullzeyeglobal.com/"><strong> https://bullzeyeglobal.com/</strong></a></li><li>Guest's Bio:  <strong>Meghna Deshraj</strong> is the <strong>Founder &amp; CEO </strong>of Bullzeye Global Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships.</li></ul><p><br><strong>Takeaways:</strong><br>-Meghna Deshraj is the CEO and founder of Bullzeye Global Growth Partners.<br>-She transitioned from a corporate career to entrepreneurship through her passion for marketing.<br>-Marketing is essential for every business, regardless of product quality.<br>-A unique approach to marketing involves understanding client goals and needs.<br>-Healthcare is a personal passion for Meghna, influenced by her family's background.<br>-Global growth for Bullzeye was driven by client demand in international markets.<br>-The Healthy Enterprise Podcast aims to bridge gaps in healthcare knowledge.<br>-Meghna has been an angel investor for over 15 years, focusing on healthcare innovations.<br>-Adapting and evolving are crucial for overcoming challenges in business.<br>-Women should take bold steps and not let setbacks hold them back.</p><p><strong>The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  </strong><a href="https://bullzeyeglobal.com/"><strong>https://bullzeyeglobal.com/</strong></a><strong><br></strong><br></p>]]>
      </itunes:summary>
      <itunes:keywords>entrepreneurship, marketing, healthcare, global growth, angel investing, women in business, adaptation, podcasting, business strategy, personal growth, growth partners, investment</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/6542d038/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Revolutionizing IV Care: Vascular Access Innovation with Vance Clement</title>
      <itunes:episode>49</itunes:episode>
      <podcast:episode>49</podcast:episode>
      <itunes:title>Revolutionizing IV Care: Vascular Access Innovation with Vance Clement</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6e33217b-1f44-4b96-a886-354d7fc360b1</guid>
      <link>https://share.transistor.fm/s/b0990119</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Vance Clement</strong>, CEO of <strong>Lineus Medical</strong>, shares how his company is transforming the vascular access space with its innovative IV device, <strong>SafeBreak</strong>. Drawing on over 30 years in the medical device industry, Vance discusses the challenges of building a healthcare startup, navigating FDA approval, and scaling in a complex market. He also explores the evolving dynamics of hospital purchasing, the power of strategic sales and marketing, and the leadership qualities—trust, perseverance, and optimism—that drive success in medtech innovation.</p><p><strong>Chapters</strong><br>00:00 Introduction to Lineus Medical and Vance Clement<br>02:55 Innovative Solutions in Vascular Access<br>06:01 The Journey of Product Development<br>08:49 Building a Sales Team in Medical Devices<br>12:00 Challenges in the Medical Device Industry<br>14:55 Navigating the Sales Cycle and Market Adoption<br>18:11 Expanding into New Markets<br>21:02 The Future of SafeBreak and Global Reach<br>29:16 Exploring Market Opportunities in Medical Devices<br>30:56 Navigating FDA Approval and Market Entry<br>32:59 Innovations and Future Developments in Medical Devices<br>35:10 Marketing Strategies for Medical Devices<br>40:07 The Evolving Role of Purchasing in Healthcare<br>43:46 Leadership Insights and Building Trust<br>47:58 Perseverance and Optimism in Entrepreneurship</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Vance Clement</strong> </li><li>Guest's Title/Position:<strong>  CEO and Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/vance-clement-4378464/"><strong>https://www.linkedin.com/in/vance-clement-4378464/</strong></a></li><li>Company / Affiliation: <strong> Lineus Medical </strong><a href="https://www.lineusmed.com/"><strong>https://www.lineusmed.com/</strong></a></li><li>Guest's Bio: <strong>Vance Clement</strong> is the CEO and Co-Founder of Lineus Medical, bringing over 30 years of experience in the medical device industry. Since joining Lineus in 2015 and becoming CEO in 2018, he has guided the company’s growth and innovation. Previously, Vance led sales and marketing at BlueInGreen, where he quadrupled annual revenue, and held senior marketing roles at Mako Surgical, helping expand the company from a small orthopedic start-up to over $100M in sales. He also spent a decade at Smith &amp; Nephew Orthopaedics and began his career at Wright Medical Technology. Vance holds a B.S. in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University. He has been recognized as a C-Suite Leader (2021), a State Tech Leader (2022), and a Distinguished Engineering Alumni (2024).</li></ul><p><strong>Takeaways:<br>-</strong>Vance Clement is the CEO of Lineus Medical, focusing on vascular access solutions.<br>-Lineus Medical's product, SafeBreak, addresses IV complications effectively.<br>-IVs fail 46% of the time, highlighting a significant healthcare issue.<br>-The device allows for safe separation of IV lines to prevent complications.<br>-Vance's background includes extensive experience in medical device sales and marketing.<br>-Building a sales team in the medical field presents unique challenges.<br>-The sales cycle for medical devices can be long and complex.<br>-Market adoption requires thorough product evaluations and nurse buy-in.<br>-The veterinary market presents new opportunities for Safebrake.<br>-Lineus Medical is expanding its reach globally, with regulatory approvals in multiple countries. <br>-There's a significant market opportunity in medical devices.<br>-Navigating FDA approval is a critical step for market entry.<br>-Innovations in medical devices can lead to better patient outcomes.<br>-Effective marketing strategies are essential for medical device companies.<br>-Purchasing departments hold significant power in healthcare decisions.<br>-Building trust and integrity is crucial in leadership roles.<br>-Perseverance and optimism are key traits for entrepreneurs.<br>-Understanding the needs of healthcare professionals can drive product success.<br>-Engaging with top management can lead to better market penetration.<br>-Digital marketing may not always yield immediate results in healthcare.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Vance Clement</strong>, CEO of <strong>Lineus Medical</strong>, shares how his company is transforming the vascular access space with its innovative IV device, <strong>SafeBreak</strong>. Drawing on over 30 years in the medical device industry, Vance discusses the challenges of building a healthcare startup, navigating FDA approval, and scaling in a complex market. He also explores the evolving dynamics of hospital purchasing, the power of strategic sales and marketing, and the leadership qualities—trust, perseverance, and optimism—that drive success in medtech innovation.</p><p><strong>Chapters</strong><br>00:00 Introduction to Lineus Medical and Vance Clement<br>02:55 Innovative Solutions in Vascular Access<br>06:01 The Journey of Product Development<br>08:49 Building a Sales Team in Medical Devices<br>12:00 Challenges in the Medical Device Industry<br>14:55 Navigating the Sales Cycle and Market Adoption<br>18:11 Expanding into New Markets<br>21:02 The Future of SafeBreak and Global Reach<br>29:16 Exploring Market Opportunities in Medical Devices<br>30:56 Navigating FDA Approval and Market Entry<br>32:59 Innovations and Future Developments in Medical Devices<br>35:10 Marketing Strategies for Medical Devices<br>40:07 The Evolving Role of Purchasing in Healthcare<br>43:46 Leadership Insights and Building Trust<br>47:58 Perseverance and Optimism in Entrepreneurship</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Vance Clement</strong> </li><li>Guest's Title/Position:<strong>  CEO and Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/vance-clement-4378464/"><strong>https://www.linkedin.com/in/vance-clement-4378464/</strong></a></li><li>Company / Affiliation: <strong> Lineus Medical </strong><a href="https://www.lineusmed.com/"><strong>https://www.lineusmed.com/</strong></a></li><li>Guest's Bio: <strong>Vance Clement</strong> is the CEO and Co-Founder of Lineus Medical, bringing over 30 years of experience in the medical device industry. Since joining Lineus in 2015 and becoming CEO in 2018, he has guided the company’s growth and innovation. Previously, Vance led sales and marketing at BlueInGreen, where he quadrupled annual revenue, and held senior marketing roles at Mako Surgical, helping expand the company from a small orthopedic start-up to over $100M in sales. He also spent a decade at Smith &amp; Nephew Orthopaedics and began his career at Wright Medical Technology. Vance holds a B.S. in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University. He has been recognized as a C-Suite Leader (2021), a State Tech Leader (2022), and a Distinguished Engineering Alumni (2024).</li></ul><p><strong>Takeaways:<br>-</strong>Vance Clement is the CEO of Lineus Medical, focusing on vascular access solutions.<br>-Lineus Medical's product, SafeBreak, addresses IV complications effectively.<br>-IVs fail 46% of the time, highlighting a significant healthcare issue.<br>-The device allows for safe separation of IV lines to prevent complications.<br>-Vance's background includes extensive experience in medical device sales and marketing.<br>-Building a sales team in the medical field presents unique challenges.<br>-The sales cycle for medical devices can be long and complex.<br>-Market adoption requires thorough product evaluations and nurse buy-in.<br>-The veterinary market presents new opportunities for Safebrake.<br>-Lineus Medical is expanding its reach globally, with regulatory approvals in multiple countries. <br>-There's a significant market opportunity in medical devices.<br>-Navigating FDA approval is a critical step for market entry.<br>-Innovations in medical devices can lead to better patient outcomes.<br>-Effective marketing strategies are essential for medical device companies.<br>-Purchasing departments hold significant power in healthcare decisions.<br>-Building trust and integrity is crucial in leadership roles.<br>-Perseverance and optimism are key traits for entrepreneurs.<br>-Understanding the needs of healthcare professionals can drive product success.<br>-Engaging with top management can lead to better market penetration.<br>-Digital marketing may not always yield immediate results in healthcare.</p>]]>
      </content:encoded>
      <pubDate>Fri, 07 Nov 2025 20:55:53 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/b0990119/8681ffd3.mp3" length="77206021" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/b_nZYplN2_rc82ZhvtUlZsqVICn6Wx-VWzlXtUCBN8o/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wNWU2/YjM3NmZmNzM4M2Fh/YmY3ZWQ5YzU1MDRk/OGRiMC5qcGc.jpg"/>
      <itunes:duration>3211</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Vance Clement</strong>, CEO of <strong>Lineus Medical</strong>, shares how his company is transforming the vascular access space with its innovative IV device, <strong>SafeBreak</strong>. Drawing on over 30 years in the medical device industry, Vance discusses the challenges of building a healthcare startup, navigating FDA approval, and scaling in a complex market. He also explores the evolving dynamics of hospital purchasing, the power of strategic sales and marketing, and the leadership qualities—trust, perseverance, and optimism—that drive success in medtech innovation.</p><p><strong>Chapters</strong><br>00:00 Introduction to Lineus Medical and Vance Clement<br>02:55 Innovative Solutions in Vascular Access<br>06:01 The Journey of Product Development<br>08:49 Building a Sales Team in Medical Devices<br>12:00 Challenges in the Medical Device Industry<br>14:55 Navigating the Sales Cycle and Market Adoption<br>18:11 Expanding into New Markets<br>21:02 The Future of SafeBreak and Global Reach<br>29:16 Exploring Market Opportunities in Medical Devices<br>30:56 Navigating FDA Approval and Market Entry<br>32:59 Innovations and Future Developments in Medical Devices<br>35:10 Marketing Strategies for Medical Devices<br>40:07 The Evolving Role of Purchasing in Healthcare<br>43:46 Leadership Insights and Building Trust<br>47:58 Perseverance and Optimism in Entrepreneurship</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Vance Clement</strong> </li><li>Guest's Title/Position:<strong>  CEO and Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/vance-clement-4378464/"><strong>https://www.linkedin.com/in/vance-clement-4378464/</strong></a></li><li>Company / Affiliation: <strong> Lineus Medical </strong><a href="https://www.lineusmed.com/"><strong>https://www.lineusmed.com/</strong></a></li><li>Guest's Bio: <strong>Vance Clement</strong> is the CEO and Co-Founder of Lineus Medical, bringing over 30 years of experience in the medical device industry. Since joining Lineus in 2015 and becoming CEO in 2018, he has guided the company’s growth and innovation. Previously, Vance led sales and marketing at BlueInGreen, where he quadrupled annual revenue, and held senior marketing roles at Mako Surgical, helping expand the company from a small orthopedic start-up to over $100M in sales. He also spent a decade at Smith &amp; Nephew Orthopaedics and began his career at Wright Medical Technology. Vance holds a B.S. in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University. He has been recognized as a C-Suite Leader (2021), a State Tech Leader (2022), and a Distinguished Engineering Alumni (2024).</li></ul><p><strong>Takeaways:<br>-</strong>Vance Clement is the CEO of Lineus Medical, focusing on vascular access solutions.<br>-Lineus Medical's product, SafeBreak, addresses IV complications effectively.<br>-IVs fail 46% of the time, highlighting a significant healthcare issue.<br>-The device allows for safe separation of IV lines to prevent complications.<br>-Vance's background includes extensive experience in medical device sales and marketing.<br>-Building a sales team in the medical field presents unique challenges.<br>-The sales cycle for medical devices can be long and complex.<br>-Market adoption requires thorough product evaluations and nurse buy-in.<br>-The veterinary market presents new opportunities for Safebrake.<br>-Lineus Medical is expanding its reach globally, with regulatory approvals in multiple countries. <br>-There's a significant market opportunity in medical devices.<br>-Navigating FDA approval is a critical step for market entry.<br>-Innovations in medical devices can lead to better patient outcomes.<br>-Effective marketing strategies are essential for medical device companies.<br>-Purchasing departments hold significant power in healthcare decisions.<br>-Building trust and integrity is crucial in leadership roles.<br>-Perseverance and optimism are key traits for entrepreneurs.<br>-Understanding the needs of healthcare professionals can drive product success.<br>-Engaging with top management can lead to better market penetration.<br>-Digital marketing may not always yield immediate results in healthcare.</p>]]>
      </itunes:summary>
      <itunes:keywords>Lineus Medical, Vascular Access, IV Care, Medical Devices, Startup, Healthcare Innovation, Sales Strategy, Hospital Adoption, Nursing Solutions, Medical Technology, IV devices, healthcare innovation, medical devices, market strategy, business development, leadership, entrepreneurship, regulatory challenges, marketing strategies, hospital purchasing</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.lineusmed.com/" img="https://img.transistorcdn.com/VRP421kbLOtQG5TBVljrw6ugSuac-dwu06QtlVc2ScI/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84YWY2/NWUwMDA3YmMzMTU4/MjY5ZGNiNzM5OWIz/MDYxZi5qcGVn.jpg">Vance Clement</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/b0990119/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b0990119/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b0990119/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b0990119/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/b0990119/transcription" type="text/html"/>
    </item>
    <item>
      <title>Entrepreneurship in Action: Building Businesses That Matter with Brett Larson</title>
      <itunes:episode>48</itunes:episode>
      <podcast:episode>48</podcast:episode>
      <itunes:title>Entrepreneurship in Action: Building Businesses That Matter with Brett Larson</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4303c24c-68a0-4ce3-a7f8-8b3547618677</guid>
      <link>https://share.transistor.fm/s/320ac895</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Bret Larsen — serial entrepreneur and CEO of Chief — shares his journey from launching his first startup in college to leading multiple high-growth B2B software companies, including the telemedicine platform E-Visit. He reflects on the lessons learned from scaling businesses, navigating the challenges of the pandemic, and transitioning from founder to CEO. Bret discusses the vision behind Chief, a predictive operations platform designed to empower sales leaders, and offers candid insights on mentorship, resilience, and the personal side of entrepreneurship.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Brett Larson and His Journey<br>03:03 The Birth of E-Visit and Telemedicine Innovations<br>06:00 The Launch of Chief: A Predictive Operations Platform<br>08:54 The Entrepreneurial Drive: Origins and Influences<br>11:50 Navigating Challenges in Healthcare Innovation<br>15:00 Growth During the Pandemic: A Turning Point<br>18:09 Managing Rapid Growth and New Responsibilities<br>20:51 Personal Growth and Leadership Development<br>24:12 The Importance of Mentorship and Skill Evolution<br>30:47 Unlocking Growth: The Role of Founders' Personal Lives<br>35:50 Navigating Identity: The Founder vs. CEO Dilemma<br>41:34 The Evolution of Chief: From Vision to Execution<br>46:50 Building Chief: Insights from Market Research<br>52:47 The Unique Value Proposition of Chief<br>56:38 Passion and Pain: The Reality of Building Businesses</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Bret Larsen</strong> </li><li>Guest's Title/Position:<strong>   Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> </a><a href="https://www.linkedin.com/in/bretalarsen/">https://www.linkedin.com/in/bretalarsen/</a></li><li>Company / Affiliation: <strong>Chief  </strong><a href="https://www.getchief.com/"><strong>https://www.getchief.com/</strong></a></li><li>Guest's Bio: <strong>Bret Larsen</strong> is the Founder and CEO of <strong>Chief</strong>, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by <em>Inc. 5000</em>, <em>Deloitte Fast 500</em>, <em>Forrester</em>, and <em>Gartner</em>. Named a <em>Titan 100 CEO</em>, <em>Top 50 CEO in Healthcare Technology</em>, and <em>Ernst &amp; Young Entrepreneur of the Year</em> finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Brett Larson is a three-time founder and CEO with a strong background in B2B software.</li><li>His first company was a small e-commerce business started during his undergraduate studies.</li><li>Brett's journey in healthcare began with E-Visit, a telemedicine platform that gained traction during the pandemic.</li><li>The idea for Chief, his latest venture, was inspired by the need for predictive operations in businesses.</li><li>Brett's entrepreneurial drive is influenced by his family background and early experiences in business.</li><li>Healthcare is often slow to adopt technology due to the risks involved, but there are opportunities for innovation.</li><li>The pandemic created a significant growth opportunity for E-Visit, leading to a 1200% increase in team size.</li><li>Navigating rapid growth requires a shift in leadership skills and adaptability.</li><li>Brett highlights the importance of mentorship and executive coaching in his development as a leader.</li><li>The role of a CEO can be lonely, and perception plays a crucial role in leadership. </li><li>You cannot increase burn for six months post-investment without proving ROI.</li><li>Founders' personal lives significantly impact business success.</li><li>Hiring talented individuals can be intimidating but is essential for growth.</li><li>Articulating a clear vision is crucial for leadership.</li><li>Goldman Sachs provides unparalleled support for startups.</li><li>Recognizing feelings of languishing can lead to renewed purpose.</li><li>Unlocking operational data is key to business success.</li><li>The ideal customer for Chief is a VP of Sales or CRO.</li><li>Pain tolerance is directly correlated to impact in business.</li><li>Passion for the problem drives resilience in entrepreneurship.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Bret Larsen — serial entrepreneur and CEO of Chief — shares his journey from launching his first startup in college to leading multiple high-growth B2B software companies, including the telemedicine platform E-Visit. He reflects on the lessons learned from scaling businesses, navigating the challenges of the pandemic, and transitioning from founder to CEO. Bret discusses the vision behind Chief, a predictive operations platform designed to empower sales leaders, and offers candid insights on mentorship, resilience, and the personal side of entrepreneurship.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Brett Larson and His Journey<br>03:03 The Birth of E-Visit and Telemedicine Innovations<br>06:00 The Launch of Chief: A Predictive Operations Platform<br>08:54 The Entrepreneurial Drive: Origins and Influences<br>11:50 Navigating Challenges in Healthcare Innovation<br>15:00 Growth During the Pandemic: A Turning Point<br>18:09 Managing Rapid Growth and New Responsibilities<br>20:51 Personal Growth and Leadership Development<br>24:12 The Importance of Mentorship and Skill Evolution<br>30:47 Unlocking Growth: The Role of Founders' Personal Lives<br>35:50 Navigating Identity: The Founder vs. CEO Dilemma<br>41:34 The Evolution of Chief: From Vision to Execution<br>46:50 Building Chief: Insights from Market Research<br>52:47 The Unique Value Proposition of Chief<br>56:38 Passion and Pain: The Reality of Building Businesses</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Bret Larsen</strong> </li><li>Guest's Title/Position:<strong>   Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> </a><a href="https://www.linkedin.com/in/bretalarsen/">https://www.linkedin.com/in/bretalarsen/</a></li><li>Company / Affiliation: <strong>Chief  </strong><a href="https://www.getchief.com/"><strong>https://www.getchief.com/</strong></a></li><li>Guest's Bio: <strong>Bret Larsen</strong> is the Founder and CEO of <strong>Chief</strong>, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by <em>Inc. 5000</em>, <em>Deloitte Fast 500</em>, <em>Forrester</em>, and <em>Gartner</em>. Named a <em>Titan 100 CEO</em>, <em>Top 50 CEO in Healthcare Technology</em>, and <em>Ernst &amp; Young Entrepreneur of the Year</em> finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Brett Larson is a three-time founder and CEO with a strong background in B2B software.</li><li>His first company was a small e-commerce business started during his undergraduate studies.</li><li>Brett's journey in healthcare began with E-Visit, a telemedicine platform that gained traction during the pandemic.</li><li>The idea for Chief, his latest venture, was inspired by the need for predictive operations in businesses.</li><li>Brett's entrepreneurial drive is influenced by his family background and early experiences in business.</li><li>Healthcare is often slow to adopt technology due to the risks involved, but there are opportunities for innovation.</li><li>The pandemic created a significant growth opportunity for E-Visit, leading to a 1200% increase in team size.</li><li>Navigating rapid growth requires a shift in leadership skills and adaptability.</li><li>Brett highlights the importance of mentorship and executive coaching in his development as a leader.</li><li>The role of a CEO can be lonely, and perception plays a crucial role in leadership. </li><li>You cannot increase burn for six months post-investment without proving ROI.</li><li>Founders' personal lives significantly impact business success.</li><li>Hiring talented individuals can be intimidating but is essential for growth.</li><li>Articulating a clear vision is crucial for leadership.</li><li>Goldman Sachs provides unparalleled support for startups.</li><li>Recognizing feelings of languishing can lead to renewed purpose.</li><li>Unlocking operational data is key to business success.</li><li>The ideal customer for Chief is a VP of Sales or CRO.</li><li>Pain tolerance is directly correlated to impact in business.</li><li>Passion for the problem drives resilience in entrepreneurship.</li></ul>]]>
      </content:encoded>
      <pubDate>Sun, 02 Nov 2025 22:22:24 -0800</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/320ac895/ca28244c.mp3" length="88932025" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/qekh9dBlTekHxh0VOesk3HGAguxPXinmxPtZP59xrI8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82ZWQ4/MDBlOTQ0ZWQ1MzJl/NThkM2U0YjY2MzY0/ODZhNi5qcGc.jpg"/>
      <itunes:duration>3697</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Bret Larsen — serial entrepreneur and CEO of Chief — shares his journey from launching his first startup in college to leading multiple high-growth B2B software companies, including the telemedicine platform E-Visit. He reflects on the lessons learned from scaling businesses, navigating the challenges of the pandemic, and transitioning from founder to CEO. Bret discusses the vision behind Chief, a predictive operations platform designed to empower sales leaders, and offers candid insights on mentorship, resilience, and the personal side of entrepreneurship.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Brett Larson and His Journey<br>03:03 The Birth of E-Visit and Telemedicine Innovations<br>06:00 The Launch of Chief: A Predictive Operations Platform<br>08:54 The Entrepreneurial Drive: Origins and Influences<br>11:50 Navigating Challenges in Healthcare Innovation<br>15:00 Growth During the Pandemic: A Turning Point<br>18:09 Managing Rapid Growth and New Responsibilities<br>20:51 Personal Growth and Leadership Development<br>24:12 The Importance of Mentorship and Skill Evolution<br>30:47 Unlocking Growth: The Role of Founders' Personal Lives<br>35:50 Navigating Identity: The Founder vs. CEO Dilemma<br>41:34 The Evolution of Chief: From Vision to Execution<br>46:50 Building Chief: Insights from Market Research<br>52:47 The Unique Value Proposition of Chief<br>56:38 Passion and Pain: The Reality of Building Businesses</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Bret Larsen</strong> </li><li>Guest's Title/Position:<strong>   Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> </a><a href="https://www.linkedin.com/in/bretalarsen/">https://www.linkedin.com/in/bretalarsen/</a></li><li>Company / Affiliation: <strong>Chief  </strong><a href="https://www.getchief.com/"><strong>https://www.getchief.com/</strong></a></li><li>Guest's Bio: <strong>Bret Larsen</strong> is the Founder and CEO of <strong>Chief</strong>, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by <em>Inc. 5000</em>, <em>Deloitte Fast 500</em>, <em>Forrester</em>, and <em>Gartner</em>. Named a <em>Titan 100 CEO</em>, <em>Top 50 CEO in Healthcare Technology</em>, and <em>Ernst &amp; Young Entrepreneur of the Year</em> finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Brett Larson is a three-time founder and CEO with a strong background in B2B software.</li><li>His first company was a small e-commerce business started during his undergraduate studies.</li><li>Brett's journey in healthcare began with E-Visit, a telemedicine platform that gained traction during the pandemic.</li><li>The idea for Chief, his latest venture, was inspired by the need for predictive operations in businesses.</li><li>Brett's entrepreneurial drive is influenced by his family background and early experiences in business.</li><li>Healthcare is often slow to adopt technology due to the risks involved, but there are opportunities for innovation.</li><li>The pandemic created a significant growth opportunity for E-Visit, leading to a 1200% increase in team size.</li><li>Navigating rapid growth requires a shift in leadership skills and adaptability.</li><li>Brett highlights the importance of mentorship and executive coaching in his development as a leader.</li><li>The role of a CEO can be lonely, and perception plays a crucial role in leadership. </li><li>You cannot increase burn for six months post-investment without proving ROI.</li><li>Founders' personal lives significantly impact business success.</li><li>Hiring talented individuals can be intimidating but is essential for growth.</li><li>Articulating a clear vision is crucial for leadership.</li><li>Goldman Sachs provides unparalleled support for startups.</li><li>Recognizing feelings of languishing can lead to renewed purpose.</li><li>Unlocking operational data is key to business success.</li><li>The ideal customer for Chief is a VP of Sales or CRO.</li><li>Pain tolerance is directly correlated to impact in business.</li><li>Passion for the problem drives resilience in entrepreneurship.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>entrepreneurship, telemedicine, healthcare innovation, predictive operations, leadership, personal growth, pandemic impact, business challenges, mentorship, technology adoption, founders, growth, coaching, identity crisis, business strategy, AI, market research, leadership, healthcare, entrepreneurship</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.getchief.com/" img="https://img.transistorcdn.com/5EPcBH72zAmqAHkVP2l0UoX1ACrfR7Rx7my9J83oAHc/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wM2Rk/Mjc4ZGEyMTExN2Ex/YjE1MjM3YjBkNmRh/NDdmNC5qcGVn.jpg">Bret Larsen</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/320ac895/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/320ac895/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/320ac895/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/320ac895/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/320ac895/transcription" type="text/html"/>
    </item>
    <item>
      <title>Unlocking RNA Secrets: Live Cell RNA Analysis Redefined with Dr. Marsha Hartman</title>
      <itunes:episode>47</itunes:episode>
      <podcast:episode>47</podcast:episode>
      <itunes:title>Unlocking RNA Secrets: Live Cell RNA Analysis Redefined with Dr. Marsha Hartman</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">eb250d1a-3446-4284-ad72-a0bf142023df</guid>
      <link>https://share.transistor.fm/s/af613d6a</link>
      <description>
        <![CDATA[<p>In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Marsha Hartman and Her Journey<br>03:09 The Intersection of Epidemiology and Immunology<br>06:00 Sales and Science: A Unique Blend<br>09:13 COVID-19: A Case Study in Epidemiology and Immunology<br>11:52 The Role of Biomarkers in Personalized Medicine<br>15:02 Exodigm: Transforming Cell Analysis<br>17:58 Marsha's Transition to CEO<br>20:48 Leadership Philosophy and Personal Growth<br>27:27 The Art of Listening in Leadership<br>30:07 Lessons from COVID-19: A Global Experience<br>34:01 The Role of Technology in Healthcare<br>36:12 The Future of Personalized Medicine<br>39:22 Patient Data Ownership and Accessibility<br>42:20 The Ethical Use of AI in Healthcare<br>44:23 Finding Your Purpose and Aligning with Others</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Marsha L. Hartman</strong></li><li>Guest's Title/Position:<strong>  Fractional CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/</a></li><li>Company / Affiliation: <strong> Exodigm Biosciences </strong><a href="https://www.exodigm.com/"><strong>https://www.exodigm.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Marsha L. Hartman</strong> is the <strong>Fractional CEO of Exodigm Biosciences</strong>, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Marsha Hartman has a unique background in epidemiology and immunology.</li><li>She transitioned from academia to sales and marketing in the life sciences.</li><li>COVID-19 highlighted the importance of understanding immunology and epidemiology together.</li><li>Biomarkers play a crucial role in personalized medicine and treatment outcomes.</li><li>Exodime is pioneering live cell RNA analysis, which could revolutionize cell therapy.</li><li>Marsha's leadership style is collaborative and focused on team success.</li><li>She believes in the power of hard work, honesty, and hope in both life and science.</li><li>Perfectionism can hinder authentic leadership and team dynamics.</li><li>Building relationships is key to successful collaboration in science and business.</li><li>Marsha's journey illustrates the importance of adaptability and continuous learning. </li><li>As a leader, you must be a philosopher and a listener.</li><li>Listening to your team can reveal insights you may not be aware of.</li><li>COVID-19 taught us valuable lessons about collective experiences.</li><li>Technology has accelerated advancements in healthcare.</li><li>Personalized medicine is the future of healthcare.</li><li>Patients should have ownership of their health data.</li><li>AI can help eliminate biases in data interpretation.</li><li>Collaboration is key to solving healthcare challenges.</li><li>Understanding your purpose can guide your actions.</li><li>Aligning with others can lead to greater impact.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Marsha Hartman and Her Journey<br>03:09 The Intersection of Epidemiology and Immunology<br>06:00 Sales and Science: A Unique Blend<br>09:13 COVID-19: A Case Study in Epidemiology and Immunology<br>11:52 The Role of Biomarkers in Personalized Medicine<br>15:02 Exodigm: Transforming Cell Analysis<br>17:58 Marsha's Transition to CEO<br>20:48 Leadership Philosophy and Personal Growth<br>27:27 The Art of Listening in Leadership<br>30:07 Lessons from COVID-19: A Global Experience<br>34:01 The Role of Technology in Healthcare<br>36:12 The Future of Personalized Medicine<br>39:22 Patient Data Ownership and Accessibility<br>42:20 The Ethical Use of AI in Healthcare<br>44:23 Finding Your Purpose and Aligning with Others</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Marsha L. Hartman</strong></li><li>Guest's Title/Position:<strong>  Fractional CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/</a></li><li>Company / Affiliation: <strong> Exodigm Biosciences </strong><a href="https://www.exodigm.com/"><strong>https://www.exodigm.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Marsha L. Hartman</strong> is the <strong>Fractional CEO of Exodigm Biosciences</strong>, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Marsha Hartman has a unique background in epidemiology and immunology.</li><li>She transitioned from academia to sales and marketing in the life sciences.</li><li>COVID-19 highlighted the importance of understanding immunology and epidemiology together.</li><li>Biomarkers play a crucial role in personalized medicine and treatment outcomes.</li><li>Exodime is pioneering live cell RNA analysis, which could revolutionize cell therapy.</li><li>Marsha's leadership style is collaborative and focused on team success.</li><li>She believes in the power of hard work, honesty, and hope in both life and science.</li><li>Perfectionism can hinder authentic leadership and team dynamics.</li><li>Building relationships is key to successful collaboration in science and business.</li><li>Marsha's journey illustrates the importance of adaptability and continuous learning. </li><li>As a leader, you must be a philosopher and a listener.</li><li>Listening to your team can reveal insights you may not be aware of.</li><li>COVID-19 taught us valuable lessons about collective experiences.</li><li>Technology has accelerated advancements in healthcare.</li><li>Personalized medicine is the future of healthcare.</li><li>Patients should have ownership of their health data.</li><li>AI can help eliminate biases in data interpretation.</li><li>Collaboration is key to solving healthcare challenges.</li><li>Understanding your purpose can guide your actions.</li><li>Aligning with others can lead to greater impact.</li></ul>]]>
      </content:encoded>
      <pubDate>Thu, 30 Oct 2025 22:51:00 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/af613d6a/6fde1cd6.mp3" length="70298376" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/6ifTW5-lDl7AxVjA6oBL8JRaP64pTWvygdU8MkARd74/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85Njgy/YWY3YzM0YmVkYTVm/ODBiY2UxZWI1ZTJh/ZjQ3ZS5qcGc.jpg"/>
      <itunes:duration>2922</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Marsha Hartman and Her Journey<br>03:09 The Intersection of Epidemiology and Immunology<br>06:00 Sales and Science: A Unique Blend<br>09:13 COVID-19: A Case Study in Epidemiology and Immunology<br>11:52 The Role of Biomarkers in Personalized Medicine<br>15:02 Exodigm: Transforming Cell Analysis<br>17:58 Marsha's Transition to CEO<br>20:48 Leadership Philosophy and Personal Growth<br>27:27 The Art of Listening in Leadership<br>30:07 Lessons from COVID-19: A Global Experience<br>34:01 The Role of Technology in Healthcare<br>36:12 The Future of Personalized Medicine<br>39:22 Patient Data Ownership and Accessibility<br>42:20 The Ethical Use of AI in Healthcare<br>44:23 Finding Your Purpose and Aligning with Others</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Marsha L. Hartman</strong></li><li>Guest's Title/Position:<strong>  Fractional CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/"> https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/</a></li><li>Company / Affiliation: <strong> Exodigm Biosciences </strong><a href="https://www.exodigm.com/"><strong>https://www.exodigm.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Marsha L. Hartman</strong> is the <strong>Fractional CEO of Exodigm Biosciences</strong>, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Marsha Hartman has a unique background in epidemiology and immunology.</li><li>She transitioned from academia to sales and marketing in the life sciences.</li><li>COVID-19 highlighted the importance of understanding immunology and epidemiology together.</li><li>Biomarkers play a crucial role in personalized medicine and treatment outcomes.</li><li>Exodime is pioneering live cell RNA analysis, which could revolutionize cell therapy.</li><li>Marsha's leadership style is collaborative and focused on team success.</li><li>She believes in the power of hard work, honesty, and hope in both life and science.</li><li>Perfectionism can hinder authentic leadership and team dynamics.</li><li>Building relationships is key to successful collaboration in science and business.</li><li>Marsha's journey illustrates the importance of adaptability and continuous learning. </li><li>As a leader, you must be a philosopher and a listener.</li><li>Listening to your team can reveal insights you may not be aware of.</li><li>COVID-19 taught us valuable lessons about collective experiences.</li><li>Technology has accelerated advancements in healthcare.</li><li>Personalized medicine is the future of healthcare.</li><li>Patients should have ownership of their health data.</li><li>AI can help eliminate biases in data interpretation.</li><li>Collaboration is key to solving healthcare challenges.</li><li>Understanding your purpose can guide your actions.</li><li>Aligning with others can lead to greater impact.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Marsha L. Hartman, cell therapy, epidemiology, immunology, COVID-19, personalized medicine, Exodime, leadership, biomarkers, sales, leadership, COVID-19, technology, healthcare, personalized medicine, patient data, AI, ethics, purpose, collaboration</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.exodigm.com/" img="https://img.transistorcdn.com/qo0Kr4mIM2RVkqMqr0Dl0wmmouIV18SEMGbZa0asYPo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZTQ0/Njk3ODMwZjI1ZGE1/NDU4NjdjOGUxNzIw/ZjVmNi5qcGVn.jpg">Dr. Marsha L. Hartman</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/af613d6a/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/af613d6a/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/af613d6a/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/af613d6a/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/af613d6a/transcription" type="text/html"/>
    </item>
    <item>
      <title>Teaching, Tech &amp; Trials: Disrupting Clinical Research with  Dr. Tia Warrick </title>
      <itunes:episode>46</itunes:episode>
      <podcast:episode>46</podcast:episode>
      <itunes:title>Teaching, Tech &amp; Trials: Disrupting Clinical Research with  Dr. Tia Warrick </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">09687c72-6f43-4af4-b2e5-2f4fa4ff70c7</guid>
      <link>https://share.transistor.fm/s/8816ac22</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Tia Warrick</strong>, CEO of <strong>Lesous Consulting</strong>, shares her journey in clinical research and healthcare education. She discusses the industry gaps that inspired her to launch Lesous, a company focused on bridging those divides through training, mentorship, and innovative technology. Dr. Warrick highlights the importance of practical, accessible education, the growing role of AI in clinical efficiency, and the need for equitable participation in clinical trials. With a passion for teaching and empowerment, she offers valuable insights on leadership, career growth, and creating supportive pathways for the next generation of healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Dr. Tia Warrick and Lesous Consulting<br>03:03 Dr. Warwick's Journey in Clinical Research<br>05:51 Identifying Gaps in Clinical Research<br>08:59 The Role of Education and Training<br>11:53 Leveraging AI in Clinical Research<br>14:51 Creating Equity in Clinical Trials<br>17:48 Innovative Training Solutions<br>20:56 The Importance of Practical Application in Training<br>24:11 Challenges and Rewards in Clinical Research<br>26:51 Bridging the Gap in Healthcare Education<br>27:16 The Journey to Teaching and Mentorship<br>29:34 The Impact of Clinical Research<br>30:54 Transforming Professional Development<br>34:39 Creating a Safe Learning Environment<br>36:37 Navigating Career Transitions<br>39:16 Finding Your True Path<br>43:00 Overcoming Industry Challenges<br>48:22 Connecting with Dr. Tia Warrick</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Dr. Tia Warrick</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drwarrick/"><strong>https://www.linkedin.com/in/drwarrick/</strong></a></li><li>Company / Affiliation: <strong>Lesous Consulting </strong><a href="https://lesousconsulting.com/"><strong>https://lesousconsulting.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Tia Warrick</strong> is the CEO of <strong>Lesous Consulting</strong>, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of <em>“Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,”</em> Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact.</li></ul><p><br>T<strong>akeaways</strong></p><ul><li>Dr. Tia Warwick is the CEO of Lesous Consulting, focusing on bridging gaps in clinical research.</li><li>80% of clinical trials fail due to inefficiencies and administrative bottlenecks.</li><li>Education and training are crucial for improving clinical research outcomes.</li><li>AI can enhance efficiency in clinical research without replacing jobs.</li><li>Creating equity in clinical trials is essential for patient access to treatments.</li><li>Practical application in training is more valuable than theoretical knowledge.</li><li>Burnout among clinical research professionals is a significant issue.</li><li>Innovative training solutions can accelerate experience and reduce mistakes.</li><li>Collaboration between institutions is key to successful clinical trials.</li><li>The cost of clinical trials impacts the affordability of treatments for consumers. </li><li>Dr. Warrick emphasizes the need for equitable healthcare education.</li><li>Teaching has always been a passion for Dr. Warrick.</li><li>Clinical research plays a crucial role in patient care.</li><li>Transforming professional development can lead to industry improvements.</li><li>Creating a safe learning environment fosters growth.</li><li>Career transitions require careful navigation and support.</li><li>Finding one's true path is essential for fulfillment.</li><li>Overcoming industry challenges involves positivity and resilience.</li><li>A holistic approach to career coaching considers all aspects of life.</li><li>Building connections and community is vital for professional success.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Tia Warrick</strong>, CEO of <strong>Lesous Consulting</strong>, shares her journey in clinical research and healthcare education. She discusses the industry gaps that inspired her to launch Lesous, a company focused on bridging those divides through training, mentorship, and innovative technology. Dr. Warrick highlights the importance of practical, accessible education, the growing role of AI in clinical efficiency, and the need for equitable participation in clinical trials. With a passion for teaching and empowerment, she offers valuable insights on leadership, career growth, and creating supportive pathways for the next generation of healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Dr. Tia Warrick and Lesous Consulting<br>03:03 Dr. Warwick's Journey in Clinical Research<br>05:51 Identifying Gaps in Clinical Research<br>08:59 The Role of Education and Training<br>11:53 Leveraging AI in Clinical Research<br>14:51 Creating Equity in Clinical Trials<br>17:48 Innovative Training Solutions<br>20:56 The Importance of Practical Application in Training<br>24:11 Challenges and Rewards in Clinical Research<br>26:51 Bridging the Gap in Healthcare Education<br>27:16 The Journey to Teaching and Mentorship<br>29:34 The Impact of Clinical Research<br>30:54 Transforming Professional Development<br>34:39 Creating a Safe Learning Environment<br>36:37 Navigating Career Transitions<br>39:16 Finding Your True Path<br>43:00 Overcoming Industry Challenges<br>48:22 Connecting with Dr. Tia Warrick</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Dr. Tia Warrick</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drwarrick/"><strong>https://www.linkedin.com/in/drwarrick/</strong></a></li><li>Company / Affiliation: <strong>Lesous Consulting </strong><a href="https://lesousconsulting.com/"><strong>https://lesousconsulting.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Tia Warrick</strong> is the CEO of <strong>Lesous Consulting</strong>, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of <em>“Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,”</em> Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact.</li></ul><p><br>T<strong>akeaways</strong></p><ul><li>Dr. Tia Warwick is the CEO of Lesous Consulting, focusing on bridging gaps in clinical research.</li><li>80% of clinical trials fail due to inefficiencies and administrative bottlenecks.</li><li>Education and training are crucial for improving clinical research outcomes.</li><li>AI can enhance efficiency in clinical research without replacing jobs.</li><li>Creating equity in clinical trials is essential for patient access to treatments.</li><li>Practical application in training is more valuable than theoretical knowledge.</li><li>Burnout among clinical research professionals is a significant issue.</li><li>Innovative training solutions can accelerate experience and reduce mistakes.</li><li>Collaboration between institutions is key to successful clinical trials.</li><li>The cost of clinical trials impacts the affordability of treatments for consumers. </li><li>Dr. Warrick emphasizes the need for equitable healthcare education.</li><li>Teaching has always been a passion for Dr. Warrick.</li><li>Clinical research plays a crucial role in patient care.</li><li>Transforming professional development can lead to industry improvements.</li><li>Creating a safe learning environment fosters growth.</li><li>Career transitions require careful navigation and support.</li><li>Finding one's true path is essential for fulfillment.</li><li>Overcoming industry challenges involves positivity and resilience.</li><li>A holistic approach to career coaching considers all aspects of life.</li><li>Building connections and community is vital for professional success.</li></ul>]]>
      </content:encoded>
      <pubDate>Thu, 23 Oct 2025 22:57:40 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/8816ac22/1d2f7f82.mp3" length="73087648" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/jCW5xFtL40DzM9XqDzp2hOfa16ynKGGKBmcwxOO7Reg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81ZDU0/NjU5ZDMxOGFhZGEy/Mzk0ODdlMjViNWFk/YmEwZS5qcGc.jpg"/>
      <itunes:duration>3038</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Tia Warrick</strong>, CEO of <strong>Lesous Consulting</strong>, shares her journey in clinical research and healthcare education. She discusses the industry gaps that inspired her to launch Lesous, a company focused on bridging those divides through training, mentorship, and innovative technology. Dr. Warrick highlights the importance of practical, accessible education, the growing role of AI in clinical efficiency, and the need for equitable participation in clinical trials. With a passion for teaching and empowerment, she offers valuable insights on leadership, career growth, and creating supportive pathways for the next generation of healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Dr. Tia Warrick and Lesous Consulting<br>03:03 Dr. Warwick's Journey in Clinical Research<br>05:51 Identifying Gaps in Clinical Research<br>08:59 The Role of Education and Training<br>11:53 Leveraging AI in Clinical Research<br>14:51 Creating Equity in Clinical Trials<br>17:48 Innovative Training Solutions<br>20:56 The Importance of Practical Application in Training<br>24:11 Challenges and Rewards in Clinical Research<br>26:51 Bridging the Gap in Healthcare Education<br>27:16 The Journey to Teaching and Mentorship<br>29:34 The Impact of Clinical Research<br>30:54 Transforming Professional Development<br>34:39 Creating a Safe Learning Environment<br>36:37 Navigating Career Transitions<br>39:16 Finding Your True Path<br>43:00 Overcoming Industry Challenges<br>48:22 Connecting with Dr. Tia Warrick</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:  <strong>Dr. Tia Warrick</strong></li><li>Guest's Title/Position:<strong>  Chief Executive Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/drwarrick/"><strong>https://www.linkedin.com/in/drwarrick/</strong></a></li><li>Company / Affiliation: <strong>Lesous Consulting </strong><a href="https://lesousconsulting.com/"><strong>https://lesousconsulting.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Tia Warrick</strong> is the CEO of <strong>Lesous Consulting</strong>, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of <em>“Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,”</em> Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact.</li></ul><p><br>T<strong>akeaways</strong></p><ul><li>Dr. Tia Warwick is the CEO of Lesous Consulting, focusing on bridging gaps in clinical research.</li><li>80% of clinical trials fail due to inefficiencies and administrative bottlenecks.</li><li>Education and training are crucial for improving clinical research outcomes.</li><li>AI can enhance efficiency in clinical research without replacing jobs.</li><li>Creating equity in clinical trials is essential for patient access to treatments.</li><li>Practical application in training is more valuable than theoretical knowledge.</li><li>Burnout among clinical research professionals is a significant issue.</li><li>Innovative training solutions can accelerate experience and reduce mistakes.</li><li>Collaboration between institutions is key to successful clinical trials.</li><li>The cost of clinical trials impacts the affordability of treatments for consumers. </li><li>Dr. Warrick emphasizes the need for equitable healthcare education.</li><li>Teaching has always been a passion for Dr. Warrick.</li><li>Clinical research plays a crucial role in patient care.</li><li>Transforming professional development can lead to industry improvements.</li><li>Creating a safe learning environment fosters growth.</li><li>Career transitions require careful navigation and support.</li><li>Finding one's true path is essential for fulfillment.</li><li>Overcoming industry challenges involves positivity and resilience.</li><li>A holistic approach to career coaching considers all aspects of life.</li><li>Building connections and community is vital for professional success.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>clinical research, public health, education, training, AI, healthcare, epidemiology, pharmaceutical industry, clinical trials, professional development, healthcare education, clinical research, professional development, mentorship, career coaching, AI in healthcare, project management, life architect, career transitions, learning environment</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://lesousconsulting.com/" img="https://img.transistorcdn.com/1XvhQv-xBareI8LvFbTaBqV6iD4A7omikevH8F3fYvA/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yMjMx/NmM5YjAxYjQ1NDFi/OTNhM2QwYjUwNzAz/ZjUzNS5qcGVn.jpg">Dr. Tia Warrick</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/8816ac22/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Biotech and Pharma: Pioneering the Next Era of Healthcare with Hadassah Jacobs</title>
      <itunes:episode>45</itunes:episode>
      <podcast:episode>45</podcast:episode>
      <itunes:title>Biotech and Pharma: Pioneering the Next Era of Healthcare with Hadassah Jacobs</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">54fcbb15-2ce5-4fbe-8fd2-4e9c48889325</guid>
      <link>https://share.transistor.fm/s/86a7c46b</link>
      <description>
        <![CDATA[<p>In this episode, <strong>Hadassah Jacobs</strong>, Founder and CEO of Hadassah Jacobs International, shares her journey as an entrepreneur and startup strategist. She discusses learning from failure, building strong systems, and her work in neuroprotection and environmental health. Hadassah also explores leadership in healthcare, the shift toward prevention, and the role of AI and marketing in creating client- and community-focused solutions.</p><p>Chapters:<br>00:00 Introduction to Hadassah Jacobs and Her Ventures<br>03:09 The Importance of Systems in Startups<br>06:11 Learning from Failure: The Entrepreneurial Journey<br>09:06 Tailored Coaching for Entrepreneurs<br>11:57 The Catalyst for Entrepreneurship: Personal Stories<br>15:02 Innovations in Pharma: Kotzker Phfarma's Mission<br>17:46 AgroDefense: Protecting Health and the Environment<br>33:14 Transitioning to CEO: Challenges and Lessons Learned<br>38:40 Navigating the Healthcare Landscape: From Intervention to Prevention<br>46:49 Revolutionizing Healthcare Systems: A Client-Centric Approach<br>56:16 Leadership in Entrepreneurship: Balancing Structure and Flexibility</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Hadassah Jacobs</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/hadasjacobs/"><strong>https://www.linkedin.com/in/hadasjacobs/</strong></a></li><li>Company / Affiliation: <strong>Hadassah Jacobs International </strong><a href="https://www.hadassahjacobs.com/"><strong>https://www.hadassahjacobs.com/ </strong></a></li><li>Guest's Bio: <strong>Hadassah Jacobs</strong> is the founder &amp; CEO of <strong>Hadassah Jacobs International (HJI)</strong>, a strategic launch and development studio helping visionaries turn ideas into successful ventures. With expertise in AI automation, biotech innovation, and digital strategy, she’s guided startups like Kotzker Phfarma from concept to emerging biopharmaceutical leader. Passionate about empowering women founders, Hadassah combines strategy, systems, and creativity to help entrepreneurs build impactful, scalable businesses.</li></ul><p><br>Takeaways:</p><ul><li>Hadassah Jacobs is the founder &amp; CEO of Hadassah Jacobs International, a startup studio and consultancy.</li><li>Systems are crucial for consistency and success in startups.</li><li>Entrepreneurs often struggle with productivity and need effective systems to manage their ideas.</li><li>Learning to fail fast is an essential part of the entrepreneurial journey.</li><li>Tailored coaching can help entrepreneurs navigate their unique challenges.</li><li>Hadassah's early experiences in entrepreneurship shaped her understanding of business.</li><li>Kotzker Phfarma focuses on developing products for brain protection and neuroregeneration.</li><li>AgroDefense is a product aimed at protecting civilians from environmental toxins.</li><li>The importance of antioxidants in health and wellness is emphasized in Hadassah's products.</li><li>Building good habits early on is vital for long-term entrepreneurial success. </li><li>Transitioning to a CEO role comes with unexpected challenges.</li><li>Navigating government bureaucracy can be time-consuming and frustrating.</li><li>The shift from medical intervention to prevention is crucial for healthcare.</li><li>Healthcare systems need to be restructured for better efficiency.</li><li>Client-centric approaches are essential in healthcare.</li><li>AI can enhance communication and service delivery in healthcare.</li><li>Effective leadership requires balancing structure with flexibility.</li><li>Planning should integrate personal and professional life for better fluidity.</li><li>Marketing is key to serving and educating the community.</li><li>Entrepreneurs should prioritize their well-being alongside business goal</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, <strong>Hadassah Jacobs</strong>, Founder and CEO of Hadassah Jacobs International, shares her journey as an entrepreneur and startup strategist. She discusses learning from failure, building strong systems, and her work in neuroprotection and environmental health. Hadassah also explores leadership in healthcare, the shift toward prevention, and the role of AI and marketing in creating client- and community-focused solutions.</p><p>Chapters:<br>00:00 Introduction to Hadassah Jacobs and Her Ventures<br>03:09 The Importance of Systems in Startups<br>06:11 Learning from Failure: The Entrepreneurial Journey<br>09:06 Tailored Coaching for Entrepreneurs<br>11:57 The Catalyst for Entrepreneurship: Personal Stories<br>15:02 Innovations in Pharma: Kotzker Phfarma's Mission<br>17:46 AgroDefense: Protecting Health and the Environment<br>33:14 Transitioning to CEO: Challenges and Lessons Learned<br>38:40 Navigating the Healthcare Landscape: From Intervention to Prevention<br>46:49 Revolutionizing Healthcare Systems: A Client-Centric Approach<br>56:16 Leadership in Entrepreneurship: Balancing Structure and Flexibility</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Hadassah Jacobs</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/hadasjacobs/"><strong>https://www.linkedin.com/in/hadasjacobs/</strong></a></li><li>Company / Affiliation: <strong>Hadassah Jacobs International </strong><a href="https://www.hadassahjacobs.com/"><strong>https://www.hadassahjacobs.com/ </strong></a></li><li>Guest's Bio: <strong>Hadassah Jacobs</strong> is the founder &amp; CEO of <strong>Hadassah Jacobs International (HJI)</strong>, a strategic launch and development studio helping visionaries turn ideas into successful ventures. With expertise in AI automation, biotech innovation, and digital strategy, she’s guided startups like Kotzker Phfarma from concept to emerging biopharmaceutical leader. Passionate about empowering women founders, Hadassah combines strategy, systems, and creativity to help entrepreneurs build impactful, scalable businesses.</li></ul><p><br>Takeaways:</p><ul><li>Hadassah Jacobs is the founder &amp; CEO of Hadassah Jacobs International, a startup studio and consultancy.</li><li>Systems are crucial for consistency and success in startups.</li><li>Entrepreneurs often struggle with productivity and need effective systems to manage their ideas.</li><li>Learning to fail fast is an essential part of the entrepreneurial journey.</li><li>Tailored coaching can help entrepreneurs navigate their unique challenges.</li><li>Hadassah's early experiences in entrepreneurship shaped her understanding of business.</li><li>Kotzker Phfarma focuses on developing products for brain protection and neuroregeneration.</li><li>AgroDefense is a product aimed at protecting civilians from environmental toxins.</li><li>The importance of antioxidants in health and wellness is emphasized in Hadassah's products.</li><li>Building good habits early on is vital for long-term entrepreneurial success. </li><li>Transitioning to a CEO role comes with unexpected challenges.</li><li>Navigating government bureaucracy can be time-consuming and frustrating.</li><li>The shift from medical intervention to prevention is crucial for healthcare.</li><li>Healthcare systems need to be restructured for better efficiency.</li><li>Client-centric approaches are essential in healthcare.</li><li>AI can enhance communication and service delivery in healthcare.</li><li>Effective leadership requires balancing structure with flexibility.</li><li>Planning should integrate personal and professional life for better fluidity.</li><li>Marketing is key to serving and educating the community.</li><li>Entrepreneurs should prioritize their well-being alongside business goal</li></ul>]]>
      </content:encoded>
      <pubDate>Mon, 20 Oct 2025 22:26:43 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/86a7c46b/81cd1e25.mp3" length="96537198" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/IRIJbmpe05R5PcUUQsKiYLDzkCkSnJFkGXeVCoAYyAQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNzhl/ZjQ3ZDA2OGI1YTBl/ODU4NDRkZjViZGI1/Y2JkMC5qcGc.jpg"/>
      <itunes:duration>4017</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, <strong>Hadassah Jacobs</strong>, Founder and CEO of Hadassah Jacobs International, shares her journey as an entrepreneur and startup strategist. She discusses learning from failure, building strong systems, and her work in neuroprotection and environmental health. Hadassah also explores leadership in healthcare, the shift toward prevention, and the role of AI and marketing in creating client- and community-focused solutions.</p><p>Chapters:<br>00:00 Introduction to Hadassah Jacobs and Her Ventures<br>03:09 The Importance of Systems in Startups<br>06:11 Learning from Failure: The Entrepreneurial Journey<br>09:06 Tailored Coaching for Entrepreneurs<br>11:57 The Catalyst for Entrepreneurship: Personal Stories<br>15:02 Innovations in Pharma: Kotzker Phfarma's Mission<br>17:46 AgroDefense: Protecting Health and the Environment<br>33:14 Transitioning to CEO: Challenges and Lessons Learned<br>38:40 Navigating the Healthcare Landscape: From Intervention to Prevention<br>46:49 Revolutionizing Healthcare Systems: A Client-Centric Approach<br>56:16 Leadership in Entrepreneurship: Balancing Structure and Flexibility</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Hadassah Jacobs</strong></li><li>Guest's Title/Position:<strong>  Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/hadasjacobs/"><strong>https://www.linkedin.com/in/hadasjacobs/</strong></a></li><li>Company / Affiliation: <strong>Hadassah Jacobs International </strong><a href="https://www.hadassahjacobs.com/"><strong>https://www.hadassahjacobs.com/ </strong></a></li><li>Guest's Bio: <strong>Hadassah Jacobs</strong> is the founder &amp; CEO of <strong>Hadassah Jacobs International (HJI)</strong>, a strategic launch and development studio helping visionaries turn ideas into successful ventures. With expertise in AI automation, biotech innovation, and digital strategy, she’s guided startups like Kotzker Phfarma from concept to emerging biopharmaceutical leader. Passionate about empowering women founders, Hadassah combines strategy, systems, and creativity to help entrepreneurs build impactful, scalable businesses.</li></ul><p><br>Takeaways:</p><ul><li>Hadassah Jacobs is the founder &amp; CEO of Hadassah Jacobs International, a startup studio and consultancy.</li><li>Systems are crucial for consistency and success in startups.</li><li>Entrepreneurs often struggle with productivity and need effective systems to manage their ideas.</li><li>Learning to fail fast is an essential part of the entrepreneurial journey.</li><li>Tailored coaching can help entrepreneurs navigate their unique challenges.</li><li>Hadassah's early experiences in entrepreneurship shaped her understanding of business.</li><li>Kotzker Phfarma focuses on developing products for brain protection and neuroregeneration.</li><li>AgroDefense is a product aimed at protecting civilians from environmental toxins.</li><li>The importance of antioxidants in health and wellness is emphasized in Hadassah's products.</li><li>Building good habits early on is vital for long-term entrepreneurial success. </li><li>Transitioning to a CEO role comes with unexpected challenges.</li><li>Navigating government bureaucracy can be time-consuming and frustrating.</li><li>The shift from medical intervention to prevention is crucial for healthcare.</li><li>Healthcare systems need to be restructured for better efficiency.</li><li>Client-centric approaches are essential in healthcare.</li><li>AI can enhance communication and service delivery in healthcare.</li><li>Effective leadership requires balancing structure with flexibility.</li><li>Planning should integrate personal and professional life for better fluidity.</li><li>Marketing is key to serving and educating the community.</li><li>Entrepreneurs should prioritize their well-being alongside business goal</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>entrepreneurship, startups, systems, coaching, failure, innovation, pharma, health, neuroprotection, business strategy, CEO challenges, healthcare innovation, prevention over intervention, client-centric healthcare, leadership strategies, entrepreneurial mindset, healthcare systems, AI in healthcare, business planning, community-focused healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.hadassahjacobs.com/" img="https://img.transistorcdn.com/9F8irO26ADjRKby_iHtqGRV1xG_4qYMg8-mN4oMiTMk/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85ZDk4/MDRlMmZmM2I2ZjA0/MDQ2OTczNTRiYmEx/NGM3OC5qcGVn.jpg">Hadassah Jacobs</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/86a7c46b/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Health Tech Revolution: AI, Data, and the New Patient Experience with Michael Gorton</title>
      <itunes:episode>44</itunes:episode>
      <podcast:episode>44</podcast:episode>
      <itunes:title>Health Tech Revolution: AI, Data, and the New Patient Experience with Michael Gorton</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d5ec00b3-23d5-4c45-8c4c-ed9163bfad15</guid>
      <link>https://share.transistor.fm/s/448c462f</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Michael Gorton shares his journey as a serial entrepreneur and pioneer in telemedicine through his work with Teladoc. He reflects on how COVID-19 accelerated virtual care adoption and introduces his new venture, Recuro, focused on early detection and prevention. The conversation explores innovations in mobile healthcare, AI-driven personal health data, and the future of diagnostics—while touching on the entrepreneurial mindset needed to overcome healthcare’s bureaucratic challenges and drive meaningful change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Michael Gorton and Telemedicine<br>04:14 The Birth of Teladoc<br>08:48 Telemedicine's Rise During COVID-19<br>15:32 Transitioning to Recuro: A New Venture<br>22:46 Innovations in Early Detection and Prevention<br>28:28 Innovations in Mobile Healthcare<br>31:08 The Future of Personal Health Data<br>34:57 The Role of AI in Early Diagnosis<br>35:41 The Journey of an Author<br>39:10 Exploring the Universe: Plasma Physics and Beyond<br>44:20 Phantom Space: The Future of Data Centers<br>51:17 Overcoming Bureaucratic Hurdles in Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Gorton</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michael-s-gorton/"><strong>https://www.linkedin.com/in/michael-s-gorton/</strong></a></li><li>Company / Affiliation: <strong>Dynamic Works Consulting h</strong><a href="https://michaelgorton.us/">ttps://michaelgorton.us/</a></li><li>Guest's Bio: <strong>Michael Gorton</strong> is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Gorton is a serial entrepreneur and founder of Teladoc.</li><li>Telemedicine gained significant traction during the COVID-19 pandemic.</li><li>87% of the U.S. population now prefers telemedicine for consultations.</li><li>Telemedicine can be more profitable for doctors compared to traditional practices.</li><li>Early detection in healthcare can prevent costly and dangerous conditions.</li><li>Recuro aims to simplify healthcare and enhance early detection.</li><li>The healthcare system is complicated and needs simplification.</li><li>Innovative technologies can aid in early diagnosis and prevention.</li><li>Access to healthcare is crucial for rural populations.</li><li>Making healthcare simple can save lives and reduce costs. </li><li>Mobile healthcare units are being developed for remote areas.</li><li>Smartwatches can collect valuable health data.</li><li>AI can help diagnose health issues early.</li><li>Personal health data ownership is crucial for patients.</li><li>Bureaucratic hurdles slow down healthcare innovation.</li><li>Persistence is key to overcoming challenges in healthcare.</li><li>Science fiction can inspire real-world innovations.</li><li>Plasma physics may hold answers to extraterrestrial intelligence.</li><li>Data centers in space could revolutionize AI processing.</li><li>Collaboration among innovators is essential for progress.<p></p></li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Michael Gorton shares his journey as a serial entrepreneur and pioneer in telemedicine through his work with Teladoc. He reflects on how COVID-19 accelerated virtual care adoption and introduces his new venture, Recuro, focused on early detection and prevention. The conversation explores innovations in mobile healthcare, AI-driven personal health data, and the future of diagnostics—while touching on the entrepreneurial mindset needed to overcome healthcare’s bureaucratic challenges and drive meaningful change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Michael Gorton and Telemedicine<br>04:14 The Birth of Teladoc<br>08:48 Telemedicine's Rise During COVID-19<br>15:32 Transitioning to Recuro: A New Venture<br>22:46 Innovations in Early Detection and Prevention<br>28:28 Innovations in Mobile Healthcare<br>31:08 The Future of Personal Health Data<br>34:57 The Role of AI in Early Diagnosis<br>35:41 The Journey of an Author<br>39:10 Exploring the Universe: Plasma Physics and Beyond<br>44:20 Phantom Space: The Future of Data Centers<br>51:17 Overcoming Bureaucratic Hurdles in Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Gorton</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michael-s-gorton/"><strong>https://www.linkedin.com/in/michael-s-gorton/</strong></a></li><li>Company / Affiliation: <strong>Dynamic Works Consulting h</strong><a href="https://michaelgorton.us/">ttps://michaelgorton.us/</a></li><li>Guest's Bio: <strong>Michael Gorton</strong> is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Gorton is a serial entrepreneur and founder of Teladoc.</li><li>Telemedicine gained significant traction during the COVID-19 pandemic.</li><li>87% of the U.S. population now prefers telemedicine for consultations.</li><li>Telemedicine can be more profitable for doctors compared to traditional practices.</li><li>Early detection in healthcare can prevent costly and dangerous conditions.</li><li>Recuro aims to simplify healthcare and enhance early detection.</li><li>The healthcare system is complicated and needs simplification.</li><li>Innovative technologies can aid in early diagnosis and prevention.</li><li>Access to healthcare is crucial for rural populations.</li><li>Making healthcare simple can save lives and reduce costs. </li><li>Mobile healthcare units are being developed for remote areas.</li><li>Smartwatches can collect valuable health data.</li><li>AI can help diagnose health issues early.</li><li>Personal health data ownership is crucial for patients.</li><li>Bureaucratic hurdles slow down healthcare innovation.</li><li>Persistence is key to overcoming challenges in healthcare.</li><li>Science fiction can inspire real-world innovations.</li><li>Plasma physics may hold answers to extraterrestrial intelligence.</li><li>Data centers in space could revolutionize AI processing.</li><li>Collaboration among innovators is essential for progress.<p></p></li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Thu, 16 Oct 2025 19:00:51 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/448c462f/b23b7f5a.mp3" length="83112581" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/xroXUNBwPDyLXhWJcbAG2pxE2_sltKTQtyN8xAomI3g/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kYjJl/ODY2MGE0NzYyMzU5/N2ZiMDUzMGFjYmU1/MjBiNi5qcGc.jpg"/>
      <itunes:duration>3454</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Michael Gorton shares his journey as a serial entrepreneur and pioneer in telemedicine through his work with Teladoc. He reflects on how COVID-19 accelerated virtual care adoption and introduces his new venture, Recuro, focused on early detection and prevention. The conversation explores innovations in mobile healthcare, AI-driven personal health data, and the future of diagnostics—while touching on the entrepreneurial mindset needed to overcome healthcare’s bureaucratic challenges and drive meaningful change.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Michael Gorton and Telemedicine<br>04:14 The Birth of Teladoc<br>08:48 Telemedicine's Rise During COVID-19<br>15:32 Transitioning to Recuro: A New Venture<br>22:46 Innovations in Early Detection and Prevention<br>28:28 Innovations in Mobile Healthcare<br>31:08 The Future of Personal Health Data<br>34:57 The Role of AI in Early Diagnosis<br>35:41 The Journey of an Author<br>39:10 Exploring the Universe: Plasma Physics and Beyond<br>44:20 Phantom Space: The Future of Data Centers<br>51:17 Overcoming Bureaucratic Hurdles in Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Gorton</strong></li><li>Guest's Title/Position:<strong>  Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michael-s-gorton/"><strong>https://www.linkedin.com/in/michael-s-gorton/</strong></a></li><li>Company / Affiliation: <strong>Dynamic Works Consulting h</strong><a href="https://michaelgorton.us/">ttps://michaelgorton.us/</a></li><li>Guest's Bio: <strong>Michael Gorton</strong> is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Gorton is a serial entrepreneur and founder of Teladoc.</li><li>Telemedicine gained significant traction during the COVID-19 pandemic.</li><li>87% of the U.S. population now prefers telemedicine for consultations.</li><li>Telemedicine can be more profitable for doctors compared to traditional practices.</li><li>Early detection in healthcare can prevent costly and dangerous conditions.</li><li>Recuro aims to simplify healthcare and enhance early detection.</li><li>The healthcare system is complicated and needs simplification.</li><li>Innovative technologies can aid in early diagnosis and prevention.</li><li>Access to healthcare is crucial for rural populations.</li><li>Making healthcare simple can save lives and reduce costs. </li><li>Mobile healthcare units are being developed for remote areas.</li><li>Smartwatches can collect valuable health data.</li><li>AI can help diagnose health issues early.</li><li>Personal health data ownership is crucial for patients.</li><li>Bureaucratic hurdles slow down healthcare innovation.</li><li>Persistence is key to overcoming challenges in healthcare.</li><li>Science fiction can inspire real-world innovations.</li><li>Plasma physics may hold answers to extraterrestrial intelligence.</li><li>Data centers in space could revolutionize AI processing.</li><li>Collaboration among innovators is essential for progress.<p></p></li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>telemedicine, Michael Gorton, Teladoc, healthcare innovation, Recuro, early detection, COVID-19, digital health, patient access, healthcare technology, telemedicine, healthcare innovation, AI in healthcare, personal health data, mobile healthcare, plasma physics, science fiction, Phantom Space, early diagnosis, healthcare bureaucracy</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://michaelgorton.us/" img="https://img.transistorcdn.com/mXVUZuUStFacpkA7im6LygqTlgAFsUksS6nDwUOiHXs/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hZGRj/MGFiNThlNjFlY2Y1/NzAzZmYyZDkxZTBm/M2YzNC5qcGVn.jpg">Michael Gorton</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/448c462f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Eye Care Innovation: Scleral Lenses Transforming Patient Lives Globally with Michele Hart</title>
      <itunes:episode>43</itunes:episode>
      <podcast:episode>43</podcast:episode>
      <itunes:title>Eye Care Innovation: Scleral Lenses Transforming Patient Lives Globally with Michele Hart</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">60465f11-285a-46db-a265-80402f4b698a</guid>
      <link>https://share.transistor.fm/s/3aa2d391</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath sits down with <strong>Michele Hart</strong>, Director of Marketing Communications at <strong>BostonSight</strong>, to explore the art and impact of nonprofit marketing in healthcare. Michele shares her journey from anthropology and journalism to leading marketing for a pioneering organization improving lives through innovative scleral lens technology. She discusses the challenges of mission-driven marketing—balancing purpose with growth, navigating the pandemic’s disruption, and aligning teams across marketing, sales, and product development—while emphasizing the importance of clear communication, the value of outsourcing for fresh perspectives, and the strategies that have helped BostonSight strengthen its brand and expand its global reach.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Michele Hart and Her Journey<br>02:52 Transitioning to Nonprofit Marketing<br>05:54 The Impact of COVID-19 on Work Dynamics<br>08:55 Understanding BostonSight and Its Mission<br>11:50 The Science Behind Scleral Lenses<br>14:59 Marketing Challenges and Strategies at BostonSight<br>17:52 Navigating the Commercial Landscape of Scleral Lenses<br>21:01 Expanding Global Reach and Partnerships<br>23:58 Optimizing Marketing Channels and Strategies<br>26:23 Streamlining Communication in Marketing<br>30:31 The Importance of Outsourcing for Fresh Perspectives<br>34:40 Aligning Marketing, Sales, and Product Development<br>36:53 Revenue Generation in Nonprofits<br>38:40 Innovative Marketing Strategies and Patient Engagement<br>42:25 The Future of Marketing: Balancing Digital and In-Person<br>45:45 Innovations in Scleral Lens Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michele Hart</strong></li><li>Guest's Title/Position:<strong>  Director, Marketing and Communications </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michelespilberghart/"><strong>https://www.linkedin.com/in/michelespilberghart/</strong></a></li><li>Company / Affiliation:<strong>BostonSight</strong><a href="https://www.bostonsight.org/"> <strong>https://www.bostonsight.org/</strong></a></li><li>Guest's Bio: <strong>Michele Har</strong>t is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including <em>The New York Times</em>, <em>The Boston Globe</em>, <em>Good Housekeeping</em>, <em>TIME</em>, and <em>Prevention Magazine</em>.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michele Hart has over 25 years of experience in healthcare marketing.</li><li>Her background in anthropology has been valuable in understanding consumer behavior.</li><li>Transitioning to nonprofit work has provided her with meaningful mission-based experiences.</li><li>COVID-19 created unique challenges but also fostered team bonding.</li><li>BostonSight specializes in scleral lenses that improve vision and comfort for patients.</li><li>The organization has a strong focus on patient care and research.</li><li>Marketing strategies include optimizing channels and building brand identity.</li><li>The commercial scleral lens is used by optometrists worldwide.</li><li>Partnerships with international eye institutes have expanded their reach.</li><li>Press releases remain a vital tool for internal communication and marketing. </li><li>Streamlining communication is essential to avoid muddled messaging.</li><li>Outsourcing can provide valuable insights and an objective perspective.</li><li>Aligning marketing, sales, and product development is crucial for success.</li><li>Nonprofits must focus on revenue generation to sustain their mission.</li><li>Innovative marketing strategies can enhance patient engagement.</li><li>In-person connections are becoming increasingly important post-pandemic.</li><li>Traditional marketing methods are seeing a resurgence in the digital age.</li><li>Scleral lenses are evolving with new technology for better patient outcomes.</li><li>A focus on prevention in healthcare could transform patient care.</li><li>Engaging with patients through webinars and testimonials builds trust. </li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath sits down with <strong>Michele Hart</strong>, Director of Marketing Communications at <strong>BostonSight</strong>, to explore the art and impact of nonprofit marketing in healthcare. Michele shares her journey from anthropology and journalism to leading marketing for a pioneering organization improving lives through innovative scleral lens technology. She discusses the challenges of mission-driven marketing—balancing purpose with growth, navigating the pandemic’s disruption, and aligning teams across marketing, sales, and product development—while emphasizing the importance of clear communication, the value of outsourcing for fresh perspectives, and the strategies that have helped BostonSight strengthen its brand and expand its global reach.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Michele Hart and Her Journey<br>02:52 Transitioning to Nonprofit Marketing<br>05:54 The Impact of COVID-19 on Work Dynamics<br>08:55 Understanding BostonSight and Its Mission<br>11:50 The Science Behind Scleral Lenses<br>14:59 Marketing Challenges and Strategies at BostonSight<br>17:52 Navigating the Commercial Landscape of Scleral Lenses<br>21:01 Expanding Global Reach and Partnerships<br>23:58 Optimizing Marketing Channels and Strategies<br>26:23 Streamlining Communication in Marketing<br>30:31 The Importance of Outsourcing for Fresh Perspectives<br>34:40 Aligning Marketing, Sales, and Product Development<br>36:53 Revenue Generation in Nonprofits<br>38:40 Innovative Marketing Strategies and Patient Engagement<br>42:25 The Future of Marketing: Balancing Digital and In-Person<br>45:45 Innovations in Scleral Lens Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michele Hart</strong></li><li>Guest's Title/Position:<strong>  Director, Marketing and Communications </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michelespilberghart/"><strong>https://www.linkedin.com/in/michelespilberghart/</strong></a></li><li>Company / Affiliation:<strong>BostonSight</strong><a href="https://www.bostonsight.org/"> <strong>https://www.bostonsight.org/</strong></a></li><li>Guest's Bio: <strong>Michele Har</strong>t is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including <em>The New York Times</em>, <em>The Boston Globe</em>, <em>Good Housekeeping</em>, <em>TIME</em>, and <em>Prevention Magazine</em>.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michele Hart has over 25 years of experience in healthcare marketing.</li><li>Her background in anthropology has been valuable in understanding consumer behavior.</li><li>Transitioning to nonprofit work has provided her with meaningful mission-based experiences.</li><li>COVID-19 created unique challenges but also fostered team bonding.</li><li>BostonSight specializes in scleral lenses that improve vision and comfort for patients.</li><li>The organization has a strong focus on patient care and research.</li><li>Marketing strategies include optimizing channels and building brand identity.</li><li>The commercial scleral lens is used by optometrists worldwide.</li><li>Partnerships with international eye institutes have expanded their reach.</li><li>Press releases remain a vital tool for internal communication and marketing. </li><li>Streamlining communication is essential to avoid muddled messaging.</li><li>Outsourcing can provide valuable insights and an objective perspective.</li><li>Aligning marketing, sales, and product development is crucial for success.</li><li>Nonprofits must focus on revenue generation to sustain their mission.</li><li>Innovative marketing strategies can enhance patient engagement.</li><li>In-person connections are becoming increasingly important post-pandemic.</li><li>Traditional marketing methods are seeing a resurgence in the digital age.</li><li>Scleral lenses are evolving with new technology for better patient outcomes.</li><li>A focus on prevention in healthcare could transform patient care.</li><li>Engaging with patients through webinars and testimonials builds trust. </li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 10 Oct 2025 12:13:19 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/3aa2d391/8c435e77.mp3" length="78391855" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/67iYKFK5IUgLPAPZ6xVnO7Eh7-zP-UVJDbtBrE8hs6Q/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNTUw/MjBhZmJhNzZlODM5/Y2Y5MDA1MTA5OGVm/ZjkyNy5qcGc.jpg"/>
      <itunes:duration>3259</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Heath sits down with <strong>Michele Hart</strong>, Director of Marketing Communications at <strong>BostonSight</strong>, to explore the art and impact of nonprofit marketing in healthcare. Michele shares her journey from anthropology and journalism to leading marketing for a pioneering organization improving lives through innovative scleral lens technology. She discusses the challenges of mission-driven marketing—balancing purpose with growth, navigating the pandemic’s disruption, and aligning teams across marketing, sales, and product development—while emphasizing the importance of clear communication, the value of outsourcing for fresh perspectives, and the strategies that have helped BostonSight strengthen its brand and expand its global reach.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Michele Hart and Her Journey<br>02:52 Transitioning to Nonprofit Marketing<br>05:54 The Impact of COVID-19 on Work Dynamics<br>08:55 Understanding BostonSight and Its Mission<br>11:50 The Science Behind Scleral Lenses<br>14:59 Marketing Challenges and Strategies at BostonSight<br>17:52 Navigating the Commercial Landscape of Scleral Lenses<br>21:01 Expanding Global Reach and Partnerships<br>23:58 Optimizing Marketing Channels and Strategies<br>26:23 Streamlining Communication in Marketing<br>30:31 The Importance of Outsourcing for Fresh Perspectives<br>34:40 Aligning Marketing, Sales, and Product Development<br>36:53 Revenue Generation in Nonprofits<br>38:40 Innovative Marketing Strategies and Patient Engagement<br>42:25 The Future of Marketing: Balancing Digital and In-Person<br>45:45 Innovations in Scleral Lens Technology</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michele Hart</strong></li><li>Guest's Title/Position:<strong>  Director, Marketing and Communications </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/michelespilberghart/"><strong>https://www.linkedin.com/in/michelespilberghart/</strong></a></li><li>Company / Affiliation:<strong>BostonSight</strong><a href="https://www.bostonsight.org/"> <strong>https://www.bostonsight.org/</strong></a></li><li>Guest's Bio: <strong>Michele Har</strong>t is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including <em>The New York Times</em>, <em>The Boston Globe</em>, <em>Good Housekeeping</em>, <em>TIME</em>, and <em>Prevention Magazine</em>.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michele Hart has over 25 years of experience in healthcare marketing.</li><li>Her background in anthropology has been valuable in understanding consumer behavior.</li><li>Transitioning to nonprofit work has provided her with meaningful mission-based experiences.</li><li>COVID-19 created unique challenges but also fostered team bonding.</li><li>BostonSight specializes in scleral lenses that improve vision and comfort for patients.</li><li>The organization has a strong focus on patient care and research.</li><li>Marketing strategies include optimizing channels and building brand identity.</li><li>The commercial scleral lens is used by optometrists worldwide.</li><li>Partnerships with international eye institutes have expanded their reach.</li><li>Press releases remain a vital tool for internal communication and marketing. </li><li>Streamlining communication is essential to avoid muddled messaging.</li><li>Outsourcing can provide valuable insights and an objective perspective.</li><li>Aligning marketing, sales, and product development is crucial for success.</li><li>Nonprofits must focus on revenue generation to sustain their mission.</li><li>Innovative marketing strategies can enhance patient engagement.</li><li>In-person connections are becoming increasingly important post-pandemic.</li><li>Traditional marketing methods are seeing a resurgence in the digital age.</li><li>Scleral lenses are evolving with new technology for better patient outcomes.</li><li>A focus on prevention in healthcare could transform patient care.</li><li>Engaging with patients through webinars and testimonials builds trust. </li></ul>]]>
      </itunes:summary>
      <itunes:keywords>marketing, nonprofit, scleral lenses, Boston Sight, healthcare, COVID-19, work dynamics, global partnerships, marketing strategies, quality of life, marketing, nonprofit, communication, outsourcing, patient engagement, innovation, healthcare, revenue generation, digital marketing, in-person connections</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Guest" href="https://www.bostonsight.org/" img="https://img.transistorcdn.com/AlUeva6Xjm8cbWbq-YsPL-GZuI4vJ_p4W9M0rSy-ZTo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNmJm/MTlhYjU5ZjE4ZTEy/ZGE3MzI0M2YzMDAz/OWI5OS5qcGVn.jpg"> Michele Hart</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/3aa2d391/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Digital Mental Health: AI and Data Shaping the Future of Care with Ataes Aggarwal</title>
      <itunes:episode>42</itunes:episode>
      <podcast:episode>42</podcast:episode>
      <itunes:title>Digital Mental Health: AI and Data Shaping the Future of Care with Ataes Aggarwal</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">21d1c6a6-8a74-4f20-99c9-cc0190d56cb1</guid>
      <link>https://share.transistor.fm/s/ec58bdbf</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath speaks with <strong>Ataes Aggarwal</strong>, co-founder of <strong>Moodr Health</strong>, an AI-driven platform improving behavioral health through remote monitoring. They discuss Moodr’s origins, its evolution from perinatal mental health to broader applications, and the ethical use of AI in healthcare. Ataes shares lessons on scaling a health tech startup, building motivated and independent teams, and navigating challenges unique to communities like Appalachia. The conversation also touches on marketing’s role in brand growth, the power of partnerships, and Ataes’ core advice: keep things simple and stay persistent.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Moodr Health and Its Mission<br>03:12 The Genesis of Moodr Health<br>06:09 The Role of Data in Behavioral Health<br>08:46 Building Relationships Through Technology<br>12:07 Ethical AI in Healthcare<br>15:00 Expanding Focus: From Perinatal to Broader Mental Health<br>18:06 Challenges and Growth in Business<br>21:04 Real-World Impact and Case Studies<br>24:02 Scalability and Future Directions<br>28:15 Motivation and Team Dynamics<br>32:24 Marketing and Brand Development<br>37:30 Scaling Challenges and Team Independence<br>40:46 Community Impact and Healthcare Challenges<br>45:05 Collaborations and Partnerships<br>48:04 Final Thoughts and Advice</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Ataes Aggarwal</strong></li><li>Guest's Title/Position:<strong>  Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ataes/"><strong>https://www.linkedin.com/in/ataes/</strong></a></li><li>Company / Affiliation: <strong>Moodr Health </strong><a href="https://moodrhealth.com/"><strong> https://moodrhealth.com/</strong></a></li><li>Guest's Bio: <strong>Ataes Aggarwal</strong> is the co-founder of <strong>Moodr Health</strong>, a company empowering healthcare organizations to build genuine, scalable connections with their patients through AI-driven, ethical technology. A Johns Hopkins Biomedical Engineering graduate, Ataes combines technical expertise with empathy to advance behavioral health. He champions responsible AI, emphasizing privacy, fairness, and respect, and believes success comes from simplicity, perseverance, and creating real impact in people’s lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Moodr Health aims to stop silent suffering in behavioral health.</li><li>The platform started with a psychiatrist using Fitbits for patient data.</li><li>Data collection in mental health can enhance treatment efficacy.</li><li>Building relationships through technology is key to patient care.</li><li>Ethical AI is crucial in healthcare applications.</li><li>Moodr Health is expanding its focus beyond perinatal mental health.</li><li>The company is passionate about serving veterans and community health.</li><li>Scalability is a challenge but the technology is designed for growth.</li><li>Real-time data can improve patient-provider communication.</li><li>The team is dedicated to making a meaningful impact in healthcare. Motivation stems from having a clear vision and a supportive team.</li><li>A strong team is essential for navigating the challenges of a startup.</li><li>Continuous learning is crucial, often through traditional methods like textbooks.</li><li>Marketing is a vital component of a startup's success.</li><li>Founders often have a deep connection to their brand and its story.</li><li>Building independence within teams is key to scaling effectively.</li><li>Healthcare challenges in Appalachia require innovative solutions.</li><li>Collaborations with organizations can enhance service delivery.</li><li>Every detail matters when serving patients and customers.</li><li>Simplicity in communication and strategy is difficult but essential.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath speaks with <strong>Ataes Aggarwal</strong>, co-founder of <strong>Moodr Health</strong>, an AI-driven platform improving behavioral health through remote monitoring. They discuss Moodr’s origins, its evolution from perinatal mental health to broader applications, and the ethical use of AI in healthcare. Ataes shares lessons on scaling a health tech startup, building motivated and independent teams, and navigating challenges unique to communities like Appalachia. The conversation also touches on marketing’s role in brand growth, the power of partnerships, and Ataes’ core advice: keep things simple and stay persistent.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Moodr Health and Its Mission<br>03:12 The Genesis of Moodr Health<br>06:09 The Role of Data in Behavioral Health<br>08:46 Building Relationships Through Technology<br>12:07 Ethical AI in Healthcare<br>15:00 Expanding Focus: From Perinatal to Broader Mental Health<br>18:06 Challenges and Growth in Business<br>21:04 Real-World Impact and Case Studies<br>24:02 Scalability and Future Directions<br>28:15 Motivation and Team Dynamics<br>32:24 Marketing and Brand Development<br>37:30 Scaling Challenges and Team Independence<br>40:46 Community Impact and Healthcare Challenges<br>45:05 Collaborations and Partnerships<br>48:04 Final Thoughts and Advice</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Ataes Aggarwal</strong></li><li>Guest's Title/Position:<strong>  Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ataes/"><strong>https://www.linkedin.com/in/ataes/</strong></a></li><li>Company / Affiliation: <strong>Moodr Health </strong><a href="https://moodrhealth.com/"><strong> https://moodrhealth.com/</strong></a></li><li>Guest's Bio: <strong>Ataes Aggarwal</strong> is the co-founder of <strong>Moodr Health</strong>, a company empowering healthcare organizations to build genuine, scalable connections with their patients through AI-driven, ethical technology. A Johns Hopkins Biomedical Engineering graduate, Ataes combines technical expertise with empathy to advance behavioral health. He champions responsible AI, emphasizing privacy, fairness, and respect, and believes success comes from simplicity, perseverance, and creating real impact in people’s lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Moodr Health aims to stop silent suffering in behavioral health.</li><li>The platform started with a psychiatrist using Fitbits for patient data.</li><li>Data collection in mental health can enhance treatment efficacy.</li><li>Building relationships through technology is key to patient care.</li><li>Ethical AI is crucial in healthcare applications.</li><li>Moodr Health is expanding its focus beyond perinatal mental health.</li><li>The company is passionate about serving veterans and community health.</li><li>Scalability is a challenge but the technology is designed for growth.</li><li>Real-time data can improve patient-provider communication.</li><li>The team is dedicated to making a meaningful impact in healthcare. Motivation stems from having a clear vision and a supportive team.</li><li>A strong team is essential for navigating the challenges of a startup.</li><li>Continuous learning is crucial, often through traditional methods like textbooks.</li><li>Marketing is a vital component of a startup's success.</li><li>Founders often have a deep connection to their brand and its story.</li><li>Building independence within teams is key to scaling effectively.</li><li>Healthcare challenges in Appalachia require innovative solutions.</li><li>Collaborations with organizations can enhance service delivery.</li><li>Every detail matters when serving patients and customers.</li><li>Simplicity in communication and strategy is difficult but essential.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 08 Oct 2025 17:08:50 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ec58bdbf/8025c2fd.mp3" length="73835746" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Gs0LOJpMOZv27bazwm3Z-tJQM2ID-FL3N6mg-fV8r4A/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81OTc4/NzI3N2Q3MTVhZWRm/ZWNiYjUxNjFkNDg5/MGZjMi5qcGc.jpg"/>
      <itunes:duration>3072</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath speaks with <strong>Ataes Aggarwal</strong>, co-founder of <strong>Moodr Health</strong>, an AI-driven platform improving behavioral health through remote monitoring. They discuss Moodr’s origins, its evolution from perinatal mental health to broader applications, and the ethical use of AI in healthcare. Ataes shares lessons on scaling a health tech startup, building motivated and independent teams, and navigating challenges unique to communities like Appalachia. The conversation also touches on marketing’s role in brand growth, the power of partnerships, and Ataes’ core advice: keep things simple and stay persistent.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Moodr Health and Its Mission<br>03:12 The Genesis of Moodr Health<br>06:09 The Role of Data in Behavioral Health<br>08:46 Building Relationships Through Technology<br>12:07 Ethical AI in Healthcare<br>15:00 Expanding Focus: From Perinatal to Broader Mental Health<br>18:06 Challenges and Growth in Business<br>21:04 Real-World Impact and Case Studies<br>24:02 Scalability and Future Directions<br>28:15 Motivation and Team Dynamics<br>32:24 Marketing and Brand Development<br>37:30 Scaling Challenges and Team Independence<br>40:46 Community Impact and Healthcare Challenges<br>45:05 Collaborations and Partnerships<br>48:04 Final Thoughts and Advice</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Ataes Aggarwal</strong></li><li>Guest's Title/Position:<strong>  Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ataes/"><strong>https://www.linkedin.com/in/ataes/</strong></a></li><li>Company / Affiliation: <strong>Moodr Health </strong><a href="https://moodrhealth.com/"><strong> https://moodrhealth.com/</strong></a></li><li>Guest's Bio: <strong>Ataes Aggarwal</strong> is the co-founder of <strong>Moodr Health</strong>, a company empowering healthcare organizations to build genuine, scalable connections with their patients through AI-driven, ethical technology. A Johns Hopkins Biomedical Engineering graduate, Ataes combines technical expertise with empathy to advance behavioral health. He champions responsible AI, emphasizing privacy, fairness, and respect, and believes success comes from simplicity, perseverance, and creating real impact in people’s lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Moodr Health aims to stop silent suffering in behavioral health.</li><li>The platform started with a psychiatrist using Fitbits for patient data.</li><li>Data collection in mental health can enhance treatment efficacy.</li><li>Building relationships through technology is key to patient care.</li><li>Ethical AI is crucial in healthcare applications.</li><li>Moodr Health is expanding its focus beyond perinatal mental health.</li><li>The company is passionate about serving veterans and community health.</li><li>Scalability is a challenge but the technology is designed for growth.</li><li>Real-time data can improve patient-provider communication.</li><li>The team is dedicated to making a meaningful impact in healthcare. Motivation stems from having a clear vision and a supportive team.</li><li>A strong team is essential for navigating the challenges of a startup.</li><li>Continuous learning is crucial, often through traditional methods like textbooks.</li><li>Marketing is a vital component of a startup's success.</li><li>Founders often have a deep connection to their brand and its story.</li><li>Building independence within teams is key to scaling effectively.</li><li>Healthcare challenges in Appalachia require innovative solutions.</li><li>Collaborations with organizations can enhance service delivery.</li><li>Every detail matters when serving patients and customers.</li><li>Simplicity in communication and strategy is difficult but essential.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Moodr Health, behavioral health, AI, remote monitoring, ethical AI, mental health, healthcare technology, chronic conditions, patient engagement, digital health, motivation, team dynamics, marketing, brand development, scaling challenges, community impact, healthcare, partnerships, digital health, independence</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://moodrhealth.com/" img="https://img.transistorcdn.com/AGHJU8a60wGN2Mj4G0VoGKRXMkv3Bw9OwSy70H5O72c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wYzQx/MTA5Y2I4MGM5ODQx/YjczODljMDQ5YzRi/ZTVjNC5qcGVn.jpg">Ataes Aggarwal</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ec58bdbf/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Future of CRISPR: Building Equity into Precision Medicine with Michael Friend</title>
      <itunes:episode>41</itunes:episode>
      <podcast:episode>41</podcast:episode>
      <itunes:title>The Future of CRISPR: Building Equity into Precision Medicine with Michael Friend</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">09dd6b9e-6e60-48d7-a89a-1ffbc68c73b1</guid>
      <link>https://share.transistor.fm/s/f9ed69ff</link>
      <description>
        <![CDATA[<p>In this conversation, Michael Friend, Founder and CEO of the Minority Coalition for Precision Medicine, discusses the critical role of precision medicine and CRISPR technology in addressing health disparities, particularly in minority communities. He shares his personal journey, the challenges faced by individuals with sickle cell disease, and the importance of building trust in healthcare. The conversation emphasizes the need for community engagement, youth involvement, and advocacy to drive change in the healthcare landscape.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Precision Medicine and CRISPR<br>03:00 Understanding Sickle Cell Disease and Its Challenges<br>06:00 The Role of CRISPR in Healthcare<br>09:02 The Importance of Trust in Healthcare for Minorities<br>11:59 The Coalition's Mission and Community Engagement<br>14:56 Overcoming Skepticism Around Precision Medicine<br>18:01 The Tipping Point for CRISPR and Public Awareness<br>21:12 Future of Precision Medicine and Business Models<br>23:49 Advocacy and Personal Motivation<br>27:03 Engaging Youth in Healthcare Conversations<br>30:05 Advice for Aspiring Change-Makers<br>33:11 Conclusion and Future Outlook</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Friend</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/michael-friend-/</strong></li><li>Company / Affiliation: <strong>Minority Coalition for Precision Medicine</strong></li><li>Guest's Bio: <strong>Michael Friend</strong> is a U.S. veteran and founder of the <strong>Minority Coalition for Precision Medicine (MCPM)</strong>, dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Friend is the CEO of the Minority Coalition for Precision Medicine.</li><li>The coalition aims to reduce health disparities in minority communities.</li><li>Sickle cell disease is a painful and complex condition.</li><li>CRISPR technology has the potential to reshape healthcare.</li><li>Building trust in healthcare is crucial for minority communities.</li><li>Community engagement is essential for awareness and education.</li><li>Skepticism around precision medicine exists but is changing.</li><li>Youth involvement is vital for the future of healthcare.</li><li>Private-public partnerships are necessary for innovation.</li><li>Advocacy and personal motivation drive change in healthcare.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Michael Friend, Founder and CEO of the Minority Coalition for Precision Medicine, discusses the critical role of precision medicine and CRISPR technology in addressing health disparities, particularly in minority communities. He shares his personal journey, the challenges faced by individuals with sickle cell disease, and the importance of building trust in healthcare. The conversation emphasizes the need for community engagement, youth involvement, and advocacy to drive change in the healthcare landscape.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Precision Medicine and CRISPR<br>03:00 Understanding Sickle Cell Disease and Its Challenges<br>06:00 The Role of CRISPR in Healthcare<br>09:02 The Importance of Trust in Healthcare for Minorities<br>11:59 The Coalition's Mission and Community Engagement<br>14:56 Overcoming Skepticism Around Precision Medicine<br>18:01 The Tipping Point for CRISPR and Public Awareness<br>21:12 Future of Precision Medicine and Business Models<br>23:49 Advocacy and Personal Motivation<br>27:03 Engaging Youth in Healthcare Conversations<br>30:05 Advice for Aspiring Change-Makers<br>33:11 Conclusion and Future Outlook</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Friend</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/michael-friend-/</strong></li><li>Company / Affiliation: <strong>Minority Coalition for Precision Medicine</strong></li><li>Guest's Bio: <strong>Michael Friend</strong> is a U.S. veteran and founder of the <strong>Minority Coalition for Precision Medicine (MCPM)</strong>, dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Friend is the CEO of the Minority Coalition for Precision Medicine.</li><li>The coalition aims to reduce health disparities in minority communities.</li><li>Sickle cell disease is a painful and complex condition.</li><li>CRISPR technology has the potential to reshape healthcare.</li><li>Building trust in healthcare is crucial for minority communities.</li><li>Community engagement is essential for awareness and education.</li><li>Skepticism around precision medicine exists but is changing.</li><li>Youth involvement is vital for the future of healthcare.</li><li>Private-public partnerships are necessary for innovation.</li><li>Advocacy and personal motivation drive change in healthcare.</li></ul>]]>
      </content:encoded>
      <pubDate>Mon, 06 Oct 2025 16:57:06 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/f9ed69ff/b2b81d39.mp3" length="64991917" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/CY_rEpE7wLhjXmTedHXac-NLq7sde8NEyZ62cRR68Jo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lMzll/OGNkOWVkNmRjZDVj/NWE0YTllY2U0NTdj/NjdiZi5qcGc.jpg"/>
      <itunes:duration>2701</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Michael Friend, Founder and CEO of the Minority Coalition for Precision Medicine, discusses the critical role of precision medicine and CRISPR technology in addressing health disparities, particularly in minority communities. He shares his personal journey, the challenges faced by individuals with sickle cell disease, and the importance of building trust in healthcare. The conversation emphasizes the need for community engagement, youth involvement, and advocacy to drive change in the healthcare landscape.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Precision Medicine and CRISPR<br>03:00 Understanding Sickle Cell Disease and Its Challenges<br>06:00 The Role of CRISPR in Healthcare<br>09:02 The Importance of Trust in Healthcare for Minorities<br>11:59 The Coalition's Mission and Community Engagement<br>14:56 Overcoming Skepticism Around Precision Medicine<br>18:01 The Tipping Point for CRISPR and Public Awareness<br>21:12 Future of Precision Medicine and Business Models<br>23:49 Advocacy and Personal Motivation<br>27:03 Engaging Youth in Healthcare Conversations<br>30:05 Advice for Aspiring Change-Makers<br>33:11 Conclusion and Future Outlook</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Michael Friend</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/michael-friend-/</strong></li><li>Company / Affiliation: <strong>Minority Coalition for Precision Medicine</strong></li><li>Guest's Bio: <strong>Michael Friend</strong> is a U.S. veteran and founder of the <strong>Minority Coalition for Precision Medicine (MCPM)</strong>, dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Michael Friend is the CEO of the Minority Coalition for Precision Medicine.</li><li>The coalition aims to reduce health disparities in minority communities.</li><li>Sickle cell disease is a painful and complex condition.</li><li>CRISPR technology has the potential to reshape healthcare.</li><li>Building trust in healthcare is crucial for minority communities.</li><li>Community engagement is essential for awareness and education.</li><li>Skepticism around precision medicine exists but is changing.</li><li>Youth involvement is vital for the future of healthcare.</li><li>Private-public partnerships are necessary for innovation.</li><li>Advocacy and personal motivation drive change in healthcare.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>CRISPR, precision medicine, sickle cell disease, healthcare disparities, minority health, gene editing, advocacy, youth engagement, healthcare innovation, public health</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/michael-friend" img="https://img.transistorcdn.com/Ukil5nCDR7laSRKR3eDdu2PZaSzZ1t6hmPysON2lMww/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zMjI1/ZTdmNjA0MzUyMDI0/NDI2MzczMTQwMjkx/NGI2MC5qcGVn.jpg">Michael Friend</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/f9ed69ff/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f9ed69ff/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f9ed69ff/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f9ed69ff/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/f9ed69ff/transcription" type="text/html"/>
    </item>
    <item>
      <title>Baseball, Business &amp; Better Medicine: Reshaping the Future of Pharmacy with Trace Voshell</title>
      <itunes:episode>40</itunes:episode>
      <podcast:episode>40</podcast:episode>
      <itunes:title>Baseball, Business &amp; Better Medicine: Reshaping the Future of Pharmacy with Trace Voshell</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1b602866-b893-4127-a20d-6256792ddcb6</guid>
      <link>https://share.transistor.fm/s/dd6c4508</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Trace Voshell</strong>, Chief Revenue Officer at <strong>GoGoMeds</strong>, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees.<br><strong><br>Chapters:</strong><br>00:00 Introduction to GoGoMeds and Trace's Journey<br>02:57 Understanding Pharmacy Operations and Patient Care<br>05:54 The Challenges of Healthcare Costs<br>09:02 Innovations in Medication Access and Employer Benefits<br>11:52 Telemedicine and Custom Pharmacy Solutions<br>14:49 Transitioning to GoGoMeds and Leadership Style<br>24:03 The Drive to Win: A Personal Philosophy<br>25:04 Documentary Insights: Uncovering Healthcare Costs<br>28:07 Marketing Strategies: Outsourcing for Growth<br>32:18 Sales Team Dynamics: Growth and Strategy<br>34:32 The Balance of Aggression and Patience in Sales<br>38:03 Building a Winning Corporate Culture<br>43:13 AI in Business: Balancing Automation and Personal Touch<br>45:13 Final Thoughts and Future Connections</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:Trace Voshell</li><li>Guest's Title/Position:<strong> Chief Revenue Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/trace-voshell-34040b7a/"><strong>https://www.linkedin.com/in/trace-voshell-34040b7a/</strong></a></li><li>Company / Affiliation: <strong>GoGoMeds </strong><a href="https://gogomeds.com/GoGoClient/home"><strong>https://gogomeds.com/GoGoClient/home</strong></a></li><li>Guest's Bio: <strong>Trace Voshell</strong> is the Chief Revenue Officer of <strong>GoGoMeds</strong>, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Trace Voshell transitioned from a baseball career to pharmacy.</li><li>GoGoMeds aims to transform patient access to medications.</li><li>Healthcare costs can be overwhelming for patients.</li><li>GoGoMeds offers significant savings on generic medications.</li><li>Employers can benefit from offering $0 medications to employees.</li><li>Telemedicine is a growing area for GoGoMeds.</li><li>Custom pharmacy solutions enhance patient care.</li><li>Trace's personal experience with cancer informs his work.</li><li>Leadership involves being hands-on and empathetic.</li><li>Failures are part of the journey to success.  I like to win, don't care about recognition.</li><li>The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.</li><li>Go Go Meds is a solution in the pharmacy space.</li><li>I was one of the producers of the documentary.</li><li>We needed to enhance our marketing efforts.</li><li>You can't just have one marketing piece for all verticals.</li><li>Aggression and patience are key in sales.</li><li>Culture is crucial for employee motivation.</li><li>You have to remain a person in sales interactions.</li><li>We're changing the pharmacy landscape for affordability.</li></ul><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Trace Voshell</strong>, Chief Revenue Officer at <strong>GoGoMeds</strong>, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees.<br><strong><br>Chapters:</strong><br>00:00 Introduction to GoGoMeds and Trace's Journey<br>02:57 Understanding Pharmacy Operations and Patient Care<br>05:54 The Challenges of Healthcare Costs<br>09:02 Innovations in Medication Access and Employer Benefits<br>11:52 Telemedicine and Custom Pharmacy Solutions<br>14:49 Transitioning to GoGoMeds and Leadership Style<br>24:03 The Drive to Win: A Personal Philosophy<br>25:04 Documentary Insights: Uncovering Healthcare Costs<br>28:07 Marketing Strategies: Outsourcing for Growth<br>32:18 Sales Team Dynamics: Growth and Strategy<br>34:32 The Balance of Aggression and Patience in Sales<br>38:03 Building a Winning Corporate Culture<br>43:13 AI in Business: Balancing Automation and Personal Touch<br>45:13 Final Thoughts and Future Connections</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:Trace Voshell</li><li>Guest's Title/Position:<strong> Chief Revenue Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/trace-voshell-34040b7a/"><strong>https://www.linkedin.com/in/trace-voshell-34040b7a/</strong></a></li><li>Company / Affiliation: <strong>GoGoMeds </strong><a href="https://gogomeds.com/GoGoClient/home"><strong>https://gogomeds.com/GoGoClient/home</strong></a></li><li>Guest's Bio: <strong>Trace Voshell</strong> is the Chief Revenue Officer of <strong>GoGoMeds</strong>, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Trace Voshell transitioned from a baseball career to pharmacy.</li><li>GoGoMeds aims to transform patient access to medications.</li><li>Healthcare costs can be overwhelming for patients.</li><li>GoGoMeds offers significant savings on generic medications.</li><li>Employers can benefit from offering $0 medications to employees.</li><li>Telemedicine is a growing area for GoGoMeds.</li><li>Custom pharmacy solutions enhance patient care.</li><li>Trace's personal experience with cancer informs his work.</li><li>Leadership involves being hands-on and empathetic.</li><li>Failures are part of the journey to success.  I like to win, don't care about recognition.</li><li>The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.</li><li>Go Go Meds is a solution in the pharmacy space.</li><li>I was one of the producers of the documentary.</li><li>We needed to enhance our marketing efforts.</li><li>You can't just have one marketing piece for all verticals.</li><li>Aggression and patience are key in sales.</li><li>Culture is crucial for employee motivation.</li><li>You have to remain a person in sales interactions.</li><li>We're changing the pharmacy landscape for affordability.</li></ul><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 03 Oct 2025 10:53:58 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/dd6c4508/3f708a88.mp3" length="69735217" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/zQ4wO_6RyJisjYdfdMau-qPNn7EadMFnoJYLUkbi4oQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NWUz/ZWE4MTkzODA3NzQz/OTExNDMwNGZjYzQ2/MjkzYS5qcGc.jpg"/>
      <itunes:duration>2899</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Trace Voshell</strong>, Chief Revenue Officer at <strong>GoGoMeds</strong>, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees.<br><strong><br>Chapters:</strong><br>00:00 Introduction to GoGoMeds and Trace's Journey<br>02:57 Understanding Pharmacy Operations and Patient Care<br>05:54 The Challenges of Healthcare Costs<br>09:02 Innovations in Medication Access and Employer Benefits<br>11:52 Telemedicine and Custom Pharmacy Solutions<br>14:49 Transitioning to GoGoMeds and Leadership Style<br>24:03 The Drive to Win: A Personal Philosophy<br>25:04 Documentary Insights: Uncovering Healthcare Costs<br>28:07 Marketing Strategies: Outsourcing for Growth<br>32:18 Sales Team Dynamics: Growth and Strategy<br>34:32 The Balance of Aggression and Patience in Sales<br>38:03 Building a Winning Corporate Culture<br>43:13 AI in Business: Balancing Automation and Personal Touch<br>45:13 Final Thoughts and Future Connections</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:Trace Voshell</li><li>Guest's Title/Position:<strong> Chief Revenue Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/trace-voshell-34040b7a/"><strong>https://www.linkedin.com/in/trace-voshell-34040b7a/</strong></a></li><li>Company / Affiliation: <strong>GoGoMeds </strong><a href="https://gogomeds.com/GoGoClient/home"><strong>https://gogomeds.com/GoGoClient/home</strong></a></li><li>Guest's Bio: <strong>Trace Voshell</strong> is the Chief Revenue Officer of <strong>GoGoMeds</strong>, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Trace Voshell transitioned from a baseball career to pharmacy.</li><li>GoGoMeds aims to transform patient access to medications.</li><li>Healthcare costs can be overwhelming for patients.</li><li>GoGoMeds offers significant savings on generic medications.</li><li>Employers can benefit from offering $0 medications to employees.</li><li>Telemedicine is a growing area for GoGoMeds.</li><li>Custom pharmacy solutions enhance patient care.</li><li>Trace's personal experience with cancer informs his work.</li><li>Leadership involves being hands-on and empathetic.</li><li>Failures are part of the journey to success.  I like to win, don't care about recognition.</li><li>The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.</li><li>Go Go Meds is a solution in the pharmacy space.</li><li>I was one of the producers of the documentary.</li><li>We needed to enhance our marketing efforts.</li><li>You can't just have one marketing piece for all verticals.</li><li>Aggression and patience are key in sales.</li><li>Culture is crucial for employee motivation.</li><li>You have to remain a person in sales interactions.</li><li>We're changing the pharmacy landscape for affordability.</li></ul><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>GoGoMeds, pharmacy, healthcare, telemedicine, medication access, patient care, healthcare costs, employer benefits, leadership, innovation, winning mindset, healthcare documentary, marketing strategies, sales growth, corporate culture, AI in business, pharmacy leadership, telemedicine, team dynamics, personal development</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://gogomeds.com/GoGoClient/home" img="https://img.transistorcdn.com/NNWMUfP0kKddi_zWjVKAKKYMX_oN57tU3gBrtemu5Lk/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jNzI0/ZWM2NzRiNDM0ZDhk/ODQ1ODUyNjgxMTIy/OTIxYy5qcGVn.jpg">Trace Voshell</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/dd6c4508/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/dd6c4508/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/dd6c4508/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/dd6c4508/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/dd6c4508/transcription" type="text/html"/>
    </item>
    <item>
      <title>Unlocking Gene Therapy: Changing the Future of Childhood Cancer with Raymond Rodriguez-Torres</title>
      <itunes:episode>39</itunes:episode>
      <podcast:episode>39</podcast:episode>
      <itunes:title>Unlocking Gene Therapy: Changing the Future of Childhood Cancer with Raymond Rodriguez-Torres</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0b48e681-8e77-44dc-8558-9b1adbad0a56</guid>
      <link>https://share.transistor.fm/s/41adb353</link>
      <description>
        <![CDATA[<p>In this heartfelt conversation, Raymond Rodriguez-Torres shares his journey as the CEO of ALC Home Health and the founder of the Live Like Bella Foundation, which supports families affected by childhood cancer. He recounts the challenges faced when his daughter Bella was diagnosed with cancer and how her spirit inspired a movement to help others. The discussion highlights the foundation's significant contributions to pediatric cancer research and the support services it provides to families in need. In this conversation, Raymond shares his journey of turning personal tragedy into a mission to help others through the Live Like Bella organization. He emphasizes the importance of living joyfully and fearlessly, serving others during difficult times, and the critical need for accurate data in pediatric cancer research. The discussion also highlights innovations in treatment and the transition to home health care, along with valuable leadership lessons about trust and purpose in work.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Raymond Rodriguez-Torres and His Journey<br>02:21 The Impact of Bella's Illness on Family and Community<br>07:12 Navigating Professional Life Amidst Personal Crisis<br>11:37 The Mission and Achievements of Live Like Bella Foundation<br>16:31 In-Treatment and Memorial Support Services<br>23:36 Living Like Bella: A Legacy of Joy and Fearlessness<br>25:05 Facing Tragedy: Finding Purpose in Adversity<br>25:42 The State of Pediatric Cancer: Data and Awareness<br>29:06 The Importance of Accurate Data in Childhood Cancer<br>32:08 Innovations in Pediatric Cancer Research<br>36:36 Transitioning to Home Health Care: A Personal Journey<br>41:11 Leadership Lessons: Trust and Purpose in Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Raymond Rodriguez-Torres</strong></li><li>Guest's Title/Position:<strong> Chairman</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/"><strong>https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/</strong></a></li><li>Company / Affiliation:  <strong>Live Like Bella® Foundation </strong><a href="https://livelikebella.org/"><strong> https://livelikebella.org/ </strong></a></li><li>Guest's Bio: <strong>Raymond Rodriguez-Torres</strong> is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk <em>Tragedy to Triumph: Live Like Bella</em> ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the <strong>Live Like Bella® Foundation</strong>, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Raymond Rodriguez-Torres is the CEO of ALC Home Health and founder of Live Like Bella.</li><li>The Live Like Bella Foundation has raised over $40 million for childhood cancer research.</li><li>Bella's illness led to the creation of a movement focused on serving others.</li><li>The foundation provides financial support for families dealing with childhood cancer.</li><li>Live Like Bella funds pediatric cancer research through innovative state funding initiatives.</li><li>The organization pays bills directly to avoid tax implications for families.</li><li>Memorial support is offered for families who have lost children to cancer.</li><li>Raymond emphasizes the importance of community support during crises.</li><li>The foundation operates in 38 countries, providing global assistance.</li><li>Raymond believes that Bella's life was a gift that continues to inspire others. Live like Bella as a guiding principle in life.</li><li>Serving others can provide strength during adversity.</li><li>Finding a purpose can help answer the question of why.</li><li>Accurate data is crucial in understanding childhood cancer.</li><li>Childhood cancer should be treated as a chronic illness.</li><li>Innovative research is leading to breakthroughs in pediatric oncology.</li><li>Home health care offers better comfort for patients.</li><li>Trust is essential in leadership and team dynamics.</li><li>Passion in work leads to fulfillment and success.</li><li>Every child deserves a chance to fight cancer at home.<p></p></li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this heartfelt conversation, Raymond Rodriguez-Torres shares his journey as the CEO of ALC Home Health and the founder of the Live Like Bella Foundation, which supports families affected by childhood cancer. He recounts the challenges faced when his daughter Bella was diagnosed with cancer and how her spirit inspired a movement to help others. The discussion highlights the foundation's significant contributions to pediatric cancer research and the support services it provides to families in need. In this conversation, Raymond shares his journey of turning personal tragedy into a mission to help others through the Live Like Bella organization. He emphasizes the importance of living joyfully and fearlessly, serving others during difficult times, and the critical need for accurate data in pediatric cancer research. The discussion also highlights innovations in treatment and the transition to home health care, along with valuable leadership lessons about trust and purpose in work.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Raymond Rodriguez-Torres and His Journey<br>02:21 The Impact of Bella's Illness on Family and Community<br>07:12 Navigating Professional Life Amidst Personal Crisis<br>11:37 The Mission and Achievements of Live Like Bella Foundation<br>16:31 In-Treatment and Memorial Support Services<br>23:36 Living Like Bella: A Legacy of Joy and Fearlessness<br>25:05 Facing Tragedy: Finding Purpose in Adversity<br>25:42 The State of Pediatric Cancer: Data and Awareness<br>29:06 The Importance of Accurate Data in Childhood Cancer<br>32:08 Innovations in Pediatric Cancer Research<br>36:36 Transitioning to Home Health Care: A Personal Journey<br>41:11 Leadership Lessons: Trust and Purpose in Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Raymond Rodriguez-Torres</strong></li><li>Guest's Title/Position:<strong> Chairman</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/"><strong>https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/</strong></a></li><li>Company / Affiliation:  <strong>Live Like Bella® Foundation </strong><a href="https://livelikebella.org/"><strong> https://livelikebella.org/ </strong></a></li><li>Guest's Bio: <strong>Raymond Rodriguez-Torres</strong> is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk <em>Tragedy to Triumph: Live Like Bella</em> ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the <strong>Live Like Bella® Foundation</strong>, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Raymond Rodriguez-Torres is the CEO of ALC Home Health and founder of Live Like Bella.</li><li>The Live Like Bella Foundation has raised over $40 million for childhood cancer research.</li><li>Bella's illness led to the creation of a movement focused on serving others.</li><li>The foundation provides financial support for families dealing with childhood cancer.</li><li>Live Like Bella funds pediatric cancer research through innovative state funding initiatives.</li><li>The organization pays bills directly to avoid tax implications for families.</li><li>Memorial support is offered for families who have lost children to cancer.</li><li>Raymond emphasizes the importance of community support during crises.</li><li>The foundation operates in 38 countries, providing global assistance.</li><li>Raymond believes that Bella's life was a gift that continues to inspire others. Live like Bella as a guiding principle in life.</li><li>Serving others can provide strength during adversity.</li><li>Finding a purpose can help answer the question of why.</li><li>Accurate data is crucial in understanding childhood cancer.</li><li>Childhood cancer should be treated as a chronic illness.</li><li>Innovative research is leading to breakthroughs in pediatric oncology.</li><li>Home health care offers better comfort for patients.</li><li>Trust is essential in leadership and team dynamics.</li><li>Passion in work leads to fulfillment and success.</li><li>Every child deserves a chance to fight cancer at home.<p></p></li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Wed, 01 Oct 2025 14:01:23 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/41adb353/9a21a4d5.mp3" length="69223837" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/5jPySeFujmisg8_f08rDLud11r8TGqySv7ejmtdGFtQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zMzMz/ZjM2OWNjNmVkOTgx/MjEzNDhlNzk2OGE2/YWZkYS5qcGc.jpg"/>
      <itunes:duration>2878</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this heartfelt conversation, Raymond Rodriguez-Torres shares his journey as the CEO of ALC Home Health and the founder of the Live Like Bella Foundation, which supports families affected by childhood cancer. He recounts the challenges faced when his daughter Bella was diagnosed with cancer and how her spirit inspired a movement to help others. The discussion highlights the foundation's significant contributions to pediatric cancer research and the support services it provides to families in need. In this conversation, Raymond shares his journey of turning personal tragedy into a mission to help others through the Live Like Bella organization. He emphasizes the importance of living joyfully and fearlessly, serving others during difficult times, and the critical need for accurate data in pediatric cancer research. The discussion also highlights innovations in treatment and the transition to home health care, along with valuable leadership lessons about trust and purpose in work.<br><strong><br>Chapters:</strong><br>00:00 Introduction to Raymond Rodriguez-Torres and His Journey<br>02:21 The Impact of Bella's Illness on Family and Community<br>07:12 Navigating Professional Life Amidst Personal Crisis<br>11:37 The Mission and Achievements of Live Like Bella Foundation<br>16:31 In-Treatment and Memorial Support Services<br>23:36 Living Like Bella: A Legacy of Joy and Fearlessness<br>25:05 Facing Tragedy: Finding Purpose in Adversity<br>25:42 The State of Pediatric Cancer: Data and Awareness<br>29:06 The Importance of Accurate Data in Childhood Cancer<br>32:08 Innovations in Pediatric Cancer Research<br>36:36 Transitioning to Home Health Care: A Personal Journey<br>41:11 Leadership Lessons: Trust and Purpose in Work</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Raymond Rodriguez-Torres</strong></li><li>Guest's Title/Position:<strong> Chairman</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/"><strong>https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/</strong></a></li><li>Company / Affiliation:  <strong>Live Like Bella® Foundation </strong><a href="https://livelikebella.org/"><strong> https://livelikebella.org/ </strong></a></li><li>Guest's Bio: <strong>Raymond Rodriguez-Torres</strong> is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk <em>Tragedy to Triumph: Live Like Bella</em> ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the <strong>Live Like Bella® Foundation</strong>, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Raymond Rodriguez-Torres is the CEO of ALC Home Health and founder of Live Like Bella.</li><li>The Live Like Bella Foundation has raised over $40 million for childhood cancer research.</li><li>Bella's illness led to the creation of a movement focused on serving others.</li><li>The foundation provides financial support for families dealing with childhood cancer.</li><li>Live Like Bella funds pediatric cancer research through innovative state funding initiatives.</li><li>The organization pays bills directly to avoid tax implications for families.</li><li>Memorial support is offered for families who have lost children to cancer.</li><li>Raymond emphasizes the importance of community support during crises.</li><li>The foundation operates in 38 countries, providing global assistance.</li><li>Raymond believes that Bella's life was a gift that continues to inspire others. Live like Bella as a guiding principle in life.</li><li>Serving others can provide strength during adversity.</li><li>Finding a purpose can help answer the question of why.</li><li>Accurate data is crucial in understanding childhood cancer.</li><li>Childhood cancer should be treated as a chronic illness.</li><li>Innovative research is leading to breakthroughs in pediatric oncology.</li><li>Home health care offers better comfort for patients.</li><li>Trust is essential in leadership and team dynamics.</li><li>Passion in work leads to fulfillment and success.</li><li>Every child deserves a chance to fight cancer at home.<p></p></li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>childhood cancer, Live Like Bella, healthcare, philanthropy, family support, pediatric cancer research, personal journey, community impact, nonprofit leadership, overcoming adversity, childhood cancer, Live Like Bella, pediatric oncology, healthcare innovation, leadership, purpose, adversity, data awareness, home health care, cancer research</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://livelikebella.org/" img="https://img.transistorcdn.com/urPg9bfekTZ_tyMke8FKITh7_5DpTcspSZKRaFkviKQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jYjE5/ZjM0YmM2ZmFhNTNl/NTNmNWI5N2NlMGJi/YTE5MC5qcGVn.jpg">Raymond Rodriguez-Torres</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/41adb353/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/41adb353/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/41adb353/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/41adb353/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/41adb353/transcription" type="text/html"/>
    </item>
    <item>
      <title>Consulting in Life Sciences: From Scientist to Communicator with Laura Lampa</title>
      <itunes:episode>38</itunes:episode>
      <podcast:episode>38</podcast:episode>
      <itunes:title>Consulting in Life Sciences: From Scientist to Communicator with Laura Lampa</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ec951a83-0367-4c26-9fe7-5ea4838d39a5</guid>
      <link>https://share.transistor.fm/s/2b1dbcd5</link>
      <description>
        <![CDATA[<p>In this episode, Laura Lampa, CEO of LML StoryLab Consulting, shares her journey from a scientist to a communication expert in the life sciences sector. She discusses the importance of effective communication in science, her transition to entrepreneurship, and the challenges of being a solopreneur. Laura emphasizes the significance of networking, leveraging AI in her work, and maintaining a work-life balance. She also provides valuable advice for aspiring entrepreneurs and shares her vision for the future of her business.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Laura Lampa and LML StoryLab<br>02:54 Journey from Science to Communication<br>05:55 The Transition to Entrepreneurship<br>09:02 Challenges of Solopreneurship<br>12:01 Networking and Building Relationships<br>15:00 Vision for the Future of LML StoryLab<br>18:11 Leveraging AI in Communication<br>20:57 Advice for Aspiring Entrepreneurs<br>23:54 Conclusion and Key Takeaways</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Laura Lampa</strong> </li><li>Guest's Title/Position:<strong> Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/lauralampa/"><strong>https://www.linkedin.com/in/lauralampa/</strong></a></li><li>Company / Affiliation: <strong>LML StoryLab Consulting </strong><a href="https://lmlstorylab.com/home"><strong>https://lmlstorylab.com/home</strong></a></li><li>Guest's Bio: <strong>Laura Lampa</strong> is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Laura Lampa transitioned from a scientist to a communication expert.</li><li>Effective communication can unlock conversations and connections.</li><li>Networking is crucial for building relationships and finding clients.</li><li>AI can be a strategic partner in writing and communication.</li><li>Time management is a significant challenge for solopreneurs.</li><li>Maintaining professional connections helps avoid loneliness.</li><li>It's important to know your limits as a solopreneur.</li><li>You can develop tools and templates for clients to use independently.</li><li>Showing up consistently builds credibility and trust.</li><li>Entrepreneurship requires a willingness to take risks and embrace challenges.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Laura Lampa, CEO of LML StoryLab Consulting, shares her journey from a scientist to a communication expert in the life sciences sector. She discusses the importance of effective communication in science, her transition to entrepreneurship, and the challenges of being a solopreneur. Laura emphasizes the significance of networking, leveraging AI in her work, and maintaining a work-life balance. She also provides valuable advice for aspiring entrepreneurs and shares her vision for the future of her business.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Laura Lampa and LML StoryLab<br>02:54 Journey from Science to Communication<br>05:55 The Transition to Entrepreneurship<br>09:02 Challenges of Solopreneurship<br>12:01 Networking and Building Relationships<br>15:00 Vision for the Future of LML StoryLab<br>18:11 Leveraging AI in Communication<br>20:57 Advice for Aspiring Entrepreneurs<br>23:54 Conclusion and Key Takeaways</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Laura Lampa</strong> </li><li>Guest's Title/Position:<strong> Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/lauralampa/"><strong>https://www.linkedin.com/in/lauralampa/</strong></a></li><li>Company / Affiliation: <strong>LML StoryLab Consulting </strong><a href="https://lmlstorylab.com/home"><strong>https://lmlstorylab.com/home</strong></a></li><li>Guest's Bio: <strong>Laura Lampa</strong> is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Laura Lampa transitioned from a scientist to a communication expert.</li><li>Effective communication can unlock conversations and connections.</li><li>Networking is crucial for building relationships and finding clients.</li><li>AI can be a strategic partner in writing and communication.</li><li>Time management is a significant challenge for solopreneurs.</li><li>Maintaining professional connections helps avoid loneliness.</li><li>It's important to know your limits as a solopreneur.</li><li>You can develop tools and templates for clients to use independently.</li><li>Showing up consistently builds credibility and trust.</li><li>Entrepreneurship requires a willingness to take risks and embrace challenges.</li></ul>]]>
      </content:encoded>
      <pubDate>Tue, 30 Sep 2025 18:05:40 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/2b1dbcd5/13ceaa17.mp3" length="60730980" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/7unTMs-gj1WZbcG5i1R8IbYSzzjqNUtrBWRO30IYJaM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yMjc1/YmJhOGMzNDI3YzEy/NDYwZTEwMDRjNTA3/ZDgzMy5qcGc.jpg"/>
      <itunes:duration>2525</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Laura Lampa, CEO of LML StoryLab Consulting, shares her journey from a scientist to a communication expert in the life sciences sector. She discusses the importance of effective communication in science, her transition to entrepreneurship, and the challenges of being a solopreneur. Laura emphasizes the significance of networking, leveraging AI in her work, and maintaining a work-life balance. She also provides valuable advice for aspiring entrepreneurs and shares her vision for the future of her business.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Laura Lampa and LML StoryLab<br>02:54 Journey from Science to Communication<br>05:55 The Transition to Entrepreneurship<br>09:02 Challenges of Solopreneurship<br>12:01 Networking and Building Relationships<br>15:00 Vision for the Future of LML StoryLab<br>18:11 Leveraging AI in Communication<br>20:57 Advice for Aspiring Entrepreneurs<br>23:54 Conclusion and Key Takeaways</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong>Laura Lampa</strong> </li><li>Guest's Title/Position:<strong> Founder and CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/lauralampa/"><strong>https://www.linkedin.com/in/lauralampa/</strong></a></li><li>Company / Affiliation: <strong>LML StoryLab Consulting </strong><a href="https://lmlstorylab.com/home"><strong>https://lmlstorylab.com/home</strong></a></li><li>Guest's Bio: <strong>Laura Lampa</strong> is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Laura Lampa transitioned from a scientist to a communication expert.</li><li>Effective communication can unlock conversations and connections.</li><li>Networking is crucial for building relationships and finding clients.</li><li>AI can be a strategic partner in writing and communication.</li><li>Time management is a significant challenge for solopreneurs.</li><li>Maintaining professional connections helps avoid loneliness.</li><li>It's important to know your limits as a solopreneur.</li><li>You can develop tools and templates for clients to use independently.</li><li>Showing up consistently builds credibility and trust.</li><li>Entrepreneurship requires a willingness to take risks and embrace challenges.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>science communication, entrepreneurship, networking, AI in business, work-life balance, solopreneurship, leadership, storytelling, life sciences, professional development</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://lmlstorylab.com/" img="https://img.transistorcdn.com/WplY9uuO3wu92IBCTmbIS3gSE6S7FYaw8XQtdapTFRY/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wYTAw/NjFlZTk3ZTExZGQ0/MmUxZjNiYjlmMGVm/NTJkYy5qcGVn.jpg">Laura Lampa</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/2b1dbcd5/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Unlocking Gene Therapy: The Power of Vector Technologies with Brian Newsom </title>
      <itunes:episode>37</itunes:episode>
      <podcast:episode>37</podcast:episode>
      <itunes:title>Unlocking Gene Therapy: The Power of Vector Technologies with Brian Newsom </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5934b559-a53b-4186-8d7b-faf013cfb8e3</guid>
      <link>https://share.transistor.fm/s/345d3f6f</link>
      <description>
        <![CDATA[<p>In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Cell and Gene Therapy Innovations</p><p>03:04 Exploring Vector Technology and Its Applications</p><p>05:59 Brian Newsom's Journey: From Science to Business</p><p>09:08 Leveraging AI and Technology in Biotech</p><p>11:59 Navigating Fundraising Challenges in Biotech</p><p>14:49 Strategic Partnerships and Market Positioning</p><p>22:12 Building Long-Term Relationships in Healthcare</p><p>23:27 Leadership Style and Team Dynamics</p><p>26:00 The Challenges of Foundership</p><p>28:32 Finding Inspiration and Motivation</p><p>31:12 The Intersection of Science Fiction and Reality</p><p>33:03 Future Trends in Healthcare</p><p>35:34 Advice for Aspiring Professionals</p><p>37:17 Navigating Tough Times in the Industry</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brian Newsom</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/brian-newsom/"><strong>https://www.linkedin.com/in/brian-newsom/</strong></a></li><li>Company / Affiliation:  <strong>Carrigent </strong><a href="https://carrigent.com/"><strong>https://carrigent.com/</strong></a></li><li>Guest's Bio: <strong>Brian Newsom</strong> is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&amp;D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&amp;M University.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.</li><li>Carrigent is developing a next-generation payload delivery system.</li><li>The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.</li><li>Brian transitioned from a scientific role to business development to have a broader impact.</li><li>AI is being leveraged to create efficiencies in biotech operations.</li><li>Fundraising in biotech is currently challenging due to market conditions.</li><li>Strategic partnerships are essential for asset development and exposure.</li><li>The ultimate goal is to partner with pharma and biotech for therapeutic development.</li><li>Brian's diverse background provides a unique perspective in the industry.</li><li>The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.</li><li>Leadership involves trusting your team to do their jobs.</li><li>Founders often struggle to let go of their vision.</li><li>Inspiration can come from various sources, including literature.</li><li>Science fiction often predicts future scientific advancements.</li><li>Early diagnostics are essential for effective treatment.</li><li>The healthcare industry is evolving with new therapies.</li><li>Resilience is key in navigating industry challenges.</li><li>Patient care should be the primary motivation for professionals.</li><li>The future of healthcare will focus on curing chronic diseases.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Cell and Gene Therapy Innovations</p><p>03:04 Exploring Vector Technology and Its Applications</p><p>05:59 Brian Newsom's Journey: From Science to Business</p><p>09:08 Leveraging AI and Technology in Biotech</p><p>11:59 Navigating Fundraising Challenges in Biotech</p><p>14:49 Strategic Partnerships and Market Positioning</p><p>22:12 Building Long-Term Relationships in Healthcare</p><p>23:27 Leadership Style and Team Dynamics</p><p>26:00 The Challenges of Foundership</p><p>28:32 Finding Inspiration and Motivation</p><p>31:12 The Intersection of Science Fiction and Reality</p><p>33:03 Future Trends in Healthcare</p><p>35:34 Advice for Aspiring Professionals</p><p>37:17 Navigating Tough Times in the Industry</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brian Newsom</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/brian-newsom/"><strong>https://www.linkedin.com/in/brian-newsom/</strong></a></li><li>Company / Affiliation:  <strong>Carrigent </strong><a href="https://carrigent.com/"><strong>https://carrigent.com/</strong></a></li><li>Guest's Bio: <strong>Brian Newsom</strong> is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&amp;D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&amp;M University.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.</li><li>Carrigent is developing a next-generation payload delivery system.</li><li>The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.</li><li>Brian transitioned from a scientific role to business development to have a broader impact.</li><li>AI is being leveraged to create efficiencies in biotech operations.</li><li>Fundraising in biotech is currently challenging due to market conditions.</li><li>Strategic partnerships are essential for asset development and exposure.</li><li>The ultimate goal is to partner with pharma and biotech for therapeutic development.</li><li>Brian's diverse background provides a unique perspective in the industry.</li><li>The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.</li><li>Leadership involves trusting your team to do their jobs.</li><li>Founders often struggle to let go of their vision.</li><li>Inspiration can come from various sources, including literature.</li><li>Science fiction often predicts future scientific advancements.</li><li>Early diagnostics are essential for effective treatment.</li><li>The healthcare industry is evolving with new therapies.</li><li>Resilience is key in navigating industry challenges.</li><li>Patient care should be the primary motivation for professionals.</li><li>The future of healthcare will focus on curing chronic diseases.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 24 Sep 2025 15:18:34 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/345d3f6f/54db7ef6.mp3" length="60588765" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/FQOysFp-lTAwNdyJ5gQnFEOHoJXf74K5e_0kAPGBhNE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTRj/ZTgwZmY1Yjk4NjMy/MWUxYzFlNTRjNDMz/MjExOC5qcGc.jpg"/>
      <itunes:duration>2517</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Cell and Gene Therapy Innovations</p><p>03:04 Exploring Vector Technology and Its Applications</p><p>05:59 Brian Newsom's Journey: From Science to Business</p><p>09:08 Leveraging AI and Technology in Biotech</p><p>11:59 Navigating Fundraising Challenges in Biotech</p><p>14:49 Strategic Partnerships and Market Positioning</p><p>22:12 Building Long-Term Relationships in Healthcare</p><p>23:27 Leadership Style and Team Dynamics</p><p>26:00 The Challenges of Foundership</p><p>28:32 Finding Inspiration and Motivation</p><p>31:12 The Intersection of Science Fiction and Reality</p><p>33:03 Future Trends in Healthcare</p><p>35:34 Advice for Aspiring Professionals</p><p>37:17 Navigating Tough Times in the Industry</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brian Newsom</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/brian-newsom/"><strong>https://www.linkedin.com/in/brian-newsom/</strong></a></li><li>Company / Affiliation:  <strong>Carrigent </strong><a href="https://carrigent.com/"><strong>https://carrigent.com/</strong></a></li><li>Guest's Bio: <strong>Brian Newsom</strong> is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&amp;D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&amp;M University.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.</li><li>Carrigent is developing a next-generation payload delivery system.</li><li>The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.</li><li>Brian transitioned from a scientific role to business development to have a broader impact.</li><li>AI is being leveraged to create efficiencies in biotech operations.</li><li>Fundraising in biotech is currently challenging due to market conditions.</li><li>Strategic partnerships are essential for asset development and exposure.</li><li>The ultimate goal is to partner with pharma and biotech for therapeutic development.</li><li>Brian's diverse background provides a unique perspective in the industry.</li><li>The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.</li><li>Leadership involves trusting your team to do their jobs.</li><li>Founders often struggle to let go of their vision.</li><li>Inspiration can come from various sources, including literature.</li><li>Science fiction often predicts future scientific advancements.</li><li>Early diagnostics are essential for effective treatment.</li><li>The healthcare industry is evolving with new therapies.</li><li>Resilience is key in navigating industry challenges.</li><li>Patient care should be the primary motivation for professionals.</li><li>The future of healthcare will focus on curing chronic diseases.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>cell therapy, gene therapy, biotechnology, AI in biotech, fundraising, vector technology, Brian Newsom, Carrigent, healthcare innovation, startup strategies, healthcare, leadership, gene therapy, science fiction, future trends, patient care, motivation, inspiration, entrepreneurship, biotechnology</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://carrigent.com/" img="https://img.transistorcdn.com/gqBneiTM9QIKfeWK0os9ZM8lne3ZzE5u7E2BD1GPNvw/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMzdl/OTMxYTE1NjdkZTEx/YzAyNmQ4ZGUwNDk5/OTI4MS5qcGVn.jpg">Brian Newsom</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/345d3f6f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Hearing Tech Breakthroughs: Cochlear Implants and Medical Device Leadership with Brent Lucas</title>
      <itunes:episode>36</itunes:episode>
      <podcast:episode>36</podcast:episode>
      <itunes:title>Hearing Tech Breakthroughs: Cochlear Implants and Medical Device Leadership with Brent Lucas</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b262d851-3996-40f2-9509-11b74aeda574</guid>
      <link>https://share.transistor.fm/s/cfa1dbaf</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Envoy Medical and Brent Lucas<br>01:01 Brent's Journey in the Hearing Loss Industry<br>05:03 Transforming Envoy Medical's Product Line<br>09:04 The Impact of Cochlear Implants on Quality of Life<br>13:01 Navigating Clinical Trials and Market Readiness<br>15:10 Transitioning from Lawyer to CEO<br>18:03 Leadership Challenges and Personal Management<br>22:07 Family Influence and Entrepreneurial Spirit<br>23:35 Going Public: A Strategic Decision<br>24:24 Navigating the Public Market: Opportunities and Challenges<br>27:39 Community Impact: Building Jobs and Relationships<br>30:10 Leadership Lessons: From Sports to Business<br>33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome<br>36:19 Innovating with Technology: The Future of Medical Devices<br>41:41 Marketing Strategy: Organic Growth Through Patient Stories</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brent Lucas</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/brent-lucas-envoy/</strong></li><li>Company / Affiliation: <strong>Envoy Medical </strong><a href="https://www.envoymedical.com/">https://www.envoymedical.com/</a></li><li>Guest's Bio: <strong>Brent  Lucas</strong> is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Envoy Medical is a 30-year-old startup focused on hearing loss solutions.</li><li>Brent Lucas became CEO during a pivotal transformation of the company.</li><li>The company specializes in fully implanted hearing devices without external components.</li><li>Cochlear implants can greatly enhance the quality of life for users.</li><li>Navigating clinical trials is a lengthy but necessary process for product launch.</li><li>Brent transitioned from a legal background to a leadership role in a medical device company.</li><li>Effective communication is crucial for leadership success.</li><li>Family influence played a significant role in Brent's entrepreneurial journey.</li><li>The decision to go public was strategic for the company's growth.</li><li>Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.</li><li>Community engagement is crucial for company culture and job creation.</li><li>Leadership lessons can be learned from unexpected places, like sports.</li><li>Imposter syndrome is a common challenge for leaders.</li><li>Innovating with technology is essential in the medical device industry.</li><li>Patient demand for fully implanted devices is expected to be high.</li><li>Organic marketing through patient stories can be powerful.</li><li>The transition to public markets comes with both opportunities and challenges.</li><li>Maintaining focus on core products is vital for success.</li><li>The surgical process for the new device is outpatient and efficient.<p></p></li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Envoy Medical and Brent Lucas<br>01:01 Brent's Journey in the Hearing Loss Industry<br>05:03 Transforming Envoy Medical's Product Line<br>09:04 The Impact of Cochlear Implants on Quality of Life<br>13:01 Navigating Clinical Trials and Market Readiness<br>15:10 Transitioning from Lawyer to CEO<br>18:03 Leadership Challenges and Personal Management<br>22:07 Family Influence and Entrepreneurial Spirit<br>23:35 Going Public: A Strategic Decision<br>24:24 Navigating the Public Market: Opportunities and Challenges<br>27:39 Community Impact: Building Jobs and Relationships<br>30:10 Leadership Lessons: From Sports to Business<br>33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome<br>36:19 Innovating with Technology: The Future of Medical Devices<br>41:41 Marketing Strategy: Organic Growth Through Patient Stories</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brent Lucas</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/brent-lucas-envoy/</strong></li><li>Company / Affiliation: <strong>Envoy Medical </strong><a href="https://www.envoymedical.com/">https://www.envoymedical.com/</a></li><li>Guest's Bio: <strong>Brent  Lucas</strong> is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Envoy Medical is a 30-year-old startup focused on hearing loss solutions.</li><li>Brent Lucas became CEO during a pivotal transformation of the company.</li><li>The company specializes in fully implanted hearing devices without external components.</li><li>Cochlear implants can greatly enhance the quality of life for users.</li><li>Navigating clinical trials is a lengthy but necessary process for product launch.</li><li>Brent transitioned from a legal background to a leadership role in a medical device company.</li><li>Effective communication is crucial for leadership success.</li><li>Family influence played a significant role in Brent's entrepreneurial journey.</li><li>The decision to go public was strategic for the company's growth.</li><li>Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.</li><li>Community engagement is crucial for company culture and job creation.</li><li>Leadership lessons can be learned from unexpected places, like sports.</li><li>Imposter syndrome is a common challenge for leaders.</li><li>Innovating with technology is essential in the medical device industry.</li><li>Patient demand for fully implanted devices is expected to be high.</li><li>Organic marketing through patient stories can be powerful.</li><li>The transition to public markets comes with both opportunities and challenges.</li><li>Maintaining focus on core products is vital for success.</li><li>The surgical process for the new device is outpatient and efficient.<p></p></li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Thu, 18 Sep 2025 13:03:35 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/cfa1dbaf/6f7e5237.mp3" length="70475112" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/4zdfZuMsG6Y9DpZlsc-F0oWHf-FCcA38QvOaCaiMA3M/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZTFh/MGNmODBmNDVhNGVh/OWYzNzljZWM4ZTZk/YzVkYS5qcGc.jpg"/>
      <itunes:duration>2928</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact.</p><p><strong><br>Chapters:</strong><br>00:00 Introduction to Envoy Medical and Brent Lucas<br>01:01 Brent's Journey in the Hearing Loss Industry<br>05:03 Transforming Envoy Medical's Product Line<br>09:04 The Impact of Cochlear Implants on Quality of Life<br>13:01 Navigating Clinical Trials and Market Readiness<br>15:10 Transitioning from Lawyer to CEO<br>18:03 Leadership Challenges and Personal Management<br>22:07 Family Influence and Entrepreneurial Spirit<br>23:35 Going Public: A Strategic Decision<br>24:24 Navigating the Public Market: Opportunities and Challenges<br>27:39 Community Impact: Building Jobs and Relationships<br>30:10 Leadership Lessons: From Sports to Business<br>33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome<br>36:19 Innovating with Technology: The Future of Medical Devices<br>41:41 Marketing Strategy: Organic Growth Through Patient Stories</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Brent Lucas</strong></li><li>Guest's Title/Position:<strong> Chief Executive Officer</strong></li><li>Guest's Linkedin: <strong>https://www.linkedin.com/in/brent-lucas-envoy/</strong></li><li>Company / Affiliation: <strong>Envoy Medical </strong><a href="https://www.envoymedical.com/">https://www.envoymedical.com/</a></li><li>Guest's Bio: <strong>Brent  Lucas</strong> is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Envoy Medical is a 30-year-old startup focused on hearing loss solutions.</li><li>Brent Lucas became CEO during a pivotal transformation of the company.</li><li>The company specializes in fully implanted hearing devices without external components.</li><li>Cochlear implants can greatly enhance the quality of life for users.</li><li>Navigating clinical trials is a lengthy but necessary process for product launch.</li><li>Brent transitioned from a legal background to a leadership role in a medical device company.</li><li>Effective communication is crucial for leadership success.</li><li>Family influence played a significant role in Brent's entrepreneurial journey.</li><li>The decision to go public was strategic for the company's growth.</li><li>Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.</li><li>Community engagement is crucial for company culture and job creation.</li><li>Leadership lessons can be learned from unexpected places, like sports.</li><li>Imposter syndrome is a common challenge for leaders.</li><li>Innovating with technology is essential in the medical device industry.</li><li>Patient demand for fully implanted devices is expected to be high.</li><li>Organic marketing through patient stories can be powerful.</li><li>The transition to public markets comes with both opportunities and challenges.</li><li>Maintaining focus on core products is vital for success.</li><li>The surgical process for the new device is outpatient and efficient.<p></p></li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>hearing loss, cochlear implants, medical devices, entrepreneurship, leadership, clinical trials, quality of life, Envoy Medical, Brent Lucas, innovation, public market, community impact, leadership, personal growth, medical devices, innovation, marketing strategy, employee engagement, technology, entrepreneurship</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.envoymedical.com/" img="https://img.transistorcdn.com/MS9YXRm-5tijccCtqmw-v5fmJIgr8bsxgwvqozr8ovw/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMmFj/ODE2MmQ1NDI3OGUz/NDIzM2MwYmFlN2Qz/ZDY3ZS5qcGVn.jpg">Brent Lucas</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/cfa1dbaf/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Streamlining Drug Development: Patient Empowerment Through Technology with Stefan Lukianov</title>
      <itunes:episode>35</itunes:episode>
      <podcast:episode>35</podcast:episode>
      <itunes:title>Streamlining Drug Development: Patient Empowerment Through Technology with Stefan Lukianov</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e06ceb50-b7bb-4860-a014-a376f6f9a3ae</guid>
      <link>https://share.transistor.fm/s/ed448201</link>
      <description>
        <![CDATA[<p>In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Salve Therapeutics and Patient Empowerment</p><p>02:58 The Role of Technology in Drug Development</p><p>06:00 Innovative Software Solutions for Rare Diseases</p><p>08:58 Patient Self-Management and Mobile Health Apps</p><p>12:06 Collaboration and Mentorship in Biotech</p><p>14:56 Real-Time Health Data and Patient Engagement</p><p>26:23 The Journey of App Development</p><p>31:01 Navigating Fundraising and Investor Relations</p><p>37:17 Transitioning from Founder to CEO</p><p>44:30 The Importance of Thoughtfulness in Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Stefan Lukianov</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/"><strong>https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/</strong></a></li><li>Company / Affiliation:  <strong>Salve Therapeutics</strong><a href="https://www.salvetherapeutics.com/"><strong> https://www.salvetherapeutics.com/</strong></a></li><li>Guest's Bio: <strong>Stefan Lukianov</strong> is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Stefan Lukianov is the founder and CEO of Salve Therapeutics.</li><li>Salve Therapeutics focuses on patient empowerment through technology.</li><li>The company aims to reduce the cost of drug development for rare diseases.</li><li>Their software is designed for drug developers to streamline the process.</li><li>Real-time health data is crucial for patient engagement.</li><li>Collaboration and mentorship are key in the biotech field.</li><li>Mobile health apps can enhance patient self-management.</li><li>The goal is to make healthcare more accessible and efficient.</li><li>Patient independence is a priority in healthcare innovation.</li><li>Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.</li><li>It's important to attract users with the app's design and functionality.</li><li>Fundraising is a complex process that requires careful planning.</li><li>Transitioning from founder to CEO involves balancing vision with operational realities.</li><li>Thoughtfulness in decision-making leads to better outcomes.</li><li>Listening to feedback is crucial for growth as a founder and CEO.</li><li>Building relationships with potential customers is key to success.</li><li>The healthcare app industry is heavily regulated, making development challenging.</li><li>Networking and attending events can lead to valuable connections.</li><li>Having a clear vision helps in managing investor expectations.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Salve Therapeutics and Patient Empowerment</p><p>02:58 The Role of Technology in Drug Development</p><p>06:00 Innovative Software Solutions for Rare Diseases</p><p>08:58 Patient Self-Management and Mobile Health Apps</p><p>12:06 Collaboration and Mentorship in Biotech</p><p>14:56 Real-Time Health Data and Patient Engagement</p><p>26:23 The Journey of App Development</p><p>31:01 Navigating Fundraising and Investor Relations</p><p>37:17 Transitioning from Founder to CEO</p><p>44:30 The Importance of Thoughtfulness in Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Stefan Lukianov</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/"><strong>https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/</strong></a></li><li>Company / Affiliation:  <strong>Salve Therapeutics</strong><a href="https://www.salvetherapeutics.com/"><strong> https://www.salvetherapeutics.com/</strong></a></li><li>Guest's Bio: <strong>Stefan Lukianov</strong> is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Stefan Lukianov is the founder and CEO of Salve Therapeutics.</li><li>Salve Therapeutics focuses on patient empowerment through technology.</li><li>The company aims to reduce the cost of drug development for rare diseases.</li><li>Their software is designed for drug developers to streamline the process.</li><li>Real-time health data is crucial for patient engagement.</li><li>Collaboration and mentorship are key in the biotech field.</li><li>Mobile health apps can enhance patient self-management.</li><li>The goal is to make healthcare more accessible and efficient.</li><li>Patient independence is a priority in healthcare innovation.</li><li>Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.</li><li>It's important to attract users with the app's design and functionality.</li><li>Fundraising is a complex process that requires careful planning.</li><li>Transitioning from founder to CEO involves balancing vision with operational realities.</li><li>Thoughtfulness in decision-making leads to better outcomes.</li><li>Listening to feedback is crucial for growth as a founder and CEO.</li><li>Building relationships with potential customers is key to success.</li><li>The healthcare app industry is heavily regulated, making development challenging.</li><li>Networking and attending events can lead to valuable connections.</li><li>Having a clear vision helps in managing investor expectations.</li></ul>]]>
      </content:encoded>
      <pubDate>Tue, 16 Sep 2025 16:49:41 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ed448201/8f5e7dd2.mp3" length="73368269" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/nGdwOVaZA41UTGhGbqwlKaHZLHWBytZynYHzoaA22kw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iMDAz/YzQ5YWUxZGZmZjNj/ZjdkMjg0ZjNlYWRj/NjMxZC5qcGc.jpg"/>
      <itunes:duration>3048</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Salve Therapeutics and Patient Empowerment</p><p>02:58 The Role of Technology in Drug Development</p><p>06:00 Innovative Software Solutions for Rare Diseases</p><p>08:58 Patient Self-Management and Mobile Health Apps</p><p>12:06 Collaboration and Mentorship in Biotech</p><p>14:56 Real-Time Health Data and Patient Engagement</p><p>26:23 The Journey of App Development</p><p>31:01 Navigating Fundraising and Investor Relations</p><p>37:17 Transitioning from Founder to CEO</p><p>44:30 The Importance of Thoughtfulness in Leadership</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Stefan Lukianov</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/"><strong>https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/</strong></a></li><li>Company / Affiliation:  <strong>Salve Therapeutics</strong><a href="https://www.salvetherapeutics.com/"><strong> https://www.salvetherapeutics.com/</strong></a></li><li>Guest's Bio: <strong>Stefan Lukianov</strong> is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Stefan Lukianov is the founder and CEO of Salve Therapeutics.</li><li>Salve Therapeutics focuses on patient empowerment through technology.</li><li>The company aims to reduce the cost of drug development for rare diseases.</li><li>Their software is designed for drug developers to streamline the process.</li><li>Real-time health data is crucial for patient engagement.</li><li>Collaboration and mentorship are key in the biotech field.</li><li>Mobile health apps can enhance patient self-management.</li><li>The goal is to make healthcare more accessible and efficient.</li><li>Patient independence is a priority in healthcare innovation.</li><li>Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.</li><li>It's important to attract users with the app's design and functionality.</li><li>Fundraising is a complex process that requires careful planning.</li><li>Transitioning from founder to CEO involves balancing vision with operational realities.</li><li>Thoughtfulness in decision-making leads to better outcomes.</li><li>Listening to feedback is crucial for growth as a founder and CEO.</li><li>Building relationships with potential customers is key to success.</li><li>The healthcare app industry is heavily regulated, making development challenging.</li><li>Networking and attending events can lead to valuable connections.</li><li>Having a clear vision helps in managing investor expectations.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Salve Therapeutics, patient empowerment, drug development, health tech, mobile health apps, biotechnology, mentorship, real-time health data, rare diseases, healthcare innovation, healthcare app, patient empowerment, fundraising, CEO transition, startup advice</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.salvetherapeutics.com/" img="https://img.transistorcdn.com/MIHgyFMmlJ5n93K-U8ZcErul8cWv8rTrzpDAqpgIbnw/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83YzZj/ZTdiNmEzYzYzMTQ1/MzJmYzFmYjQ4NmRl/Y2JkMy5qcGVn.jpg">Stefan Lukianov</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ed448201/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ed448201/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ed448201/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ed448201/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/ed448201/transcription" type="text/html"/>
    </item>
    <item>
      <title>Rethinking Injection Tech: A Biomimicry Breakthrough for Global Health with Marc Koska</title>
      <itunes:episode>34</itunes:episode>
      <podcast:episode>34</podcast:episode>
      <itunes:title>Rethinking Injection Tech: A Biomimicry Breakthrough for Global Health with Marc Koska</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">009f7007-b60a-4164-b61b-f3dce0656c64</guid>
      <link>https://share.transistor.fm/s/ce7dca22</link>
      <description>
        <![CDATA[<p>In this episode, Marc Koska shares his journey as a social entrepreneur and healthcare innovator. He discusses creating the K1 auto-disabled syringe, which has saved millions of lives by preventing the spread of blood-borne diseases, and his transition to Apiject to advance healthcare delivery with new injection technologies. Marc also reflects on lessons from biomimicry and product design, the challenges of global health in developing countries, and the importance of firsthand experience, social awareness, and data-driven decision-making in driving meaningful innovation.</p><p><strong>Chapters:<br></strong>00:00 Introduction to Marc Koska and His Innovations<br>05:03 The Birth of the K1 Auto-Disabled Syringe<br>12:09 Impact of the K1 Syringe on Global Health<br>17:50 Transition to Apiject and New Innovations<br>25:03 Future of Healthcare and Injection Devices<br>26:59 Empowerment Through Creation<br>29:20 The Birth of Biomimicry<br>32:12 Social Impact and Empowerment<br>35:24 Innovations in Design and Technology<br>39:35 The Journey of Social Entrepreneurship<br>45:55 Advice for Aspiring Innovators</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Marc Koska</strong></li><li>Guest's Title/Position:<strong> Co-founder and Head of Production Design</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/marc-koska-5761181a/"><strong>https://www.linkedin.com/in/marc-koska-5761181a/</strong></a></li><li>Company / Affiliation: <strong>ApiJect </strong><a href="https://apiject.com/"><strong>https://apiject.com/</strong></a></li><li>Guest's Bio: The inventor of the Apiject Platform and its first BFS injection device is <strong>Marc Koska</strong>, a highly honored “social entrepreneur.” The Prefilled Apiject Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading Apiject R&amp;D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of Apiject’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The Apiject Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Marc Koska invented the K1 auto-disabled syringe to prevent disease spread.</li><li>The K1 syringe has saved approximately 12 million lives.</li><li>Syringe reuse was a major transmission route for HIV.</li><li>Marc's journey involved extensive research and learning about syringes.</li><li>The K1 syringe design was a significant innovation in healthcare.</li><li>Marc's work has had a profound impact on global health education.</li><li>Apiject aims to provide safer and more accessible injection devices.</li><li>The new injection devices are designed for self-administration.</li><li>Environmental concerns are addressed with new syringe designs.</li><li>Marc's career reflects a commitment to solving large-scale health problems. Empowerment comes from creating impactful solutions.</li><li>Biomimicry is a study of nature's designs and interactions.</li><li>Social entrepreneurship requires understanding the core truth of problems.</li><li>Technology, like AI and 3D printing, enhances design processes.</li><li>Traveling and seeing problems firsthand is crucial for entrepreneurs.</li><li>Data and understanding all viewpoints are essential for success.</li><li>Innovative design must consider social implications.</li><li>Creating a supportive team culture is vital for success.</li><li>Challenging the status quo is necessary for meaningful change.</li><li>Success in social entrepreneurship requires a combination of passion and practicality.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Marc Koska shares his journey as a social entrepreneur and healthcare innovator. He discusses creating the K1 auto-disabled syringe, which has saved millions of lives by preventing the spread of blood-borne diseases, and his transition to Apiject to advance healthcare delivery with new injection technologies. Marc also reflects on lessons from biomimicry and product design, the challenges of global health in developing countries, and the importance of firsthand experience, social awareness, and data-driven decision-making in driving meaningful innovation.</p><p><strong>Chapters:<br></strong>00:00 Introduction to Marc Koska and His Innovations<br>05:03 The Birth of the K1 Auto-Disabled Syringe<br>12:09 Impact of the K1 Syringe on Global Health<br>17:50 Transition to Apiject and New Innovations<br>25:03 Future of Healthcare and Injection Devices<br>26:59 Empowerment Through Creation<br>29:20 The Birth of Biomimicry<br>32:12 Social Impact and Empowerment<br>35:24 Innovations in Design and Technology<br>39:35 The Journey of Social Entrepreneurship<br>45:55 Advice for Aspiring Innovators</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Marc Koska</strong></li><li>Guest's Title/Position:<strong> Co-founder and Head of Production Design</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/marc-koska-5761181a/"><strong>https://www.linkedin.com/in/marc-koska-5761181a/</strong></a></li><li>Company / Affiliation: <strong>ApiJect </strong><a href="https://apiject.com/"><strong>https://apiject.com/</strong></a></li><li>Guest's Bio: The inventor of the Apiject Platform and its first BFS injection device is <strong>Marc Koska</strong>, a highly honored “social entrepreneur.” The Prefilled Apiject Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading Apiject R&amp;D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of Apiject’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The Apiject Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Marc Koska invented the K1 auto-disabled syringe to prevent disease spread.</li><li>The K1 syringe has saved approximately 12 million lives.</li><li>Syringe reuse was a major transmission route for HIV.</li><li>Marc's journey involved extensive research and learning about syringes.</li><li>The K1 syringe design was a significant innovation in healthcare.</li><li>Marc's work has had a profound impact on global health education.</li><li>Apiject aims to provide safer and more accessible injection devices.</li><li>The new injection devices are designed for self-administration.</li><li>Environmental concerns are addressed with new syringe designs.</li><li>Marc's career reflects a commitment to solving large-scale health problems. Empowerment comes from creating impactful solutions.</li><li>Biomimicry is a study of nature's designs and interactions.</li><li>Social entrepreneurship requires understanding the core truth of problems.</li><li>Technology, like AI and 3D printing, enhances design processes.</li><li>Traveling and seeing problems firsthand is crucial for entrepreneurs.</li><li>Data and understanding all viewpoints are essential for success.</li><li>Innovative design must consider social implications.</li><li>Creating a supportive team culture is vital for success.</li><li>Challenging the status quo is necessary for meaningful change.</li><li>Success in social entrepreneurship requires a combination of passion and practicality.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Wed, 10 Sep 2025 11:42:59 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ce7dca22/732f934b.mp3" length="74928523" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/d0a_Bxkli0aqET83Hya1JXTbjFPaJUAUMLha1Y-MXio/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81Yjg5/YjU4MTNhODRiNDU1/MjhiYmE3NTc0Yjg3/ZTM2Mi5qcGc.jpg"/>
      <itunes:duration>3116</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Marc Koska shares his journey as a social entrepreneur and healthcare innovator. He discusses creating the K1 auto-disabled syringe, which has saved millions of lives by preventing the spread of blood-borne diseases, and his transition to Apiject to advance healthcare delivery with new injection technologies. Marc also reflects on lessons from biomimicry and product design, the challenges of global health in developing countries, and the importance of firsthand experience, social awareness, and data-driven decision-making in driving meaningful innovation.</p><p><strong>Chapters:<br></strong>00:00 Introduction to Marc Koska and His Innovations<br>05:03 The Birth of the K1 Auto-Disabled Syringe<br>12:09 Impact of the K1 Syringe on Global Health<br>17:50 Transition to Apiject and New Innovations<br>25:03 Future of Healthcare and Injection Devices<br>26:59 Empowerment Through Creation<br>29:20 The Birth of Biomimicry<br>32:12 Social Impact and Empowerment<br>35:24 Innovations in Design and Technology<br>39:35 The Journey of Social Entrepreneurship<br>45:55 Advice for Aspiring Innovators</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Marc Koska</strong></li><li>Guest's Title/Position:<strong> Co-founder and Head of Production Design</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/marc-koska-5761181a/"><strong>https://www.linkedin.com/in/marc-koska-5761181a/</strong></a></li><li>Company / Affiliation: <strong>ApiJect </strong><a href="https://apiject.com/"><strong>https://apiject.com/</strong></a></li><li>Guest's Bio: The inventor of the Apiject Platform and its first BFS injection device is <strong>Marc Koska</strong>, a highly honored “social entrepreneur.” The Prefilled Apiject Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading Apiject R&amp;D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of Apiject’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The Apiject Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives.</li></ul><p><br></p><p><strong>Takeaways:</strong></p><ul><li>Marc Koska invented the K1 auto-disabled syringe to prevent disease spread.</li><li>The K1 syringe has saved approximately 12 million lives.</li><li>Syringe reuse was a major transmission route for HIV.</li><li>Marc's journey involved extensive research and learning about syringes.</li><li>The K1 syringe design was a significant innovation in healthcare.</li><li>Marc's work has had a profound impact on global health education.</li><li>Apiject aims to provide safer and more accessible injection devices.</li><li>The new injection devices are designed for self-administration.</li><li>Environmental concerns are addressed with new syringe designs.</li><li>Marc's career reflects a commitment to solving large-scale health problems. Empowerment comes from creating impactful solutions.</li><li>Biomimicry is a study of nature's designs and interactions.</li><li>Social entrepreneurship requires understanding the core truth of problems.</li><li>Technology, like AI and 3D printing, enhances design processes.</li><li>Traveling and seeing problems firsthand is crucial for entrepreneurs.</li><li>Data and understanding all viewpoints are essential for success.</li><li>Innovative design must consider social implications.</li><li>Creating a supportive team culture is vital for success.</li><li>Challenging the status quo is necessary for meaningful change.</li><li>Success in social entrepreneurship requires a combination of passion and practicality.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Mark Koska, K1 syringe, AppEject, healthcare innovation, social entrepreneurship, global health, auto-disabled syringe, vaccination, oxytocin, medical devices, biomimicry, social entrepreneurship, innovation, empowerment, design, technology, AI, 3D printing, healthcare, sustainability</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://apiject.com/" img="https://img.transistorcdn.com/9Z28r05FnItraOHWGmkivBGV2opZ7gT2AtNpCdg16uo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zM2Q3/NGJkZGI1YzllOGYw/YmNlNWNmNjczMzY2/NzU4MS5qcGVn.jpg">Marc Koska</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ce7dca22/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title> Technology for Humanity: The Crossroads of Care and AI with Gautham Pasupuleti</title>
      <itunes:episode>33</itunes:episode>
      <podcast:episode>33</podcast:episode>
      <itunes:title> Technology for Humanity: The Crossroads of Care and AI with Gautham Pasupuleti</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">77d2af3c-644b-44c3-b8e7-e73f4754c87e</guid>
      <link>https://share.transistor.fm/s/68d9c43d</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Biodesign Innovation Labs</p><p>02:47 Innovative Medical Devices for Critical Care</p><p>05:50 AI and Precision Medicine in Cancer Care</p><p>08:48 The Journey of Entrepreneurship in Healthcare</p><p>12:05 Personal Experiences Shaping Innovation</p><p>14:56 Building a Team and Community Engagement</p><p>17:51 The Role of Mentorship and Collaboration</p><p>21:07 Navigating the Healthcare Ecosystem</p><p>23:56 Advice for Aspiring Innovators</p><p>29:21 Journey into Medical Device Innovation</p><p>32:53 Overcoming Personal Tragedy and Professional Challenges</p><p>35:46 The Importance of Team Dynamics in Medical Innovation</p><p>39:28 Leadership Lessons from Personal Loss</p><p>44:37 Future Aspirations in Cancer Treatment and AI</p><p>48:19 Advice for Aspiring Entrepreneurs</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Gautham Pasupuleti</strong></li><li>Guest's Title/Position:<strong> Co Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/gautham-pasupuleti-84884054/"><strong>https://www.linkedin.com/in/gautham-pasupuleti-84884054/</strong></a></li><li>Company / Affiliation:<strong> Biodesign Innovation Labs</strong> <a href="https://biodesigninnovationlabs.com/"><strong>https://biodesigninnovationlabs.com/</strong></a></li><li>Guest's Bio: <strong>Gautham Pasupuleti</strong> is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Biodesign Innovation Labs focuses on life-saving medical devices.</li><li>Respirate is an automated solution for manual ventilation.</li><li>The company started its journey in 2017 with a focus on critical care.</li><li>Personal experiences can drive innovation in healthcare.</li><li>Community engagement is crucial for understanding healthcare needs.</li><li>Mentorship plays a significant role in entrepreneurial success.</li><li>AI solutions are being developed for early cancer detection.</li><li>Building a team with diverse skills is essential for success.</li><li>Hands-on experience is vital for understanding real-world problems.</li><li>Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.</li><li>He collaborated on a VR and AR device for children's eye exams.</li><li>After his brother's passing, he took on significant responsibilities in their startup.</li><li>The importance of innovation in medical devices cannot be overstated.</li><li>Team dynamics and diverse skill sets are crucial for success.</li><li>Personal experiences can drive motivation to solve meaningful problems.</li><li>Leadership requires making tough decisions and trusting your instincts.</li><li>Gautham learned valuable lessons from his brother's mentorship.</li><li>Resilience and persistence are key traits for entrepreneurs.</li><li>Networking with experienced individuals can provide valuable insights. </li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Biodesign Innovation Labs</p><p>02:47 Innovative Medical Devices for Critical Care</p><p>05:50 AI and Precision Medicine in Cancer Care</p><p>08:48 The Journey of Entrepreneurship in Healthcare</p><p>12:05 Personal Experiences Shaping Innovation</p><p>14:56 Building a Team and Community Engagement</p><p>17:51 The Role of Mentorship and Collaboration</p><p>21:07 Navigating the Healthcare Ecosystem</p><p>23:56 Advice for Aspiring Innovators</p><p>29:21 Journey into Medical Device Innovation</p><p>32:53 Overcoming Personal Tragedy and Professional Challenges</p><p>35:46 The Importance of Team Dynamics in Medical Innovation</p><p>39:28 Leadership Lessons from Personal Loss</p><p>44:37 Future Aspirations in Cancer Treatment and AI</p><p>48:19 Advice for Aspiring Entrepreneurs</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Gautham Pasupuleti</strong></li><li>Guest's Title/Position:<strong> Co Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/gautham-pasupuleti-84884054/"><strong>https://www.linkedin.com/in/gautham-pasupuleti-84884054/</strong></a></li><li>Company / Affiliation:<strong> Biodesign Innovation Labs</strong> <a href="https://biodesigninnovationlabs.com/"><strong>https://biodesigninnovationlabs.com/</strong></a></li><li>Guest's Bio: <strong>Gautham Pasupuleti</strong> is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Biodesign Innovation Labs focuses on life-saving medical devices.</li><li>Respirate is an automated solution for manual ventilation.</li><li>The company started its journey in 2017 with a focus on critical care.</li><li>Personal experiences can drive innovation in healthcare.</li><li>Community engagement is crucial for understanding healthcare needs.</li><li>Mentorship plays a significant role in entrepreneurial success.</li><li>AI solutions are being developed for early cancer detection.</li><li>Building a team with diverse skills is essential for success.</li><li>Hands-on experience is vital for understanding real-world problems.</li><li>Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.</li><li>He collaborated on a VR and AR device for children's eye exams.</li><li>After his brother's passing, he took on significant responsibilities in their startup.</li><li>The importance of innovation in medical devices cannot be overstated.</li><li>Team dynamics and diverse skill sets are crucial for success.</li><li>Personal experiences can drive motivation to solve meaningful problems.</li><li>Leadership requires making tough decisions and trusting your instincts.</li><li>Gautham learned valuable lessons from his brother's mentorship.</li><li>Resilience and persistence are key traits for entrepreneurs.</li><li>Networking with experienced individuals can provide valuable insights. </li></ul>]]>
      </content:encoded>
      <pubDate>Thu, 04 Sep 2025 14:42:31 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/68d9c43d/e41dff7a.mp3" length="76462087" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Ikj2WL52MVktKXQ0X3JaEFJGp3Z94oER-_z14BSNq98/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jOGJk/YzdjOWYzMTI4ODYy/MzdlNDdhNDQ1ZTg1/MjBmZS5qcGc.jpg"/>
      <itunes:duration>3178</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise Podcast</em>, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Biodesign Innovation Labs</p><p>02:47 Innovative Medical Devices for Critical Care</p><p>05:50 AI and Precision Medicine in Cancer Care</p><p>08:48 The Journey of Entrepreneurship in Healthcare</p><p>12:05 Personal Experiences Shaping Innovation</p><p>14:56 Building a Team and Community Engagement</p><p>17:51 The Role of Mentorship and Collaboration</p><p>21:07 Navigating the Healthcare Ecosystem</p><p>23:56 Advice for Aspiring Innovators</p><p>29:21 Journey into Medical Device Innovation</p><p>32:53 Overcoming Personal Tragedy and Professional Challenges</p><p>35:46 The Importance of Team Dynamics in Medical Innovation</p><p>39:28 Leadership Lessons from Personal Loss</p><p>44:37 Future Aspirations in Cancer Treatment and AI</p><p>48:19 Advice for Aspiring Entrepreneurs</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Gautham Pasupuleti</strong></li><li>Guest's Title/Position:<strong> Co Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/gautham-pasupuleti-84884054/"><strong>https://www.linkedin.com/in/gautham-pasupuleti-84884054/</strong></a></li><li>Company / Affiliation:<strong> Biodesign Innovation Labs</strong> <a href="https://biodesigninnovationlabs.com/"><strong>https://biodesigninnovationlabs.com/</strong></a></li><li>Guest's Bio: <strong>Gautham Pasupuleti</strong> is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Biodesign Innovation Labs focuses on life-saving medical devices.</li><li>Respirate is an automated solution for manual ventilation.</li><li>The company started its journey in 2017 with a focus on critical care.</li><li>Personal experiences can drive innovation in healthcare.</li><li>Community engagement is crucial for understanding healthcare needs.</li><li>Mentorship plays a significant role in entrepreneurial success.</li><li>AI solutions are being developed for early cancer detection.</li><li>Building a team with diverse skills is essential for success.</li><li>Hands-on experience is vital for understanding real-world problems.</li><li>Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.</li><li>He collaborated on a VR and AR device for children's eye exams.</li><li>After his brother's passing, he took on significant responsibilities in their startup.</li><li>The importance of innovation in medical devices cannot be overstated.</li><li>Team dynamics and diverse skill sets are crucial for success.</li><li>Personal experiences can drive motivation to solve meaningful problems.</li><li>Leadership requires making tough decisions and trusting your instincts.</li><li>Gautham learned valuable lessons from his brother's mentorship.</li><li>Resilience and persistence are key traits for entrepreneurs.</li><li>Networking with experienced individuals can provide valuable insights. </li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Biodesign Innovation Labs, medical devices, AI, precision medicine, cancer care, entrepreneurship, healthcare innovation, mentorship, community engagement, healthcare ecosystem, medical devices, entrepreneurship, AI, precision medicine, leadership, personal tragedy, innovation, team dynamics, cancer treatment, resilience</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://biodesigninnovationlabs.com/" img="https://img.transistorcdn.com/WLoag7Tprh3MNOzffdNSV_1rXxWHv_nu2IqZQu9HViE/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNjk1/ODEwYWNhZGVkMWU5/YjdlMzkzNWVhODg4/NTU1Yi5qcGc.jpg">Gautham Pasupuleti </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/68d9c43d/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/68d9c43d/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/68d9c43d/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/68d9c43d/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/68d9c43d/transcription" type="text/html"/>
    </item>
    <item>
      <title>Clarity Through Technology: Imaging Innovation for Women’s Health with Kevin Harris</title>
      <itunes:episode>32</itunes:episode>
      <podcast:episode>32</podcast:episode>
      <itunes:title>Clarity Through Technology: Imaging Innovation for Women’s Health with Kevin Harris</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">96243423-b49e-46f1-a6b1-9213b5bd9677</guid>
      <link>https://share.transistor.fm/s/f535bc20</link>
      <description>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to AI in Healthcare<br>03:49 The Genesis of CureMetrix<br>09:10 Challenges in Mammography<br>14:58 Innovations in Breast Cancer Detection<br>21:10 Leadership and Team Dynamics at CureMetrix<br>26:19 Building a Professional Culture<br>27:37 Challenges in AI Adoption<br>31:24 Navigating Regulatory Hurdles<br>34:40 Sales Strategies in a Niche Market<br>39:02 AI's Role in Women's Healthcare<br>42:04 Opportunities in Healthcare Careers</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kevin Harris</strong></li><li>Guest's Title/Position:<strong> President and co-founder </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kevindavidharris/"><strong>https://www.linkedin.com/in/kevindavidharris/</strong></a></li><li>Company / Affiliation: <strong>CureMetrix </strong><a href="https://curemetrix.com/"><strong>https://curemetrix.com/</strong></a></li><li>Guest's Bio: <strong>Kevin Harris</strong> is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Kevin Harris has over 35 years of experience in technology.</li><li>CureMetrix was founded to leverage AI in healthcare.</li><li>The company focuses on improving mammography outcomes.</li><li>Breast arterial calcifications can indicate serious health issues.</li><li>AI can help reduce false positives in mammography.</li><li>CureMetrix's software provides valuable insights to radiologists.</li><li>Collaboration with data scientists is crucial for innovation.</li><li>Building a strong team and mentorship is key to success.</li><li>Understanding the healthcare landscape is essential for leaders.</li><li>Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.</li><li>AI is perceived as a tool rather than a replacement for doctors.</li><li>AI operates consistently without human limitations.</li><li>Regulatory challenges are significant in bringing AI to market.</li><li>Sales strategies must target the right decision-makers in healthcare.</li><li>Education is crucial for the adoption of AI in healthcare.</li><li>AI can help radiologists focus on more critical cases.</li><li>There are opportunities to automate certain healthcare tasks safely.</li><li>AI can assist in pre-reading medical images to save time.</li><li>The healthcare system needs to improve public education on health issues.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to AI in Healthcare<br>03:49 The Genesis of CureMetrix<br>09:10 Challenges in Mammography<br>14:58 Innovations in Breast Cancer Detection<br>21:10 Leadership and Team Dynamics at CureMetrix<br>26:19 Building a Professional Culture<br>27:37 Challenges in AI Adoption<br>31:24 Navigating Regulatory Hurdles<br>34:40 Sales Strategies in a Niche Market<br>39:02 AI's Role in Women's Healthcare<br>42:04 Opportunities in Healthcare Careers</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kevin Harris</strong></li><li>Guest's Title/Position:<strong> President and co-founder </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kevindavidharris/"><strong>https://www.linkedin.com/in/kevindavidharris/</strong></a></li><li>Company / Affiliation: <strong>CureMetrix </strong><a href="https://curemetrix.com/"><strong>https://curemetrix.com/</strong></a></li><li>Guest's Bio: <strong>Kevin Harris</strong> is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Kevin Harris has over 35 years of experience in technology.</li><li>CureMetrix was founded to leverage AI in healthcare.</li><li>The company focuses on improving mammography outcomes.</li><li>Breast arterial calcifications can indicate serious health issues.</li><li>AI can help reduce false positives in mammography.</li><li>CureMetrix's software provides valuable insights to radiologists.</li><li>Collaboration with data scientists is crucial for innovation.</li><li>Building a strong team and mentorship is key to success.</li><li>Understanding the healthcare landscape is essential for leaders.</li><li>Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.</li><li>AI is perceived as a tool rather than a replacement for doctors.</li><li>AI operates consistently without human limitations.</li><li>Regulatory challenges are significant in bringing AI to market.</li><li>Sales strategies must target the right decision-makers in healthcare.</li><li>Education is crucial for the adoption of AI in healthcare.</li><li>AI can help radiologists focus on more critical cases.</li><li>There are opportunities to automate certain healthcare tasks safely.</li><li>AI can assist in pre-reading medical images to save time.</li><li>The healthcare system needs to improve public education on health issues.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 03 Sep 2025 11:55:16 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/f535bc20/d27540e8.mp3" length="70207640" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ByILv4SfYeDTa5_zp7ejn9d8vZs1N0gCXR_ghf37568/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80Y2Rh/NGU4YzY1M2ViOGNm/Yzg0OWRmY2M3MWRi/MDBhYS5qcGc.jpg"/>
      <itunes:duration>2917</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals.</p><p><strong>Chapters:</strong><br>00:00 Introduction to AI in Healthcare<br>03:49 The Genesis of CureMetrix<br>09:10 Challenges in Mammography<br>14:58 Innovations in Breast Cancer Detection<br>21:10 Leadership and Team Dynamics at CureMetrix<br>26:19 Building a Professional Culture<br>27:37 Challenges in AI Adoption<br>31:24 Navigating Regulatory Hurdles<br>34:40 Sales Strategies in a Niche Market<br>39:02 AI's Role in Women's Healthcare<br>42:04 Opportunities in Healthcare Careers</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Kevin Harris</strong></li><li>Guest's Title/Position:<strong> President and co-founder </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kevindavidharris/"><strong>https://www.linkedin.com/in/kevindavidharris/</strong></a></li><li>Company / Affiliation: <strong>CureMetrix </strong><a href="https://curemetrix.com/"><strong>https://curemetrix.com/</strong></a></li><li>Guest's Bio: <strong>Kevin Harris</strong> is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Kevin Harris has over 35 years of experience in technology.</li><li>CureMetrix was founded to leverage AI in healthcare.</li><li>The company focuses on improving mammography outcomes.</li><li>Breast arterial calcifications can indicate serious health issues.</li><li>AI can help reduce false positives in mammography.</li><li>CureMetrix's software provides valuable insights to radiologists.</li><li>Collaboration with data scientists is crucial for innovation.</li><li>Building a strong team and mentorship is key to success.</li><li>Understanding the healthcare landscape is essential for leaders.</li><li>Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.</li><li>AI is perceived as a tool rather than a replacement for doctors.</li><li>AI operates consistently without human limitations.</li><li>Regulatory challenges are significant in bringing AI to market.</li><li>Sales strategies must target the right decision-makers in healthcare.</li><li>Education is crucial for the adoption of AI in healthcare.</li><li>AI can help radiologists focus on more critical cases.</li><li>There are opportunities to automate certain healthcare tasks safely.</li><li>AI can assist in pre-reading medical images to save time.</li><li>The healthcare system needs to improve public education on health issues.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>CureMetrix, AI in healthcare, breast cancer detection, mammography, healthcare technology, radiology, patient outcomes, leadership in healthcare, breast arterial calcifications, healthcare innovation, AI, healthcare, company culture, regulatory challenges, sales strategies, women's health, education, technology adoption, radiology, patient care</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://curemetrix.com/" img="https://img.transistorcdn.com/IS1neB-351YHBh5seGb0CRBdxR6GbXVP1w57x1YQD2s/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMjA5/YmFmMjQzYTI0MDk3/YmFhODM1NTI1NGRk/OTcwZC5qcGVn.jpg">Kevin Harris</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/f535bc20/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f535bc20/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f535bc20/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f535bc20/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/f535bc20/transcription" type="text/html"/>
    </item>
    <item>
      <title>AI’s Role in Modern Oncology: A New Era of Evidence-Based Cancer Care with Anna Forsythe</title>
      <itunes:episode>31</itunes:episode>
      <podcast:episode>31</podcast:episode>
      <itunes:title>AI’s Role in Modern Oncology: A New Era of Evidence-Based Cancer Care with Anna Forsythe</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">90ed10df-a937-4912-8135-ca1579b388e6</guid>
      <link>https://share.transistor.fm/s/594e04b2</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Oncoscope-AI and Anna Forsythe</p><p>03:04 The Need for Real-Time Oncology Data</p><p>05:59 Transitioning from Manual to Automated Data Processing</p><p>09:11 The Role of AI in Oncology</p><p>12:13 Feedback and Response from Healthcare Professionals</p><p>14:45 Data Sources and Systematic Reviews in Oncology</p><p>18:02 Future Developments and Expanding Services</p><p>21:53 AI in Research: Balancing Trust and Efficiency</p><p>25:52 Business Model and Revenue Streams</p><p>29:44 Personal Journey and Altruism in Business</p><p>32:56 Challenges and Opportunities in Healthcare</p><p>35:34 Leadership and Team Dynamics</p><p>39:29 Visionary Leadership and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Anna Forsythe</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/anna-forsythe-3667143/"><strong> https://www.linkedin.com/in/anna-forsythe-3667143/ </strong></a></li><li>Company / Affiliation:  <strong>Oncoscope-AI </strong><a href="https://oncoscope-ai.com/"><strong>https://oncoscope-ai.com/</strong></a> </li><li>Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 <em>JAMA Pediatrics</em> article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Anna Forsythe is the founder and CEO of Oncoscope AI.</li><li>Oncoscope AI provides real-time oncology treatment data and clinical guidelines.</li><li>Doctors are overwhelmed with the volume of new evidence and guidelines.</li><li>The platform aims to simplify access to oncology data, similar to Expedia for travel.</li><li>AI is used to automate data processing but has limitations in consistency and accuracy.</li><li>The platform is currently free for doctors to encourage adoption.</li><li>Feedback from healthcare professionals is shaping the development of the platform.</li><li>Data is sourced from publicly available databases like PubMed and clinical trials.</li><li>The platform is expanding to include more cancer types and features.</li><li>The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.</li><li>A standardized database enhances research efficiency.</li><li>The business model aims for profit while providing value.</li><li>Personal experiences shape the desire to help others.</li><li>Gathering data from doctors can lead to significant advertising revenue.</li><li>The speaker is focused on launching multiple cancer treatments.</li><li>Trust and transparency are crucial in AI innovation.</li><li>Working with young talent is fulfilling and beneficial.</li><li>Challenges in scaling the business are common in startups.</li><li>Visionary leadership requires prioritization and focus.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Oncoscope-AI and Anna Forsythe</p><p>03:04 The Need for Real-Time Oncology Data</p><p>05:59 Transitioning from Manual to Automated Data Processing</p><p>09:11 The Role of AI in Oncology</p><p>12:13 Feedback and Response from Healthcare Professionals</p><p>14:45 Data Sources and Systematic Reviews in Oncology</p><p>18:02 Future Developments and Expanding Services</p><p>21:53 AI in Research: Balancing Trust and Efficiency</p><p>25:52 Business Model and Revenue Streams</p><p>29:44 Personal Journey and Altruism in Business</p><p>32:56 Challenges and Opportunities in Healthcare</p><p>35:34 Leadership and Team Dynamics</p><p>39:29 Visionary Leadership and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Anna Forsythe</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/anna-forsythe-3667143/"><strong> https://www.linkedin.com/in/anna-forsythe-3667143/ </strong></a></li><li>Company / Affiliation:  <strong>Oncoscope-AI </strong><a href="https://oncoscope-ai.com/"><strong>https://oncoscope-ai.com/</strong></a> </li><li>Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 <em>JAMA Pediatrics</em> article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Anna Forsythe is the founder and CEO of Oncoscope AI.</li><li>Oncoscope AI provides real-time oncology treatment data and clinical guidelines.</li><li>Doctors are overwhelmed with the volume of new evidence and guidelines.</li><li>The platform aims to simplify access to oncology data, similar to Expedia for travel.</li><li>AI is used to automate data processing but has limitations in consistency and accuracy.</li><li>The platform is currently free for doctors to encourage adoption.</li><li>Feedback from healthcare professionals is shaping the development of the platform.</li><li>Data is sourced from publicly available databases like PubMed and clinical trials.</li><li>The platform is expanding to include more cancer types and features.</li><li>The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.</li><li>A standardized database enhances research efficiency.</li><li>The business model aims for profit while providing value.</li><li>Personal experiences shape the desire to help others.</li><li>Gathering data from doctors can lead to significant advertising revenue.</li><li>The speaker is focused on launching multiple cancer treatments.</li><li>Trust and transparency are crucial in AI innovation.</li><li>Working with young talent is fulfilling and beneficial.</li><li>Challenges in scaling the business are common in startups.</li><li>Visionary leadership requires prioritization and focus.</li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 29 Aug 2025 15:53:11 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/594e04b2/9ecc4540.mp3" length="67082708" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Gcw6vrW33XkJrtnAX20EENwvQ7K8j3Lw_5HenlzDQHo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83OWQ4/YzdkYzU4MDUxY2Fk/MmUxZDc1ODRhZWFm/YmU5Ni5qcGc.jpg"/>
      <itunes:duration>2788</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Oncoscope-AI and Anna Forsythe</p><p>03:04 The Need for Real-Time Oncology Data</p><p>05:59 Transitioning from Manual to Automated Data Processing</p><p>09:11 The Role of AI in Oncology</p><p>12:13 Feedback and Response from Healthcare Professionals</p><p>14:45 Data Sources and Systematic Reviews in Oncology</p><p>18:02 Future Developments and Expanding Services</p><p>21:53 AI in Research: Balancing Trust and Efficiency</p><p>25:52 Business Model and Revenue Streams</p><p>29:44 Personal Journey and Altruism in Business</p><p>32:56 Challenges and Opportunities in Healthcare</p><p>35:34 Leadership and Team Dynamics</p><p>39:29 Visionary Leadership and Future Aspirations</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Anna Forsythe</strong></li><li>Guest's Title/Position:<strong> Founder &amp; CEO</strong></li><li>Guest's Linkedin:<a href="https://www.linkedin.com/in/anna-forsythe-3667143/"><strong> https://www.linkedin.com/in/anna-forsythe-3667143/ </strong></a></li><li>Company / Affiliation:  <strong>Oncoscope-AI </strong><a href="https://oncoscope-ai.com/"><strong>https://oncoscope-ai.com/</strong></a> </li><li>Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 <em>JAMA Pediatrics</em> article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Anna Forsythe is the founder and CEO of Oncoscope AI.</li><li>Oncoscope AI provides real-time oncology treatment data and clinical guidelines.</li><li>Doctors are overwhelmed with the volume of new evidence and guidelines.</li><li>The platform aims to simplify access to oncology data, similar to Expedia for travel.</li><li>AI is used to automate data processing but has limitations in consistency and accuracy.</li><li>The platform is currently free for doctors to encourage adoption.</li><li>Feedback from healthcare professionals is shaping the development of the platform.</li><li>Data is sourced from publicly available databases like PubMed and clinical trials.</li><li>The platform is expanding to include more cancer types and features.</li><li>The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.</li><li>A standardized database enhances research efficiency.</li><li>The business model aims for profit while providing value.</li><li>Personal experiences shape the desire to help others.</li><li>Gathering data from doctors can lead to significant advertising revenue.</li><li>The speaker is focused on launching multiple cancer treatments.</li><li>Trust and transparency are crucial in AI innovation.</li><li>Working with young talent is fulfilling and beneficial.</li><li>Challenges in scaling the business are common in startups.</li><li>Visionary leadership requires prioritization and focus.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Oncology, AI, healthcare, data processing, clinical guidelines, cancer treatment, healthcare technology, real-time data, systematic reviews, healthcare professionals, AI, healthcare, business model, cancer treatment, research, leadership, altruism, revenue streams, technology, innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://oncoscope-ai.com/" img="https://img.transistorcdn.com/F47ztnxfU80ZkoKZDzxOu3QFuavTaIjqMJL2D5EoiMc/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zZjEz/YzM3NzU1ZThjYjc1/OWRjZmExNTQxNjA1/YTQ1Mi5qcGVn.jpg">Anna Forsythe</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/594e04b2/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/594e04b2/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/594e04b2/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/594e04b2/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/594e04b2/transcription" type="text/html"/>
    </item>
    <item>
      <title>Credentialing Made Simple: A Nurse’s Vision to Cut Through the Chaos with Sarah Bellenger</title>
      <itunes:episode>30</itunes:episode>
      <podcast:episode>30</podcast:episode>
      <itunes:title>Credentialing Made Simple: A Nurse’s Vision to Cut Through the Chaos with Sarah Bellenger</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9eaff58a-b641-4cf5-b175-66013366ca84</guid>
      <link>https://share.transistor.fm/s/4c01bd36</link>
      <description>
        <![CDATA[<p>In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating <em>Manage You</em>, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for <em>Manage You</em>’s future impact on the industry.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Sarah Bellenger and Manage You</p><p>03:07 The Need for Credentialing Solutions</p><p>05:53 The Development Journey of Manage You</p><p>08:48 Challenges in Healthcare Credentialing</p><p>12:06 The App's Features and User Experience</p><p>14:58 Expanding Manage You's Reach</p><p>18:03 Future Developments and Scalability</p><p>20:58 Entrepreneurial Insights and Challenges</p><p>23:51 The Role of Women in Entrepreneurship</p><p>26:47 Vision for the Future of Credentialing</p><p>30:00 Conclusion and Call to Action</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sarah Bellenger</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sarahrbellenger/"><strong>https://www.linkedin.com/in/sarahrbellenger/</strong></a></li><li>Company / Affiliation: <strong>Manage You App </strong><a href="https://www.manageyouapp.com/"><strong>https://www.manageyouapp.com/</strong></a></li><li>Guest's Bio: <strong>Sarah Bellenger</strong> is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it.<br>Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.</li></ul><p>T<strong>akeaways:</strong></p><ul><li>Sarah Bellenger is a nurse veteran and entrepreneur.</li><li>Manage You addresses the inefficiencies in the credentialing process.</li><li>Credentialing is a $39 billion industry with significant waste.</li><li>The app allows users to store and manage their credentials efficiently.</li><li>Users receive reminders for expiring documents directly on their phones.</li><li>The app is designed to be user-friendly and secure.</li><li>Sarah emphasizes the importance of networking and mentorship in entrepreneurship.</li><li>Women face unique challenges in securing venture capital funding.</li><li>The future of credentialing may involve digital verification and AI.</li><li>Sarah is committed to making healthcare credentialing more efficient.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating <em>Manage You</em>, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for <em>Manage You</em>’s future impact on the industry.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Sarah Bellenger and Manage You</p><p>03:07 The Need for Credentialing Solutions</p><p>05:53 The Development Journey of Manage You</p><p>08:48 Challenges in Healthcare Credentialing</p><p>12:06 The App's Features and User Experience</p><p>14:58 Expanding Manage You's Reach</p><p>18:03 Future Developments and Scalability</p><p>20:58 Entrepreneurial Insights and Challenges</p><p>23:51 The Role of Women in Entrepreneurship</p><p>26:47 Vision for the Future of Credentialing</p><p>30:00 Conclusion and Call to Action</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sarah Bellenger</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sarahrbellenger/"><strong>https://www.linkedin.com/in/sarahrbellenger/</strong></a></li><li>Company / Affiliation: <strong>Manage You App </strong><a href="https://www.manageyouapp.com/"><strong>https://www.manageyouapp.com/</strong></a></li><li>Guest's Bio: <strong>Sarah Bellenger</strong> is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it.<br>Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.</li></ul><p>T<strong>akeaways:</strong></p><ul><li>Sarah Bellenger is a nurse veteran and entrepreneur.</li><li>Manage You addresses the inefficiencies in the credentialing process.</li><li>Credentialing is a $39 billion industry with significant waste.</li><li>The app allows users to store and manage their credentials efficiently.</li><li>Users receive reminders for expiring documents directly on their phones.</li><li>The app is designed to be user-friendly and secure.</li><li>Sarah emphasizes the importance of networking and mentorship in entrepreneurship.</li><li>Women face unique challenges in securing venture capital funding.</li><li>The future of credentialing may involve digital verification and AI.</li><li>Sarah is committed to making healthcare credentialing more efficient.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Wed, 27 Aug 2025 14:16:23 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/4c01bd36/fc3d1e7e.mp3" length="70783830" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/SD9623fVWsgGWxg1wgzbGe22ge83wcBPGc3CvGlowcw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84YTk3/ZjhkODdkNmM1YjEx/ZDk5NGUzMjQwYjNh/Y2ExZS5qcGc.jpg"/>
      <itunes:duration>2944</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating <em>Manage You</em>, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for <em>Manage You</em>’s future impact on the industry.</p><p><strong>Chapters</strong></p><p>00:00 Introduction to Sarah Bellenger and Manage You</p><p>03:07 The Need for Credentialing Solutions</p><p>05:53 The Development Journey of Manage You</p><p>08:48 Challenges in Healthcare Credentialing</p><p>12:06 The App's Features and User Experience</p><p>14:58 Expanding Manage You's Reach</p><p>18:03 Future Developments and Scalability</p><p>20:58 Entrepreneurial Insights and Challenges</p><p>23:51 The Role of Women in Entrepreneurship</p><p>26:47 Vision for the Future of Credentialing</p><p>30:00 Conclusion and Call to Action</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Sarah Bellenger</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/sarahrbellenger/"><strong>https://www.linkedin.com/in/sarahrbellenger/</strong></a></li><li>Company / Affiliation: <strong>Manage You App </strong><a href="https://www.manageyouapp.com/"><strong>https://www.manageyouapp.com/</strong></a></li><li>Guest's Bio: <strong>Sarah Bellenger</strong> is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it.<br>Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.</li></ul><p>T<strong>akeaways:</strong></p><ul><li>Sarah Bellenger is a nurse veteran and entrepreneur.</li><li>Manage You addresses the inefficiencies in the credentialing process.</li><li>Credentialing is a $39 billion industry with significant waste.</li><li>The app allows users to store and manage their credentials efficiently.</li><li>Users receive reminders for expiring documents directly on their phones.</li><li>The app is designed to be user-friendly and secure.</li><li>Sarah emphasizes the importance of networking and mentorship in entrepreneurship.</li><li>Women face unique challenges in securing venture capital funding.</li><li>The future of credentialing may involve digital verification and AI.</li><li>Sarah is committed to making healthcare credentialing more efficient.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>credentialing, healthcare app, Manage You, entrepreneurship, nursing, technology, healthcare innovation, app development, user experience, digital solutions, entrepreneurship, healthcare, innovation, female leadership, funding, Manage You App, app development, credentialing, nursing, technology</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.manageyouapp.com/" img="https://img.transistorcdn.com/rUtBEVXk7ZnF811aLFTVinOqGbhh79RVZ3eSJbdEvGs/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNmZk/OWY3YWZhZjkyMzZj/Yzg5MWY0ZjhlZDll/Yzk0MC5qcGVn.jpg">Sarah Bellenger</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/4c01bd36/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/4c01bd36/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/4c01bd36/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/4c01bd36/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/4c01bd36/transcription" type="text/html"/>
    </item>
    <item>
      <title>Pet Tech in Action: Dog DNA, AI &amp; the Future of Pet Health with Erin Morrow</title>
      <itunes:episode>29</itunes:episode>
      <podcast:episode>29</podcast:episode>
      <itunes:title>Pet Tech in Action: Dog DNA, AI &amp; the Future of Pet Health with Erin Morrow</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7217daf9-722b-4a58-9402-989e63497e4c</guid>
      <link>https://share.transistor.fm/s/d791c38d</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Embark Veterinary and Its Mission<br>03:04 Erin Morrow's Journey and Background<br>05:57 Understanding Dog DNA and Its Impact on Care<br>09:03 The Role of Technology in Pet Care<br>12:00 Future Innovations in Pet Health and AI<br>14:59 Challenges in Product Development and Strategy<br>17:55 The Value of Fractional Leadership<br>20:49 Customer Feedback and Engagement Strategies<br>26:49 Embracing AI in the Workplace<br>30:12 Navigating Marketing Strategies<br>38:41 Innovative Collaborations in Pet Care<br>43:50 Advice for Aspiring Professionals</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Erin Morrow </strong></li><li>Guest's Title/Position:<strong> Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/erin-morrow-68336829/"><strong>https://www.linkedin.com/in/erin-morrow-68336829/</strong></a></li><li>Company / Affiliation: <strong>Embark Veterinary </strong><a href="https://embarkvet.com/"><strong>https://embarkvet.com/</strong></a></li><li>Guest's Bio: <strong>Erin Morrow</strong> is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Embark Veterinary focuses on using genetics to enhance dog health.</li><li>Erin Morrow has a diverse background in product management and animal science.</li><li>Understanding a dog's DNA can significantly impact care decisions.</li><li>The company has tested over 2 million dogs worldwide.</li><li>AI and genomics are key to future pet health innovations.</li><li>Customer feedback is crucial for product development.</li><li>Fractional leadership can provide valuable insights and direction.</li><li>Engaging with customers through social media enhances feedback.</li><li>The importance of transitioning to a product-led organization.</li><li>Continuous improvement in product offerings is essential for growth. </li><li>We're starting to use AI internally and for customer-facing features.</li><li>If you're writing an email, use ChatGPT for assistance.</li><li>You still need to check your work; you are the subject matter expert.</li><li>Finding the right tools is complex; experiment with different options.</li><li>Word of mouth is still our strongest marketing engine.</li><li>We collaborated with Colossus for our commercials.</li><li>Our partnership with Disney was a significant campaign.</li><li>We track brand awareness through customer feedback.</li><li>Collaborations in the pet care space are yielding positive results.</li><li>Follow your passion, but stay open-minded in your career. </li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Embark Veterinary and Its Mission<br>03:04 Erin Morrow's Journey and Background<br>05:57 Understanding Dog DNA and Its Impact on Care<br>09:03 The Role of Technology in Pet Care<br>12:00 Future Innovations in Pet Health and AI<br>14:59 Challenges in Product Development and Strategy<br>17:55 The Value of Fractional Leadership<br>20:49 Customer Feedback and Engagement Strategies<br>26:49 Embracing AI in the Workplace<br>30:12 Navigating Marketing Strategies<br>38:41 Innovative Collaborations in Pet Care<br>43:50 Advice for Aspiring Professionals</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Erin Morrow </strong></li><li>Guest's Title/Position:<strong> Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/erin-morrow-68336829/"><strong>https://www.linkedin.com/in/erin-morrow-68336829/</strong></a></li><li>Company / Affiliation: <strong>Embark Veterinary </strong><a href="https://embarkvet.com/"><strong>https://embarkvet.com/</strong></a></li><li>Guest's Bio: <strong>Erin Morrow</strong> is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Embark Veterinary focuses on using genetics to enhance dog health.</li><li>Erin Morrow has a diverse background in product management and animal science.</li><li>Understanding a dog's DNA can significantly impact care decisions.</li><li>The company has tested over 2 million dogs worldwide.</li><li>AI and genomics are key to future pet health innovations.</li><li>Customer feedback is crucial for product development.</li><li>Fractional leadership can provide valuable insights and direction.</li><li>Engaging with customers through social media enhances feedback.</li><li>The importance of transitioning to a product-led organization.</li><li>Continuous improvement in product offerings is essential for growth. </li><li>We're starting to use AI internally and for customer-facing features.</li><li>If you're writing an email, use ChatGPT for assistance.</li><li>You still need to check your work; you are the subject matter expert.</li><li>Finding the right tools is complex; experiment with different options.</li><li>Word of mouth is still our strongest marketing engine.</li><li>We collaborated with Colossus for our commercials.</li><li>Our partnership with Disney was a significant campaign.</li><li>We track brand awareness through customer feedback.</li><li>Collaborations in the pet care space are yielding positive results.</li><li>Follow your passion, but stay open-minded in your career. </li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 22 Aug 2025 11:00:16 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/d791c38d/7f5172d2.mp3" length="75004002" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/scQ-I-obBsVxURVDYev2cNPw6zSy-kC0Q-IZZAkLbp4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMWVl/YWUxMWI0NjAxMDJl/NDhiN2E4NzJmOTAw/ZDJmNS5qcGc.jpg"/>
      <itunes:duration>3119</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Embark Veterinary and Its Mission<br>03:04 Erin Morrow's Journey and Background<br>05:57 Understanding Dog DNA and Its Impact on Care<br>09:03 The Role of Technology in Pet Care<br>12:00 Future Innovations in Pet Health and AI<br>14:59 Challenges in Product Development and Strategy<br>17:55 The Value of Fractional Leadership<br>20:49 Customer Feedback and Engagement Strategies<br>26:49 Embracing AI in the Workplace<br>30:12 Navigating Marketing Strategies<br>38:41 Innovative Collaborations in Pet Care<br>43:50 Advice for Aspiring Professionals</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Erin Morrow </strong></li><li>Guest's Title/Position:<strong> Director of Product Management</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/erin-morrow-68336829/"><strong>https://www.linkedin.com/in/erin-morrow-68336829/</strong></a></li><li>Company / Affiliation: <strong>Embark Veterinary </strong><a href="https://embarkvet.com/"><strong>https://embarkvet.com/</strong></a></li><li>Guest's Bio: <strong>Erin Morrow</strong> is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Embark Veterinary focuses on using genetics to enhance dog health.</li><li>Erin Morrow has a diverse background in product management and animal science.</li><li>Understanding a dog's DNA can significantly impact care decisions.</li><li>The company has tested over 2 million dogs worldwide.</li><li>AI and genomics are key to future pet health innovations.</li><li>Customer feedback is crucial for product development.</li><li>Fractional leadership can provide valuable insights and direction.</li><li>Engaging with customers through social media enhances feedback.</li><li>The importance of transitioning to a product-led organization.</li><li>Continuous improvement in product offerings is essential for growth. </li><li>We're starting to use AI internally and for customer-facing features.</li><li>If you're writing an email, use ChatGPT for assistance.</li><li>You still need to check your work; you are the subject matter expert.</li><li>Finding the right tools is complex; experiment with different options.</li><li>Word of mouth is still our strongest marketing engine.</li><li>We collaborated with Colossus for our commercials.</li><li>Our partnership with Disney was a significant campaign.</li><li>We track brand awareness through customer feedback.</li><li>Collaborations in the pet care space are yielding positive results.</li><li>Follow your passion, but stay open-minded in your career. </li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Embark Veterinary, dog DNA, pet care, AI, genomics, Erin Morrow, product management, pet health, customer feedback, technology, AI, marketing, pet care, startups, collaboration, innovation, product management, customer experience, technology, business strategy</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://embarkvet.com/" img="https://img.transistorcdn.com/wfqgWngV33ULoeuOmPklydaEaSd0I8jDeyjVHfNdScA/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zMjRk/NjQ2NjM0MjcxZTA0/OGU1NjZkZWI2Yzgz/NDE1Ny5qcGVn.jpg">Erin Morrow</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/d791c38d/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d791c38d/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d791c38d/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d791c38d/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/d791c38d/transcription" type="text/html"/>
    </item>
    <item>
      <title>AI-Powered Clinical Trials: Building Health Equity through Technology with Dr. Harsha Rajasimha</title>
      <itunes:episode>28</itunes:episode>
      <podcast:episode>28</podcast:episode>
      <itunes:title>AI-Powered Clinical Trials: Building Health Equity through Technology with Dr. Harsha Rajasimha</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d7e73a86-25ed-43d1-896c-2de01c9dc106</guid>
      <link>https://share.transistor.fm/s/f6755147</link>
      <description>
        <![CDATA[<p>In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema</p><p>02:50 The Clinical Trial Process: Challenges and Innovations</p><p>05:51 AI in Clinical Trials: Enhancing Efficiency and Security</p><p>08:59 The Role of AI Agents in Clinical Research</p><p>11:55 Addressing Inequities in Clinical Trials</p><p>15:02 Philanthropy and Patient Advocacy in Rare Diseases</p><p>18:08 The Journey of an Entrepreneur: Insights and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Harsha K. Rajasimha</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/harsharajasimha/"><strong>https://www.linkedin.com/in/harsharajasimha/</strong></a></li><li>Company / Affiliation: <strong>Jeeva Clinical Trials </strong><a href="https://jeevatrials.com/"><strong>https://jeevatrials.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Harsha K. Rajasimha</strong> is a scientist, entrepreneur, and patient advocate, and the Founder &amp; CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.</li><li>Clinical trials typically take 8-10 years to complete.</li><li>AI can significantly reduce the time and cost of clinical trials.</li><li>The current clinical trial infrastructure is complex and fragmented.</li><li>Jeeva aims to unify the clinical trial process with a single platform.</li><li>AI agents will automate repetitive tasks in clinical trials.</li><li>Inclusivity in clinical trials is crucial for diverse patient representation.</li><li>Philanthropy plays a key role in Dr. Rajasimha's mission.</li><li>The platform supports over 100 languages for global accessibility.</li><li>Community support is essential for entrepreneurial success.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema</p><p>02:50 The Clinical Trial Process: Challenges and Innovations</p><p>05:51 AI in Clinical Trials: Enhancing Efficiency and Security</p><p>08:59 The Role of AI Agents in Clinical Research</p><p>11:55 Addressing Inequities in Clinical Trials</p><p>15:02 Philanthropy and Patient Advocacy in Rare Diseases</p><p>18:08 The Journey of an Entrepreneur: Insights and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Harsha K. Rajasimha</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/harsharajasimha/"><strong>https://www.linkedin.com/in/harsharajasimha/</strong></a></li><li>Company / Affiliation: <strong>Jeeva Clinical Trials </strong><a href="https://jeevatrials.com/"><strong>https://jeevatrials.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Harsha K. Rajasimha</strong> is a scientist, entrepreneur, and patient advocate, and the Founder &amp; CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.</li><li>Clinical trials typically take 8-10 years to complete.</li><li>AI can significantly reduce the time and cost of clinical trials.</li><li>The current clinical trial infrastructure is complex and fragmented.</li><li>Jeeva aims to unify the clinical trial process with a single platform.</li><li>AI agents will automate repetitive tasks in clinical trials.</li><li>Inclusivity in clinical trials is crucial for diverse patient representation.</li><li>Philanthropy plays a key role in Dr. Rajasimha's mission.</li><li>The platform supports over 100 languages for global accessibility.</li><li>Community support is essential for entrepreneurial success.</li></ul>]]>
      </content:encoded>
      <pubDate>Mon, 18 Aug 2025 16:48:47 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/f6755147/0d130f1d.mp3" length="71925077" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/PNHkoyGnBpUqM9yDTRzyUdb2lgGePq6Q7AlWAbwkYuI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYjEy/MTQzZDFjYzNiMzc5/MDkxMDVkYWMxMDcz/ODJkZi5qcGc.jpg"/>
      <itunes:duration>2991</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.</p><p><strong>Chapters:</strong></p><p>00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema</p><p>02:50 The Clinical Trial Process: Challenges and Innovations</p><p>05:51 AI in Clinical Trials: Enhancing Efficiency and Security</p><p>08:59 The Role of AI Agents in Clinical Research</p><p>11:55 Addressing Inequities in Clinical Trials</p><p>15:02 Philanthropy and Patient Advocacy in Rare Diseases</p><p>18:08 The Journey of an Entrepreneur: Insights and Advice</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Harsha K. Rajasimha</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/harsharajasimha/"><strong>https://www.linkedin.com/in/harsharajasimha/</strong></a></li><li>Company / Affiliation: <strong>Jeeva Clinical Trials </strong><a href="https://jeevatrials.com/"><strong>https://jeevatrials.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Harsha K. Rajasimha</strong> is a scientist, entrepreneur, and patient advocate, and the Founder &amp; CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.</li><li>Clinical trials typically take 8-10 years to complete.</li><li>AI can significantly reduce the time and cost of clinical trials.</li><li>The current clinical trial infrastructure is complex and fragmented.</li><li>Jeeva aims to unify the clinical trial process with a single platform.</li><li>AI agents will automate repetitive tasks in clinical trials.</li><li>Inclusivity in clinical trials is crucial for diverse patient representation.</li><li>Philanthropy plays a key role in Dr. Rajasimha's mission.</li><li>The platform supports over 100 languages for global accessibility.</li><li>Community support is essential for entrepreneurial success.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>clinical trials, AI in healthcare, biotech, patient advocacy, drug development, healthcare technology, rare diseases, healthcare innovation, Jeeva Clinical Trials, health tech</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://jeevatrials.com/" img="https://img.transistorcdn.com/38SokCmmAsXLFNczDSeFHWAo7dL-2QXuA22vN_ReTiM/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85MGFj/YWI1MDUxODA3YzQ4/ZGJlYjYyMWQ4NzY1/NjgwZC5qcGVn.jpg">Dr. Harsha K. Rajasimha</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/f6755147/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f6755147/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f6755147/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/f6755147/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/f6755147/transcription" type="text/html"/>
    </item>
    <item>
      <title>Breath Analysis Technology: Revolutionizing Early Cancer Detection with Bill Wittmeyer </title>
      <itunes:episode>27</itunes:episode>
      <podcast:episode>27</podcast:episode>
      <itunes:title>Breath Analysis Technology: Revolutionizing Early Cancer Detection with Bill Wittmeyer </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d81387a8-69a9-4723-b0a8-f56827088934</guid>
      <link>https://share.transistor.fm/s/8442c623</link>
      <description>
        <![CDATA[<p>In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Bill Wittmeyer and Maggie's Breath<br>03:04 The Journey to Breath Analysis Technology<br>05:55 The Importance of Early Detection in Breast Cancer<br>08:56 Innovative Screening Methods and Their Implications<br>11:49 The Role of Metabolic Compounds in Disease Detection<br>15:05 Challenges in Implementing New Screening Technologies<br>18:01 Mobile Screening Solutions for Breast Cancer<br>20:59 Future Directions and Global Health Implications<br>26:55 Clinical Trials and Market Opportunities<br>30:02 Innovative Screening Technologies<br>34:04 Navigating Regulatory Challenges<br>36:10 The Journey of a Startup Founder<br>41:45 Personal Loss and Legacy<br>49:30 Fundraising and Community Engagement</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Bill Wittmeyer</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bill-wittmeyer-b0628a/"><strong>https://www.linkedin.com/in/bill-wittmeyer-b0628a/</strong></a></li><li>Company / Affiliation: <strong>Maggie's Breath </strong><a href="https://www.maggiesbreath.com/"><strong>https://www.maggiesbreath.com/ </strong></a></li><li>Guest's Bio: <strong>Bill Wittmeye</strong>r is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.</li></ul><p><strong>Takeaways:</strong><br>-Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection.<br>-Maggie's Breath aims to provide a non-invasive screening tool for breast cancer.<br>-The technology can analyze breath samples in just one minute.<br>-Breast cancer is increasingly affecting younger women, necessitating early detection methods.<br>-Current mammogram practices may not be effective for women with dense breast tissue.<br>-Breath analysis could complement existing mammogram technologies.<br>-The goal is to provide diagnostically actionable information at the point of care.<br>-Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer.<br>-The company is seeking funding and partnerships to conduct clinical trials in Mexico.<br>-Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. <br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Bill Wittmeyer and Maggie's Breath<br>03:04 The Journey to Breath Analysis Technology<br>05:55 The Importance of Early Detection in Breast Cancer<br>08:56 Innovative Screening Methods and Their Implications<br>11:49 The Role of Metabolic Compounds in Disease Detection<br>15:05 Challenges in Implementing New Screening Technologies<br>18:01 Mobile Screening Solutions for Breast Cancer<br>20:59 Future Directions and Global Health Implications<br>26:55 Clinical Trials and Market Opportunities<br>30:02 Innovative Screening Technologies<br>34:04 Navigating Regulatory Challenges<br>36:10 The Journey of a Startup Founder<br>41:45 Personal Loss and Legacy<br>49:30 Fundraising and Community Engagement</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Bill Wittmeyer</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bill-wittmeyer-b0628a/"><strong>https://www.linkedin.com/in/bill-wittmeyer-b0628a/</strong></a></li><li>Company / Affiliation: <strong>Maggie's Breath </strong><a href="https://www.maggiesbreath.com/"><strong>https://www.maggiesbreath.com/ </strong></a></li><li>Guest's Bio: <strong>Bill Wittmeye</strong>r is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.</li></ul><p><strong>Takeaways:</strong><br>-Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection.<br>-Maggie's Breath aims to provide a non-invasive screening tool for breast cancer.<br>-The technology can analyze breath samples in just one minute.<br>-Breast cancer is increasingly affecting younger women, necessitating early detection methods.<br>-Current mammogram practices may not be effective for women with dense breast tissue.<br>-Breath analysis could complement existing mammogram technologies.<br>-The goal is to provide diagnostically actionable information at the point of care.<br>-Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer.<br>-The company is seeking funding and partnerships to conduct clinical trials in Mexico.<br>-Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. <br></p>]]>
      </content:encoded>
      <pubDate>Fri, 15 Aug 2025 10:02:04 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/8442c623/2b53f9b7.mp3" length="75849129" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/clB70tBQnG8b4-6QruHeIWNwitiHY4lrsKh7l7ns5ZU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMDRl/Nzg3YzUzYTQwYTg0/OWU5NmQwMzY0OTYz/Y2U4Mi5qcGc.jpg"/>
      <itunes:duration>3155</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Bill Wittmeyer and Maggie's Breath<br>03:04 The Journey to Breath Analysis Technology<br>05:55 The Importance of Early Detection in Breast Cancer<br>08:56 Innovative Screening Methods and Their Implications<br>11:49 The Role of Metabolic Compounds in Disease Detection<br>15:05 Challenges in Implementing New Screening Technologies<br>18:01 Mobile Screening Solutions for Breast Cancer<br>20:59 Future Directions and Global Health Implications<br>26:55 Clinical Trials and Market Opportunities<br>30:02 Innovative Screening Technologies<br>34:04 Navigating Regulatory Challenges<br>36:10 The Journey of a Startup Founder<br>41:45 Personal Loss and Legacy<br>49:30 Fundraising and Community Engagement</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Bill Wittmeyer</strong></li><li>Guest's Title/Position:<strong> Founder &amp; Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bill-wittmeyer-b0628a/"><strong>https://www.linkedin.com/in/bill-wittmeyer-b0628a/</strong></a></li><li>Company / Affiliation: <strong>Maggie's Breath </strong><a href="https://www.maggiesbreath.com/"><strong>https://www.maggiesbreath.com/ </strong></a></li><li>Guest's Bio: <strong>Bill Wittmeye</strong>r is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.</li></ul><p><strong>Takeaways:</strong><br>-Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection.<br>-Maggie's Breath aims to provide a non-invasive screening tool for breast cancer.<br>-The technology can analyze breath samples in just one minute.<br>-Breast cancer is increasingly affecting younger women, necessitating early detection methods.<br>-Current mammogram practices may not be effective for women with dense breast tissue.<br>-Breath analysis could complement existing mammogram technologies.<br>-The goal is to provide diagnostically actionable information at the point of care.<br>-Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer.<br>-The company is seeking funding and partnerships to conduct clinical trials in Mexico.<br>-Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. <br></p>]]>
      </itunes:summary>
      <itunes:keywords>breath analysis, breast cancer, early detection, healthcare innovation, Maggie's Breath, non-invasive screening, cancer diagnosis, technology in healthcare, Bill Whitmire, Electronic Sensors, Inc.</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.maggiesbreath.com/" img="https://img.transistorcdn.com/hIfGukHDLWe4-Thib4kbdUULGoXVTGKHbfcK6eaDdnU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81Njhj/MjRjZGE2NmM4OGU3/ZWZjNmM1MDNkNjIx/ZDY4YS5qcGVn.jpg">Bill Wittmeyer</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/8442c623/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8442c623/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8442c623/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8442c623/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/8442c623/transcription" type="text/html"/>
    </item>
    <item>
      <title>Revolutionizing Orthopedic Care: Cutting-Edge Advances in Joint Treatment with Steve Schutzer </title>
      <itunes:episode>26</itunes:episode>
      <podcast:episode>26</podcast:episode>
      <itunes:title>Revolutionizing Orthopedic Care: Cutting-Edge Advances in Joint Treatment with Steve Schutzer </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f0434103-1cae-445f-a547-ad0859a046f2</guid>
      <link>https://share.transistor.fm/s/1f4d8fd4</link>
      <description>
        <![CDATA[<p>In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.</p><p><strong><br>Chapters:</strong></p><p>00:00 Introduction to Dr. Steve Schutzer and Upswing Health</p><p>02:49 Dr. Schutzer's Journey in Medicine</p><p>06:02 Mentorship and the Impact of Innovation in Orthopedics</p><p>08:51 Creating Centers of Excellence in Joint Replacement</p><p>11:55 Challenges in Healthcare and the Role of Legislation</p><p>14:50 Direct Pay and Direct Primary Care Innovations</p><p>18:01 Functional Medicine and Preventative Healthcare</p><p>21:06 The Future of Healthcare and Entrepreneurial Medicine</p><p>31:39 The Shift to Entrepreneurship</p><p>32:25 Building Centers of Excellence</p><p>34:48 Identifying the Ouch Moment</p><p>36:12 Innovative Solutions in Orthopedics</p><p>39:11 The Evolution of Orthopedic Management</p><p>41:28 The Vision for Upswing</p><p>44:20 Navigating Healthcare Challenges</p><p>47:30 Interoperability in Healthcare</p><p>51:27 The Future of Upswing</p><p>55:45 The Role of Employers in Healthcare</p><p>58:42 Marketing Strategies for Upswing</p><p><br></p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Steve Schutzer</strong> </li><li>Guest's Title/Position: <strong>Co-Founder and Chief Medical Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/steve-schutzer-md-81616125/"><strong>https://www.linkedin.com/in/steve-schutzer-md-81616125/</strong></a></li><li>Company / Affiliation: <strong>Upswing Health </strong><a href="https://upswinghealth.com/"><strong>https://upswinghealth.com/</strong></a></li><li>Guest's Bio: <strong>Steve Schutzer</strong> is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Schutzer's journey reflects the unpredictability of career paths.</li><li>The importance of mentorship in shaping a physician's career.</li><li>Building centers of excellence can significantly improve patient care.</li><li>Healthcare challenges are often rooted in financial disincentives.</li><li>Direct primary care offers a promising alternative to traditional models.</li><li>Functional medicine focuses on prevention and holistic care.</li><li>Upswing Health aims to provide quick access to orthopedic care.</li><li>Interoperability in healthcare is crucial for better patient outcomes.</li><li>The rise of early onset cancers highlights the need for preventive care.</li><li>Entrepreneurship in healthcare requires resilience and adaptability.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.</p><p><strong><br>Chapters:</strong></p><p>00:00 Introduction to Dr. Steve Schutzer and Upswing Health</p><p>02:49 Dr. Schutzer's Journey in Medicine</p><p>06:02 Mentorship and the Impact of Innovation in Orthopedics</p><p>08:51 Creating Centers of Excellence in Joint Replacement</p><p>11:55 Challenges in Healthcare and the Role of Legislation</p><p>14:50 Direct Pay and Direct Primary Care Innovations</p><p>18:01 Functional Medicine and Preventative Healthcare</p><p>21:06 The Future of Healthcare and Entrepreneurial Medicine</p><p>31:39 The Shift to Entrepreneurship</p><p>32:25 Building Centers of Excellence</p><p>34:48 Identifying the Ouch Moment</p><p>36:12 Innovative Solutions in Orthopedics</p><p>39:11 The Evolution of Orthopedic Management</p><p>41:28 The Vision for Upswing</p><p>44:20 Navigating Healthcare Challenges</p><p>47:30 Interoperability in Healthcare</p><p>51:27 The Future of Upswing</p><p>55:45 The Role of Employers in Healthcare</p><p>58:42 Marketing Strategies for Upswing</p><p><br></p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Steve Schutzer</strong> </li><li>Guest's Title/Position: <strong>Co-Founder and Chief Medical Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/steve-schutzer-md-81616125/"><strong>https://www.linkedin.com/in/steve-schutzer-md-81616125/</strong></a></li><li>Company / Affiliation: <strong>Upswing Health </strong><a href="https://upswinghealth.com/"><strong>https://upswinghealth.com/</strong></a></li><li>Guest's Bio: <strong>Steve Schutzer</strong> is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Schutzer's journey reflects the unpredictability of career paths.</li><li>The importance of mentorship in shaping a physician's career.</li><li>Building centers of excellence can significantly improve patient care.</li><li>Healthcare challenges are often rooted in financial disincentives.</li><li>Direct primary care offers a promising alternative to traditional models.</li><li>Functional medicine focuses on prevention and holistic care.</li><li>Upswing Health aims to provide quick access to orthopedic care.</li><li>Interoperability in healthcare is crucial for better patient outcomes.</li><li>The rise of early onset cancers highlights the need for preventive care.</li><li>Entrepreneurship in healthcare requires resilience and adaptability.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 13 Aug 2025 13:54:40 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/1f4d8fd4/439fd4d3.mp3" length="88755134" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/oh67zF9kPodUJwzZJwtO6fMPMcMG-n5tHlNi4UOYX50/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYTA1/ZGFjYzgxZmY2ZDY4/ZjIyMzQ3NGQ5ODRm/NzNmYi5qcGc.jpg"/>
      <itunes:duration>3691</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.</p><p><strong><br>Chapters:</strong></p><p>00:00 Introduction to Dr. Steve Schutzer and Upswing Health</p><p>02:49 Dr. Schutzer's Journey in Medicine</p><p>06:02 Mentorship and the Impact of Innovation in Orthopedics</p><p>08:51 Creating Centers of Excellence in Joint Replacement</p><p>11:55 Challenges in Healthcare and the Role of Legislation</p><p>14:50 Direct Pay and Direct Primary Care Innovations</p><p>18:01 Functional Medicine and Preventative Healthcare</p><p>21:06 The Future of Healthcare and Entrepreneurial Medicine</p><p>31:39 The Shift to Entrepreneurship</p><p>32:25 Building Centers of Excellence</p><p>34:48 Identifying the Ouch Moment</p><p>36:12 Innovative Solutions in Orthopedics</p><p>39:11 The Evolution of Orthopedic Management</p><p>41:28 The Vision for Upswing</p><p>44:20 Navigating Healthcare Challenges</p><p>47:30 Interoperability in Healthcare</p><p>51:27 The Future of Upswing</p><p>55:45 The Role of Employers in Healthcare</p><p>58:42 Marketing Strategies for Upswing</p><p><br></p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Steve Schutzer</strong> </li><li>Guest's Title/Position: <strong>Co-Founder and Chief Medical Officer </strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/steve-schutzer-md-81616125/"><strong>https://www.linkedin.com/in/steve-schutzer-md-81616125/</strong></a></li><li>Company / Affiliation: <strong>Upswing Health </strong><a href="https://upswinghealth.com/"><strong>https://upswinghealth.com/</strong></a></li><li>Guest's Bio: <strong>Steve Schutzer</strong> is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.</li></ul><p><strong>Takeaways:</strong></p><ul><li>Dr. Schutzer's journey reflects the unpredictability of career paths.</li><li>The importance of mentorship in shaping a physician's career.</li><li>Building centers of excellence can significantly improve patient care.</li><li>Healthcare challenges are often rooted in financial disincentives.</li><li>Direct primary care offers a promising alternative to traditional models.</li><li>Functional medicine focuses on prevention and holistic care.</li><li>Upswing Health aims to provide quick access to orthopedic care.</li><li>Interoperability in healthcare is crucial for better patient outcomes.</li><li>The rise of early onset cancers highlights the need for preventive care.</li><li>Entrepreneurship in healthcare requires resilience and adaptability.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>healthcare, orthopedic care, patient experience, entrepreneurship, direct primary care, functional medicine, upswing health, healthcare innovation, centers of excellence, healthcare challenges</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://upswinghealth.com/" img="https://img.transistorcdn.com/jNF2ARX_eZ_TULPkp2ucENSuJmSTSQ3EnwTKyHyuwe8/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iYzQz/ZjEwMDI0MGY3YjYy/NDljNGRmZGI0NDY2/YzMxNS5qcGVn.jpg">Steve Schutzer </podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/1f4d8fd4/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/1f4d8fd4/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/1f4d8fd4/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/1f4d8fd4/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/1f4d8fd4/transcription" type="text/html"/>
    </item>
    <item>
      <title>Bridging the Research Gap: Genetically Modified Pigs in Cancer Trials with Jessicca Rege</title>
      <itunes:episode>25</itunes:episode>
      <podcast:episode>25</podcast:episode>
      <itunes:title>Bridging the Research Gap: Genetically Modified Pigs in Cancer Trials with Jessicca Rege</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9bba2108-f809-4cfa-88ce-9cbbc1017890</guid>
      <link>https://share.transistor.fm/s/925e5e6e</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.</p><p><strong>Chapters</strong>:</p><p>00:00 Introduction to Jessicca Rege and Sus Clinicals</p><p>07:30 The Oncopig Model: Revolutionizing Cancer Research</p><p>18:04 The Journey of a Mutant Pig Farmer</p><p>24:51 AI in Cancer Research and Future Directions</p><p>27:14 Introduction to OncoScope AI and Leadership Roles</p><p>28:36 Disruptive Leadership and Questioning the Status Quo</p><p>30:45 Navigating Imposter Syndrome as a CEO</p><p>32:42 The Challenges of Being a Female Leader</p><p>35:41 Cultivating Future Female Leaders</p><p>39:03 Steering Growth at Sus Clinicals</p><p>41:33 Innovative Approaches in Large Animal Research</p><p>45:34 Future Outlook and Goals for Sus Clinicals</p><p>49:25 Advice for Aspiring Leaders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jessicca Rege</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jessiccarege/"><strong>https://www.linkedin.com/in/jessiccarege/</strong></a></li><li>Company / Affiliation: <strong>Sus Clinicals </strong><a href="https://susclinicals.com/"><strong>https://susclinicals.com/</strong></a></li><li>Guest's Bio: J<strong>essicca Rege </strong>is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&amp;D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Jessicca Rege is passionate about transformative research in cancer.</li><li>Sus Clinicals uses genetically modified pigs to advance cancer research.</li><li>The Oncopig model allows for testing efficacy, safety, and metabolic effects.</li><li>Cancer patients are often more knowledgeable about their conditions than expected.</li><li>Jessica emphasizes the importance of empathy in patient care.</li><li>The Oncopig model can replicate human cancers on demand.</li><li>Precision medicine is becoming the standard in oncology.</li><li>AI is being utilized in cancer research for systematic literature reviews.</li><li>Jessica's journey reflects a commitment to improving patient outcomes.</li><li>The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.</li><li>Imposter syndrome is always going to be with us.</li><li>We want to continue to build models that enable researchers.</li><li>We have a hundred percent success rate in being able to induce tumors.</li><li>We believe the uptake is coming in.</li><li>We could sell each of our different models to a different CRO.</li><li>We hope to become a profitable company by 2027.</li><li>You get more nos than you get yeses.</li><li>I love the impact that I'm making on the teams.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.</p><p><strong>Chapters</strong>:</p><p>00:00 Introduction to Jessicca Rege and Sus Clinicals</p><p>07:30 The Oncopig Model: Revolutionizing Cancer Research</p><p>18:04 The Journey of a Mutant Pig Farmer</p><p>24:51 AI in Cancer Research and Future Directions</p><p>27:14 Introduction to OncoScope AI and Leadership Roles</p><p>28:36 Disruptive Leadership and Questioning the Status Quo</p><p>30:45 Navigating Imposter Syndrome as a CEO</p><p>32:42 The Challenges of Being a Female Leader</p><p>35:41 Cultivating Future Female Leaders</p><p>39:03 Steering Growth at Sus Clinicals</p><p>41:33 Innovative Approaches in Large Animal Research</p><p>45:34 Future Outlook and Goals for Sus Clinicals</p><p>49:25 Advice for Aspiring Leaders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jessicca Rege</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jessiccarege/"><strong>https://www.linkedin.com/in/jessiccarege/</strong></a></li><li>Company / Affiliation: <strong>Sus Clinicals </strong><a href="https://susclinicals.com/"><strong>https://susclinicals.com/</strong></a></li><li>Guest's Bio: J<strong>essicca Rege </strong>is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&amp;D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Jessicca Rege is passionate about transformative research in cancer.</li><li>Sus Clinicals uses genetically modified pigs to advance cancer research.</li><li>The Oncopig model allows for testing efficacy, safety, and metabolic effects.</li><li>Cancer patients are often more knowledgeable about their conditions than expected.</li><li>Jessica emphasizes the importance of empathy in patient care.</li><li>The Oncopig model can replicate human cancers on demand.</li><li>Precision medicine is becoming the standard in oncology.</li><li>AI is being utilized in cancer research for systematic literature reviews.</li><li>Jessica's journey reflects a commitment to improving patient outcomes.</li><li>The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.</li><li>Imposter syndrome is always going to be with us.</li><li>We want to continue to build models that enable researchers.</li><li>We have a hundred percent success rate in being able to induce tumors.</li><li>We believe the uptake is coming in.</li><li>We could sell each of our different models to a different CRO.</li><li>We hope to become a profitable company by 2027.</li><li>You get more nos than you get yeses.</li><li>I love the impact that I'm making on the teams.</li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 08 Aug 2025 13:06:09 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/925e5e6e/6f2416aa.mp3" length="77743096" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/izDg27Af4DERnddqApUwq6D-uhz6Bc7RX_0kAlzbojA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNDk0/ZjI2ZWE5ZTE4YzVi/MmQyNjFmOTkxODE5/MGNmMS5qcGc.jpg"/>
      <itunes:duration>3233</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.</p><p><strong>Chapters</strong>:</p><p>00:00 Introduction to Jessicca Rege and Sus Clinicals</p><p>07:30 The Oncopig Model: Revolutionizing Cancer Research</p><p>18:04 The Journey of a Mutant Pig Farmer</p><p>24:51 AI in Cancer Research and Future Directions</p><p>27:14 Introduction to OncoScope AI and Leadership Roles</p><p>28:36 Disruptive Leadership and Questioning the Status Quo</p><p>30:45 Navigating Imposter Syndrome as a CEO</p><p>32:42 The Challenges of Being a Female Leader</p><p>35:41 Cultivating Future Female Leaders</p><p>39:03 Steering Growth at Sus Clinicals</p><p>41:33 Innovative Approaches in Large Animal Research</p><p>45:34 Future Outlook and Goals for Sus Clinicals</p><p>49:25 Advice for Aspiring Leaders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Jessicca Rege</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/jessiccarege/"><strong>https://www.linkedin.com/in/jessiccarege/</strong></a></li><li>Company / Affiliation: <strong>Sus Clinicals </strong><a href="https://susclinicals.com/"><strong>https://susclinicals.com/</strong></a></li><li>Guest's Bio: J<strong>essicca Rege </strong>is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&amp;D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Jessicca Rege is passionate about transformative research in cancer.</li><li>Sus Clinicals uses genetically modified pigs to advance cancer research.</li><li>The Oncopig model allows for testing efficacy, safety, and metabolic effects.</li><li>Cancer patients are often more knowledgeable about their conditions than expected.</li><li>Jessica emphasizes the importance of empathy in patient care.</li><li>The Oncopig model can replicate human cancers on demand.</li><li>Precision medicine is becoming the standard in oncology.</li><li>AI is being utilized in cancer research for systematic literature reviews.</li><li>Jessica's journey reflects a commitment to improving patient outcomes.</li><li>The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.</li><li>Imposter syndrome is always going to be with us.</li><li>We want to continue to build models that enable researchers.</li><li>We have a hundred percent success rate in being able to induce tumors.</li><li>We believe the uptake is coming in.</li><li>We could sell each of our different models to a different CRO.</li><li>We hope to become a profitable company by 2027.</li><li>You get more nos than you get yeses.</li><li>I love the impact that I'm making on the teams.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>cancer research, Oncopig model, Dr. Jessicca Regge, Seuss Clinicals, precision medicine, AI in healthcare, transformative research, oncology, genetically modified pigs, patient care, OncoScope AI, disruptive leadership, imposter syndrome, female leaders, Sue's Clinicals, large animal research, cancer research, mentorship, growth strategies, biotech</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://susclinicals.com/" img="https://img.transistorcdn.com/qO_0BaFtGK2hJyxzTshe4b_-hNYmvi4FnNDMT6BuriA/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NWY3/YjEzNGIwMzI0ODlm/YWQ2NTJiODBjN2Vm/NGUwZC5qcGVn.jpg">Jessicca Rege</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/925e5e6e/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/925e5e6e/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/925e5e6e/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/925e5e6e/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/925e5e6e/transcription" type="text/html"/>
    </item>
    <item>
      <title>The Hidden Costs of Healthcare: Resolving America's Silent Crisis of Medical Debt with Braden Pan</title>
      <itunes:episode>24</itunes:episode>
      <podcast:episode>24</podcast:episode>
      <itunes:title>The Hidden Costs of Healthcare: Resolving America's Silent Crisis of Medical Debt with Braden Pan</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">da828e91-df29-4057-bab4-9dd639cc2740</guid>
      <link>https://share.transistor.fm/s/a65b9fae</link>
      <description>
        <![CDATA[<p>In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Resolve and Medical Debt<br>03:11 Braden's Personal Journey and Founding Resolve<br>06:11 Navigating the Complexities of Medical Billing<br>09:05 The Role of AI in Medical Billing Solutions<br>12:05 Understanding Hospital Billing Practices<br>14:47 The Impact of Medical Debt on Patients<br>17:58 Marketing Strategies and Patient Success Stories<br>20:53 Future Directions for Resolve<br>22:37 Navigating Financial Aid in Healthcare<br>25:22 The Role of a Founder and CEO<br>30:40 Shifting Business Strategies and Messaging<br>32:14 Future Aspirations and Goals<br>35:25 Leadership Evolution and Team Dynamics<br>39:34 Advice for Aspiring Founders and Co-founders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Braden Pan</strong></li><li>Guest's Title/Position: <strong>CEO and Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bradenpan/"><strong>https://www.linkedin.com/in/bradenpan/</strong></a></li><li>Company / Affiliation: <strong>Resolve </strong><a href="https://www.resolvemedicalbills.com/"><strong>https://www.resolvemedicalbills.com/</strong></a></li><li>Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.</li></ul><p><strong>Takeaways</strong>:</p><ul><li>Medical debt is a massive issue affecting many Americans.</li><li>Resolve has saved patients over $55 million on medical bills.</li><li>Braden's personal experience with medical debt inspired him to start Resolve.</li><li>The healthcare system is complex and often designed to confuse patients.</li><li>AI is being integrated into Resolve's processes to improve efficiency.</li><li>Hospitals often prefer working with Resolve to lower their collection costs.</li><li>Financial aid programs exist but are underutilized by patients.</li><li>Braden emphasizes the importance of having a co-founder.</li><li>Leadership evolves over time, especially in a startup environment.</li><li>The future of Resolve includes expanding services to address all types of debt.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Resolve and Medical Debt<br>03:11 Braden's Personal Journey and Founding Resolve<br>06:11 Navigating the Complexities of Medical Billing<br>09:05 The Role of AI in Medical Billing Solutions<br>12:05 Understanding Hospital Billing Practices<br>14:47 The Impact of Medical Debt on Patients<br>17:58 Marketing Strategies and Patient Success Stories<br>20:53 Future Directions for Resolve<br>22:37 Navigating Financial Aid in Healthcare<br>25:22 The Role of a Founder and CEO<br>30:40 Shifting Business Strategies and Messaging<br>32:14 Future Aspirations and Goals<br>35:25 Leadership Evolution and Team Dynamics<br>39:34 Advice for Aspiring Founders and Co-founders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Braden Pan</strong></li><li>Guest's Title/Position: <strong>CEO and Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bradenpan/"><strong>https://www.linkedin.com/in/bradenpan/</strong></a></li><li>Company / Affiliation: <strong>Resolve </strong><a href="https://www.resolvemedicalbills.com/"><strong>https://www.resolvemedicalbills.com/</strong></a></li><li>Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.</li></ul><p><strong>Takeaways</strong>:</p><ul><li>Medical debt is a massive issue affecting many Americans.</li><li>Resolve has saved patients over $55 million on medical bills.</li><li>Braden's personal experience with medical debt inspired him to start Resolve.</li><li>The healthcare system is complex and often designed to confuse patients.</li><li>AI is being integrated into Resolve's processes to improve efficiency.</li><li>Hospitals often prefer working with Resolve to lower their collection costs.</li><li>Financial aid programs exist but are underutilized by patients.</li><li>Braden emphasizes the importance of having a co-founder.</li><li>Leadership evolves over time, especially in a startup environment.</li><li>The future of Resolve includes expanding services to address all types of debt.</li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 01 Aug 2025 09:01:31 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/a65b9fae/079230e1.mp3" length="65246308" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/U1_7TFiVk9BvPfQgWQTq513EdlVJQxe3gLAZLzyzZww/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81YTFk/ODAwZmFhNmJlNWI2/NmU5NGNhNmZiZTlj/MTllYi5qcGc.jpg"/>
      <itunes:duration>2714</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.</p><p><strong>Chapters</strong>:<br>00:00 Introduction to Resolve and Medical Debt<br>03:11 Braden's Personal Journey and Founding Resolve<br>06:11 Navigating the Complexities of Medical Billing<br>09:05 The Role of AI in Medical Billing Solutions<br>12:05 Understanding Hospital Billing Practices<br>14:47 The Impact of Medical Debt on Patients<br>17:58 Marketing Strategies and Patient Success Stories<br>20:53 Future Directions for Resolve<br>22:37 Navigating Financial Aid in Healthcare<br>25:22 The Role of a Founder and CEO<br>30:40 Shifting Business Strategies and Messaging<br>32:14 Future Aspirations and Goals<br>35:25 Leadership Evolution and Team Dynamics<br>39:34 Advice for Aspiring Founders and Co-founders</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Braden Pan</strong></li><li>Guest's Title/Position: <strong>CEO and Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/bradenpan/"><strong>https://www.linkedin.com/in/bradenpan/</strong></a></li><li>Company / Affiliation: <strong>Resolve </strong><a href="https://www.resolvemedicalbills.com/"><strong>https://www.resolvemedicalbills.com/</strong></a></li><li>Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.</li></ul><p><strong>Takeaways</strong>:</p><ul><li>Medical debt is a massive issue affecting many Americans.</li><li>Resolve has saved patients over $55 million on medical bills.</li><li>Braden's personal experience with medical debt inspired him to start Resolve.</li><li>The healthcare system is complex and often designed to confuse patients.</li><li>AI is being integrated into Resolve's processes to improve efficiency.</li><li>Hospitals often prefer working with Resolve to lower their collection costs.</li><li>Financial aid programs exist but are underutilized by patients.</li><li>Braden emphasizes the importance of having a co-founder.</li><li>Leadership evolves over time, especially in a startup environment.</li><li>The future of Resolve includes expanding services to address all types of debt.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Keywords  medical debt, healthcare, Resolve, Braden Penn, financial aid, AI in healthcare, startup journey, leadership, co-founder advice, patient advocacy</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.resolvemedicalbills.com/" img="https://img.transistorcdn.com/8mzpKprTouaMFe3ijzd-H2ItruDxat86gYBiHCjw6SQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xYmEy/MDA4NTJiMDVjMzVm/NjNiNTIwMDAxN2M0/ZmY0My5qcGVn.jpg">Braden Pan</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/a65b9fae/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Maximizing Workforce Efficiency: The Future of Healthcare Productivity with Stephanie Dorwart</title>
      <itunes:episode>23</itunes:episode>
      <podcast:episode>23</podcast:episode>
      <itunes:title>Maximizing Workforce Efficiency: The Future of Healthcare Productivity with Stephanie Dorwart</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0bcac6cd-118c-4fe1-970f-9f9714f3ed80</guid>
      <link>https://share.transistor.fm/s/e70d3acc</link>
      <description>
        <![CDATA[<p>In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Altius Healthcare Consulting<br>02:46 Stephanie's Journey into Healthcare<br>06:50 Impact of COVID-19 on Healthcare Innovation<br>10:32 The Role of Data in Healthcare<br>12:02 Empowering Leaders through Data<br>14:28 Building Trust and Accountability in Leadership<br>18:13 The Importance of Continuous Improvement in Healthcare<br>22:31 Navigating Leadership Development<br>30:12 The Entrepreneurial Leap<br>37:59 Innovations in Healthcare<br>41:14 Vision for the Future of Altius</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Stephanie Dorwart</strong><br>Guest's Title/Position: <strong>Chief Executive Officer</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/stephanie-dorwart/">https://www.linkedin.com/in/stephanie-dorwart/</a> <br>Company/Affiliation: <strong>Altius Healthcare Consulting Group</strong> <a href="https://altiushcg.com/">https://altiushcg.com/</a><br>Guest's Bio: <strong>Stephanie Dorwart is the CEO of ALTIUS</strong>, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. </p><p><strong>Takeaways:</strong></p><ul><li>Altius focuses on improving financial and operational performance in healthcare.</li><li>Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.</li><li>COVID-19 accelerated the adoption of telehealth and innovative care models.</li><li>Data in healthcare is relatively new and can significantly impact productivity.</li><li>Empowering leaders with data helps them make informed decisions.</li><li>Building trust within teams is essential for effective leadership.</li><li>Accountability starts with setting clear goals and regular check-ins.</li><li>Time management is crucial for leaders to think strategically.</li><li>Rural healthcare systems face unique challenges and need support.</li><li>The future of healthcare may focus more on preventive care and nutrition.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Altius Healthcare Consulting<br>02:46 Stephanie's Journey into Healthcare<br>06:50 Impact of COVID-19 on Healthcare Innovation<br>10:32 The Role of Data in Healthcare<br>12:02 Empowering Leaders through Data<br>14:28 Building Trust and Accountability in Leadership<br>18:13 The Importance of Continuous Improvement in Healthcare<br>22:31 Navigating Leadership Development<br>30:12 The Entrepreneurial Leap<br>37:59 Innovations in Healthcare<br>41:14 Vision for the Future of Altius</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Stephanie Dorwart</strong><br>Guest's Title/Position: <strong>Chief Executive Officer</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/stephanie-dorwart/">https://www.linkedin.com/in/stephanie-dorwart/</a> <br>Company/Affiliation: <strong>Altius Healthcare Consulting Group</strong> <a href="https://altiushcg.com/">https://altiushcg.com/</a><br>Guest's Bio: <strong>Stephanie Dorwart is the CEO of ALTIUS</strong>, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. </p><p><strong>Takeaways:</strong></p><ul><li>Altius focuses on improving financial and operational performance in healthcare.</li><li>Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.</li><li>COVID-19 accelerated the adoption of telehealth and innovative care models.</li><li>Data in healthcare is relatively new and can significantly impact productivity.</li><li>Empowering leaders with data helps them make informed decisions.</li><li>Building trust within teams is essential for effective leadership.</li><li>Accountability starts with setting clear goals and regular check-ins.</li><li>Time management is crucial for leaders to think strategically.</li><li>Rural healthcare systems face unique challenges and need support.</li><li>The future of healthcare may focus more on preventive care and nutrition.</li></ul>]]>
      </content:encoded>
      <pubDate>Mon, 28 Jul 2025 15:51:56 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/e70d3acc/493bc78b.mp3" length="64867974" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/M-IvE5tBbOu7DNFf_z7_Wz80ppBnaynX6D5YUuGQzeQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xZjgy/MjYwNDRlMzc0MmFi/MGMzODYyYjMwY2Rm/ZWFmYy5qcGc.jpg"/>
      <itunes:duration>2696</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Altius Healthcare Consulting<br>02:46 Stephanie's Journey into Healthcare<br>06:50 Impact of COVID-19 on Healthcare Innovation<br>10:32 The Role of Data in Healthcare<br>12:02 Empowering Leaders through Data<br>14:28 Building Trust and Accountability in Leadership<br>18:13 The Importance of Continuous Improvement in Healthcare<br>22:31 Navigating Leadership Development<br>30:12 The Entrepreneurial Leap<br>37:59 Innovations in Healthcare<br>41:14 Vision for the Future of Altius</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Stephanie Dorwart</strong><br>Guest's Title/Position: <strong>Chief Executive Officer</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/stephanie-dorwart/">https://www.linkedin.com/in/stephanie-dorwart/</a> <br>Company/Affiliation: <strong>Altius Healthcare Consulting Group</strong> <a href="https://altiushcg.com/">https://altiushcg.com/</a><br>Guest's Bio: <strong>Stephanie Dorwart is the CEO of ALTIUS</strong>, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. </p><p><strong>Takeaways:</strong></p><ul><li>Altius focuses on improving financial and operational performance in healthcare.</li><li>Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.</li><li>COVID-19 accelerated the adoption of telehealth and innovative care models.</li><li>Data in healthcare is relatively new and can significantly impact productivity.</li><li>Empowering leaders with data helps them make informed decisions.</li><li>Building trust within teams is essential for effective leadership.</li><li>Accountability starts with setting clear goals and regular check-ins.</li><li>Time management is crucial for leaders to think strategically.</li><li>Rural healthcare systems face unique challenges and need support.</li><li>The future of healthcare may focus more on preventive care and nutrition.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Keywords  healthcare, productivity, leadership, data, telehealth, innovation, rural healthcare, accountability, entrepreneurship, Altius Healthcare Consulting</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://altiushcg.com/" img="https://img.transistorcdn.com/TL-Id8zUZMRJnn19lpF1OVq_uVSKogqKPjVbRM3Qk2s/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80NDUw/YjFmZmVkMWExZGFk/NDY4N2JiZDIyZWE0/OGRiMS5qcGVn.jpg">Stephanie Dorwart</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/e70d3acc/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Biotech for the Planet: An AI-Driven Approach to Sustainable Materials with Yuliana Mihaylova</title>
      <itunes:episode>22</itunes:episode>
      <podcast:episode>22</podcast:episode>
      <itunes:title>Biotech for the Planet: An AI-Driven Approach to Sustainable Materials with Yuliana Mihaylova</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7e37de2a-c82c-4e6b-8dca-6ed2b0f694a0</guid>
      <link>https://share.transistor.fm/s/72a7a042</link>
      <description>
        <![CDATA[<p>In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.</p><p><br><strong>Chapters:</strong><br>00:14 Introduction to OliveBio and Yuliana's Background<br>02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution<br>06:15 Understanding PHAs: A Sustainable Bioplastic Solution<br>11:59 OliveBio's Innovative Production Process for PHAs<br>15:57 Applications and Future of Bioplastics<br>18:21 Yuliana's Entrepreneurial Journey and Challenges<br>22:36 Leveraging AI and Automation in Biotech<br>33:13 Marketing and Growth Strategy for OliveBio<br>36:49 Vision for OliveBio's Future Impact<br>39:43 Key Learnings and Advice for Aspiring Innovators</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Yuliana Mihaylova</strong></li><li>Guest's Title/Position: <strong>CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/yulianamihaylova/">https://www.linkedin.com/in/yulianamihaylova/</a></li><li>Company / Affiliation: <strong>OliveBio</strong> <a href="https://olivebio.com/">https://olivebio.com/</a></li><li>Guest's Bio: <strong>Yuliana Mihaylova</strong> is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&amp;D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.<br>Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollution</li><li>Focuses on PHAs, biodegradable polymers from renewable sources that leave no microplastics</li><li>Uses enzyme-based production instead of bacterial fermentation for better precision and lower costs</li><li>PHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like sutures</li><li>Yuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resources</li><li>AI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracy</li><li>Marketing strategy targets B2B2C—engaging businesses and influencing consumer demand</li><li>Long-term vision is to build a sustainable, impactful company rather than seeking early acquisition</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.</p><p><br><strong>Chapters:</strong><br>00:14 Introduction to OliveBio and Yuliana's Background<br>02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution<br>06:15 Understanding PHAs: A Sustainable Bioplastic Solution<br>11:59 OliveBio's Innovative Production Process for PHAs<br>15:57 Applications and Future of Bioplastics<br>18:21 Yuliana's Entrepreneurial Journey and Challenges<br>22:36 Leveraging AI and Automation in Biotech<br>33:13 Marketing and Growth Strategy for OliveBio<br>36:49 Vision for OliveBio's Future Impact<br>39:43 Key Learnings and Advice for Aspiring Innovators</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Yuliana Mihaylova</strong></li><li>Guest's Title/Position: <strong>CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/yulianamihaylova/">https://www.linkedin.com/in/yulianamihaylova/</a></li><li>Company / Affiliation: <strong>OliveBio</strong> <a href="https://olivebio.com/">https://olivebio.com/</a></li><li>Guest's Bio: <strong>Yuliana Mihaylova</strong> is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&amp;D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.<br>Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollution</li><li>Focuses on PHAs, biodegradable polymers from renewable sources that leave no microplastics</li><li>Uses enzyme-based production instead of bacterial fermentation for better precision and lower costs</li><li>PHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like sutures</li><li>Yuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resources</li><li>AI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracy</li><li>Marketing strategy targets B2B2C—engaging businesses and influencing consumer demand</li><li>Long-term vision is to build a sustainable, impactful company rather than seeking early acquisition</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Thu, 24 Jul 2025 16:30:25 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/72a7a042/b42c35e6.mp3" length="64834358" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/pFpP_ZJwhm2CVN7MoqpejnFdIm4P7TSohwEOAuvpHMg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zODIz/MDAzMmZkMTE5Nzdk/N2U5MDZmZmJlM2Q0/N2I5OS5qcGc.jpg"/>
      <itunes:duration>2697</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.</p><p><br><strong>Chapters:</strong><br>00:14 Introduction to OliveBio and Yuliana's Background<br>02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution<br>06:15 Understanding PHAs: A Sustainable Bioplastic Solution<br>11:59 OliveBio's Innovative Production Process for PHAs<br>15:57 Applications and Future of Bioplastics<br>18:21 Yuliana's Entrepreneurial Journey and Challenges<br>22:36 Leveraging AI and Automation in Biotech<br>33:13 Marketing and Growth Strategy for OliveBio<br>36:49 Vision for OliveBio's Future Impact<br>39:43 Key Learnings and Advice for Aspiring Innovators</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Yuliana Mihaylova</strong></li><li>Guest's Title/Position: <strong>CEO &amp; Co-Founder</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/yulianamihaylova/">https://www.linkedin.com/in/yulianamihaylova/</a></li><li>Company / Affiliation: <strong>OliveBio</strong> <a href="https://olivebio.com/">https://olivebio.com/</a></li><li>Guest's Bio: <strong>Yuliana Mihaylova</strong> is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&amp;D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.<br>Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollution</li><li>Focuses on PHAs, biodegradable polymers from renewable sources that leave no microplastics</li><li>Uses enzyme-based production instead of bacterial fermentation for better precision and lower costs</li><li>PHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like sutures</li><li>Yuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resources</li><li>AI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracy</li><li>Marketing strategy targets B2B2C—engaging businesses and influencing consumer demand</li><li>Long-term vision is to build a sustainable, impactful company rather than seeking early acquisition</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Bioplastics, Sustainable Innovation, Eco-friendly Alternatives, Petrochemical Plastics, AI in Manufacturing, Environmental Impact, Entrepreneurship, Biotechnology, OliveBio</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://olivebio.com/" img="https://img.transistorcdn.com/9tBJ3A5ij7pZPk1W6lySpkiFbAOoExc5RHqm2xlv4Xk/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZWNk/MzE2ZWEzMzFlZDUw/YjdkNTVkODZhOTVk/MmQzNS5qcGVn.jpg">Yuliana Mihaylova</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/72a7a042/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Disruptive MedTech Innovation: The New Era of Breast Imaging Technology with David Georges</title>
      <itunes:episode>21</itunes:episode>
      <podcast:episode>21</podcast:episode>
      <itunes:title>Disruptive MedTech Innovation: The New Era of Breast Imaging Technology with David Georges</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c41556ab-4e99-4da0-89f4-981b6d8777f1</guid>
      <link>https://share.transistor.fm/s/4307f22e</link>
      <description>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Breast Imaging Innovations</p><p>02:49 David Georges' Journey in Breast Cancer Detection</p><p>06:02 The Evolution of Breast Imaging Technology</p><p>08:54 Challenges in Mammography and Patient Compliance</p><p>11:58 Commercialization of BreastCT Technology</p><p>14:46 Navigating Change in Medical Imaging</p><p>18:11 Global Expansion and Future Vision for Koning Health</p><p>20:45 The Impact of BreastCT on Patient Experience</p><p>23:51 Addressing Resistance and Building Trust in New Technology</p><p>26:58 The Future of Breast Imaging and Biopsy Procedures</p><p>30:33 Understanding the Breast Imaging Industry</p><p>32:28 The Role of AI in Breast Imaging</p><p>34:04 Creating Commercial Viability for New Technology</p><p>36:30 Educating Radiologists on New Imaging Techniques</p><p>39:18 Building Confidence in Radiologists</p><p>42:10 Transitioning to New Technologies in Imaging</p><p>44:57 Career Guidance in Healthcare and Technology</p><p>49:42 Mobile Breast Imaging Solutions</p><p>54:08 The Economic Impact of Early Detection</p><p>56:34 Future Prospects for Breast Imaging Technology</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>David Georges</strong></li><li>Guest's Title/Position: <strong>North American President</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/david-georges-48a14020/">https://www.linkedin.com/in/david-georges-48a14020/</a></li><li>Company / Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>David George</strong>s has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.<p>Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.</p></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>David Georges has 40 years of experience in breast imaging.</li><li>BreastCT technology offers true isotropic 3D imaging without compression.</li><li>Early detection of breast cancer significantly improves treatment outcomes.</li><li>Patient compliance with mammograms is low due to discomfort.</li><li>Koning Health aims to integrate BreastCT into existing facilities easily.</li><li>The technology is gaining traction in global markets, including China and Australia.</li><li>AI will play a crucial role in interpreting BreastCT images.</li><li>Mobile BreastCT units are being deployed to increase accessibility.</li><li>Healthcare economics favor early detection to reduce treatment costs.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Breast Imaging Innovations</p><p>02:49 David Georges' Journey in Breast Cancer Detection</p><p>06:02 The Evolution of Breast Imaging Technology</p><p>08:54 Challenges in Mammography and Patient Compliance</p><p>11:58 Commercialization of BreastCT Technology</p><p>14:46 Navigating Change in Medical Imaging</p><p>18:11 Global Expansion and Future Vision for Koning Health</p><p>20:45 The Impact of BreastCT on Patient Experience</p><p>23:51 Addressing Resistance and Building Trust in New Technology</p><p>26:58 The Future of Breast Imaging and Biopsy Procedures</p><p>30:33 Understanding the Breast Imaging Industry</p><p>32:28 The Role of AI in Breast Imaging</p><p>34:04 Creating Commercial Viability for New Technology</p><p>36:30 Educating Radiologists on New Imaging Techniques</p><p>39:18 Building Confidence in Radiologists</p><p>42:10 Transitioning to New Technologies in Imaging</p><p>44:57 Career Guidance in Healthcare and Technology</p><p>49:42 Mobile Breast Imaging Solutions</p><p>54:08 The Economic Impact of Early Detection</p><p>56:34 Future Prospects for Breast Imaging Technology</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>David Georges</strong></li><li>Guest's Title/Position: <strong>North American President</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/david-georges-48a14020/">https://www.linkedin.com/in/david-georges-48a14020/</a></li><li>Company / Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>David George</strong>s has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.<p>Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.</p></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>David Georges has 40 years of experience in breast imaging.</li><li>BreastCT technology offers true isotropic 3D imaging without compression.</li><li>Early detection of breast cancer significantly improves treatment outcomes.</li><li>Patient compliance with mammograms is low due to discomfort.</li><li>Koning Health aims to integrate BreastCT into existing facilities easily.</li><li>The technology is gaining traction in global markets, including China and Australia.</li><li>AI will play a crucial role in interpreting BreastCT images.</li><li>Mobile BreastCT units are being deployed to increase accessibility.</li><li>Healthcare economics favor early detection to reduce treatment costs.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 23 Jul 2025 10:29:10 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/4307f22e/a534e8eb.mp3" length="85136311" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/hYekThZSLuBqtRY0MOxymtwNnkbu8HFyEFjOdW8neVk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMjM3/YjJmMmIzMWQxZTRm/MTk2YjZhMDUwZjAz/NzNjMC5qcGc.jpg"/>
      <itunes:duration>3544</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Breast Imaging Innovations</p><p>02:49 David Georges' Journey in Breast Cancer Detection</p><p>06:02 The Evolution of Breast Imaging Technology</p><p>08:54 Challenges in Mammography and Patient Compliance</p><p>11:58 Commercialization of BreastCT Technology</p><p>14:46 Navigating Change in Medical Imaging</p><p>18:11 Global Expansion and Future Vision for Koning Health</p><p>20:45 The Impact of BreastCT on Patient Experience</p><p>23:51 Addressing Resistance and Building Trust in New Technology</p><p>26:58 The Future of Breast Imaging and Biopsy Procedures</p><p>30:33 Understanding the Breast Imaging Industry</p><p>32:28 The Role of AI in Breast Imaging</p><p>34:04 Creating Commercial Viability for New Technology</p><p>36:30 Educating Radiologists on New Imaging Techniques</p><p>39:18 Building Confidence in Radiologists</p><p>42:10 Transitioning to New Technologies in Imaging</p><p>44:57 Career Guidance in Healthcare and Technology</p><p>49:42 Mobile Breast Imaging Solutions</p><p>54:08 The Economic Impact of Early Detection</p><p>56:34 Future Prospects for Breast Imaging Technology</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>David Georges</strong></li><li>Guest's Title/Position: <strong>North American President</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/david-georges-48a14020/">https://www.linkedin.com/in/david-georges-48a14020/</a></li><li>Company / Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>David George</strong>s has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.<p>Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.</p></li></ul><p><br><strong>Takeaways:</strong></p><ul><li>David Georges has 40 years of experience in breast imaging.</li><li>BreastCT technology offers true isotropic 3D imaging without compression.</li><li>Early detection of breast cancer significantly improves treatment outcomes.</li><li>Patient compliance with mammograms is low due to discomfort.</li><li>Koning Health aims to integrate BreastCT into existing facilities easily.</li><li>The technology is gaining traction in global markets, including China and Australia.</li><li>AI will play a crucial role in interpreting BreastCT images.</li><li>Mobile BreastCT units are being deployed to increase accessibility.</li><li>Healthcare economics favor early detection to reduce treatment costs.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>breast imaging, BreastCT, healthcare technology, early detection, mammography, patient compliance, AI in healthcare, mobile imaging, healthcare leadership, innovation in medicine</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.koninghealth.com/" img="https://img.transistorcdn.com/zmnkUIym9pwyyMPKUwHyMwG3Vr7u9upA6i3HKW1SBAo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85NTQw/YTg5YTNjMDRmNTE0/NzgyYjI4YmY5YmE0/OWI4Ny5qcGVn.jpg">David Georges</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/4307f22e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Diagnosing the Future: Biomarkers, AI, and the Fight Against Type 1 Diabetes with Eitan Akirav </title>
      <itunes:episode>20</itunes:episode>
      <podcast:episode>20</podcast:episode>
      <itunes:title>Diagnosing the Future: Biomarkers, AI, and the Fight Against Type 1 Diabetes with Eitan Akirav </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">dec6df1a-2ea1-46fa-94e0-36bd9deb45e1</guid>
      <link>https://share.transistor.fm/s/ad0f1cf6</link>
      <description>
        <![CDATA[<p>In this episode, <strong>Eitan Akirav</strong> shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Eitan Akirav and His Journey<br>03:13 Transitioning from Academia to Industry<br>06:03 The Role of Mentorship in Career Development<br>09:04 Leadership in Academia vs. Industry<br>11:58 Innovations in Diabetes Research and Patents<br>15:02 The Future of Diabetes Detection and Prevention<br>17:56 The Impact of AI in Healthcare<br>21:03 Disruptive Innovations in Life Sciences<br>25:31 The Concept of Cure in Cancer Treatment<br>28:09 Balancing Technology and Human Touch in Healthcare<br>29:52 The Economic Challenges of Drug Development<br>32:50 Advice for Newcomers in the Science Industry<br>36:46 Challenges in Consulting and Marketing Yourself<br>44:44 Final Thoughts and Reflections on the Journey</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Eitan Akirav </strong><br>Guest's Title/Position: <strong>Founder &amp; CEO</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/eitan-akirav/">https://www.linkedin.com/in/eitan-akirav/</a><br>Company/Affiliation: <strong>KonKai Ventures </strong><a href="https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all">https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all</a><br>Guest's Bio: <strong>Eitan Akirav</strong> is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in <em>PNAS</em> and <em>Nature Immunology</em>, Eitan continues to advance science at the intersection of research, innovation, and real-world application.</p><p><strong>Takeaways</strong>:</p><ul><li>Eitan Akirav has over 17 years of experience in biotech.</li><li>Mentorship plays a crucial role in career transitions.</li><li>The transition from academia to industry can be challenging but rewarding.</li><li>Innovations in diabetes research are focused on early detection.</li><li>AI is a powerful tool that can save time in healthcare.</li><li>The future of oncology may involve re-engineering immune cells.</li><li>Customized medications based on genetic information are on the rise.</li><li>The drug approval process is lengthy and complex.</li><li>Newcomers in biotech should pursue their passion, not just titles.</li><li>Consulting requires effective self-marketing and client relationship management.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, <strong>Eitan Akirav</strong> shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Eitan Akirav and His Journey<br>03:13 Transitioning from Academia to Industry<br>06:03 The Role of Mentorship in Career Development<br>09:04 Leadership in Academia vs. Industry<br>11:58 Innovations in Diabetes Research and Patents<br>15:02 The Future of Diabetes Detection and Prevention<br>17:56 The Impact of AI in Healthcare<br>21:03 Disruptive Innovations in Life Sciences<br>25:31 The Concept of Cure in Cancer Treatment<br>28:09 Balancing Technology and Human Touch in Healthcare<br>29:52 The Economic Challenges of Drug Development<br>32:50 Advice for Newcomers in the Science Industry<br>36:46 Challenges in Consulting and Marketing Yourself<br>44:44 Final Thoughts and Reflections on the Journey</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Eitan Akirav </strong><br>Guest's Title/Position: <strong>Founder &amp; CEO</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/eitan-akirav/">https://www.linkedin.com/in/eitan-akirav/</a><br>Company/Affiliation: <strong>KonKai Ventures </strong><a href="https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all">https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all</a><br>Guest's Bio: <strong>Eitan Akirav</strong> is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in <em>PNAS</em> and <em>Nature Immunology</em>, Eitan continues to advance science at the intersection of research, innovation, and real-world application.</p><p><strong>Takeaways</strong>:</p><ul><li>Eitan Akirav has over 17 years of experience in biotech.</li><li>Mentorship plays a crucial role in career transitions.</li><li>The transition from academia to industry can be challenging but rewarding.</li><li>Innovations in diabetes research are focused on early detection.</li><li>AI is a powerful tool that can save time in healthcare.</li><li>The future of oncology may involve re-engineering immune cells.</li><li>Customized medications based on genetic information are on the rise.</li><li>The drug approval process is lengthy and complex.</li><li>Newcomers in biotech should pursue their passion, not just titles.</li><li>Consulting requires effective self-marketing and client relationship management.</li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 18 Jul 2025 16:07:06 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ad0f1cf6/b36191b5.mp3" length="67253344" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/HVzV-mCFIuEZJx_ikClYqUOwZzSgBqc4fzohomq0Jy4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lY2Rh/ZDMxMTBhZTczOGM1/YzljNDM2MzlkNjkw/MTJkNy5qcGc.jpg"/>
      <itunes:duration>2798</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, <strong>Eitan Akirav</strong> shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.</p><p><br><strong>Chapters:</strong><br>00:00 Introduction to Eitan Akirav and His Journey<br>03:13 Transitioning from Academia to Industry<br>06:03 The Role of Mentorship in Career Development<br>09:04 Leadership in Academia vs. Industry<br>11:58 Innovations in Diabetes Research and Patents<br>15:02 The Future of Diabetes Detection and Prevention<br>17:56 The Impact of AI in Healthcare<br>21:03 Disruptive Innovations in Life Sciences<br>25:31 The Concept of Cure in Cancer Treatment<br>28:09 Balancing Technology and Human Touch in Healthcare<br>29:52 The Economic Challenges of Drug Development<br>32:50 Advice for Newcomers in the Science Industry<br>36:46 Challenges in Consulting and Marketing Yourself<br>44:44 Final Thoughts and Reflections on the Journey</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Eitan Akirav </strong><br>Guest's Title/Position: <strong>Founder &amp; CEO</strong><br>Guest's Linkedin: <a href="https://www.linkedin.com/in/eitan-akirav/">https://www.linkedin.com/in/eitan-akirav/</a><br>Company/Affiliation: <strong>KonKai Ventures </strong><a href="https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all">https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all</a><br>Guest's Bio: <strong>Eitan Akirav</strong> is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in <em>PNAS</em> and <em>Nature Immunology</em>, Eitan continues to advance science at the intersection of research, innovation, and real-world application.</p><p><strong>Takeaways</strong>:</p><ul><li>Eitan Akirav has over 17 years of experience in biotech.</li><li>Mentorship plays a crucial role in career transitions.</li><li>The transition from academia to industry can be challenging but rewarding.</li><li>Innovations in diabetes research are focused on early detection.</li><li>AI is a powerful tool that can save time in healthcare.</li><li>The future of oncology may involve re-engineering immune cells.</li><li>Customized medications based on genetic information are on the rise.</li><li>The drug approval process is lengthy and complex.</li><li>Newcomers in biotech should pursue their passion, not just titles.</li><li>Consulting requires effective self-marketing and client relationship management.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Keywords  biotech, diabetes, mentorship, AI in healthcare, oncology, customized medications, consulting, career development, biomarkers, innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/eitan-akirav" img="https://img.transistorcdn.com/sBffNbF1KcMKs_mzjnRQ7OdJML5iQdKpu53PM1N76Ss/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80YThj/MmExMmMzZDZmYWE2/Y2M5NjBkNzUzMDhk/MTliYS5qcGVn.jpg">Eitan Akirav</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ad0f1cf6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Business of Better Care: Using AI to Empower Providers and Patients with Dr. Josh Funk</title>
      <itunes:episode>19</itunes:episode>
      <podcast:episode>19</podcast:episode>
      <itunes:title>The Business of Better Care: Using AI to Empower Providers and Patients with Dr. Josh Funk</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6d2808fd-8054-4bd4-84b5-124ba966bf67</guid>
      <link>https://share.transistor.fm/s/b8ed05ee</link>
      <description>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Josh Funk</strong>, CEO of <strong>Rehab to Perform</strong>, shares his journey from college athlete to the head of a thriving, multi-location physical therapy practice. He dives into what it takes to build a business rooted in performance, culture, and innovation—especially in the evolving healthcare space. Dr. Funk discusses strategies for leadership, employee retention, and navigating growth while staying true to core values. From adapting during the COVID-19 pandemic to embracing AI and automation, Dr. Funk emphasizes the need for transparency, adaptability, and a relentless focus on patient empowerment to stay ahead in the industry.</p><p><br><strong>Chapters:</strong><br><strong><br></strong>00:00 Introduction to Dr. Josh Funk and Rehab 2 Perform<br>01:07 Dr. Funk's Journey: From Athlete to Entrepreneur<br>03:48 Growth of Rehab 2 Perform: From One to Eleven Locations<br>06:38 Leadership and Culture: Infusing Vision Across Locations<br>12:20 Retention Strategies: Keeping the Right Talent<br>17:07 Challenges and Learning: Navigating Business Growth<br>20:20 Adapting to COVID-19: Innovations and Changes<br>24:01 Balancing Process and Human Connection<br>27:10 Innovative Service Delivery in Physical Therapy<br>30:03 The Role of Patient Participation in Recovery<br>35:13 Growth Strategies for Rehab 2 Perform<br>38:07 Navigating Marketing in a Competitive Landscape<br>40:43 Challenges in the Healthcare System<br>43:12 Leveraging AI for Efficiency<br>48:40 Envisioning a Better Healthcare System</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Josh Funk</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/joshfunk/">https://www.linkedin.com/in/joshfunk/</a></li><li>Company / Affiliation: <a href="https://rehab2perform.com/"><strong>Rehab 2 Perform</strong></a><strong> </strong><a href="https://rehab2perform.com/"><strong>https://rehab2perform.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Josh Funk</strong> is the Founder and CEO of <strong>Rehab 2 Perform (R2P)</strong>, a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal.<br>Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? <strong>Treat people like athletes, build a better baseline, and help them perform for life.</strong><br>Dr. Funk also co-leads <strong>R2P Academy</strong>, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Funk’s background as an athlete shapes his leadership style.</li><li>Strong company culture is essential for multi-location success.</li><li>Retention strategies are key when working with a young team.</li><li>The pandemic accelerated innovation and adaptation.</li><li>Balancing systems with human connection is critical in healthcare.</li><li>Patient empowerment leads to better recovery and long-term results.</li><li>Focusing on movement and performance—not just pain—is core to R2P’s approach.</li><li>AI and automation can improve operations without replacing people.</li><li>Transparent leadership builds alignment and trust.</li><li>R2P plans to continue expanding its reach and impact.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Josh Funk</strong>, CEO of <strong>Rehab to Perform</strong>, shares his journey from college athlete to the head of a thriving, multi-location physical therapy practice. He dives into what it takes to build a business rooted in performance, culture, and innovation—especially in the evolving healthcare space. Dr. Funk discusses strategies for leadership, employee retention, and navigating growth while staying true to core values. From adapting during the COVID-19 pandemic to embracing AI and automation, Dr. Funk emphasizes the need for transparency, adaptability, and a relentless focus on patient empowerment to stay ahead in the industry.</p><p><br><strong>Chapters:</strong><br><strong><br></strong>00:00 Introduction to Dr. Josh Funk and Rehab 2 Perform<br>01:07 Dr. Funk's Journey: From Athlete to Entrepreneur<br>03:48 Growth of Rehab 2 Perform: From One to Eleven Locations<br>06:38 Leadership and Culture: Infusing Vision Across Locations<br>12:20 Retention Strategies: Keeping the Right Talent<br>17:07 Challenges and Learning: Navigating Business Growth<br>20:20 Adapting to COVID-19: Innovations and Changes<br>24:01 Balancing Process and Human Connection<br>27:10 Innovative Service Delivery in Physical Therapy<br>30:03 The Role of Patient Participation in Recovery<br>35:13 Growth Strategies for Rehab 2 Perform<br>38:07 Navigating Marketing in a Competitive Landscape<br>40:43 Challenges in the Healthcare System<br>43:12 Leveraging AI for Efficiency<br>48:40 Envisioning a Better Healthcare System</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Josh Funk</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/joshfunk/">https://www.linkedin.com/in/joshfunk/</a></li><li>Company / Affiliation: <a href="https://rehab2perform.com/"><strong>Rehab 2 Perform</strong></a><strong> </strong><a href="https://rehab2perform.com/"><strong>https://rehab2perform.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Josh Funk</strong> is the Founder and CEO of <strong>Rehab 2 Perform (R2P)</strong>, a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal.<br>Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? <strong>Treat people like athletes, build a better baseline, and help them perform for life.</strong><br>Dr. Funk also co-leads <strong>R2P Academy</strong>, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Funk’s background as an athlete shapes his leadership style.</li><li>Strong company culture is essential for multi-location success.</li><li>Retention strategies are key when working with a young team.</li><li>The pandemic accelerated innovation and adaptation.</li><li>Balancing systems with human connection is critical in healthcare.</li><li>Patient empowerment leads to better recovery and long-term results.</li><li>Focusing on movement and performance—not just pain—is core to R2P’s approach.</li><li>AI and automation can improve operations without replacing people.</li><li>Transparent leadership builds alignment and trust.</li><li>R2P plans to continue expanding its reach and impact.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Wed, 16 Jul 2025 19:14:27 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/b8ed05ee/24c9e842.mp3" length="75379298" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Pyde9DH3x5m1xYQ8IzYbnPNkNKQpLAo01oxLSj_1cJU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kMTM2/ZjMxNjNkMDEwNGVl/MDFjZWY0M2U4M2Y5/YzYyZS5qcGc.jpg"/>
      <itunes:duration>3137</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of <em>The Healthy Enterprise</em>, <strong>Dr. Josh Funk</strong>, CEO of <strong>Rehab to Perform</strong>, shares his journey from college athlete to the head of a thriving, multi-location physical therapy practice. He dives into what it takes to build a business rooted in performance, culture, and innovation—especially in the evolving healthcare space. Dr. Funk discusses strategies for leadership, employee retention, and navigating growth while staying true to core values. From adapting during the COVID-19 pandemic to embracing AI and automation, Dr. Funk emphasizes the need for transparency, adaptability, and a relentless focus on patient empowerment to stay ahead in the industry.</p><p><br><strong>Chapters:</strong><br><strong><br></strong>00:00 Introduction to Dr. Josh Funk and Rehab 2 Perform<br>01:07 Dr. Funk's Journey: From Athlete to Entrepreneur<br>03:48 Growth of Rehab 2 Perform: From One to Eleven Locations<br>06:38 Leadership and Culture: Infusing Vision Across Locations<br>12:20 Retention Strategies: Keeping the Right Talent<br>17:07 Challenges and Learning: Navigating Business Growth<br>20:20 Adapting to COVID-19: Innovations and Changes<br>24:01 Balancing Process and Human Connection<br>27:10 Innovative Service Delivery in Physical Therapy<br>30:03 The Role of Patient Participation in Recovery<br>35:13 Growth Strategies for Rehab 2 Perform<br>38:07 Navigating Marketing in a Competitive Landscape<br>40:43 Challenges in the Healthcare System<br>43:12 Leveraging AI for Efficiency<br>48:40 Envisioning a Better Healthcare System</p><p>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr. Josh Funk</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/joshfunk/">https://www.linkedin.com/in/joshfunk/</a></li><li>Company / Affiliation: <a href="https://rehab2perform.com/"><strong>Rehab 2 Perform</strong></a><strong> </strong><a href="https://rehab2perform.com/"><strong>https://rehab2perform.com/</strong></a></li><li>Guest's Bio: <strong>Dr. Josh Funk</strong> is the Founder and CEO of <strong>Rehab 2 Perform (R2P)</strong>, a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal.<br>Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? <strong>Treat people like athletes, build a better baseline, and help them perform for life.</strong><br>Dr. Funk also co-leads <strong>R2P Academy</strong>, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.</li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Funk’s background as an athlete shapes his leadership style.</li><li>Strong company culture is essential for multi-location success.</li><li>Retention strategies are key when working with a young team.</li><li>The pandemic accelerated innovation and adaptation.</li><li>Balancing systems with human connection is critical in healthcare.</li><li>Patient empowerment leads to better recovery and long-term results.</li><li>Focusing on movement and performance—not just pain—is core to R2P’s approach.</li><li>AI and automation can improve operations without replacing people.</li><li>Transparent leadership builds alignment and trust.</li><li>R2P plans to continue expanding its reach and impact.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>physical therapy, business growth, healthcare, leadership, patient empowerment, retention strategies, AI in healthcare, entrepreneurship, company culture, pandemic recovery</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://rehab2perform.com/" img="https://img.transistorcdn.com/Eed42Tx1UtMopXSQCym9ROXrYgWwm7Yicgg4JHtd92M/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85NmY5/YTk5NTU3OWQxOTU0/MGY5NTQxZTdlNjEy/MWZmOC5qcGVn.jpg">Dr. Josh Funk</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/b8ed05ee/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Data, Drugs, and Disruption: Biotech for a Better Future with Ed Fleischer</title>
      <itunes:episode>18</itunes:episode>
      <podcast:episode>18</podcast:episode>
      <itunes:title>Data, Drugs, and Disruption: Biotech for a Better Future with Ed Fleischer</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1dc38da0-6e91-4ae8-aee7-34daada97cdd</guid>
      <link>https://share.transistor.fm/s/940a3c69</link>
      <description>
        <![CDATA[<p>In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.</p><p><strong>Chapters:</strong></p><p><strong>0:00</strong> - Introduction to Ed Fleischer</p><p><strong>2:09</strong> - From Biotechnology to Consultancy</p><p><strong>10:00</strong> - The Journey Through Major Pharma</p><p><strong>13:00</strong> - Staying Current in a Dynamic Field</p><p><strong>14:43</strong> - The Impact of AI on QC</p><p><strong>21:06</strong> - The "Why" Behind the Work</p><p><strong>32:20</strong> - Leadership and Authenticity</p><p><strong>36:51</strong> - The Value of Public Speaking</p><p><strong>42:42</strong> - Delivering on Trust</p><p><strong>46:11</strong> - Conclusion and Takeaways</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Ed Fleischer</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong> </li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ed-fleischer-a780482/">https://www.linkedin.com/in/ed-fleischer-a780482/</a></li><li>Company/Affiliation: <strong>Beachside Compliance Solutions</strong></li><li>Guest's Bio: <strong>Ed Fleischer</strong> is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the<strong> CEO of Beachside Compliance Solutions</strong>, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.</li></ul><p><strong>Takeaways:<br>-</strong>He transitioned to consultancy after working in various pharmaceutical companies.<br>-Staying current with regulations and industry trends is crucial for success.<br>-AI is becoming increasingly important in the biotech field.<br>-Innovations in quality control are revolutionizing the industry.<br>-Ed's impactful experience with a patient highlighted the importance of their work.<br>-Leadership requires authenticity and the ability to communicate effectively.<br>-Diversity in teams leads to better problem-solving and innovation.<br>-Consultants care about the outcomes of their work and follow up with clients.<br>-The pharmaceutical industry is driven by the need to deliver safe and effective medicines. <br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.</p><p><strong>Chapters:</strong></p><p><strong>0:00</strong> - Introduction to Ed Fleischer</p><p><strong>2:09</strong> - From Biotechnology to Consultancy</p><p><strong>10:00</strong> - The Journey Through Major Pharma</p><p><strong>13:00</strong> - Staying Current in a Dynamic Field</p><p><strong>14:43</strong> - The Impact of AI on QC</p><p><strong>21:06</strong> - The "Why" Behind the Work</p><p><strong>32:20</strong> - Leadership and Authenticity</p><p><strong>36:51</strong> - The Value of Public Speaking</p><p><strong>42:42</strong> - Delivering on Trust</p><p><strong>46:11</strong> - Conclusion and Takeaways</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Ed Fleischer</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong> </li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ed-fleischer-a780482/">https://www.linkedin.com/in/ed-fleischer-a780482/</a></li><li>Company/Affiliation: <strong>Beachside Compliance Solutions</strong></li><li>Guest's Bio: <strong>Ed Fleischer</strong> is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the<strong> CEO of Beachside Compliance Solutions</strong>, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.</li></ul><p><strong>Takeaways:<br>-</strong>He transitioned to consultancy after working in various pharmaceutical companies.<br>-Staying current with regulations and industry trends is crucial for success.<br>-AI is becoming increasingly important in the biotech field.<br>-Innovations in quality control are revolutionizing the industry.<br>-Ed's impactful experience with a patient highlighted the importance of their work.<br>-Leadership requires authenticity and the ability to communicate effectively.<br>-Diversity in teams leads to better problem-solving and innovation.<br>-Consultants care about the outcomes of their work and follow up with clients.<br>-The pharmaceutical industry is driven by the need to deliver safe and effective medicines. <br></p>]]>
      </content:encoded>
      <pubDate>Mon, 14 Jul 2025 17:49:25 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/940a3c69/5a2116a9.mp3" length="72591380" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/9T26M5PgEbnFGAtMuULiUvjWinZUH599MGsZjkx6DnA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zOTdh/OWNjMzViNDhkY2Ux/MWIwYzQ0NzMyYjZj/MWNkNy5qcGc.jpg"/>
      <itunes:duration>3017</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.</p><p><strong>Chapters:</strong></p><p><strong>0:00</strong> - Introduction to Ed Fleischer</p><p><strong>2:09</strong> - From Biotechnology to Consultancy</p><p><strong>10:00</strong> - The Journey Through Major Pharma</p><p><strong>13:00</strong> - Staying Current in a Dynamic Field</p><p><strong>14:43</strong> - The Impact of AI on QC</p><p><strong>21:06</strong> - The "Why" Behind the Work</p><p><strong>32:20</strong> - Leadership and Authenticity</p><p><strong>36:51</strong> - The Value of Public Speaking</p><p><strong>42:42</strong> - Delivering on Trust</p><p><strong>46:11</strong> - Conclusion and Takeaways</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Ed Fleischer</strong></li><li>Guest's Title/Position: <strong>Chief Executive Officer</strong> </li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/ed-fleischer-a780482/">https://www.linkedin.com/in/ed-fleischer-a780482/</a></li><li>Company/Affiliation: <strong>Beachside Compliance Solutions</strong></li><li>Guest's Bio: <strong>Ed Fleischer</strong> is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the<strong> CEO of Beachside Compliance Solutions</strong>, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.</li></ul><p><strong>Takeaways:<br>-</strong>He transitioned to consultancy after working in various pharmaceutical companies.<br>-Staying current with regulations and industry trends is crucial for success.<br>-AI is becoming increasingly important in the biotech field.<br>-Innovations in quality control are revolutionizing the industry.<br>-Ed's impactful experience with a patient highlighted the importance of their work.<br>-Leadership requires authenticity and the ability to communicate effectively.<br>-Diversity in teams leads to better problem-solving and innovation.<br>-Consultants care about the outcomes of their work and follow up with clients.<br>-The pharmaceutical industry is driven by the need to deliver safe and effective medicines. <br></p>]]>
      </itunes:summary>
      <itunes:keywords>Keywords  biotech, consultancy, quality control, AI, leadership, pharmaceutical industry, career journey, innovations, communication, impact</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/ed-fleischer" img="https://img.transistorcdn.com/uPYVq7SSg2wi_OXrRg-kT82OyA50_PdldBHz1jMarHI/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNGM2/NjYyOTc3YzJiOGYw/OTdkOTc2ZmRmNjk0/YmNjYi5qcGVn.jpg">Ed Fleischer</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/940a3c69/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Reimagining Wound Care &amp; Empowering Women in Entrepreneurship with Dr Wendy Slone</title>
      <itunes:episode>17</itunes:episode>
      <podcast:episode>17</podcast:episode>
      <itunes:title>Reimagining Wound Care &amp; Empowering Women in Entrepreneurship with Dr Wendy Slone</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">dec36174-d001-43ea-961a-cc6e70ab5a8d</guid>
      <link>https://share.transistor.fm/s/232d89e3</link>
      <description>
        <![CDATA[<p>In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.</p><p><strong>Chapters:<br>00:13</strong> Introducing Dr. Wendy Sloan &amp; B-Tech<br><strong>01:13</strong> The Halcyon Smart Patch: Healing from the Inside Out<br><strong>02:02</strong> The Personal Spark Behind B-Tech<br><strong>03:32</strong> From NASA to Public Policy: Dr. Sloan’s Journey<br><strong>06:26</strong> Far Infrared Light, Explained<br><strong>07:58</strong> The Chronic Wound Care Crisis<br><strong>10:00</strong> The Hidden Burden of Chronic Wounds<br><strong>13:51</strong> B-Tech’s Buzz &amp; Upcoming Human Trials<br><strong>15:06</strong> Real-World Potential: Animals, Space &amp; Defense<br><strong>18:53</strong> Growing B-Tech: Early Lessons &amp; Challenges<br><strong>20:07</strong> Why Strategy Matters More Than Just the Product<br><strong>27:26</strong> Building Investor Trust &amp; Strategic Partnerships<br><strong>33:04</strong> Mentorship, Boldness &amp; Breaking Barriers<br><strong>36:09</strong> Owning the Room &amp; Overcoming Imposter Syndrome<br><strong>41:18</strong> Resilience, Community &amp; Entrepreneurial Grit<br><strong>43:05</strong> Final Reflections on a Remarkable Journey</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr Wendy Slone</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/wendy-s-ba02b240/">https://www.linkedin.com/in/wendy-s-ba02b240/</a></li><li>Company / Affiliation: <strong>bTECH</strong><a href="https://btechls.com/"><strong> </strong>https://btechls.com/</a></li><li>Guest's Bio: <strong>Dr. Wendy Slone</strong> is the founder and CEO of <strong>bTECH Inc.</strong>, where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.</li></ul><p><br></p><p><strong>Takeaways</strong>:</p><ul><li>BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.</li><li>Microcirculation is crucial for effective wound healing.</li><li>The wound care industry is often overlooked despite its significance.</li><li>Entrepreneurship involves navigating various challenges and obstacles.</li><li>Building a solid business model is essential for success.</li><li>Networking and building relationships are key to finding investors.</li><li>Women entrepreneurs often face unique challenges and need support.</li><li>It's important to maintain a positive attitude and resilience in business.</li><li>Asking questions and challenging the status quo is vital for growth.</li><li>Creating a core support system can significantly impact an entrepreneur's journey.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.</p><p><strong>Chapters:<br>00:13</strong> Introducing Dr. Wendy Sloan &amp; B-Tech<br><strong>01:13</strong> The Halcyon Smart Patch: Healing from the Inside Out<br><strong>02:02</strong> The Personal Spark Behind B-Tech<br><strong>03:32</strong> From NASA to Public Policy: Dr. Sloan’s Journey<br><strong>06:26</strong> Far Infrared Light, Explained<br><strong>07:58</strong> The Chronic Wound Care Crisis<br><strong>10:00</strong> The Hidden Burden of Chronic Wounds<br><strong>13:51</strong> B-Tech’s Buzz &amp; Upcoming Human Trials<br><strong>15:06</strong> Real-World Potential: Animals, Space &amp; Defense<br><strong>18:53</strong> Growing B-Tech: Early Lessons &amp; Challenges<br><strong>20:07</strong> Why Strategy Matters More Than Just the Product<br><strong>27:26</strong> Building Investor Trust &amp; Strategic Partnerships<br><strong>33:04</strong> Mentorship, Boldness &amp; Breaking Barriers<br><strong>36:09</strong> Owning the Room &amp; Overcoming Imposter Syndrome<br><strong>41:18</strong> Resilience, Community &amp; Entrepreneurial Grit<br><strong>43:05</strong> Final Reflections on a Remarkable Journey</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr Wendy Slone</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/wendy-s-ba02b240/">https://www.linkedin.com/in/wendy-s-ba02b240/</a></li><li>Company / Affiliation: <strong>bTECH</strong><a href="https://btechls.com/"><strong> </strong>https://btechls.com/</a></li><li>Guest's Bio: <strong>Dr. Wendy Slone</strong> is the founder and CEO of <strong>bTECH Inc.</strong>, where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.</li></ul><p><br></p><p><strong>Takeaways</strong>:</p><ul><li>BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.</li><li>Microcirculation is crucial for effective wound healing.</li><li>The wound care industry is often overlooked despite its significance.</li><li>Entrepreneurship involves navigating various challenges and obstacles.</li><li>Building a solid business model is essential for success.</li><li>Networking and building relationships are key to finding investors.</li><li>Women entrepreneurs often face unique challenges and need support.</li><li>It's important to maintain a positive attitude and resilience in business.</li><li>Asking questions and challenging the status quo is vital for growth.</li><li>Creating a core support system can significantly impact an entrepreneur's journey.</li></ul>]]>
      </content:encoded>
      <pubDate>Thu, 10 Jul 2025 15:24:25 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/232d89e3/10a4001b.mp3" length="68846585" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/CrCpI94gvmy_qmXRG9z9lp9ysbmP2-okZ6J9QlKDMyI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jYmY1/N2Y2NzhiYTdkYTZm/NTk2NGFmYmVkZjM3/YzQzNi5qcGc.jpg"/>
      <itunes:duration>2865</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.</p><p><strong>Chapters:<br>00:13</strong> Introducing Dr. Wendy Sloan &amp; B-Tech<br><strong>01:13</strong> The Halcyon Smart Patch: Healing from the Inside Out<br><strong>02:02</strong> The Personal Spark Behind B-Tech<br><strong>03:32</strong> From NASA to Public Policy: Dr. Sloan’s Journey<br><strong>06:26</strong> Far Infrared Light, Explained<br><strong>07:58</strong> The Chronic Wound Care Crisis<br><strong>10:00</strong> The Hidden Burden of Chronic Wounds<br><strong>13:51</strong> B-Tech’s Buzz &amp; Upcoming Human Trials<br><strong>15:06</strong> Real-World Potential: Animals, Space &amp; Defense<br><strong>18:53</strong> Growing B-Tech: Early Lessons &amp; Challenges<br><strong>20:07</strong> Why Strategy Matters More Than Just the Product<br><strong>27:26</strong> Building Investor Trust &amp; Strategic Partnerships<br><strong>33:04</strong> Mentorship, Boldness &amp; Breaking Barriers<br><strong>36:09</strong> Owning the Room &amp; Overcoming Imposter Syndrome<br><strong>41:18</strong> Resilience, Community &amp; Entrepreneurial Grit<br><strong>43:05</strong> Final Reflections on a Remarkable Journey</p><p><br>G<strong>uest Information:</strong></p><ul><li>Guest's Name: <strong>Dr Wendy Slone</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/wendy-s-ba02b240/">https://www.linkedin.com/in/wendy-s-ba02b240/</a></li><li>Company / Affiliation: <strong>bTECH</strong><a href="https://btechls.com/"><strong> </strong>https://btechls.com/</a></li><li>Guest's Bio: <strong>Dr. Wendy Slone</strong> is the founder and CEO of <strong>bTECH Inc.</strong>, where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.</li></ul><p><br></p><p><strong>Takeaways</strong>:</p><ul><li>BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.</li><li>Microcirculation is crucial for effective wound healing.</li><li>The wound care industry is often overlooked despite its significance.</li><li>Entrepreneurship involves navigating various challenges and obstacles.</li><li>Building a solid business model is essential for success.</li><li>Networking and building relationships are key to finding investors.</li><li>Women entrepreneurs often face unique challenges and need support.</li><li>It's important to maintain a positive attitude and resilience in business.</li><li>Asking questions and challenging the status quo is vital for growth.</li><li>Creating a core support system can significantly impact an entrepreneur's journey.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>BTECH, Halcyon Smart Patch, wound care, microcirculation, entrepreneurship, innovation, health technology, networking, women in business, personal growth</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://btechls.com/" img="https://img.transistorcdn.com/BDTzpuBtPdyGxpOnz0HEMS5NBwHkcpDBTRnh0r8p0RI/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZjVl/NmVhZjgwYmFiOGRh/ZmRmODZkYWNlYjUw/MjVlYS5qcGVn.jpg">Wendy Slone, Ph.D. </podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/232d89e3/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Search Everything Optimization: Navigating SEO, AI, and Authenticity with Aimee Taylor</title>
      <itunes:episode>16</itunes:episode>
      <podcast:episode>16</podcast:episode>
      <itunes:title>Search Everything Optimization: Navigating SEO, AI, and Authenticity with Aimee Taylor</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d398f5c8-58f9-4cd8-81ab-cf139c684bcc</guid>
      <link>https://share.transistor.fm/s/8f67b748</link>
      <description>
        <![CDATA[<p>In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Digital Marketing and Transition from Traditional Media<br>05:02 The Importance of Strategy in Marketing<br>09:53 Navigating the AI Landscape in Marketing<br>15:02 Understanding SEO and Its Evolution<br>19:59 The Role of Websites in Modern Marketing<br>24:47 The Role of Human Operators in Marketing<br>25:42 Authenticity and Credibility in the Digital Age<br>27:05 Navigating Google Business Profiles<br>28:54 The Importance of Local SEO and Reviews<br>30:39 The Value of Human Connection in Marketing<br>32:58 Understanding the Client's Journey<br>34:54 The Impact of Call Tracking on Business<br>36:23 Healthcare Marketing: A Shift in Consumer Behavior<br>38:51 The Future of Preventative Healthcare<br>40:25 Adapting to AI in Marketing<br>42:07 Leadership and Team Dynamics in Marketing<br>46:35 Advice for Aspiring Marketers</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Aimee Taylor</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aimee-taylor/">https://www.linkedin.com/in/aimee-taylor/</a></li><li>Company/Affiliation: <strong>Alt Digital Marketing </strong><a href="https://altdigitalmarketing.com/">https://altdigitalmarketing.com/</a></li><li>Guest's Bio: <strong>Aimee Taylor is the Founder and CEO of Alt Digital Marketing</strong>, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Digital marketing offers more trackable results compared to traditional media.</li><li>Strategy is crucial in navigating the complex marketing landscape.</li><li>Clients need to niche down to effectively market their services.</li><li>AI is reshaping marketing, but human oversight remains essential.</li><li>Authenticity and credibility are vital for successful marketing campaigns.</li><li>The website serves as the foundation for all marketing efforts.</li><li>Engagement with clients enhances the effectiveness of marketing strategies.</li><li>Healthcare marketing is evolving towards a focus on wellness and preventative care.</li><li>Effective leadership involves hiring the right people and fostering a positive team culture.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Digital Marketing and Transition from Traditional Media<br>05:02 The Importance of Strategy in Marketing<br>09:53 Navigating the AI Landscape in Marketing<br>15:02 Understanding SEO and Its Evolution<br>19:59 The Role of Websites in Modern Marketing<br>24:47 The Role of Human Operators in Marketing<br>25:42 Authenticity and Credibility in the Digital Age<br>27:05 Navigating Google Business Profiles<br>28:54 The Importance of Local SEO and Reviews<br>30:39 The Value of Human Connection in Marketing<br>32:58 Understanding the Client's Journey<br>34:54 The Impact of Call Tracking on Business<br>36:23 Healthcare Marketing: A Shift in Consumer Behavior<br>38:51 The Future of Preventative Healthcare<br>40:25 Adapting to AI in Marketing<br>42:07 Leadership and Team Dynamics in Marketing<br>46:35 Advice for Aspiring Marketers</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Aimee Taylor</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aimee-taylor/">https://www.linkedin.com/in/aimee-taylor/</a></li><li>Company/Affiliation: <strong>Alt Digital Marketing </strong><a href="https://altdigitalmarketing.com/">https://altdigitalmarketing.com/</a></li><li>Guest's Bio: <strong>Aimee Taylor is the Founder and CEO of Alt Digital Marketing</strong>, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Digital marketing offers more trackable results compared to traditional media.</li><li>Strategy is crucial in navigating the complex marketing landscape.</li><li>Clients need to niche down to effectively market their services.</li><li>AI is reshaping marketing, but human oversight remains essential.</li><li>Authenticity and credibility are vital for successful marketing campaigns.</li><li>The website serves as the foundation for all marketing efforts.</li><li>Engagement with clients enhances the effectiveness of marketing strategies.</li><li>Healthcare marketing is evolving towards a focus on wellness and preventative care.</li><li>Effective leadership involves hiring the right people and fostering a positive team culture.</li></ul>]]>
      </content:encoded>
      <pubDate>Tue, 08 Jul 2025 17:54:46 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/8f67b748/d0e22213.mp3" length="72748075" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/2LBM7QboPmAZjJkRKvpfTDKl6R8m5-gF_zp5OYBDL7E/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjUy/MTBkOTNiMzIwYzAx/NGM0YWZmZmNjMWM0/NDc1Yi5qcGc.jpg"/>
      <itunes:duration>3028</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.</p><p><strong>Chapters:</strong><br>00:00 Introduction to Digital Marketing and Transition from Traditional Media<br>05:02 The Importance of Strategy in Marketing<br>09:53 Navigating the AI Landscape in Marketing<br>15:02 Understanding SEO and Its Evolution<br>19:59 The Role of Websites in Modern Marketing<br>24:47 The Role of Human Operators in Marketing<br>25:42 Authenticity and Credibility in the Digital Age<br>27:05 Navigating Google Business Profiles<br>28:54 The Importance of Local SEO and Reviews<br>30:39 The Value of Human Connection in Marketing<br>32:58 Understanding the Client's Journey<br>34:54 The Impact of Call Tracking on Business<br>36:23 Healthcare Marketing: A Shift in Consumer Behavior<br>38:51 The Future of Preventative Healthcare<br>40:25 Adapting to AI in Marketing<br>42:07 Leadership and Team Dynamics in Marketing<br>46:35 Advice for Aspiring Marketers</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Aimee Taylor</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/aimee-taylor/">https://www.linkedin.com/in/aimee-taylor/</a></li><li>Company/Affiliation: <strong>Alt Digital Marketing </strong><a href="https://altdigitalmarketing.com/">https://altdigitalmarketing.com/</a></li><li>Guest's Bio: <strong>Aimee Taylor is the Founder and CEO of Alt Digital Marketing</strong>, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.</li></ul><p><br><strong>Takeaways:</strong></p><ul><li>Digital marketing offers more trackable results compared to traditional media.</li><li>Strategy is crucial in navigating the complex marketing landscape.</li><li>Clients need to niche down to effectively market their services.</li><li>AI is reshaping marketing, but human oversight remains essential.</li><li>Authenticity and credibility are vital for successful marketing campaigns.</li><li>The website serves as the foundation for all marketing efforts.</li><li>Engagement with clients enhances the effectiveness of marketing strategies.</li><li>Healthcare marketing is evolving towards a focus on wellness and preventative care.</li><li>Effective leadership involves hiring the right people and fostering a positive team culture.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>digital marketing, SEO, AI in marketing, healthcare marketing, marketing strategy, client engagement, authenticity, niche marketing, leadership in marketing, Google Business Profiles</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://altdigitalmarketing.com/" img="https://img.transistorcdn.com/FCBZenBpCVUiNEHcBs2FEdpv8miziZlQ3ZitfbPVld0/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMjRk/M2YyOTgzY2UxZDNl/MWNjOTg5ZWVmM2Qw/Y2U5MC5qcGVn.jpg">Aimee Taylor</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/8f67b748/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8f67b748/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8f67b748/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/8f67b748/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/8f67b748/transcription" type="text/html"/>
    </item>
    <item>
      <title>Transforming Pharma Consulting: The Fractional Model with Mary Hames</title>
      <itunes:episode>15</itunes:episode>
      <podcast:episode>15</podcast:episode>
      <itunes:title>Transforming Pharma Consulting: The Fractional Model with Mary Hames</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">dad14a9b-2c8c-480a-b35f-73c47166ebd5</guid>
      <link>https://share.transistor.fm/s/ffc006fc</link>
      <description>
        <![CDATA[<p>In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.</p><p>00:00 Introduction to BioLogic Pharma Solutions<br>03:01 The Fractional Model in Biotech Consulting<br>06:00 Navigating Uncertainty in Drug Development<br>09:04 Mary's Entrepreneurial Journey<br>11:50 Vision for the Future of Biotech Consulting<br>14:45 Challenges in Consulting and Growth<br>17:57 The Importance of Trust in Entrepreneurship<br>26:49 The Importance of Delegation in Business<br>28:02 Navigating Client Acquisition and Marketing Strategies<br>30:35 Effective Client Engagement and Presentation Techniques<br>34:12 Understanding Market Dynamics and Client Feedback<br>36:11 Identifying the Sweet Spot in the Drug Development Process<br>39:25 Building a Flexible Workforce and Consultant Relationships<br>40:19 Future Aspirations and Growth Strategies for the Company<br>46:12 Reflections on the Entrepreneurial Journey</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Mary Hames</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/">https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/</a></li><li>Company / Affiliation: <strong>BioLogic Pharma Solutions </strong><a href="https://biologicpharmasolutions.com/">https://biologicpharmasolutions.com/</a></li><li>Guest's Bio: <strong>Mary Hames</strong> is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&amp;D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>The fractional model allows companies to access expertise without full-time hires.</li><li>Building a company culture is essential for employee satisfaction.</li><li>Consulting can be lonely, but teamwork helps mitigate that.</li><li>Marketing strategies include presentations and SEO efforts.</li><li>Trust is crucial for entrepreneurs to delegate responsibilities.</li><li>The future of BioLogic includes becoming a go-to firm for pre-commercial products.</li><li>Navigating uncertainty in drug development is a common challenge.</li><li>Mary's entrepreneurial journey includes learning from past failures.</li><li>The sweet spot for consulting is between phase two and three of drug development.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.</p><p>00:00 Introduction to BioLogic Pharma Solutions<br>03:01 The Fractional Model in Biotech Consulting<br>06:00 Navigating Uncertainty in Drug Development<br>09:04 Mary's Entrepreneurial Journey<br>11:50 Vision for the Future of Biotech Consulting<br>14:45 Challenges in Consulting and Growth<br>17:57 The Importance of Trust in Entrepreneurship<br>26:49 The Importance of Delegation in Business<br>28:02 Navigating Client Acquisition and Marketing Strategies<br>30:35 Effective Client Engagement and Presentation Techniques<br>34:12 Understanding Market Dynamics and Client Feedback<br>36:11 Identifying the Sweet Spot in the Drug Development Process<br>39:25 Building a Flexible Workforce and Consultant Relationships<br>40:19 Future Aspirations and Growth Strategies for the Company<br>46:12 Reflections on the Entrepreneurial Journey</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Mary Hames</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/">https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/</a></li><li>Company / Affiliation: <strong>BioLogic Pharma Solutions </strong><a href="https://biologicpharmasolutions.com/">https://biologicpharmasolutions.com/</a></li><li>Guest's Bio: <strong>Mary Hames</strong> is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&amp;D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>The fractional model allows companies to access expertise without full-time hires.</li><li>Building a company culture is essential for employee satisfaction.</li><li>Consulting can be lonely, but teamwork helps mitigate that.</li><li>Marketing strategies include presentations and SEO efforts.</li><li>Trust is crucial for entrepreneurs to delegate responsibilities.</li><li>The future of BioLogic includes becoming a go-to firm for pre-commercial products.</li><li>Navigating uncertainty in drug development is a common challenge.</li><li>Mary's entrepreneurial journey includes learning from past failures.</li><li>The sweet spot for consulting is between phase two and three of drug development.</li></ul>]]>
      </content:encoded>
      <pubDate>Tue, 01 Jul 2025 09:41:39 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/ffc006fc/aa4ec391.mp3" length="71247653" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ux_GEaFfwVX3F2gSxYWD_kRADsfRKhCCs2BkclG5Sv4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82Nzkw/NTVlNzRkZGEyM2Zj/ODY4ZWRlMzY0MGYw/NjVhMy5qcGc.jpg"/>
      <itunes:duration>2961</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.</p><p>00:00 Introduction to BioLogic Pharma Solutions<br>03:01 The Fractional Model in Biotech Consulting<br>06:00 Navigating Uncertainty in Drug Development<br>09:04 Mary's Entrepreneurial Journey<br>11:50 Vision for the Future of Biotech Consulting<br>14:45 Challenges in Consulting and Growth<br>17:57 The Importance of Trust in Entrepreneurship<br>26:49 The Importance of Delegation in Business<br>28:02 Navigating Client Acquisition and Marketing Strategies<br>30:35 Effective Client Engagement and Presentation Techniques<br>34:12 Understanding Market Dynamics and Client Feedback<br>36:11 Identifying the Sweet Spot in the Drug Development Process<br>39:25 Building a Flexible Workforce and Consultant Relationships<br>40:19 Future Aspirations and Growth Strategies for the Company<br>46:12 Reflections on the Entrepreneurial Journey</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: <strong>Mary Hames</strong> </li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/">https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/</a></li><li>Company / Affiliation: <strong>BioLogic Pharma Solutions </strong><a href="https://biologicpharmasolutions.com/">https://biologicpharmasolutions.com/</a></li><li>Guest's Bio: <strong>Mary Hames</strong> is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&amp;D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. </li></ul><p><br><strong>Takeaways:</strong></p><ul><li>The fractional model allows companies to access expertise without full-time hires.</li><li>Building a company culture is essential for employee satisfaction.</li><li>Consulting can be lonely, but teamwork helps mitigate that.</li><li>Marketing strategies include presentations and SEO efforts.</li><li>Trust is crucial for entrepreneurs to delegate responsibilities.</li><li>The future of BioLogic includes becoming a go-to firm for pre-commercial products.</li><li>Navigating uncertainty in drug development is a common challenge.</li><li>Mary's entrepreneurial journey includes learning from past failures.</li><li>The sweet spot for consulting is between phase two and three of drug development.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>biotech, pharmaceutical consulting, commercialization, fractional model, entrepreneurship, drug development, company culture, marketing strategies, client relationships, growth strategies</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://biologicpharmasolutions.com/" img="https://img.transistorcdn.com/RAaaCVCvWMXufHJnxC2E7JaRUOcpNCzjOrLrwbt2tJw/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82OGQy/OGY5NzZjZDJjMTgy/YTYwMTk2NjYyMWVk/NTdlNi5qcGVn.jpg">Mary Hames</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/1TXixnMvwoMqwPoWbL1Lb4xZhNqEeL4vlcBWR_jtlgo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTQ4/ZTcxZDViOTQzNjBi/YzNlN2FhZDYyYzc0/YzgzNS5qcGVn.jpg">Griffin Fletcher</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/ffc006fc/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ffc006fc/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ffc006fc/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/ffc006fc/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/ffc006fc/transcription" type="text/html"/>
    </item>
    <item>
      <title>Revolutionizing Access: A Seamless Patient Experience with Dr. Paula Muto</title>
      <itunes:episode>14</itunes:episode>
      <podcast:episode>14</podcast:episode>
      <itunes:title>Revolutionizing Access: A Seamless Patient Experience with Dr. Paula Muto</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">eb0526c6-da2a-4005-a8b3-bd6563850de6</guid>
      <link>https://share.transistor.fm/s/e2d6fd41</link>
      <description>
        <![CDATA[<p>In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.</p><p>00:00 Introduction to Dr. Paula Muto and Her Journey</p><p>02:33 Building the Muto Vein Center: A Personal Journey</p><p>04:26 Leadership in Healthcare: Building a Strong Team</p><p>07:06 Challenges in Modern Medicine: The Human Element</p><p>09:38 Gender Disparities in Surgery: A Personal Perspective</p><p>12:01 The Evolution of Surgical Practices and Technology</p><p>12:46 Introducing UberDoc: A Solution for Patient Access</p><p>15:55 The UberDoc Model: Direct Access to Care</p><p>20:23 Insurance and Flexibility: The Future of Healthcare</p><p>22:24 Overcoming Resistance: The Journey of UberDoc</p><p>26:09 Expanding the Network: The Growth of UberDoc</p><p>28:16 Streamlining Patient Appointments</p><p>31:18 The Evolution of Telemedicine</p><p>34:59 Building the UberDoc Team</p><p>38:17 Funding and Expansion Strategies</p><p>40:52 The Future of Direct Pay Healthcare</p><p>45:03 Reimagining Patient Care</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Paula Muto</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/paulamutomd/">https://www.linkedin.com/in/paulamutomd/</a></li><li>Company/Affiliation:  <strong>UBERDOC - </strong><a href="https://uber-docs.com/"><strong>https://uber-docs.com/</strong></a></li><li>Guest's Bio: <strong>UBERDOC</strong> Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. </li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.</li><li>Leadership in healthcare requires understanding and flexibility with team dynamics.</li><li>Women in medicine face unique challenges, including compensation disparities.</li><li>The healthcare system often prioritizes billing over patient care, leading to inefficiencies.</li><li>UberDoc was created to solve the problem of access to healthcare for patients.</li><li>The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.</li><li>Building a strong team is crucial for the success of any healthcare venture.</li><li>Direct pay models are gaining traction as a solution to healthcare access issues.</li><li>The future of healthcare may involve more technology and patient empowerment.</li><li>Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.</p><p>00:00 Introduction to Dr. Paula Muto and Her Journey</p><p>02:33 Building the Muto Vein Center: A Personal Journey</p><p>04:26 Leadership in Healthcare: Building a Strong Team</p><p>07:06 Challenges in Modern Medicine: The Human Element</p><p>09:38 Gender Disparities in Surgery: A Personal Perspective</p><p>12:01 The Evolution of Surgical Practices and Technology</p><p>12:46 Introducing UberDoc: A Solution for Patient Access</p><p>15:55 The UberDoc Model: Direct Access to Care</p><p>20:23 Insurance and Flexibility: The Future of Healthcare</p><p>22:24 Overcoming Resistance: The Journey of UberDoc</p><p>26:09 Expanding the Network: The Growth of UberDoc</p><p>28:16 Streamlining Patient Appointments</p><p>31:18 The Evolution of Telemedicine</p><p>34:59 Building the UberDoc Team</p><p>38:17 Funding and Expansion Strategies</p><p>40:52 The Future of Direct Pay Healthcare</p><p>45:03 Reimagining Patient Care</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Paula Muto</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/paulamutomd/">https://www.linkedin.com/in/paulamutomd/</a></li><li>Company/Affiliation:  <strong>UBERDOC - </strong><a href="https://uber-docs.com/"><strong>https://uber-docs.com/</strong></a></li><li>Guest's Bio: <strong>UBERDOC</strong> Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. </li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.</li><li>Leadership in healthcare requires understanding and flexibility with team dynamics.</li><li>Women in medicine face unique challenges, including compensation disparities.</li><li>The healthcare system often prioritizes billing over patient care, leading to inefficiencies.</li><li>UberDoc was created to solve the problem of access to healthcare for patients.</li><li>The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.</li><li>Building a strong team is crucial for the success of any healthcare venture.</li><li>Direct pay models are gaining traction as a solution to healthcare access issues.</li><li>The future of healthcare may involve more technology and patient empowerment.</li><li>Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.</li></ul>]]>
      </content:encoded>
      <pubDate>Fri, 27 Jun 2025 15:17:04 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/e2d6fd41/f103cfd3.mp3" length="74035504" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/UljDKgrg1pTBQYO1_FaeIFKhIwgITQMciF1ifQD355A/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iYWRh/NGJmMWEzOGY4ZjMy/ZTc5ZDdjMjEwYjVh/MDZiZS5qcGc.jpg"/>
      <itunes:duration>3079</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.</p><p>00:00 Introduction to Dr. Paula Muto and Her Journey</p><p>02:33 Building the Muto Vein Center: A Personal Journey</p><p>04:26 Leadership in Healthcare: Building a Strong Team</p><p>07:06 Challenges in Modern Medicine: The Human Element</p><p>09:38 Gender Disparities in Surgery: A Personal Perspective</p><p>12:01 The Evolution of Surgical Practices and Technology</p><p>12:46 Introducing UberDoc: A Solution for Patient Access</p><p>15:55 The UberDoc Model: Direct Access to Care</p><p>20:23 Insurance and Flexibility: The Future of Healthcare</p><p>22:24 Overcoming Resistance: The Journey of UberDoc</p><p>26:09 Expanding the Network: The Growth of UberDoc</p><p>28:16 Streamlining Patient Appointments</p><p>31:18 The Evolution of Telemedicine</p><p>34:59 Building the UberDoc Team</p><p>38:17 Funding and Expansion Strategies</p><p>40:52 The Future of Direct Pay Healthcare</p><p>45:03 Reimagining Patient Care</p><p><br><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Paula Muto</strong></li><li>Guest's Title/Position: <strong>Founder &amp; CEO</strong></li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/paulamutomd/">https://www.linkedin.com/in/paulamutomd/</a></li><li>Company/Affiliation:  <strong>UBERDOC - </strong><a href="https://uber-docs.com/"><strong>https://uber-docs.com/</strong></a></li><li>Guest's Bio: <strong>UBERDOC</strong> Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. </li></ul><p><strong><br>Takeaways:</strong></p><ul><li>Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.</li><li>Leadership in healthcare requires understanding and flexibility with team dynamics.</li><li>Women in medicine face unique challenges, including compensation disparities.</li><li>The healthcare system often prioritizes billing over patient care, leading to inefficiencies.</li><li>UberDoc was created to solve the problem of access to healthcare for patients.</li><li>The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.</li><li>Building a strong team is crucial for the success of any healthcare venture.</li><li>Direct pay models are gaining traction as a solution to healthcare access issues.</li><li>The future of healthcare may involve more technology and patient empowerment.</li><li>Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>Healthcare Innovation, UberDoc, Patient Access, Medical Entrepreneurship, Direct Pay Healthcare, Dr. Paula Muto, Muto Vein Center, Online Booking System, Affordable Healthcare, Transparent Pricing, Vascular Surgeon, Healthcare Technology, AI in Healthcare, Healthcare Challenges, Healthcare Solutions,healthcare, surgery, entrepreneurship, UberDoc, patient access, medical innovation, leadership, women in medicine, healthcare challenges, direct pay model</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://uber-docs.com/" img="https://img.transistorcdn.com/06a0eWxa03I6C_6ZP0HdQmUbkwLbZM6N9xsumOrbYZE/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MWVm/MjkzZjI0YzdiNzI0/YWI3NDRhMzZiMDE4/MjJjYS5qcGVn.jpg">Dr. Paula Muto</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/e2d6fd41/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/e2d6fd41/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/e2d6fd41/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/e2d6fd41/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/e2d6fd41/transcription" type="text/html"/>
    </item>
    <item>
      <title>Bridging Science &amp; Business: A Real-World Approach with Kevin Scanlon</title>
      <itunes:episode>13</itunes:episode>
      <podcast:episode>13</podcast:episode>
      <itunes:title>Bridging Science &amp; Business: A Real-World Approach with Kevin Scanlon</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">74e6a88b-838e-4b9f-810f-e02fc5a3a80b</guid>
      <link>https://share.transistor.fm/s/3766f369</link>
      <description>
        <![CDATA[<p>In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.</p><p>00:00 Introduction and Background</p><p>01:50 Navigating the Science and Business Divide</p><p>05:46 The Role of Angel Investors</p><p>09:51 Teaching Entrepreneurship</p><p>13:38 Trust and Team Dynamics in Startups</p><p>17:38 Investment Strategies and Risk Management</p><p>21:14 Regional Differences in Medical Investment</p><p>23:02 International Consulting and Global Perspectives</p><p>25:32 Cultural Insights from Global Experiences</p><p>26:59 The Shark Tank Experience: Reality vs. TV</p><p>29:21 The Rigorous Selection Process for Entrepreneurs</p><p>31:33 Challenges in Startup Growth and Team Dynamics</p><p>33:14 Funding Roadblocks and Cultural Differences</p><p>37:11 Success Stories: From Struggles to Triumphs</p><p>40:53 The Future of Investment: Incubators and Mentorship</p><p>44:13 The Importance of Character in Entrepreneurship</p><p>46:25 Investor Perspectives on Entrepreneurial Success</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Dr. Kevin Scanlon</strong><br>Guest's Title/Position: <strong>Founder &amp; CEO of International BioScience</strong> <br>Guest's Linkedin: <a href="https://www.linkedin.com/in/kjscanlon/">https://www.linkedin.com/in/kjscanlon/</a><br>Company/Affiliation: Pasadena Angels <a href="https://www.linkedin.com/company/pasadena-angels/">https://www.linkedin.com/company/pasadena-angels/</a><br>Guest's Bio: <br><strong>Dr. Kevin Scanlon</strong> is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.</p><p>Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.</p><p>His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of <em>Cancer Gene Therapy</em> (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of <a href="https://www.amazon.ca/Hybrid-Entrepreneur-Career-Science-Business/dp/1637424442"><em>The Hybrid Entrepreneur</em>. </a></p><p><br><strong>Takeaways</strong></p><ul><li>Character is crucial for entrepreneurial success.</li><li>Investors look for strong team dynamics.</li><li>Mentorship can significantly impact startup growth.</li><li>Understanding investor vocabulary is essential for entrepreneurs.</li><li>Trust issues can hinder investor-entrepreneur relationships.</li><li>A strong team can pivot and adapt to challenges.</li><li>Financial strategy is often a weak point for entrepreneurs.</li><li>Communication of complex ideas is vital for success.</li><li>Cultural differences can create friction in teams.</li><li>Success stories often come from perseverance and adaptability.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.</p><p>00:00 Introduction and Background</p><p>01:50 Navigating the Science and Business Divide</p><p>05:46 The Role of Angel Investors</p><p>09:51 Teaching Entrepreneurship</p><p>13:38 Trust and Team Dynamics in Startups</p><p>17:38 Investment Strategies and Risk Management</p><p>21:14 Regional Differences in Medical Investment</p><p>23:02 International Consulting and Global Perspectives</p><p>25:32 Cultural Insights from Global Experiences</p><p>26:59 The Shark Tank Experience: Reality vs. TV</p><p>29:21 The Rigorous Selection Process for Entrepreneurs</p><p>31:33 Challenges in Startup Growth and Team Dynamics</p><p>33:14 Funding Roadblocks and Cultural Differences</p><p>37:11 Success Stories: From Struggles to Triumphs</p><p>40:53 The Future of Investment: Incubators and Mentorship</p><p>44:13 The Importance of Character in Entrepreneurship</p><p>46:25 Investor Perspectives on Entrepreneurial Success</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Dr. Kevin Scanlon</strong><br>Guest's Title/Position: <strong>Founder &amp; CEO of International BioScience</strong> <br>Guest's Linkedin: <a href="https://www.linkedin.com/in/kjscanlon/">https://www.linkedin.com/in/kjscanlon/</a><br>Company/Affiliation: Pasadena Angels <a href="https://www.linkedin.com/company/pasadena-angels/">https://www.linkedin.com/company/pasadena-angels/</a><br>Guest's Bio: <br><strong>Dr. Kevin Scanlon</strong> is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.</p><p>Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.</p><p>His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of <em>Cancer Gene Therapy</em> (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of <a href="https://www.amazon.ca/Hybrid-Entrepreneur-Career-Science-Business/dp/1637424442"><em>The Hybrid Entrepreneur</em>. </a></p><p><br><strong>Takeaways</strong></p><ul><li>Character is crucial for entrepreneurial success.</li><li>Investors look for strong team dynamics.</li><li>Mentorship can significantly impact startup growth.</li><li>Understanding investor vocabulary is essential for entrepreneurs.</li><li>Trust issues can hinder investor-entrepreneur relationships.</li><li>A strong team can pivot and adapt to challenges.</li><li>Financial strategy is often a weak point for entrepreneurs.</li><li>Communication of complex ideas is vital for success.</li><li>Cultural differences can create friction in teams.</li><li>Success stories often come from perseverance and adaptability.</li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 25 Jun 2025 16:23:56 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/3766f369/d1441c21.mp3" length="67785807" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Tl_szoW_AUjmmP3EZtlipPQK7W5-5i6Pv1nUd2CaxhU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80OTMw/Mzk5YWZlZjI1YTIz/NzMyZDliNDRlMmE2/Yjc1Ny5qcGc.jpg"/>
      <itunes:duration>2818</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.</p><p>00:00 Introduction and Background</p><p>01:50 Navigating the Science and Business Divide</p><p>05:46 The Role of Angel Investors</p><p>09:51 Teaching Entrepreneurship</p><p>13:38 Trust and Team Dynamics in Startups</p><p>17:38 Investment Strategies and Risk Management</p><p>21:14 Regional Differences in Medical Investment</p><p>23:02 International Consulting and Global Perspectives</p><p>25:32 Cultural Insights from Global Experiences</p><p>26:59 The Shark Tank Experience: Reality vs. TV</p><p>29:21 The Rigorous Selection Process for Entrepreneurs</p><p>31:33 Challenges in Startup Growth and Team Dynamics</p><p>33:14 Funding Roadblocks and Cultural Differences</p><p>37:11 Success Stories: From Struggles to Triumphs</p><p>40:53 The Future of Investment: Incubators and Mentorship</p><p>44:13 The Importance of Character in Entrepreneurship</p><p>46:25 Investor Perspectives on Entrepreneurial Success</p><p><strong>Guest Information:</strong><br>Guest's Name: <strong>Dr. Kevin Scanlon</strong><br>Guest's Title/Position: <strong>Founder &amp; CEO of International BioScience</strong> <br>Guest's Linkedin: <a href="https://www.linkedin.com/in/kjscanlon/">https://www.linkedin.com/in/kjscanlon/</a><br>Company/Affiliation: Pasadena Angels <a href="https://www.linkedin.com/company/pasadena-angels/">https://www.linkedin.com/company/pasadena-angels/</a><br>Guest's Bio: <br><strong>Dr. Kevin Scanlon</strong> is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.</p><p>Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.</p><p>His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of <em>Cancer Gene Therapy</em> (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of <a href="https://www.amazon.ca/Hybrid-Entrepreneur-Career-Science-Business/dp/1637424442"><em>The Hybrid Entrepreneur</em>. </a></p><p><br><strong>Takeaways</strong></p><ul><li>Character is crucial for entrepreneurial success.</li><li>Investors look for strong team dynamics.</li><li>Mentorship can significantly impact startup growth.</li><li>Understanding investor vocabulary is essential for entrepreneurs.</li><li>Trust issues can hinder investor-entrepreneur relationships.</li><li>A strong team can pivot and adapt to challenges.</li><li>Financial strategy is often a weak point for entrepreneurs.</li><li>Communication of complex ideas is vital for success.</li><li>Cultural differences can create friction in teams.</li><li>Success stories often come from perseverance and adaptability.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>entrepreneurship, investment, startups, mentorship, character, team dynamics, investor relations, business strategy, technology, innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/dr-kevin-scanlon" img="https://img.transistorcdn.com/rZ59iDqMcgrL1K7P4yV6XvdgQ2JhJKN4K2MoVQu16KI/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zZjFj/Njc5ZjY2Yjk5ZmI1/YTA1YjdhODQ0MmEx/YjVlYS5qcGVn.jpg">Dr. Kevin Scanlon</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/3766f369/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/3766f369/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/3766f369/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/3766f369/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/3766f369/transcription" type="text/html"/>
    </item>
    <item>
      <title>Women's Health Tech: The Future of Breast Imaging with Naomi Cosman</title>
      <itunes:episode>12</itunes:episode>
      <podcast:episode>12</podcast:episode>
      <itunes:title>Women's Health Tech: The Future of Breast Imaging with Naomi Cosman</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">52bd6a6d-cd92-4bf9-938d-c13f0bc4d88f</guid>
      <link>https://share.transistor.fm/s/d3d74f37</link>
      <description>
        <![CDATA[<p>In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.</p><p>00:00 Introduction to Koning Health and Breast Imaging Innovation</p><p>02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT</p><p>05:47 The Importance of Early Detection and Patient Comfort</p><p>10:20 Overcoming Industry Resistance and Adoption Challenges</p><p>15:49 Mobile Units and Accessibility in Breast Imaging</p><p>20:43 Marketing Strategies: Engaging Patients and Physicians</p><p>25:57 Insurance Challenges and Cost of Exams</p><p>30:22 The Startup Culture and Passion for Healthcare</p><p>35:59 Balancing Technology and Human Connection in Marketing</p><p>40:24 Conclusion and Call to Action for Breast Health Awareness</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Naomi Cosman</strong></li><li>Guest's Title/Position: Global Head of Marketing &amp; Investor Relations</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/">https://www.linkedin.com/in/naomicosman/ </a></li><li>Company/Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.</p><p>00:00 Introduction to Koning Health and Breast Imaging Innovation</p><p>02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT</p><p>05:47 The Importance of Early Detection and Patient Comfort</p><p>10:20 Overcoming Industry Resistance and Adoption Challenges</p><p>15:49 Mobile Units and Accessibility in Breast Imaging</p><p>20:43 Marketing Strategies: Engaging Patients and Physicians</p><p>25:57 Insurance Challenges and Cost of Exams</p><p>30:22 The Startup Culture and Passion for Healthcare</p><p>35:59 Balancing Technology and Human Connection in Marketing</p><p>40:24 Conclusion and Call to Action for Breast Health Awareness</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Naomi Cosman</strong></li><li>Guest's Title/Position: Global Head of Marketing &amp; Investor Relations</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/">https://www.linkedin.com/in/naomicosman/ </a></li><li>Company/Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 03 Jun 2025 17:12:43 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/d3d74f37/0b0716d7.mp3" length="62074371" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/NINp2XR_tDJ7CrKR85DnmYoiHGmMVH4bkXJ_SzV3jCY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jNDhj/OTJlZWU2NWI1ZDY4/NjFhYmU3ZTFkNDU0/MTFkNS5qcGc.jpg"/>
      <itunes:duration>2580</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.</p><p>00:00 Introduction to Koning Health and Breast Imaging Innovation</p><p>02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT</p><p>05:47 The Importance of Early Detection and Patient Comfort</p><p>10:20 Overcoming Industry Resistance and Adoption Challenges</p><p>15:49 Mobile Units and Accessibility in Breast Imaging</p><p>20:43 Marketing Strategies: Engaging Patients and Physicians</p><p>25:57 Insurance Challenges and Cost of Exams</p><p>30:22 The Startup Culture and Passion for Healthcare</p><p>35:59 Balancing Technology and Human Connection in Marketing</p><p>40:24 Conclusion and Call to Action for Breast Health Awareness</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> </strong> <strong>Naomi Cosman</strong></li><li>Guest's Title/Position: Global Head of Marketing &amp; Investor Relations</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/naomicosman/">https://www.linkedin.com/in/naomicosman/ </a></li><li>Company/Affiliation: <strong>Koning Health</strong> <a href="https://www.koninghealth.com/">https://www.koninghealth.com/</a></li><li>Guest's Bio: <strong>Naomi Cosman</strong> is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>breast imaging, healthcare marketing, early detection, patient comfort, Koning Corporation, breast cancer, innovative technology, healthcare startups, mobile health units, insurance challenges</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.koninghealth.com/" img="https://img.transistorcdn.com/gwuTxnUmfuC91S946EYcaWBj1OTNBzGSW8hQwnbPtac/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zM2I2/NGZiMzUzZDUzMzRh/NDQxMTQ5NTcwZDI1/ZmJiMS5qcGVn.jpg">Naomi Cosman</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/d3d74f37/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d3d74f37/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d3d74f37/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d3d74f37/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/d3d74f37/transcription" type="text/html"/>
    </item>
    <item>
      <title>Science Behind Nutrition: Understanding Longevity with Dr. Axa Yox</title>
      <itunes:episode>11</itunes:episode>
      <podcast:episode>11</podcast:episode>
      <itunes:title>Science Behind Nutrition: Understanding Longevity with Dr. Axa Yox</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0d235dac-bf5c-4b2a-b2a3-dc910a860b2a</guid>
      <link>https://share.transistor.fm/s/34981814</link>
      <description>
        <![CDATA[<p>In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.</p><p>Chapters:<br>00:00 Introduction to Dr. Oksa Jox</p><p>02:11 Journey from Biotechnology to Nutrition</p><p>04:30 Learning from Failures</p><p>08:20 The Importance of Market Understanding</p><p>10:07 Building a Personal Brand</p><p>18:22 Explaining the Mechanisms of Healthy Eating</p><p>26:32 The Role of Environment in Health</p><p>30:03 Understanding Insulin and Glucose Metabolism</p><p>32:56 The Importance of Intermittent Fasting</p><p>36:05 Personal Health Transformations Through Diet</p><p>39:02 The Misconceptions of Food Labels</p><p>41:54 Building a Personal Brand in Health</p><p>46:06 Future Aspirations and Growth in Health Coaching</p><p>48:02 Stress Management and Breathing Techniques</p><p>52:11 The Concept of Promises and Personal Growth</p><p><strong>Guest Information:</strong><br>Guest's Name: Dr. Axa Yox<br>Guest's Title/Position: Fouder &amp; Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/dr-axa-yox/">https://www.linkedin.com/in/dr-axa-yox/</a><br>Company/Affiliation: <strong>X Theory Inc</strong> <a href="https://x-theory.kit.com/1e03b15cdc">https://x-theory.kit.com/1e03b15cdc</a><br>Guest's Bio: <strong>Dr. Axa Yox</strong> is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of <em>X Theory</em>, host of the <em>W.H.Y. – What How Y</em> podcast, and author of <em>Foolfilled Life</em>, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at <em>BRAINZ Magazine</em>, Axa brings deep scientific insight to personal development, branding, and the psychology of change.<br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.</p><p>Chapters:<br>00:00 Introduction to Dr. Oksa Jox</p><p>02:11 Journey from Biotechnology to Nutrition</p><p>04:30 Learning from Failures</p><p>08:20 The Importance of Market Understanding</p><p>10:07 Building a Personal Brand</p><p>18:22 Explaining the Mechanisms of Healthy Eating</p><p>26:32 The Role of Environment in Health</p><p>30:03 Understanding Insulin and Glucose Metabolism</p><p>32:56 The Importance of Intermittent Fasting</p><p>36:05 Personal Health Transformations Through Diet</p><p>39:02 The Misconceptions of Food Labels</p><p>41:54 Building a Personal Brand in Health</p><p>46:06 Future Aspirations and Growth in Health Coaching</p><p>48:02 Stress Management and Breathing Techniques</p><p>52:11 The Concept of Promises and Personal Growth</p><p><strong>Guest Information:</strong><br>Guest's Name: Dr. Axa Yox<br>Guest's Title/Position: Fouder &amp; Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/dr-axa-yox/">https://www.linkedin.com/in/dr-axa-yox/</a><br>Company/Affiliation: <strong>X Theory Inc</strong> <a href="https://x-theory.kit.com/1e03b15cdc">https://x-theory.kit.com/1e03b15cdc</a><br>Guest's Bio: <strong>Dr. Axa Yox</strong> is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of <em>X Theory</em>, host of the <em>W.H.Y. – What How Y</em> podcast, and author of <em>Foolfilled Life</em>, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at <em>BRAINZ Magazine</em>, Axa brings deep scientific insight to personal development, branding, and the psychology of change.<br></p>]]>
      </content:encoded>
      <pubDate>Mon, 02 Jun 2025 17:29:43 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/34981814/ff695041.mp3" length="87880997" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/El_RL8wiKHTK7uihT8GEPv48Bn9GedfEPewlIWzlkhw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84ODUy/ODg2MDQwZGI3ZWEx/MTk1M2YxYjY5NDJh/NzQxOS5qcGc.jpg"/>
      <itunes:duration>3658</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.</p><p>Chapters:<br>00:00 Introduction to Dr. Oksa Jox</p><p>02:11 Journey from Biotechnology to Nutrition</p><p>04:30 Learning from Failures</p><p>08:20 The Importance of Market Understanding</p><p>10:07 Building a Personal Brand</p><p>18:22 Explaining the Mechanisms of Healthy Eating</p><p>26:32 The Role of Environment in Health</p><p>30:03 Understanding Insulin and Glucose Metabolism</p><p>32:56 The Importance of Intermittent Fasting</p><p>36:05 Personal Health Transformations Through Diet</p><p>39:02 The Misconceptions of Food Labels</p><p>41:54 Building a Personal Brand in Health</p><p>46:06 Future Aspirations and Growth in Health Coaching</p><p>48:02 Stress Management and Breathing Techniques</p><p>52:11 The Concept of Promises and Personal Growth</p><p><strong>Guest Information:</strong><br>Guest's Name: Dr. Axa Yox<br>Guest's Title/Position: Fouder &amp; Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/dr-axa-yox/">https://www.linkedin.com/in/dr-axa-yox/</a><br>Company/Affiliation: <strong>X Theory Inc</strong> <a href="https://x-theory.kit.com/1e03b15cdc">https://x-theory.kit.com/1e03b15cdc</a><br>Guest's Bio: <strong>Dr. Axa Yox</strong> is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of <em>X Theory</em>, host of the <em>W.H.Y. – What How Y</em> podcast, and author of <em>Foolfilled Life</em>, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at <em>BRAINZ Magazine</em>, Axa brings deep scientific insight to personal development, branding, and the psychology of change.<br></p>]]>
      </itunes:summary>
      <itunes:keywords>Axa Yox, nutrition, biotechnology, personal branding, health mechanisms, longevity, epigenetics, diet, gut microbiota, failures, biochemistry, health, intermittent fasting, diet, personal transformation, food choices, personal branding, stress management, community engagement, longevity</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://x-theory.kit.com/1e03b15cdc" img="https://img.transistorcdn.com/vR_Xa5TWuRAu_kTpeJS-6WCoSWZZ8y3o-Lp6gFttMpg/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iMTQ2/YTc3NjQxNGQ4OTI1/YjczNGU5OWU3MjUy/NjJiMi5qcGVn.jpg">Dr. Axa Yox</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/34981814/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/34981814/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/34981814/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/34981814/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/34981814/transcription" type="text/html"/>
    </item>
    <item>
      <title>Wellness Through Genomics: Innovative Genetic Analysis Technology with Len May </title>
      <itunes:episode>10</itunes:episode>
      <podcast:episode>10</podcast:episode>
      <itunes:title>Wellness Through Genomics: Innovative Genetic Analysis Technology with Len May </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">55db3aaf-f14b-49a7-beaa-c0f7952475f3</guid>
      <link>https://share.transistor.fm/s/5b1b2007</link>
      <description>
        <![CDATA[<p>In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.</p><p><strong>Guest Information:</strong><br>Guest's Name: Len May<br>Guest's Title/Position: Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/lenmay/">https://www.linkedin.com/in/lenmay/</a> <br>Company/Affiliation: <a href="https://endodna.com/">EndoDNA</a><br>Guest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast <em>Everything is Personal</em>. His books <em>Making Cannabis Personal</em> and <em>ADD is a Superpower</em> highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.</p><p><br><strong>Links and Resources:</strong><br>Podcast:<a href="https://open.spotify.com/show/3eTaSgbTA2oafrb3cbrDAK"> <em>Everything is Personal </em></a><br>Books: <a href="https://www.amazon.ca/Making-Cannabis-Personal-Guesswork-Experience-ebook/dp/B0B7FM8XFG/ref=sr_1_3?dib=eyJ2IjoiMSJ9.CZ80fji9rmcXj7kJYaCXsm1mIT_WRGDnjD6aIv7Mg4EsGoP2n_9O0wdKYHziYGDs0RIT38nT1MAhKLGeW3a-I5j0zGvm9n0DFRr68SsoOlw9UWDZQZREs2CpjPQXfxoQ5LAE06Fg3OtFLAulNvw-grFjk4JNnq66ULVL63Fx90A3Z6t2WPCrf2L_H1wNZ2ZLakH_b8PJiziT9dHN_8tUJSPXJqsGE3Yndmwh4I_66O0.ANZSzXSM5fBN9peaeEhbxLGRmXtHWBm2JUeuq824qag&amp;dib_tag=se&amp;qid=1748460944&amp;refinements=p_27%3ALen+May&amp;s=books&amp;sr=1-3&amp;text=Len+May"><em>Making Cannabis Personal</em> </a>/ <em>ADD is a Superpower</em><br>Website: <a href="https://www.lenmaycoaching.com/">https://www.lenmaycoaching.com/</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.</p><p><strong>Guest Information:</strong><br>Guest's Name: Len May<br>Guest's Title/Position: Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/lenmay/">https://www.linkedin.com/in/lenmay/</a> <br>Company/Affiliation: <a href="https://endodna.com/">EndoDNA</a><br>Guest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast <em>Everything is Personal</em>. His books <em>Making Cannabis Personal</em> and <em>ADD is a Superpower</em> highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.</p><p><br><strong>Links and Resources:</strong><br>Podcast:<a href="https://open.spotify.com/show/3eTaSgbTA2oafrb3cbrDAK"> <em>Everything is Personal </em></a><br>Books: <a href="https://www.amazon.ca/Making-Cannabis-Personal-Guesswork-Experience-ebook/dp/B0B7FM8XFG/ref=sr_1_3?dib=eyJ2IjoiMSJ9.CZ80fji9rmcXj7kJYaCXsm1mIT_WRGDnjD6aIv7Mg4EsGoP2n_9O0wdKYHziYGDs0RIT38nT1MAhKLGeW3a-I5j0zGvm9n0DFRr68SsoOlw9UWDZQZREs2CpjPQXfxoQ5LAE06Fg3OtFLAulNvw-grFjk4JNnq66ULVL63Fx90A3Z6t2WPCrf2L_H1wNZ2ZLakH_b8PJiziT9dHN_8tUJSPXJqsGE3Yndmwh4I_66O0.ANZSzXSM5fBN9peaeEhbxLGRmXtHWBm2JUeuq824qag&amp;dib_tag=se&amp;qid=1748460944&amp;refinements=p_27%3ALen+May&amp;s=books&amp;sr=1-3&amp;text=Len+May"><em>Making Cannabis Personal</em> </a>/ <em>ADD is a Superpower</em><br>Website: <a href="https://www.lenmaycoaching.com/">https://www.lenmaycoaching.com/</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 28 May 2025 14:00:00 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/5b1b2007/cb2750d2.mp3" length="99697749" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/_jYlhAyK96E-lmhFzz0M_857H_OcKrm5aEb5mZHB_rc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kMzk2/NWIyM2JjMTEzZTdk/MDgzZjEwZWM0NmFj/OWM2Yy5qcGc.jpg"/>
      <itunes:duration>4149</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.</p><p><strong>Guest Information:</strong><br>Guest's Name: Len May<br>Guest's Title/Position: Chief Executive Officer<br>Guest's Linkedin: <a href="https://www.linkedin.com/in/lenmay/">https://www.linkedin.com/in/lenmay/</a> <br>Company/Affiliation: <a href="https://endodna.com/">EndoDNA</a><br>Guest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast <em>Everything is Personal</em>. His books <em>Making Cannabis Personal</em> and <em>ADD is a Superpower</em> highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.</p><p><br><strong>Links and Resources:</strong><br>Podcast:<a href="https://open.spotify.com/show/3eTaSgbTA2oafrb3cbrDAK"> <em>Everything is Personal </em></a><br>Books: <a href="https://www.amazon.ca/Making-Cannabis-Personal-Guesswork-Experience-ebook/dp/B0B7FM8XFG/ref=sr_1_3?dib=eyJ2IjoiMSJ9.CZ80fji9rmcXj7kJYaCXsm1mIT_WRGDnjD6aIv7Mg4EsGoP2n_9O0wdKYHziYGDs0RIT38nT1MAhKLGeW3a-I5j0zGvm9n0DFRr68SsoOlw9UWDZQZREs2CpjPQXfxoQ5LAE06Fg3OtFLAulNvw-grFjk4JNnq66ULVL63Fx90A3Z6t2WPCrf2L_H1wNZ2ZLakH_b8PJiziT9dHN_8tUJSPXJqsGE3Yndmwh4I_66O0.ANZSzXSM5fBN9peaeEhbxLGRmXtHWBm2JUeuq824qag&amp;dib_tag=se&amp;qid=1748460944&amp;refinements=p_27%3ALen+May&amp;s=books&amp;sr=1-3&amp;text=Len+May"><em>Making Cannabis Personal</em> </a>/ <em>ADD is a Superpower</em><br>Website: <a href="https://www.lenmaycoaching.com/">https://www.lenmaycoaching.com/</a></p>]]>
      </itunes:summary>
      <itunes:keywords>EndoDNA, genetics, genomics, healthcare, personalized medicine, cannabis, testing solutions, healthcare professionals, lifestyle choices, patient stories, innovation, healthcare, preventative health, longevity, endocannabinoid system, partnerships, precision health, lifestyle, genetics, mentorship, music</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://endodna.com/" img="https://img.transistorcdn.com/aU-JWo0jZj4rTIKvdd7TGxaYy-wCvragN68yj9eqCII/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZmQw/ZGE0NmVjMmQ3YjFl/M2IyYjVkMDM1NDhj/NzcxYy5qcGVn.jpg">Len May</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/5b1b2007/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5b1b2007/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5b1b2007/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5b1b2007/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/5b1b2007/transcription" type="text/html"/>
    </item>
    <item>
      <title>AI in Modern Medicine: The Future of Patient Interaction with Dr. Jay H. Sanders</title>
      <itunes:episode>9</itunes:episode>
      <podcast:episode>9</podcast:episode>
      <itunes:title>AI in Modern Medicine: The Future of Patient Interaction with Dr. Jay H. Sanders</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">405b89db-1469-4672-b4f8-c088101fd4ef</guid>
      <link>https://share.transistor.fm/s/b9a0bd05</link>
      <description>
        <![CDATA[<p>In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.</p><p><strong>Chapters</strong><br>00:00 Introduction to Jay Sanders and Telemedicine<br>05:05 The Evolution of Telemedicine<br>10:02 Economic Impact of Telemedicine on Rural Healthcare<br>15:04 The Role of AI in Medicine<br>20:12 Current Work and Future of Telemedicine<br>25:06 The Future of Healthcare: Anticipatory Medicine<br>27:55 Leveraging Technology for Patient Care<br>30:02 AI in Medical Decision Making<br>31:59 Cybersecurity in Healthcare Data<br>34:10 The Future of Healthcare Post-Pandemic<br>41:01 Innovations in Telemedicine and AI<br>45:57 The Vision for Future Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Jay H. Sanders</strong></li><li>Guest's Title/Position: Chief Executive Officer</li><li>Guest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/.  </li><li>Company/Affiliation: <strong>The Global Telemedicine Group</strong></li><li>Guest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.</li></ul><p><br><strong>Links and Resources:</strong></p><ul><li><strong>Co-Author of the Book Digital Medical Home</strong></li><li>Available on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKY</li></ul><p><br><strong>Takeaways</strong></p><ul><li>The term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.</li><li>Telemedicine can significantly improve healthcare access in rural areas.</li><li>Economic factors play a crucial role in the sustainability of rural hospitals.</li><li>AI has the potential to surpass human physicians in certain areas of healthcare.</li><li>The best examination of a patient occurs in their home environment.</li><li>Telemedicine has evolved from using microwave antennas to modern telecommunications.</li><li>COVID-19 accelerated the acceptance and payment for telemedicine services.</li><li>Healthcare needs to shift from reactionary to anticipatory models.</li><li>Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.</li><li>AI can assist in making informed medical decisions.</li><li>Cybersecurity is a critical concern for healthcare data.</li><li>The pandemic has accelerated changes in healthcare delivery.</li><li>Patients need to take more responsibility for their health.</li><li>Telemedicine is becoming a standard practice in healthcare.</li><li>Integrating genetics into healthcare can enhance treatment specificity.</li><li>Healthcare systems must adapt to new technologies for better outcomes.</li><li>Access to healthcare is essential, but accuracy is equally important.</li><li>The future of healthcare will rely on innovative technologies and patient engagement.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.</p><p><strong>Chapters</strong><br>00:00 Introduction to Jay Sanders and Telemedicine<br>05:05 The Evolution of Telemedicine<br>10:02 Economic Impact of Telemedicine on Rural Healthcare<br>15:04 The Role of AI in Medicine<br>20:12 Current Work and Future of Telemedicine<br>25:06 The Future of Healthcare: Anticipatory Medicine<br>27:55 Leveraging Technology for Patient Care<br>30:02 AI in Medical Decision Making<br>31:59 Cybersecurity in Healthcare Data<br>34:10 The Future of Healthcare Post-Pandemic<br>41:01 Innovations in Telemedicine and AI<br>45:57 The Vision for Future Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Jay H. Sanders</strong></li><li>Guest's Title/Position: Chief Executive Officer</li><li>Guest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/.  </li><li>Company/Affiliation: <strong>The Global Telemedicine Group</strong></li><li>Guest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.</li></ul><p><br><strong>Links and Resources:</strong></p><ul><li><strong>Co-Author of the Book Digital Medical Home</strong></li><li>Available on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKY</li></ul><p><br><strong>Takeaways</strong></p><ul><li>The term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.</li><li>Telemedicine can significantly improve healthcare access in rural areas.</li><li>Economic factors play a crucial role in the sustainability of rural hospitals.</li><li>AI has the potential to surpass human physicians in certain areas of healthcare.</li><li>The best examination of a patient occurs in their home environment.</li><li>Telemedicine has evolved from using microwave antennas to modern telecommunications.</li><li>COVID-19 accelerated the acceptance and payment for telemedicine services.</li><li>Healthcare needs to shift from reactionary to anticipatory models.</li><li>Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.</li><li>AI can assist in making informed medical decisions.</li><li>Cybersecurity is a critical concern for healthcare data.</li><li>The pandemic has accelerated changes in healthcare delivery.</li><li>Patients need to take more responsibility for their health.</li><li>Telemedicine is becoming a standard practice in healthcare.</li><li>Integrating genetics into healthcare can enhance treatment specificity.</li><li>Healthcare systems must adapt to new technologies for better outcomes.</li><li>Access to healthcare is essential, but accuracy is equally important.</li><li>The future of healthcare will rely on innovative technologies and patient engagement.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 20 May 2025 17:40:11 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/b9a0bd05/f0e0f552.mp3" length="74187739" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/0RH3OvArrpg5FCSkkh5Tfzctn7wJhLO2KgD5BTdv3So/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NTg2/OTI4NDQzYTFlNDY3/MWVhMjQ3YzgzNjIz/NmViMi5qcGc.jpg"/>
      <itunes:duration>3080</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.</p><p><strong>Chapters</strong><br>00:00 Introduction to Jay Sanders and Telemedicine<br>05:05 The Evolution of Telemedicine<br>10:02 Economic Impact of Telemedicine on Rural Healthcare<br>15:04 The Role of AI in Medicine<br>20:12 Current Work and Future of Telemedicine<br>25:06 The Future of Healthcare: Anticipatory Medicine<br>27:55 Leveraging Technology for Patient Care<br>30:02 AI in Medical Decision Making<br>31:59 Cybersecurity in Healthcare Data<br>34:10 The Future of Healthcare Post-Pandemic<br>41:01 Innovations in Telemedicine and AI<br>45:57 The Vision for Future Healthcare</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name:<strong> Dr. Jay H. Sanders</strong></li><li>Guest's Title/Position: Chief Executive Officer</li><li>Guest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/.  </li><li>Company/Affiliation: <strong>The Global Telemedicine Group</strong></li><li>Guest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.</li></ul><p><br><strong>Links and Resources:</strong></p><ul><li><strong>Co-Author of the Book Digital Medical Home</strong></li><li>Available on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKY</li></ul><p><br><strong>Takeaways</strong></p><ul><li>The term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.</li><li>Telemedicine can significantly improve healthcare access in rural areas.</li><li>Economic factors play a crucial role in the sustainability of rural hospitals.</li><li>AI has the potential to surpass human physicians in certain areas of healthcare.</li><li>The best examination of a patient occurs in their home environment.</li><li>Telemedicine has evolved from using microwave antennas to modern telecommunications.</li><li>COVID-19 accelerated the acceptance and payment for telemedicine services.</li><li>Healthcare needs to shift from reactionary to anticipatory models.</li><li>Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.</li><li>AI can assist in making informed medical decisions.</li><li>Cybersecurity is a critical concern for healthcare data.</li><li>The pandemic has accelerated changes in healthcare delivery.</li><li>Patients need to take more responsibility for their health.</li><li>Telemedicine is becoming a standard practice in healthcare.</li><li>Integrating genetics into healthcare can enhance treatment specificity.</li><li>Healthcare systems must adapt to new technologies for better outcomes.</li><li>Access to healthcare is essential, but accuracy is equally important.</li><li>The future of healthcare will rely on innovative technologies and patient engagement.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>telemedicine, AI in healthcare, rural healthcare, healthcare technology, Jay Sanders, medical innovation, healthcare delivery, economic impact, anticipatory medicine, healthcare systems, healthcare, technology, AI, telemedicine, patient care, cybersecurity, medical records, future of healthcare, innovations, healthcare data</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKY" img="https://img.transistorcdn.com/gnQjNaro8Ng0Qp59PTp-GId078ydWtqwzJfUs6D59gU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MGFj/NGI1NWI3NjQ0ZDZh/OWVjYmNjODNlZTli/NzAwZC5qcGVn.jpg">Dr. Jay H. Sanders</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/b9a0bd05/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b9a0bd05/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b9a0bd05/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/b9a0bd05/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/b9a0bd05/transcription" type="text/html"/>
    </item>
    <item>
      <title>Health Tech Evolution - The Future of Bio-Electronic Medicine with Dan Goldberger</title>
      <itunes:episode>8</itunes:episode>
      <podcast:episode>8</podcast:episode>
      <itunes:title>Health Tech Evolution - The Future of Bio-Electronic Medicine with Dan Goldberger</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1dca5806-4e39-48ad-b4d8-c2653467880a</guid>
      <link>https://share.transistor.fm/s/aa970251</link>
      <description>
        <![CDATA[<p>In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.</p><p><strong>Special Podcast Offer: 10%</strong><a href="https://www.truvaga.com/"><strong> truvaga</strong></a><strong> discount code HEALTH10</strong></p><p><br>00:00<br>Introduction to Electric Core and Its Innovations</p><p>04:48<br>Understanding Vagus Nerve Stimulation</p><p>10:00<br>The Impact of Headaches and PTSD</p><p>15:02<br>Leadership Lessons and Building Culture</p><p>19:59<br>The Future of Bio-Electronic Medicine</p><p>21:06<br>The Electrical Nature of the Human Body</p><p>28:29<br>Marketing Evolution in Healthcare</p><p>33:59<br>Navigating AI and Automation in Health Tech</p><p>37:32<br>Reflections on Career and Life Lessons</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Dan Goldberger</li><li>Guest's Title/Position: Chief Executive Officer</li><li>https://www.linkedin.com/in/goldbergerdan/</li><li>Company/Affiliation: <a href="https://www.electrocore.com/">electroCore</a></li><li>Guest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. </li></ul><p><br><strong>Links and Resources:</strong></p><ul><li>electroCore Website:<a href="https://www.electrocore.com/"> https://www.electrocore.com/</a></li><li>Special Podcast<strong> </strong>Offer: 10%<a href="https://www.truvaga.com/"><strong> truvaga</strong></a> discount code <strong>HEALTH10</strong></li></ul><p><br><strong>Key Takeaways</strong></p><ul><li>The company offers products for treating headaches and is expanding into PTSD treatment.</li><li>Vagus nerve stimulation has a wide range of potential applications in medicine.</li><li>The technology has a benign safety profile with minimal side effects.</li><li>Leadership is about surrounding yourself with the right people and building a strong culture.</li><li>Listening is a crucial skill for effective leadership and learning.</li><li>Embracing change is essential for resilience in business.</li><li>The future of bio-electronic medicine is promising and innovative.</li><li>Dan emphasizes the importance of leading by example in building company culture.</li><li>The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.</li><li>Bioelectronics is an emerging field in healthcare.</li><li>The vagus nerve plays a crucial role in balance.</li><li>Stimulating the vagus nerve can restore homeostasis.</li><li>Marketing in healthcare is increasingly complex.</li><li>AI is not yet a strategic focus for their company.</li><li>Direct consumer access to health tech is growing.</li><li>Ethics and morality are vital in business.</li><li>Career reflections emphasize the importance of relationships.</li><li>Helping others is the core motivation in health tech.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.</p><p><strong>Special Podcast Offer: 10%</strong><a href="https://www.truvaga.com/"><strong> truvaga</strong></a><strong> discount code HEALTH10</strong></p><p><br>00:00<br>Introduction to Electric Core and Its Innovations</p><p>04:48<br>Understanding Vagus Nerve Stimulation</p><p>10:00<br>The Impact of Headaches and PTSD</p><p>15:02<br>Leadership Lessons and Building Culture</p><p>19:59<br>The Future of Bio-Electronic Medicine</p><p>21:06<br>The Electrical Nature of the Human Body</p><p>28:29<br>Marketing Evolution in Healthcare</p><p>33:59<br>Navigating AI and Automation in Health Tech</p><p>37:32<br>Reflections on Career and Life Lessons</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Dan Goldberger</li><li>Guest's Title/Position: Chief Executive Officer</li><li>https://www.linkedin.com/in/goldbergerdan/</li><li>Company/Affiliation: <a href="https://www.electrocore.com/">electroCore</a></li><li>Guest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. </li></ul><p><br><strong>Links and Resources:</strong></p><ul><li>electroCore Website:<a href="https://www.electrocore.com/"> https://www.electrocore.com/</a></li><li>Special Podcast<strong> </strong>Offer: 10%<a href="https://www.truvaga.com/"><strong> truvaga</strong></a> discount code <strong>HEALTH10</strong></li></ul><p><br><strong>Key Takeaways</strong></p><ul><li>The company offers products for treating headaches and is expanding into PTSD treatment.</li><li>Vagus nerve stimulation has a wide range of potential applications in medicine.</li><li>The technology has a benign safety profile with minimal side effects.</li><li>Leadership is about surrounding yourself with the right people and building a strong culture.</li><li>Listening is a crucial skill for effective leadership and learning.</li><li>Embracing change is essential for resilience in business.</li><li>The future of bio-electronic medicine is promising and innovative.</li><li>Dan emphasizes the importance of leading by example in building company culture.</li><li>The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.</li><li>Bioelectronics is an emerging field in healthcare.</li><li>The vagus nerve plays a crucial role in balance.</li><li>Stimulating the vagus nerve can restore homeostasis.</li><li>Marketing in healthcare is increasingly complex.</li><li>AI is not yet a strategic focus for their company.</li><li>Direct consumer access to health tech is growing.</li><li>Ethics and morality are vital in business.</li><li>Career reflections emphasize the importance of relationships.</li><li>Helping others is the core motivation in health tech.</li></ul>]]>
      </content:encoded>
      <pubDate>Thu, 15 May 2025 14:37:18 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/aa970251/1551be4b.mp3" length="59543590" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/RTaH1aSNy1-Qwn_DwPR7JyK2MXwCMzzNSkKt018OZZE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMjE4/Yjg5MGNkYmU4NTJm/ZmMzYWY5M2JhZDBk/YjY0My5qcGc.jpg"/>
      <itunes:duration>2475</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.</p><p><strong>Special Podcast Offer: 10%</strong><a href="https://www.truvaga.com/"><strong> truvaga</strong></a><strong> discount code HEALTH10</strong></p><p><br>00:00<br>Introduction to Electric Core and Its Innovations</p><p>04:48<br>Understanding Vagus Nerve Stimulation</p><p>10:00<br>The Impact of Headaches and PTSD</p><p>15:02<br>Leadership Lessons and Building Culture</p><p>19:59<br>The Future of Bio-Electronic Medicine</p><p>21:06<br>The Electrical Nature of the Human Body</p><p>28:29<br>Marketing Evolution in Healthcare</p><p>33:59<br>Navigating AI and Automation in Health Tech</p><p>37:32<br>Reflections on Career and Life Lessons</p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Dan Goldberger</li><li>Guest's Title/Position: Chief Executive Officer</li><li>https://www.linkedin.com/in/goldbergerdan/</li><li>Company/Affiliation: <a href="https://www.electrocore.com/">electroCore</a></li><li>Guest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. </li></ul><p><br><strong>Links and Resources:</strong></p><ul><li>electroCore Website:<a href="https://www.electrocore.com/"> https://www.electrocore.com/</a></li><li>Special Podcast<strong> </strong>Offer: 10%<a href="https://www.truvaga.com/"><strong> truvaga</strong></a> discount code <strong>HEALTH10</strong></li></ul><p><br><strong>Key Takeaways</strong></p><ul><li>The company offers products for treating headaches and is expanding into PTSD treatment.</li><li>Vagus nerve stimulation has a wide range of potential applications in medicine.</li><li>The technology has a benign safety profile with minimal side effects.</li><li>Leadership is about surrounding yourself with the right people and building a strong culture.</li><li>Listening is a crucial skill for effective leadership and learning.</li><li>Embracing change is essential for resilience in business.</li><li>The future of bio-electronic medicine is promising and innovative.</li><li>Dan emphasizes the importance of leading by example in building company culture.</li><li>The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.</li><li>Bioelectronics is an emerging field in healthcare.</li><li>The vagus nerve plays a crucial role in balance.</li><li>Stimulating the vagus nerve can restore homeostasis.</li><li>Marketing in healthcare is increasingly complex.</li><li>AI is not yet a strategic focus for their company.</li><li>Direct consumer access to health tech is growing.</li><li>Ethics and morality are vital in business.</li><li>Career reflections emphasize the importance of relationships.</li><li>Helping others is the core motivation in health tech.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>ElectroCore, Vagus Nerve Stimulation, Headache Treatment, PTSD, Bio-Electronic Medicine, Health Technology, Medical Innovations, Leadership, Company Culture, Medical Devices, bioelectronics, healthcare, marketing, AI, wellness, vagus nerve, PTSD, migraines, health tech</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.electrocore.com/" img="https://img.transistorcdn.com/ZSkcJ2AIHQXd7AHRdOeTksRZYfcgnE2OQowcKMkHcRQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZjJk/ZTgyMTJhMmMyMDk1/NTBlOTk5YzRhYTA1/MmE2Zi5qcGVn.jpg">Dan Goldberger</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/aa970251/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/aa970251/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/aa970251/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/aa970251/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/aa970251/transcription" type="text/html"/>
    </item>
    <item>
      <title>Rise of Fractional Executives - Finding Your Suite Spot with Real Rousseau</title>
      <itunes:episode>7</itunes:episode>
      <podcast:episode>7</podcast:episode>
      <itunes:title>Rise of Fractional Executives - Finding Your Suite Spot with Real Rousseau</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">758555a7-6f39-41c1-9a44-2edaa594dc76</guid>
      <link>https://share.transistor.fm/s/55bf70c9</link>
      <description>
        <![CDATA[<p>In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.</p><p><br><strong>Chapters<br></strong><br></p><p>00:00<br>Introduction to Fractional Management</p><p>02:56<br>The Rise of Fractional Executives</p><p>05:57<br>Benefits of Fractional C-Suite Engagement</p><p>08:59<br>Identifying the Right Time for Fractional Support</p><p>11:59<br>Strategic Planning and Implementation</p><p>14:49<br>The Role of Fractional Executives in Growth</p><p>18:02<br>Leveraging Experience Across Industries</p><p>20:57<br>Conclusion and Future of Fractional Management</p><p><br></p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Real Rousseau</li><li>Guest's Title/Position: Chief Strategy Officer</li><li>https://www.linkedin.com/in/real-rousseau-5b150422/</li><li>Company/Affiliation: <a href="https://thebullzeye.com/">Bullzeye Media Marketing</a></li><li>Guest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.</li></ul><p><br><strong>Takeaways</strong></p><ul><li>Fractional management offers executive expertise at a lower cost.</li><li>The rise of fractional executives coincided with the COVID-19 pandemic.</li><li>Fractional executives are part of the team, unlike consultants.</li><li>Hiring junior staff may not always provide the needed expertise.</li><li>Fractional executives can help identify when a business needs support.</li><li>Strategic planning is crucial for business growth and accountability.</li><li>Fractional executives can help implement financial processes and budgeting.</li><li>AI tools can assist but cannot replace the need for human expertise.</li><li>Fractional roles can evolve as the business grows and changes.</li><li>Collaboration between fractional executives and business owners enhances growth.</li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.</p><p><br><strong>Chapters<br></strong><br></p><p>00:00<br>Introduction to Fractional Management</p><p>02:56<br>The Rise of Fractional Executives</p><p>05:57<br>Benefits of Fractional C-Suite Engagement</p><p>08:59<br>Identifying the Right Time for Fractional Support</p><p>11:59<br>Strategic Planning and Implementation</p><p>14:49<br>The Role of Fractional Executives in Growth</p><p>18:02<br>Leveraging Experience Across Industries</p><p>20:57<br>Conclusion and Future of Fractional Management</p><p><br></p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Real Rousseau</li><li>Guest's Title/Position: Chief Strategy Officer</li><li>https://www.linkedin.com/in/real-rousseau-5b150422/</li><li>Company/Affiliation: <a href="https://thebullzeye.com/">Bullzeye Media Marketing</a></li><li>Guest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.</li></ul><p><br><strong>Takeaways</strong></p><ul><li>Fractional management offers executive expertise at a lower cost.</li><li>The rise of fractional executives coincided with the COVID-19 pandemic.</li><li>Fractional executives are part of the team, unlike consultants.</li><li>Hiring junior staff may not always provide the needed expertise.</li><li>Fractional executives can help identify when a business needs support.</li><li>Strategic planning is crucial for business growth and accountability.</li><li>Fractional executives can help implement financial processes and budgeting.</li><li>AI tools can assist but cannot replace the need for human expertise.</li><li>Fractional roles can evolve as the business grows and changes.</li><li>Collaboration between fractional executives and business owners enhances growth.</li></ul>]]>
      </content:encoded>
      <pubDate>Tue, 13 May 2025 10:46:27 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/55bf70c9/de30ebb5.mp3" length="36830256" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/onszvbai06rMdziqhXEOp19sMJzSrEG1E4itb9sM0JY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hZDkx/YzE0NWJkYmIzNmZk/YzU1ZTA2ODdkMDg2/ZjgxYi5qcGc.jpg"/>
      <itunes:duration>1532</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.</p><p><br><strong>Chapters<br></strong><br></p><p>00:00<br>Introduction to Fractional Management</p><p>02:56<br>The Rise of Fractional Executives</p><p>05:57<br>Benefits of Fractional C-Suite Engagement</p><p>08:59<br>Identifying the Right Time for Fractional Support</p><p>11:59<br>Strategic Planning and Implementation</p><p>14:49<br>The Role of Fractional Executives in Growth</p><p>18:02<br>Leveraging Experience Across Industries</p><p>20:57<br>Conclusion and Future of Fractional Management</p><p><br></p><p><strong>Guest Information:</strong></p><ul><li>Guest's Name: Real Rousseau</li><li>Guest's Title/Position: Chief Strategy Officer</li><li>https://www.linkedin.com/in/real-rousseau-5b150422/</li><li>Company/Affiliation: <a href="https://thebullzeye.com/">Bullzeye Media Marketing</a></li><li>Guest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.</li></ul><p><br><strong>Takeaways</strong></p><ul><li>Fractional management offers executive expertise at a lower cost.</li><li>The rise of fractional executives coincided with the COVID-19 pandemic.</li><li>Fractional executives are part of the team, unlike consultants.</li><li>Hiring junior staff may not always provide the needed expertise.</li><li>Fractional executives can help identify when a business needs support.</li><li>Strategic planning is crucial for business growth and accountability.</li><li>Fractional executives can help implement financial processes and budgeting.</li><li>AI tools can assist but cannot replace the need for human expertise.</li><li>Fractional roles can evolve as the business grows and changes.</li><li>Collaboration between fractional executives and business owners enhances growth.</li></ul>]]>
      </itunes:summary>
      <itunes:keywords>ractional management, C-suite, executive leadership, consulting, business growth, strategy, operational management, fractional executives, entrepreneurship, organizational structure</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/ZD-LWRw7JkJiqNf4dsUmW2OYaEtHlKoX5yoahN6WbBU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MTZj/MTQwN2FjNTQ0Yzky/MjgzYTg1YjkwNTVl/YzBkYi5qcGVn.jpg">Real Rousseau</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/55bf70c9/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/55bf70c9/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/55bf70c9/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/55bf70c9/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/55bf70c9/transcription" type="text/html"/>
    </item>
    <item>
      <title>Vision Meets Innovation: Leading in Life Sciences with David Esposito</title>
      <itunes:episode>6</itunes:episode>
      <podcast:episode>6</podcast:episode>
      <itunes:title>Vision Meets Innovation: Leading in Life Sciences with David Esposito</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3a7d9e4f-a9a9-49a6-b1c3-fa760334c53f</guid>
      <link>https://share.transistor.fm/s/fc8a3038</link>
      <description>
        <![CDATA[<p>In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and David Esposito's Background</li><li>02:09 - ONL Therapeutics and its Focus</li><li>09:05 - David Esposito’s Career Journey</li><li>24:47 - Leadership and Team Building</li><li>32:35 - Challenges in Biotech and Company Growth</li><li>48:22 - Marketing and Clinical Trial Enrollment</li><li>58:52 - Funding and Future Outlook</li><li>1:09:09 - Inspiration and Advice</li><li>1:19:31 - The Future of Healthcare Innovation</li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: David Esposito</li><li>Guest's Title/Position: CEO</li><li>Company/Affiliation: <a href="https://onltherapeutics.com/">ONL Therapeutics</a></li><li>Guest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.</li></ul><p><br>Links and Resources:</p><ul><li>ONL Therapeutics: <a href="https://onltherapeutics.com/">https://onltherapeutics.com/</a></li><li>RA Capital: <a href="https://www.racap.com/">https://www.racap.com/</a></li><li>Andreessen Horowitz: <a href="https://a16z.com/">https://a16z.com/</a></li></ul><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and David Esposito's Background</li><li>02:09 - ONL Therapeutics and its Focus</li><li>09:05 - David Esposito’s Career Journey</li><li>24:47 - Leadership and Team Building</li><li>32:35 - Challenges in Biotech and Company Growth</li><li>48:22 - Marketing and Clinical Trial Enrollment</li><li>58:52 - Funding and Future Outlook</li><li>1:09:09 - Inspiration and Advice</li><li>1:19:31 - The Future of Healthcare Innovation</li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: David Esposito</li><li>Guest's Title/Position: CEO</li><li>Company/Affiliation: <a href="https://onltherapeutics.com/">ONL Therapeutics</a></li><li>Guest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.</li></ul><p><br>Links and Resources:</p><ul><li>ONL Therapeutics: <a href="https://onltherapeutics.com/">https://onltherapeutics.com/</a></li><li>RA Capital: <a href="https://www.racap.com/">https://www.racap.com/</a></li><li>Andreessen Horowitz: <a href="https://a16z.com/">https://a16z.com/</a></li></ul><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:32:41 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/fc8a3038/16891564.mp3" length="56013552" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/psmn0F237yyykkZDRt5Katu9Vq9filLMXk11Y50hf5Y/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNjQz/ZDJhYTY5Mzg3YWQ5/NjBjOGI4YmIyOGYw/ZjYwMi5qcGc.jpg"/>
      <itunes:duration>2330</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and David Esposito's Background</li><li>02:09 - ONL Therapeutics and its Focus</li><li>09:05 - David Esposito’s Career Journey</li><li>24:47 - Leadership and Team Building</li><li>32:35 - Challenges in Biotech and Company Growth</li><li>48:22 - Marketing and Clinical Trial Enrollment</li><li>58:52 - Funding and Future Outlook</li><li>1:09:09 - Inspiration and Advice</li><li>1:19:31 - The Future of Healthcare Innovation</li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: David Esposito</li><li>Guest's Title/Position: CEO</li><li>Company/Affiliation: <a href="https://onltherapeutics.com/">ONL Therapeutics</a></li><li>Guest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.</li></ul><p><br>Links and Resources:</p><ul><li>ONL Therapeutics: <a href="https://onltherapeutics.com/">https://onltherapeutics.com/</a></li><li>RA Capital: <a href="https://www.racap.com/">https://www.racap.com/</a></li><li>Andreessen Horowitz: <a href="https://a16z.com/">https://a16z.com/</a></li></ul><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Healthcare, biotech, CEO, leadership, ophthalmology, drug development, clinical trials, business strategy, innovation, team building</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://onltherapeutics.com/" img="https://img.transistorcdn.com/70NpiNKvsC_IHMcbXGMVNXZLUciIdu3hpmuFI_KxjzQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iYTAz/OTQ5OTJlMmEwZGVm/OWRjZmJmNjViY2Y0/ZmIxMC5qcGVn.jpg">David Esposito</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/fc8a3038/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fc8a3038/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fc8a3038/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fc8a3038/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/fc8a3038/transcription" type="text/html"/>
    </item>
    <item>
      <title>Disrupting Skincare Standards: A Foundation of Science with Dr. Alena Butkevica</title>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>Disrupting Skincare Standards: A Foundation of Science with Dr. Alena Butkevica</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d8171d50-9ec2-4fdd-8df9-e4359097a855</guid>
      <link>https://share.transistor.fm/s/d36c2aa2</link>
      <description>
        <![CDATA[<p>In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Alena Butkevica's Background    </li><li>10:00 - Dr. Alena Butkevica's Career and Surgical Experience    </li><li>37:00 - Explanation of Circulation and the Effects of Aging    </li><li>55:00 - Development of AB Bio Products    </li><li>1:20:00 - Discussion on Skincare Ingredients and Product Application    </li><li>1:40:00 - The Future of AB Bio and the Importance of Marketing    </li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: Dr. Alena Butkevica</li><li>Guest's Title/Position: MD, DMD, PhD, CEO, and Lead Researcher</li><li>Company/Affiliation: <a href="https://abbio.io/">AB Bio Innovations</a></li><li>Guest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.    </li></ul><p><br></p><p><br></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Alena Butkevica's Background    </li><li>10:00 - Dr. Alena Butkevica's Career and Surgical Experience    </li><li>37:00 - Explanation of Circulation and the Effects of Aging    </li><li>55:00 - Development of AB Bio Products    </li><li>1:20:00 - Discussion on Skincare Ingredients and Product Application    </li><li>1:40:00 - The Future of AB Bio and the Importance of Marketing    </li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: Dr. Alena Butkevica</li><li>Guest's Title/Position: MD, DMD, PhD, CEO, and Lead Researcher</li><li>Company/Affiliation: <a href="https://abbio.io/">AB Bio Innovations</a></li><li>Guest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.    </li></ul><p><br></p><p><br></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:32:30 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/d36c2aa2/a5bff161.mp3" length="75575178" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/kbbtjDr5V-Lfsir4IyPkrjET3cA4X6w-Do45WwXm2oA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kMmM1/YmY2NzRmNWIxZTU3/NzM3ZTFjOWE0Zjdm/NDlmNy5qcGc.jpg"/>
      <itunes:duration>3143</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Alena Butkevica's Background    </li><li>10:00 - Dr. Alena Butkevica's Career and Surgical Experience    </li><li>37:00 - Explanation of Circulation and the Effects of Aging    </li><li>55:00 - Development of AB Bio Products    </li><li>1:20:00 - Discussion on Skincare Ingredients and Product Application    </li><li>1:40:00 - The Future of AB Bio and the Importance of Marketing    </li></ul><p><br></p><p>Guest Information:</p><ul><li>Guest's Name: Dr. Alena Butkevica</li><li>Guest's Title/Position: MD, DMD, PhD, CEO, and Lead Researcher</li><li>Company/Affiliation: <a href="https://abbio.io/">AB Bio Innovations</a></li><li>Guest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.    </li></ul><p><br></p><p><br></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Skincare, anti-aging, surgery alternatives, natural ingredients, nanotechnology, skin health, wound healing, AB Bio Innovations, scientific research, product development</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://abbio.io/" img="https://img.transistorcdn.com/j5GbnAXq3Dr_m7jK-p4hPI6N-Rd87ol6JIYW_y15Qs0/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjVh/YjQwYWFmZGRjYWEy/MDEwZWUzNjQ1MDNh/Mjg4MS5qcGVn.jpg">Dr. Alena Butkevica</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/d36c2aa2/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d36c2aa2/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d36c2aa2/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/d36c2aa2/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/d36c2aa2/transcription" type="text/html"/>
    </item>
    <item>
      <title>Biotech on the Blockchain: Rare Disease Solutions with Dr. Ethan Perlstein</title>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>Biotech on the Blockchain: Rare Disease Solutions with Dr. Ethan Perlstein</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9880f40b-5a0e-459a-8dd0-0cb6ce67beef</guid>
      <link>https://share.transistor.fm/s/5a79775a</link>
      <description>
        <![CDATA[<p>In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Ethan Perlstein's Background    </li><li>08:50 - The Challenge of Rare Diseases    </li><li>21:25 - Curetopia's Mission and Approach    </li><li>31:54 - Blockchain and the Future of Drug Development    </li><li>40:09 - The Future of Curetopia and Rare Disease Research</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Dr. Ethan Perlstein</li><li>Guest's Title/Position: Founder and CEO</li><li>Company/Affiliation: <a href="https://www.curetopia.xyz/">Curetopia</a></li><li>Guest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.</li></ul><p><br>Links and Resources:</p><ul><li>Curetopia Website: <a href="https://www.curetopia.xyz/">https://www.curetopia.xyz/</a></li><li>Curetopia on Telegram: <a href="https://t.me/curetopia">https://t.me/curetopia</a></li><li>Curetopia on X (Twitter): <a href="https://x.com/endrarediseases">https://x.com/endrarediseases</a></li></ul><p><br></p><p>Key Takeaways/Highlights:</p><ul><li>Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.</li><li>The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.</li><li>Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.</li><li>Curetopia's mission to end rare diseases through innovative drug development strategies.</li><li>The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.</li><li>Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Ethan Perlstein's Background    </li><li>08:50 - The Challenge of Rare Diseases    </li><li>21:25 - Curetopia's Mission and Approach    </li><li>31:54 - Blockchain and the Future of Drug Development    </li><li>40:09 - The Future of Curetopia and Rare Disease Research</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Dr. Ethan Perlstein</li><li>Guest's Title/Position: Founder and CEO</li><li>Company/Affiliation: <a href="https://www.curetopia.xyz/">Curetopia</a></li><li>Guest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.</li></ul><p><br>Links and Resources:</p><ul><li>Curetopia Website: <a href="https://www.curetopia.xyz/">https://www.curetopia.xyz/</a></li><li>Curetopia on Telegram: <a href="https://t.me/curetopia">https://t.me/curetopia</a></li><li>Curetopia on X (Twitter): <a href="https://x.com/endrarediseases">https://x.com/endrarediseases</a></li></ul><p><br></p><p>Key Takeaways/Highlights:</p><ul><li>Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.</li><li>The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.</li><li>Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.</li><li>Curetopia's mission to end rare diseases through innovative drug development strategies.</li><li>The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.</li><li>Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:32:19 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/5a79775a/50ae9a1a.mp3" length="62380568" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/yxf8i0UPyXXi-SMDocQmFkSxXl7ezqXLgJsuOIt11CQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NWQ4/NzQ5NjM3NTg1NGMz/MDhhYzExZTk5MzM4/M2JlNS5qcGc.jpg"/>
      <itunes:duration>2596</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Dr. Ethan Perlstein's Background    </li><li>08:50 - The Challenge of Rare Diseases    </li><li>21:25 - Curetopia's Mission and Approach    </li><li>31:54 - Blockchain and the Future of Drug Development    </li><li>40:09 - The Future of Curetopia and Rare Disease Research</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Dr. Ethan Perlstein</li><li>Guest's Title/Position: Founder and CEO</li><li>Company/Affiliation: <a href="https://www.curetopia.xyz/">Curetopia</a></li><li>Guest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.</li></ul><p><br>Links and Resources:</p><ul><li>Curetopia Website: <a href="https://www.curetopia.xyz/">https://www.curetopia.xyz/</a></li><li>Curetopia on Telegram: <a href="https://t.me/curetopia">https://t.me/curetopia</a></li><li>Curetopia on X (Twitter): <a href="https://x.com/endrarediseases">https://x.com/endrarediseases</a></li></ul><p><br></p><p>Key Takeaways/Highlights:</p><ul><li>Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.</li><li>The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.</li><li>Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.</li><li>Curetopia's mission to end rare diseases through innovative drug development strategies.</li><li>The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.</li><li>Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Rare diseases, genetic diseases, drug development, biotech, blockchain, Web3, Curetopia, scientific research, healthcare innovation, entrepreneurship, investment</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.curetopia.xyz/" img="https://img.transistorcdn.com/IjASWkR63QS_OsD49KLvtCnfKeX6ujRYdyQyDsD8cBU/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80MDhk/MmM0NDVhMWNlNjI1/ZTJhNzZjZGY3YTBl/MTdmZi5qcGVn.jpg">Dr. Ethan Perlstein</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/5a79775a/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5a79775a/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5a79775a/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/5a79775a/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/5a79775a/transcription" type="text/html"/>
    </item>
    <item>
      <title>Building Healthcare Brands: Storytelling Opportunities with Kerchanin Allen</title>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>Building Healthcare Brands: Storytelling Opportunities with Kerchanin Allen</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ef280d56-8c0d-43eb-83c0-7eea88f22a05</guid>
      <link>https://share.transistor.fm/s/fef2f305</link>
      <description>
        <![CDATA[<p>In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Kerchanin Allen's Background    </li><li>09:02 - Strategic Marketing and Storytelling    </li><li>21:25 - Marketing to Diverse Audiences    </li><li>31:54 - AI in Healthcare Marketing    </li><li>40:09 - Sales and Marketing Alignment    </li><li>47:04 - Advice for Healthcare Marketers and Final Thoughts    </li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Kerchanin Allen</li><li>Guest's Title/Position: Marketing Expert</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kerchanina/">https://www.linkedin.com/in/kerchanina/</a></li><li>Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH.    </li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Kerchanin Allen's background in journalism and how it informs her approach to marketing.    </li><li>The importance of strategic versus cosmetic marketing in healthcare.    </li><li>Challenges and strategies for marketing to diverse audiences (patients, providers, investors).    </li><li>The role of storytelling and creating cohesive brand narratives.    </li><li>Navigating compliance and legal considerations in healthcare marketing.    </li><li>The impact of AI on marketing and its potential in the healthcare sector.    </li><li>The importance of collaboration between sales and marketing teams.    </li><li>Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.      </li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Kerchanin Allen's Background    </li><li>09:02 - Strategic Marketing and Storytelling    </li><li>21:25 - Marketing to Diverse Audiences    </li><li>31:54 - AI in Healthcare Marketing    </li><li>40:09 - Sales and Marketing Alignment    </li><li>47:04 - Advice for Healthcare Marketers and Final Thoughts    </li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Kerchanin Allen</li><li>Guest's Title/Position: Marketing Expert</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kerchanina/">https://www.linkedin.com/in/kerchanina/</a></li><li>Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH.    </li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Kerchanin Allen's background in journalism and how it informs her approach to marketing.    </li><li>The importance of strategic versus cosmetic marketing in healthcare.    </li><li>Challenges and strategies for marketing to diverse audiences (patients, providers, investors).    </li><li>The role of storytelling and creating cohesive brand narratives.    </li><li>Navigating compliance and legal considerations in healthcare marketing.    </li><li>The impact of AI on marketing and its potential in the healthcare sector.    </li><li>The importance of collaboration between sales and marketing teams.    </li><li>Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.      </li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:31:59 -0700</pubDate>
      <author>Bullzeye Media Marketing</author>
      <enclosure url="https://media.transistor.fm/fef2f305/4695c0fc.mp3" length="67626412" type="audio/mpeg"/>
      <itunes:author>Bullzeye Media Marketing</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/sjI7cNszeLcYpMcC-aLSdpmbdfDLzoo1VzBARcgFFDg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NzMz/Y2Q0MzkzNGJmNmRk/NmQ5YmUwYWM1NzNk/NGU2MC5qcGc.jpg"/>
      <itunes:duration>2814</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.</p><p>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Kerchanin Allen's Background    </li><li>09:02 - Strategic Marketing and Storytelling    </li><li>21:25 - Marketing to Diverse Audiences    </li><li>31:54 - AI in Healthcare Marketing    </li><li>40:09 - Sales and Marketing Alignment    </li><li>47:04 - Advice for Healthcare Marketers and Final Thoughts    </li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Kerchanin Allen</li><li>Guest's Title/Position: Marketing Expert</li><li>Guest's Linkedin: <a href="https://www.linkedin.com/in/kerchanina/">https://www.linkedin.com/in/kerchanina/</a></li><li>Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH.    </li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Kerchanin Allen's background in journalism and how it informs her approach to marketing.    </li><li>The importance of strategic versus cosmetic marketing in healthcare.    </li><li>Challenges and strategies for marketing to diverse audiences (patients, providers, investors).    </li><li>The role of storytelling and creating cohesive brand narratives.    </li><li>Navigating compliance and legal considerations in healthcare marketing.    </li><li>The impact of AI on marketing and its potential in the healthcare sector.    </li><li>The importance of collaboration between sales and marketing teams.    </li><li>Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.      </li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Healthcare marketing, marketing strategy, storytelling, healthcare industry, AI in marketing, digital marketing, brand identity, communications, patient experience, Medicare, compliance</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://healthyenterprise.transistor.fm/people/kerchanin-allen" img="https://img.transistorcdn.com/3ohvkiinr9S0YjGOJTkfq7k1c8LBYK01BwT6Sbq0CY8/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNjEw/ZmZkMjA2N2ExOWJk/YzhiNGJmYTk1NGFm/YTZmNi5wbmc.jpg">Kerchanin Allen</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/fef2f305/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fef2f305/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fef2f305/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/fef2f305/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/fef2f305/transcription" type="text/html"/>
    </item>
    <item>
      <title>Genetics Meets Business: Precision Medicine with Jessica Gibson</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>Genetics Meets Business: Precision Medicine with Jessica Gibson</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b9ae7f3d-52d1-4b74-acd4-3e26ece9f198</guid>
      <link>https://share.transistor.fm/s/bf20cb25</link>
      <description>
        <![CDATA[<p>In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.</p><p><br></p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Jessica Gibson's Background</li><li>08:50 - Ariel Precision Medicine and its Mission</li><li>21:25 - The Role of AI and Technology in Precision Medicine</li><li>31:54 - Addressing Challenges in Healthcare and Drug Development</li><li>40:09 - Marketing and Collaboration Strategies</li><li>47:04 - Jessica Gibson's Vision for the Future of Aerial Precision Medicine</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Jessica Gibson</li><li>Guest's Title/Position: CEO and Cofounder</li><li>Guest's Company/Affiliation: <a href="https://arielmedicine.com/">Aerial Precision Medicine</a></li><li>Guest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Aerial Precision Medicine Website: <a href="https://arielmedicine.com/">https://arielmedicine.com/</a></li><li>Jessica Gibson LinkedIn: <a href="https://www.linkedin.com/in/jessica-gibson-80426124/">https://www.linkedin.com/in/jessica-gibson-80426124</a></li><li>National Pancreas Foundation: <a href="https://nationalpancreasfoundations.org/">https://nationalpancreasfoundations.org/</a></li><li>Rebecca's Wish: <a href="https://rebeccaswish.org/">https://rebeccaswish.org/</a></li><li>Mission Cure: <a href="https://mission-cure.org/">https://mission-cure.org/</a></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.</li><li>Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.</li><li>The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.</li><li>How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.</li><li>The importance of data quality and human oversight in the use of AI in healthcare.</li><li>Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.</li><li>The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.</li><li>Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.</p><p><br></p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Jessica Gibson's Background</li><li>08:50 - Ariel Precision Medicine and its Mission</li><li>21:25 - The Role of AI and Technology in Precision Medicine</li><li>31:54 - Addressing Challenges in Healthcare and Drug Development</li><li>40:09 - Marketing and Collaboration Strategies</li><li>47:04 - Jessica Gibson's Vision for the Future of Aerial Precision Medicine</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Jessica Gibson</li><li>Guest's Title/Position: CEO and Cofounder</li><li>Guest's Company/Affiliation: <a href="https://arielmedicine.com/">Aerial Precision Medicine</a></li><li>Guest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Aerial Precision Medicine Website: <a href="https://arielmedicine.com/">https://arielmedicine.com/</a></li><li>Jessica Gibson LinkedIn: <a href="https://www.linkedin.com/in/jessica-gibson-80426124/">https://www.linkedin.com/in/jessica-gibson-80426124</a></li><li>National Pancreas Foundation: <a href="https://nationalpancreasfoundations.org/">https://nationalpancreasfoundations.org/</a></li><li>Rebecca's Wish: <a href="https://rebeccaswish.org/">https://rebeccaswish.org/</a></li><li>Mission Cure: <a href="https://mission-cure.org/">https://mission-cure.org/</a></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.</li><li>Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.</li><li>The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.</li><li>How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.</li><li>The importance of data quality and human oversight in the use of AI in healthcare.</li><li>Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.</li><li>The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.</li><li>Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:30:54 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/bf20cb25/b9d9e2a2.mp3" length="63380670" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/uW5wHUXROdjKU3XVASjJnlu_qNQLQpMpDqFXfgAQuk4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNzIx/NzA0OTY3ZjY4YTBi/OTQyNDgyZGY2ZTMy/OTMyNC5qcGc.jpg"/>
      <itunes:duration>2637</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.</p><p><br></p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Jessica Gibson's Background</li><li>08:50 - Ariel Precision Medicine and its Mission</li><li>21:25 - The Role of AI and Technology in Precision Medicine</li><li>31:54 - Addressing Challenges in Healthcare and Drug Development</li><li>40:09 - Marketing and Collaboration Strategies</li><li>47:04 - Jessica Gibson's Vision for the Future of Aerial Precision Medicine</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Jessica Gibson</li><li>Guest's Title/Position: CEO and Cofounder</li><li>Guest's Company/Affiliation: <a href="https://arielmedicine.com/">Aerial Precision Medicine</a></li><li>Guest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Aerial Precision Medicine Website: <a href="https://arielmedicine.com/">https://arielmedicine.com/</a></li><li>Jessica Gibson LinkedIn: <a href="https://www.linkedin.com/in/jessica-gibson-80426124/">https://www.linkedin.com/in/jessica-gibson-80426124</a></li><li>National Pancreas Foundation: <a href="https://nationalpancreasfoundations.org/">https://nationalpancreasfoundations.org/</a></li><li>Rebecca's Wish: <a href="https://rebeccaswish.org/">https://rebeccaswish.org/</a></li><li>Mission Cure: <a href="https://mission-cure.org/">https://mission-cure.org/</a></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.</li><li>Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.</li><li>The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.</li><li>How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.</li><li>The importance of data quality and human oversight in the use of AI in healthcare.</li><li>Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.</li><li>The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.</li><li>Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Aerial Precision Medicine, precision medicine, genetics, chronic disease, healthcare, AI, drug development, diagnosis, treatment, patient care, technology, health tech, pharmaceuticals, scientific research</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://arielmedicine.com/" img="https://img.transistorcdn.com/ZmcdYz7zBFN6Ud_u9t-lIpIX-3vaMHeFY-_fJUgP78U/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zOTA2/NjdlNGUzMGU5ZjY1/MGQwZjkyNWQ2NTM1/OWU5NC5qcGVn.jpg">Jessica Gibson</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/bf20cb25/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/bf20cb25/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/bf20cb25/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/bf20cb25/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/bf20cb25/transcription" type="text/html"/>
    </item>
    <item>
      <title>Data-Driven Rehab: Making Recovery Smarter with Joe Banach</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>Data-Driven Rehab: Making Recovery Smarter with Joe Banach</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8bcefc06-3198-4631-944c-49a39f47e6ec</guid>
      <link>https://share.transistor.fm/s/0fb7b884</link>
      <description>
        <![CDATA[<p>In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Joe's Background</li><li>02:59 - Next Step Robotics and the AMBL Device</li><li>05:50 - The Role of Data in Therapy</li><li>09:02 - Sales and Marketing Strategies in Healthcare</li><li>12:06 - Challenges in Educating the Market</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Joe Banach</li><li>Guest's Title/Position: Director of Sales and Marketing</li><li>Guest's Company/Affiliation: <a href="https://www.nextsteprobo.com/">Next Step Robotics</a></li><li>Guest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Next Step Robotics Website: <a href="https://www.nextsteprobo.com/">www.nextsteprobo.com</a></li><li>LinkedIn: <a href="https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/">https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/</a></li><li>Book Recommendation: <strong>The Sales Acceleration Formula by Mark Roberge</strong></li><li>Book Recommendation: <strong>Never Split The Difference by Chris Voss</strong></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.</li><li>Next Step Robotics' AMBL device and its focus on patient-contributed movement.</li><li>The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.</li><li>The role of neuroplasticity and cognitive engagement in effective rehabilitation.</li><li>Using data and gamification to motivate patients and track progress.</li><li>Challenges in educating the market and building trust for new rehabilitation technologies.</li><li>Sales strategies for navigating long sales cycles and competing in the health tech industry.</li><li>The impact of therapist turnover on the adoption of new technologies in rehab clinics.</li></ul><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Joe's Background</li><li>02:59 - Next Step Robotics and the AMBL Device</li><li>05:50 - The Role of Data in Therapy</li><li>09:02 - Sales and Marketing Strategies in Healthcare</li><li>12:06 - Challenges in Educating the Market</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Joe Banach</li><li>Guest's Title/Position: Director of Sales and Marketing</li><li>Guest's Company/Affiliation: <a href="https://www.nextsteprobo.com/">Next Step Robotics</a></li><li>Guest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Next Step Robotics Website: <a href="https://www.nextsteprobo.com/">www.nextsteprobo.com</a></li><li>LinkedIn: <a href="https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/">https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/</a></li><li>Book Recommendation: <strong>The Sales Acceleration Formula by Mark Roberge</strong></li><li>Book Recommendation: <strong>Never Split The Difference by Chris Voss</strong></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.</li><li>Next Step Robotics' AMBL device and its focus on patient-contributed movement.</li><li>The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.</li><li>The role of neuroplasticity and cognitive engagement in effective rehabilitation.</li><li>Using data and gamification to motivate patients and track progress.</li><li>Challenges in educating the market and building trust for new rehabilitation technologies.</li><li>Sales strategies for navigating long sales cycles and competing in the health tech industry.</li><li>The impact of therapist turnover on the adoption of new technologies in rehab clinics.</li></ul><p><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Apr 2025 16:30:14 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/0fb7b884/85aa0393.mp3" length="56707021" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Zofyrf6IcbbXUFlfvNx1OXLB6C_SdSxTE2AcoBKTo6g/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ODFm/ZWRjODY3Nzg2Njkw/ZTgwNjRjNDYwYzQ5/YWFmNS5qcGc.jpg"/>
      <itunes:duration>2357</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.</p><p><br>Chapters/Timestamps:</p><ul><li>00:00 - Introduction and Joe's Background</li><li>02:59 - Next Step Robotics and the AMBL Device</li><li>05:50 - The Role of Data in Therapy</li><li>09:02 - Sales and Marketing Strategies in Healthcare</li><li>12:06 - Challenges in Educating the Market</li></ul><p><br>Guest Information:</p><ul><li>Guest's Name: Joe Banach</li><li>Guest's Title/Position: Director of Sales and Marketing</li><li>Guest's Company/Affiliation: <a href="https://www.nextsteprobo.com/">Next Step Robotics</a></li><li>Guest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.</li></ul><p><br>Links and Resources:</p><ul><li>Next Step Robotics Website: <a href="https://www.nextsteprobo.com/">www.nextsteprobo.com</a></li><li>LinkedIn: <a href="https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/">https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/</a></li><li>Book Recommendation: <strong>The Sales Acceleration Formula by Mark Roberge</strong></li><li>Book Recommendation: <strong>Never Split The Difference by Chris Voss</strong></li></ul><p><br>Key Takeaways/Highlights:</p><ul><li>Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.</li><li>Next Step Robotics' AMBL device and its focus on patient-contributed movement.</li><li>The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.</li><li>The role of neuroplasticity and cognitive engagement in effective rehabilitation.</li><li>Using data and gamification to motivate patients and track progress.</li><li>Challenges in educating the market and building trust for new rehabilitation technologies.</li><li>Sales strategies for navigating long sales cycles and competing in the health tech industry.</li><li>The impact of therapist turnover on the adoption of new technologies in rehab clinics.</li></ul><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Next Step Robotics, rehabilitation, robotics, physical therapy, sales, marketing, healthcare, patient care, technology, innovation, AMBL, neuroplasticity, gamification</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Guest" href="https://www.nextsteprobo.com/" img="https://img.transistorcdn.com/nLIfSPokAWrhcxy0w7KfqvM-3xGf7ZR1EX1prGjqfFM/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZTEy/YWVkYTE5YzI1Njhk/N2NmYWVmOTU4YTcx/NGNjZi5qcGVn.jpg">Joe Banach</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:person role="Editor" href="https://bullzeyemediamarketing.com/" img="https://img.transistorcdn.com/QAObrlpVffxAsL2v7ZOL4p5s96GJQnmNgq1C67ArE2c/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDIw/NGYwMjllOTVlMWY1/Mzc5OGI2OTlkN2I1/NWJmMC5qcGVn.jpg">Tricia Cooney</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/0fb7b884/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/0fb7b884/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/0fb7b884/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/0fb7b884/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/0fb7b884/transcription" type="text/html"/>
    </item>
    <item>
      <title>The Healthy Enterprise Trailer</title>
      <itunes:title>The Healthy Enterprise Trailer</itunes:title>
      <itunes:episodeType>trailer</itunes:episodeType>
      <guid isPermaLink="false">1b134600-12f8-457a-8ba9-7140f9c61e78</guid>
      <link>https://share.transistor.fm/s/2c703c20</link>
      <description>
        <![CDATA[<p>Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.</p><p>This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!<br> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.</p><p>This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!<br> </p>]]>
      </content:encoded>
      <pubDate>Mon, 14 Apr 2025 12:57:00 -0700</pubDate>
      <author>Heath Fletcher</author>
      <enclosure url="https://media.transistor.fm/2c703c20/e41900d4.mp3" length="794208" type="audio/mpeg"/>
      <itunes:author>Heath Fletcher</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/HxeCMavbAZrDE7_yLiJft9LmsS3PFGprSApeAvneiNE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84Nzcz/ZDU5MDQyOTJlOGJj/MTBlOGVhMmRhNjdj/MzQ3OS5qcGc.jpg"/>
      <itunes:duration>32</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.</p><p>This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!<br> </p>]]>
      </itunes:summary>
      <itunes:keywords>Life Sciences, Leadership, HealthTech podcast, Digital Health podcast, Healthcare Business podcast, Medical Technology podcast, Healthcare Leadership podcast, Healthcare Marketing podcast, Healthcare Entrepreneurship podcast, Healthcare Industry Executives, AI in Healthcare podcast, Healthcare Startups podcast, Patient-Centered Care, Healthcare Strategy, Future of Medicine, HealthTech Trends, Scaling Healthcare Businesses, Telemedicine and Virtual Care, Investing in HealthTech, Healthcare Growth, HealthTech, Digital Health, Healthcare Business, Medical Technology, Healthcare Leadership, Healthcare Marketing, Healthcare Entrepreneurship, Industry Executives, AI in Healthcare, Healthcare Startups, Telemedicine &amp; Virtual Care,Investors</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/5uTgv99ePh-cJg6USPgrsurtrfvQ7re_EmqxpYtVdaQ/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjhj/NDQ4NzNlYTRmMzFk/ZTYyZmU4YzgyMTdm/NGRmNS5qcGc.jpg">Heath Fletcher</podcast:person>
      <podcast:person role="Producer" href="https://thebullzeye.com/" img="https://img.transistorcdn.com/PNDINMH0HCzQkVOYkDDvyC5ObsrCj0PI48PW_W-dwMo/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZGNk/ZTI5MjQ1ZmI1ZDFl/ZDZlNWIwNzI2YmRj/ZTBlYy5wbmc.jpg">Meghna Deshraj </podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/2c703c20/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/2c703c20/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/2c703c20/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/2c703c20/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/2c703c20/transcription" type="text/html"/>
    </item>
  </channel>
</rss>
